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Abstract		
	
Background	
Interventions	delivered	by	mobile	phone	have	been	demonstrated	to	be	effective	in	
other	health	areas.	This	thesis	focuses	on	interventions	delivered	by	mobile	phone	to	
increase	contraception	use.		
Methods	
This	thesis	comprises	a	systematic	review,	development	and	evaluation	of	the	MObile	
Technology	for	Improved	Family	Planning	(MOTIF)	intervention	to	support	post-
abortion	contraception	in	Cambodia	with	randomised	controlled	trial,	and	a	mixed	
methods	process	evaluation.		
Results	
The	systematic	review	identified	five	trials,	two	of	which	increased	self-reported	
contraception	use,	one	in	the	USA	and	the	MOTIF	trial	in	Cambodia	(four-month	data	
only).	A	meta-analysis	was	not	possible	due	to	differing	interventions	and	outcome	
measures.	
Development	of	the	MOTIF	intervention	involved	literature	reviews	on	determinants	
of	contraceptive	use,	interviews	and	focus	groups	with	women	seeking	abortion	
services	in	Cambodia.	The	intervention	comprised	six	interactive	voice	messages	with	
counsellor	support	depending	on	the	response	to	the	message.		
The	intervention	was	associated	with	increased	self-reported	use	of	effective	
contraception	at	four	months	post-abortion	(64%	vs.	46%;	Risk	Ratio	(RR):	1.39;	95%	
Confidence	Interval	(CI):	1.17–1.66)	but	not	at	12	months	(50%	versus	43%;	RR:	1.16;	
95%	CI:	0.92–1.47).	Long-acting	contraception	use	(intrauterine	device,	implant,	
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permanent	method)	was	increased	at	four	and	12	months.	There	was	no	significant	
difference	in	repeat	pregnancies	or	abortions	at	four	or	12	months.		
The	intervention	effect	was	primarily	due	to	increased	initiation	of	long-acting	
contraception.	The	majority	of	women	were	positive	about	the	intervention	which	
provided	support	for	physical	and	emotional	issues	in	addition	to	contraception	use.	
The	intervention	could	be	implemented	in	current	form,	however	cost-effectiveness	
data	is	lacking.	The	intervention	could	potentially	be	improved	and	further	evaluated.	
Conclusions	
Interventions	delivered	by	mobile	phone	can	increase	contraception	use,	but	the	
evidence	to	date	is	mixed.	Further	trials	of	interventions	delivered	by	mobile	phone	to	
increase	contraception	use	are	required.	 	
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1.	Study	background	
This	PhD	thesis	examines	interventions	delivered	by	mobile	phone	to	increase	use	of	
contraception.	The	main	body	of	work	relates	to	the	Mobile	Technology	for	Improved	
Family	Planning	(MOTIF)	trial;	a	randomised	controlled	trial	(RCT)	of	a	mobile	phone-
based	intervention	to	support	post-abortion	family	planning	(PAFP)	in	Cambodia.	This	
chapter	reviews	literature	on	contraception	and	interventions	delivered	by	mobile	
phone	with	a	particular	focus	on	the	Cambodian	context,	and	outlines	the	aims	and	
objectives	of	this	thesis.	
1.1	Global	contraceptive	trends	and	determinants	
Contraception,	abortion	and	post-abortion	family	planning	(PAFP)	
Contraception	-	methods	or	devices	to	prevent	pregnancy	-	has	significant	benefits	for	
both	women’s	and	child	health.	The	use	of	contraception	prevents	unintended	
pregnancies,	reduces	the	number	of	abortions	and	maternal	deaths,	and	can	improve	
perinatal	outcomes	and	child	survival	by	widening	the	interval	between	successive	
pregnancies.(1)	Reducing	unintended	pregnancies	can	result	in	substantial	social	and	
economic	benefits	such	as	improved	educational	and	employment	opportunities	for	
women	leading	to	increasing	family	savings	and	economic	growth.(2)		
Contraception	can	be	classified	in	different	ways.	Contraception	can	be	categorised	as	
either	modern	(for	example	sub-dermal	implant,	injectables)	or	traditional	(for	
example	rhythm/periodic	abstinence,	withdrawal).(3)	Furthermore,	distinctions	can	be	
made	between	hormonal	or	non-hormonal	methods	(e.g.	sub-dermal	implant	vs.	
condom)	or	by	duration	of	action	(for	example	short,	long-acting,	permanent	methods,	
or	Long-Acting	Reversible	Methods	(LARC),	a	term	commonly	used	in	the	United	
Kingdom).(4)	One	drawback	of	categorising	according	to	duration	of	action	is	that	the	
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definition	of	a	method	can	vary	in	different	locations,	for	example	the	National	
Institute	for	Health	and	Clinical	Excellence	(NICE)	considers	LARC	methods	those	that	
require	administering	less	than	once	per	cycle	or	month	and	thus	the	three-monthly	
injectable	to	be	a	long-acting	method.(4)	Elsewhere,	for	example	in	Cambodia,	the	
injectable	is	considered	to	be	a	short-acting	method.(5)	Unless	otherwise	stated,	in	
this	thesis	‘long-acting’	contraception	encompasses	reversible	methods	(intra-uterine	
device	and	implant,	but	not	injectable)	and	permanent	methods.	
The	World	Health	Organization	(WHO)	classifies	methods	according	to	effectiveness,	
according	to	estimated	rates	of	unintended	pregnancies	per	100	women;	either	with	
consistent	and	correct	use,	or	as	commonly	used,	using	data	derived	from	the	United	
States	and	from	developing	countries.(6)(7)(8)		
In	this	thesis,	contraception	is	generally	described	in	terms	of	effectiveness	as	per	the	
WHO	definition	with	effective	modern	methods	those	associated	with	less	than	10%	
12-month	pregnancy	rates	as	commonly	used.(6)	Examples	of	commonly	used	
effective	methods	include	oral	contraceptive	(OC),	injectable,	implant,	intrauterine	
devices	and	permanent	methods.	Method-specific	contraceptive	prevalence	varies	
widely	across	the	world.(9)	Medical	Eligibility	Criteria	guidance	provides	information	
on	who	can	use	contraceptive	methods	safely,	including	risks	of	contraceptive	use	for	
different	medical	conditions,	often	adapted	for	different	settings.(10)	
Oral	contraception	
Oral	contraception,	often	referred	to	as	the	‘pill’	was	first	developed	during	the	1950s,	
with	approvals	and	increased	use	in	the	1960s.(11)	The	combined	oral	contraceptive	
pill	(COCP)	generally	contains	oestrogen	and	progestogen	hormones	whereas	the	
progesterone	only	pill	(POP),	or	‘mini’	pill	contains	one	hormone.(6)	Combined	oral	
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contraceptives	act	primarily	to	prevent	ovulation,	whereas	the	POP	primarily	works	by	
thickening	cervical	mucus	and	suppressing	ovulation	to	a	variable	degree.	Worldwide,	
approximately	9%	of	married	on	in-union	women	used	oral	contraception	in	2015.(9)	
In	the	United	Kingdom	(UK),	the	COCP	and	POP	accounted	for	16%	and	6%	of	use	
respectively	in	2008-9.(12)		
The	combined	pill	is	taken	for	three	weeks	followed	by	a	pill-free	week,	thus	mimicking	
the	menstrual	cycle	whereas	the	POP	is	taken	continuously.(6)	Advantages	of	the	COCP	
include	regular,	lighter	and	less	painful	periods	and	reduced	risk	of	ovarian	and	uterine	
cancer.	Risks	of	COCP	include	a	small	increased	risk	of	vascular	events	such	as	stroke	
and	venous	thromboembolism,	as	well	as	a	small	increased	risk	of	cervical	and	a	
possible	small	increase	in	risk	of	breast	cancer.(6)	In	contrast,	the	POP,	and	
progesterone-only	contraception	in	general,	have	fewer	health	risks	and	contra-
indications	to	use,	but	are	often	associated	with	menstrual	irregularities	such	as	
amenorrhoea	or	irregular	bleeding.(6)	Both	the	COCP	and	the	POP	pill	have	a	0.3%	12-
month	pregnancy	rate	with	consistent	and	correct	use	compared	to	7-8%	as	commonly	
used.(6)		
Injectable	contraceptive	
Worldwide,	approximately	5%	of	married	on	in-union	women	used	the	injectable	in	
2015.(9)	The	most	commonly	used	injectable	is	the	progesterone-only	injectable	
‘Depo-Provera’	containing	depot	medroxyprogesterone	acetate	(DMPA)	which	was	
licensed	for	long-term	use	in	the	1980s.(13)	Depo-Provera	is	administered	three-
monthly	and	usually	requires	administration	by	a	healthcare	professional	but	self-
injectable	products	are	available	in	some	countries.(9)	The	progesterone-only	
injectable	works	by	thickening	cervical	mucus,	suppressing	endometrial	growth	and	
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preventing	ovulation,	and	is	considered	a	very	effective	method	with	a	0.3%	12-month	
pregnancy	rate	with	consistent	and	correct	use	reducing	to	2-3%	as	commonly	used.(6)	
Advantages	of	the	injectable	are	that	it	can	be	used	discreetly	and	doesn’t	require	
remembering	to	take	a	pill	everyday	but	users	need	to	remember	to	attend	
subsequent	appointments.	It	has	few	health	risks	although	studies	have	suggested	an	
increased	risk	of	Human	Immunodeficiency	Virus	(HIV)	acquisition	amongst	women	
using	DMPA.(14)	There	is	conflicting	evidence	that	DMPA	reduces	bone	density	and	
therefore	alternative	methods	are	often	preferred	in	women	aged	<18	years	or	with	
risk	factors	for	osteoporosis.(15)	The	injectable	usually	causes	amenorrhoea	over	time	
and	menstruation	and	return	to	normal	fertility	can	take	several	months	to	return	to	
normal	after	discontinuing.(6)	
Contraceptive	implants	
Contraceptive	implants	are	small	flexible	tubes	inserted	under	the	skin	that	release	a	
small	amount	of	progestogen	over	several	years	(typically	3-5	years	depending	on	
product).(6)	As	with	other	long-acting	methods,	the	implant	is	effective	and	associated	
with	a	0.5%	12-month	pregnancy	rate	with	consistent	and	correct	use	and	as	
commonly	used	and	users	don’t	have	to	remember	to	take	pills	or	attend	frequent	
appointments	during	its	duration	of	use.(6)	As	with	other	progesterone-only	methods,	
the	implant	has	few	health	risks.	The	main	disadvantages	of	the	implant	are	that	it	has	
to	be	inserted	and	removed	by	trained	professionals,	and	menstrual	bleeding	changes	
are	commonly	experienced.(6)	Worldwide,	approximately	0.7%	of	married	on	in-union	
women	used	the	implant	in	2015.(9)	
Intra-uterine	contraception	
There	are	two	types	of	intrauterine	contraception,	the	intrauterine	device	(IUD)	and	
	
	
21	
the	Intrauterine	system	(IUS).(6)	Intrauterine	contraceptives	were	the	second	most	
common	method	worldwide	in	2015,	with	14%	of	married	on	in-union	women	relying	
on	this	method.(9)	Both	have	advantages	of	being	effective,	forgettable,	long-acting	
methods	associated	with	low	discontinuation,(16)	but	need	to	be	inserted	by	trained	
healthcare	professionals.		
The	IUD	is	a	non-hormonal	method	generally	containing	copper	which	is	toxic	to	sperm	
and	prevents	fertilization	and	implantation.	The	IUD	is	a	cost-effective	method	given	
its	low	cost	and	long	duration	of	action	(5-10	years).(11)	Disadvantages	of	the	copper	
coil	can	include	heavier	periods	leading	to	anaemia,	and	small	risks	of	expulsion,	
perforation	and	infection.	The	IUS	is	a	hormonal	method,	first	introduced	in	Europe	in	
1990.(9)	It	releases	a	small	amount	of	progestogen	and	is	typically	effective	for	3-5	
years.	In	contrast	to	the	IUD,	the	IUS	typically	results	in	lighter	periods	and	helps	
protect	against	anaemia.(6)	However,	to	date,	the	cost	of	the	IUS	has	limited	
widespread	use	in	resource-poor	settings.(17)	
Permanent	contraception	
Permanent	methods	include	male	or	female	sterilisation.(6)	Female	sterilisation	was	
the	most	common	method	globally	in	2015.	Worldwide,	approximately	19%	of	married	
on	in-union	women	relied	on	female	sterilisation.(9)	Female	sterilisation	involves	
fallopian	tube	occlusion	either	by	applying	clips,	cutting	or	cauterising	and	is	a	very	
effective	method	with	a	lifetime	failure	rate	of	around	1	in	200	women.(6)	It	is	
associated	with	several	risks	related	to	the	surgical	procedure	such	as	risk	of	bleeding,	
infection	or	injury	to	the	bowel	or	bladder.(6)	In	contrast,	male	sterilisation	
(vasectomy),	severing	the	vas	deferens,	is	more	effective	(lifetime	failure	rate	of	1	in	
2000	men),	less	expensive	to	perform	and	associated	with	fewer	complications	than	
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female	sterilisation.(6)	However,	with	the	exception	of	a	few	countries	such	as	the	UK	
and	Australia,	male	sterilisation	is	much	less	common	compared	to	female	
sterilisation.(9)			
Condoms	
Condoms	are	barrier	methods	that	also	provide	protection	against	sexually	
transmitted	diseases	and	require	both	male	and	female	partner’s	cooperation.(6)	Male	
or	female	condoms	are	not	generally	considered	to	be	effective	methods	for	to	protect	
against	pregnancy	as	they	have	12-month	failure	rates	as	typically	used	of	around	10	
and	21%	respectively,	but	may	be	a	good	choice	for	women	who	have	infrequent	sex,	
or	cannot	or	prefer	not	to	use	hormonal	methods.(6)	Worldwide,	approximately	8%	of	
married	on	in-union	women	used	condoms	in	2015.(9)	
Unmet	need	for	contraception	
Despite	the	health	benefits	of	contraception	and	existence	of	a	range	of	different	
methods,	there	is	significant	unmet	need	for	contraception.	Unmet	need	refers	to	
fecund	women	of	reproductive	age	who	want	no	more	children	or	want	to	postpone	
having	a	child	in	the	next	two	years,	but	are	not	using	a	modern	contraceptive	
method.(18)	An	estimated	222	million	women	of	childbearing	age	in	2012	had	unmet	
need	for	contraception.(19)	It	has	been	estimated	that	if	unmet	need	for	modern	
methods	of	contraception	were	met	amongst	women	in	developing	countries,	this	
could	prevent	an	additional	54	million	unintended	pregnancies,	26	million	abortions	
(of	which	half	would	be	unsafe),	79,000	maternal	deaths	and	1.1	million	infant	
deaths.(19)		
Abortion	
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Globally	around	25%	of	pregnancies	resulted	in	induced	abortion	in	2010-14,	equating	
to	an	annual	abortion	rate	of	35	per	1000	women	aged	15-44.(20)	Induced	abortion	is	
medically	safe	if	performed	by	trained	professionals	in	accordance	with	recommended	
guidelines.(21)	Although	the	proportion	of	abortions	that	are	unsafe	is	not	currently	
known,	almost	all	abortion-related	deaths	occur	in	developing	countries,	representing	
8-18%	of	maternal	deaths,	and	an	estimated	22,500	to	44,000	deaths	in	2014.(21)	
Induced	abortions	can	be	broadly	categorised	as	medical	or	surgical.	Surgical	abortion	
is	performed	by	vacuum	aspiration	(typically	for	pregnancies	up	to	15	weeks)	or	
dilatation	and	evacuation	(typically	for	pregnancies	after	15	weeks	duration).(22)	
Medical	abortion	drugs,	first	approved	in	China	and	France	in	1988,	generally	involve	a	
regimen	composed	of	mifepristone	and	misoprostol	for	pregnancies	up	to	9	
weeks.(23)(24)	Increasing	use	of	medical	abortion	has	made	it	more	difficult	to	
measure	abortion	incidence	in	many	countries.(20)	
A	study	looking	at	evidence	from	27	countries	in	1998	found	that	women	have	induced	
abortions	for	a	variety	of	reasons;	most	commonly	to	postpone	or	stop	childbearing	
which	could	be	due	to	socioeconomic	concerns	such	as	disruption	of	employment,	
relationship	problems	with	a	husband	or	partner	or	health	problems.(25)	A	qualitative	
study	in	the	UK	from	2004	found	that	decisions	to	have	an	abortion	were	mostly	
related	to	social	and	economic	context	in	the	women’s	lives	rather	than	moral	views	
and	that	similar	factors	influenced	decision-making	process	regardless	of	the	women’s	
age.(26)			
Post-abortion	family	planning	(PAFP):	rationale	and	determinants	
Women	seeking	abortion	services	often	have	an	unmet	need	for	family	planning.(27)		
Post-abortion	family	planning	(PAFP)	can	reduce	subsequent	unplanned	pregnancies	
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and	health	risks	of	repeat	abortion,	particularly	in	settings	where	abortion	is	illegal	
and/or	unsafe,(28)	and	was	identified	as	a	High-Impact	Practice	in	family	planning	by	a	
technical	advisory	group	in	2012.(29)	Contraception	and	family	planning	services	are	
considered	one	of	the	five	essential	elements	of	post-abortion	care,	the	others	being	
community	and	service	provider	partnerships,	counselling,	treatment,	and	
reproductive	and	other	health	services.(30)	An	observational	study	in	Finland	
published	in	2012	found	that	women	who	had	three	or	more	abortions	had	increased	
odds	of	subsequent	preterm	birth	or	low	birthweight	outcomes	in	subsequent	
pregnancies	after	adjusting	for	social	factors.(31)	Women	are	at	risk	of	pregnancy	
almost	immediately	after	having	an	abortion,	with	studies	showing	that	more	than	
80%	of	women	ovulate	in	the	first	cycle	after	abortion.(32)(33)	The	World	Health	
Organization	have	recommended	a	minimum	spacing	interval	of	six	months	in	order	to	
reduce	risks	of	adverse	maternal	and	perinatal	outcomes.(34)(35)	As	studies	have	
shown	that	over	50%	of	women	will	resume	sexual	activity	within	two	weeks	of	having	
an	abortion	and	up	to	50%	do	not	attend	subsequent	follow	up	appointments,	
contraception	should	be	started	as	soon	as	possible	to	reduce	the	risk	of	subsequent	
unintended	pregnancy.(27)	It	is	safe	to	use	a	wide	range	of	contraception	methods	in	
the	immediate	post-abortion	period,	with	no	evidence	that	use	of	hormonal	methods	
adversely	affect	the	efficacy	of	medical	abortion,	or	vice	versa.(10)(27)	Intra-uterine	
devices	can	be	inserted	at	the	time	of	surgical	abortion	but	should	be	delayed	after	
medical	abortion	until	the	abortion	is	complete.(27)	Observational	studies	have	shown	
that	use	of	long-acting	methods	(i.e.	the	intrauterine	device,	intrauterine	system	or	
implants)	have	been	shown	to	reduce	subsequent	unintended	pregnancies	in	women	
who	have	had	an	abortion.(27)(36)(37)(38)		
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Provision	of	contraception	services	when	women	seek	abortion	services	would	appear	
to	be	a	practical	and	convenient	time	to	initiate	contraception	methods	to	reduce	the	
risk	of	subsequent	unintended	pregnancies.	However	studies	assessing	contraceptive	
provision	have	identified	several	challenges	to	providing	contraception	at	the	time	
when	women	seek	abortion	services.(27)	
On	the	demand	side,	it	is	thought	that	women	may	be	motivated	to	start	a	method	at	
this	time,	however	studies	addressing	the	degree	to	which	women	want	to	discuss	
contraception	at	the	time	of	seeking	abortion	services	show	mixed	findings.(27)(39)	
One	study	in	the	United	States	of	America	(USA)	found	that	69%	of	abortion	patients	
felt	that	the	abortion	setting	was	an	appropriate	one	for	receiving	contraceptive	
information.(40)	However,	another	study	in	the	USA	found	that	64%	of	women	did	not	
want	to	discuss	contraception	on	the	day	of	their	abortion	mostly	because	they	
already	knew	what	they	wanted	for	pregnancy	prevention.(41)	A	study	in	the	UK	found	
that	the	majority	of	women	considered	addressing	contraception	at	the	time	of	
seeking	medical	abortion	to	be	acceptable,	provided	it	was	done	in	a	non-judgmental	
way	and	that	health	professionals	were	not	too	‘pushy’	towards	making	a	
contraceptive	decision.	The	authors	commented	that	women	already	have	important	
decisions	to	make	at	the	time	of	seeking	abortion	services	and	might	feel	like	they	
have	little	agency	and	that	the	decision	to	adopt	contraception	could	represent	a	
process	over	which	they	feel	able	to	exercise	control.(39)	Another	study	in	the	USA	
found	that	women	desired	an	intimate,	friend-like	relationship	with	their	
providers.(42)	Other	potential	barriers	to	uptake	of	PAFP	from	the	demand	side	
include	cost	of	additional	services	and	additional	time	required	in	the	clinic	if	opting	
for	a	long-acting	method.(27)		
	
	
26	
Several	supply	side	factors	can	influence	provision	of	contraception	at	the	time	when	
women	seek	abortion	services.	Less	research	has	been	undertaken	exploring	
healthcare	professionals’	experiences	with	providing	PAFP	but	a	qualitative	study	in	
Scotland	found	that	healthcare	professionals	considered	PAFP	to	be	important	in	
relation	to	preventing	subsequent	abortions.(39)	However,	providers	may	be	
concerned	that	women	might	be	too	distressed	or	overloaded	with	information	to	
discuss	contraception	at	the	time	of	seeking	abortion	services.(27)	It	is	not	always	the	
case	that	a	full	range	of	contraceptive	methods	are	available	to	women	seeking	
abortion	services,	and	providers	may	lack	the	training	and	time	to	provide	
comprehensive	contraception	counselling.(27)	In	this	regard,	provision	of	information	
about	abortion	via	an	audiovisual	digital	video	disc	in	the	UK	resulted	in	staff	having	
more	time	to	discuss	patient	concerns	and	contraception.(43)	Additional	training	and	
the	time	required	for	insertion	have	been	identified	as	barriers	to	provision	of	long-
acting	contraception,	adding	pressure	to	already	busy	clinic	workloads.	Thus	it	can	be	
more	time-consuming	to	insert	an	implant	or	IUD	compared	with	handing	over	a	
supply	of	pills	or	condoms,	even	though	these	methods	are	associated	with	higher	
discontinuation	and	user	failure	rates.(27)(44)		
Contraception	use	over	the	extended	post-abortion	period	
Whilst	data	is	often	available	from	abortion	service	delivery	providers	on	immediate	
post-abortion	contraception	uptake,	less	is	known	globally	on	contraception	use	
following	an	induced	abortion	over	an	extended	time	period.	It	is	not	possible	to	
determine	patterns	of	contraceptive	use	using	data	from	Demographic	and	Health	
Surveys	as	they	do	not	distinguish	between	induced	and	spontaneous	abortion,	and	
thus	are	rarely	analysed	for	studying	post-abortion	contraception	trends.(28)	
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A	review	of	post-abortion	contraception	in	2015	found	four	studies	examining	patterns	
of	contraception	use,	two	in	India	and	two	in	Nepal.(28)	A	cross	sectional	study	in	India	
found	that	only	30%	of	women	used	any	method	following	an	abortion,	induced	or	
spontaneous.	Overall,	40%	discontinued	spacing	methods	by	24	months.(45)	A	cross	
sectional	study	in	Nepal	found	that	women	who	had	an	induced	abortion	were	more	
likely	than	postpartum	women	to	adopt	a	contraception	method	within	12	months	
(56%	vs.	34%;	p<0.001)	but	they	were	more	likely	to	discontinue	use	within	12	months	
(48%	vs.	44%;	p=0.016).	Discontinuation	was	more	likely	with	traditional	methods	
compared	to	modern	spacing	methods.(46)	A	cohort	study	in	India	found	that	94%	of	
women	who	had	a	surgical	abortion	and	89%	of	women	who	had	a	medical	abortion	
were	using	contraception	at	six	months.	There	was	higher	use	of	female	sterilisation	at	
one-month	among	women	having	surgical	compared	to	medical	abortions	(25%	vs.	
1%).	The	six-month	discontinuation	rates	at	six	months	were	similar;	8%	for	surgical	
and	5%	for	medical	abortion.(47)	A	cohort	study	in	Nepal	found	that	one	in	three	
women	seeking	abortion	services	received	no	information	on	contraceptive	method.	
Women	not	living	with	a	husband	or	with	no	children	were	less	likely	to	receive	
counselling.	Lack	of	equipment	and	trained	staff	meant	that	48%	of	women	selecting	
LARC	and	83%	of	women	selecting	female	sterilisation	left	the	facility	without	an	
effective	method.(48)	
Overall,	these	studies	show	wide	variation	in	patterns	of	contraceptive	use	in	the	post-
abortion	period	and	highlight	some	of	the	challenges	in	providing	contraception	at	the	
time	when	women	seek	abortion	services.	Additional	data	on	PAFP	can	be	obtained	
from	the	control	arm	of	trials	of	interventions	to	increase	contraception	use	and	are	
discussed	in	Section	1.3.		
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Theory	on	determinants	of	contraception	use	
This	section	introduces	theory	on	the	determinants	of	contraceptive	use.	Michie	et	al	
described	theory	as	“a	set	of	concepts	and/or	statements	with	specification	of	how	
phenomena	relate	to	each	other”,	and	behaviour	as	“anything	a	person	does	in	
response	to	internal	or	external	events”.(49)	Various	theories	and	models	have	been	
developed	to	describe	and	predict	contraceptive	use	for	pregnancy	avoidance.(50)(51)	
These	broadly	include	developmental	models	which	emphasise	contraception	use	as	
involving	a	series	of	stages,	and	decision-making	models	which	examine	the	
psychological	factors	that	predict	contraception	use.	Developmental	models	include	
Lindemann’s	Three-Stage	theory	and	Rains’s	model.	Decision-making	models	include	
the	Subjective	expected	Utility	Theory,	the	Health	Belief	model,	the	sexual	behaviour	
sequence	model	and	Herold	and	McNamee’s	model.(52)		
Lindemann’s	Three-Stage	theory	suggests	that	individuals	are	more	likely	to	use	
contraception	as	they	progress	through	three	stages;	the	natural	stage	where	
intercourse	is	relatively	unplanned	and	contraception	use	is	unlikely,	the	peer	
prescription	phase	where	the	individual	seeks	contraceptive	advice	from	friends	and	
less	effective	contraception	is	used,	and	the	expert	stage	where	the	individual	has	
incorporated	sexuality	into	their	self-concept	and	will	obtain	professional	advice	and	
plan	contraception	use.(53)	
Rains’s	model	suggests	that	contraception	use	is	more	likely	to	occur	when	individuals	
believe	that	sexual	activity	is	‘right	for	them’	and	involves	four	stages.(54)	The	first	
stage	is	falling	in	love,	providing	a	rationale	for	sex.	The	second	stage	is	having	an	
exclusive	long-term	relationship	.The	third	stage	is	sexual	intercourse	becoming	an	
acceptable	behaviour.	The	fourth	stage	where	individuals	accept	themselves	as	sexual	
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and	planning	sex	for	the	future	predicts	reliable	contraception	use.		
The	Subjective	Expected	Utility	Theory	is	the	basis	of	most	decision-making	models	
that	regard	contraception	use	resulting	from	an	analysis	of	different	variables.(50)	
Subjective	utility	theory	suggests	that	individuals	make	decisions	based	on	subjective	
estimates	of	potential	costs	and	benefits	of	a	particular	behaviour.	In	the	context	of	
contraception	use,	individuals	consider	the	costs	and	benefits	of	pregnancy	compared	
to	the	costs	and	benefits	of	contraception.(55)	This	theory	is	predominantly	
individualistic	with	a	greater	emphasis	on	individual	cognitions	compared	to	
relationship	and	social	contexts.(50)		
The	Health	Belief	model	was	initially	developed	in	the	1960’s	in	order	to	predict	
preventive	health	behaviours	and	has	been	subsequently	used	to	predict	a	wide	
variety	of	health-related	behaviours.(56)	It	is	a	social	cognition	model	that	attempts	to	
place	the	individual	within	the	context	of	relationships	and	broader	social	norms.(50)	
The	health	belief	model	has	been	used	to	predict	contraception	use	considering	
variables	such	as	knowledge	and	attitudes	about	sex	and	contraception,	previous	
experiences	and	relationship	status.(57)	
The	sexual	behaviour	sequence	model	is	based	on	the	theory	of	reasoned	action	and	
with	the	addition	of	sexual	arousal	and	emotional	responses	to	sex.	The	theory	of	
reasoned	action	is	also	a	social	cognition	model	that	examines	the	predictors	and	
precursors	to	health	behaviour.(58)	This	model	suggests	that	decisions	about	
contraception	are	made	in	the	context	of	both	rational	information	processing	and	
factors	such	as	how	sexually	aroused	an	individual	is	at	the	time	of	making	a	decision	
about	contraception.		
Herold	and	McNamee’s	model	is	made	up	of	six	variables;	parental	and	peer	group	
	
	
30	
norms,	number	of	lifetime	sexual	partners,	guilt	about	intercourse	and	attitudes	to	
contraception,	involvement	with	current	partner,	partner’s	influence	to	use	
contraception	and	frequency	of	intercourse.(59)	This	model	is	different	from	other	
models	of	contraception	use	as	it	includes	details	of	the	relationship.(50)		
Developmental	models	describe	contraception	use	resulting	from	the	transition	
through	a	series	of	changes	do	not	examine	the	psychological	factors	that	may	speed	
up	or	delay	transition	through	the	series	of	stages.	Decision-making	models,	in	
contrast,	emphasize	individuals’	cognitions	within	the	context	of	relations	and	social	
norms,	to	varying	degrees.(50)	
Sheeran	et	al	proposed	combining	developmental	and	decision-making	
perspectives.(52)	Sheeran’s	model	combines	developmental	and	decision-making	
approaches	to	contraceptive	use	and	it	the	principal	model	referred	to	in	this	thesis	as	
it	includes	a	combination	of	individual	and	social	variables.	Reviewing	nine	theoretical	
accounts	of	contraceptive	behaviour,	Sheeran	proposed	that	contraceptive	use	is	a	
product	of	background,	intrapersonal,	interpersonal	and	situational	factors.(52)	
Background	(demographic)	factors	that	have	been	found	to	influence	contraception	
use	include	age,	sex,	ethnicity,	social	class	and	education.(60)(61)	Intrapersonal	factors	
include	knowledge,	attitudes	and	personality.	Studies	have	shown	mixed	findings	
between	associations	between	knowledge	about	contraception,	fertility	and	
behaviour.(62)(50)(57)	Several	studies	have	found	associations	between	positive	
attitudes	towards	contraception	and	actual	use.(63)(64)	Studies	have	shown	that	
different	personality	types	can	be	associated	with	contraception	use.	Conservatism	
was	shown	to	be	negatively	associated	with	contraception	use.(65)	An	internal	locus	of	
control,	sex	guilt	and	sex	anxiety	have	been	found	to	be	positively	associated	with	
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contraception	use.(59)(66)	Interpersonal	factors	include	the	role	of	partners,	parents	
and	peers.	Aspect	of	partner	relationships	that	may	influence	contraception	use	
include	duration	of	relationship,	intimacy,	type	of	relationship,	exclusivity	and	ability	to	
discuss	contraception.(67)(68)	There	is	some	evidence	that	mother	and	daughter	
communication	and	parental	permissiveness	are	related	to	contraception	use.(59)	
Similarly,	contraception	use	can	be	associated	with	peer	permissiveness	and	peer’s	
own	contraceptive	behaviour.(69)	Situational	factors	identified	that	contribute	to	
contraceptive	use	include	spontaneity	of	sex,	substance	use	prior	to	sex,	accessibility	
of	contraception.	Spontaneity	of	sex	can	be	a	reason	for	not	using	contraception.(70)	
Use	of	alcohol	or	drugs	may	be	associated	with	risky	sex.(71)	Easy	access	to	
contraception	in	general	and	at	the	time	of	contemplating	sex	has	been	shown	to	be	
positively	associated	with	contraception	use.(72)	I	will	next	review	literature	on	
contraceptive	trends	and	determinants	in	Cambodia	considering	these	background	
(demographic),	intrapersonal,	interpersonal	and	situational	variables.		
1.2	Contraceptive	trends	and	determinants	in	Cambodia		
Cambodia	experienced	a	baby	boom	following	the	end	of	the	Khmer	Rouge-led	
genocide	of	1975-1979.(73)	However,	Cambodia	is	now	in	the	process	of	a	
demographic	transition	from	high	birth	and	death	rates	to	lower	birth	and	death	rates	
and	has	a	young	population	with	43%	aged	less	than	20	years.(74)	The	total	fertility	
rate	(TFR)	decreased	considerably	over	the	last	three	decades	from	6	in	1980,	to	3.4	in	
2005,	3.0	in	2010	and	2.7	in	2014.	At	the	same	time,	the	maternal	mortality	rate	
(deaths	per	100,000	live	births)	decreased	from	472	in	2005	to	206	in	2010,	and	to	170	
in	2014.(74)(75)(76)(77)		
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Family	planning	services	with	modern	contraceptives	became	available	in	1991	in	
Cambodia,	supported	by	international	non-governmental	organisations.	In	1994	the	
Cambodian	government	started	to	implement	its	own	family	planning	programme	
which	included	introduction	of	services	at	health	centres.	The	Maternal	and	Child	
Health	Plan	1994-1996	and	Birth	Spacing	Policy	for	Cambodia	in	1995	introduced	
specific	objectives	for	lengthening	birth	intervals.(73)	
Reflecting	Cambodia’s	pluralistic	health	system,	contraception	is	available	in	Cambodia	
through	a	range	of	service	delivery	systems	including	public	health	facilities	(e.g.	
hospitals/health	centres),	private	health	facilities	(e.g.	private	clinics/pharmacies	and	
non-governmental	organisations)	and	community	distribution.	The	2014	Cambodia	
DHS	survey	reported	that	users	of	modern	contraceptives	obtain	their	methods	from	
the	public	sector	more	than	the	private	sector	(47%	vs.	39%)	and	less	so	from	other	
sources	such	as	community	distribution	(8%)	but	this	varied	by	method.	Women	were	
more	likely	to	obtain	female	sterilisation	(76%	vs.	22%),	IUD	(53%	vs.	35%)	and	
injectables	(65%	vs.	48%)	from	the	public	sector	vs.	the	private	sector,	but	less	likely	to	
obtain	oral	contraceptive	(35%	vs.	42%)	and	male	condom	(17%	vs.	65%),	with	similar	
proportions	for	implant	(49%	vs.	48%).(74)	Almost	all	oral	contraceptive	(95%)	and	
condom	(88%)	users	were	using	a	socially	marketed	contraceptive	brand.(74)	
The	Cambodia	DHS	reported	that	knowledge	of	any	contraceptive	method	and	any	
modern	method	was	nearly	universal.	Overall,	56%	of	married	women	were	using	any	
contraception	method	in	2014,	but	there	was	substantial	variation	by	province	ranging	
from	63%	in	Phnom	Penh	to	42%	in	more	rural	provinces.	Contraception	use	was	
reported	to	be	higher	amongst	urban	women,	women	of	higher	parity,	and	women	
with	increasing	education	and	wealth.(74)	
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The	cost	of	obtaining	contraception	varies	according	to	where	it	is	obtained	and	incurs	
a	user	charge	in	most	cases.(78)	Typical	fees	for	one	month	of	the	oral	contraceptive	
or	a	three-monthly	injection	from	a	local	healthcare	worker	operating	from	the	market	
or	their	house	in	2012	were	reported	to	be	$0.25	USD1	and	$0.5-1	respectively.(79)	
Long-acting	methods	such	as	IUD	and	implant	are	typically	less	available	in	rural	areas	
and	therefore	are	likely	to	incur	additional	opportunity	costs	related	to	lost	income	
and	travel	to	a	bigger	clinic.(79)	Typical	user	fees	for	contraception	at	private/non-
governmental	clinics	in	2013	were	as	follows:	IUD	insertion	($5),	implant	insertion	
($25),	three-monthly	injectable	($1),	one	cycle	of	oral	contraceptive	($0.40)	but	fee’s	
can	be	waived	on	a	case-by-case	basis	for	clients	who	are	unable	to	pay2.	
In	1997	in	response	to	the	high	maternal	mortality,	estimated	at	900/100,000	live	
births,	the	abortion	law	was	reformed	to	allow	abortion	on	request	up	till	the	12th	
week	of	pregnancy.	However,	after	the	abortion	law	reform,	implementation	of	safe	
abortion	services	was	slow	and	it	was	only	following	the	introduction	of	the	national	
Comprehensive	Abortion	Care	(CAC)	training	curriculum	in	2007	that	safe	abortion	
services	were	introduced	in	public	hospitals	in	Phnom	Penh	city	and	the	provinces,	
non-governmental	organisation	clinics,	and	some	registered	private	clinics	and	
registered	pharmacies.(73)(75)	The	medical	abortion	pack	‘Medabon’	containing	
mifepristone	and	misoprostol	was	approved	by	the	Cambodia	Ministry	of	Health	in	
2010.(75)		
The	2005,	2010	and	2014	Cambodia	demographic	and	health	surveys	reported	the	
‘proportion	of	women	reporting	having	had	an	abortion	in	the	previous	5	years’	rather	
than	the	standard	indicator	of	abortions	per	1,000	women.	The	proportion	of	women	
																																																						
1	All	costs	in	this	section	are	in	United	States	Dollars	
2	Source:	internal	Marie	Stopes	International	Cambodia	data	
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reporting	having	had	an	induced	abortion	in	the	previous	five	years	increased	from	4	in	
2005	to	5	in	2010,	to	7	in	2014.(74)(76)(77)	The	proportion	of	women	reporting	an	
abortion	in	their	lifetime	increased	from	8%	in	2005	to	12%	in	2014.	(74)(76)	The	
proportion	of	women	having	a	medical	abortion	rather	than	a	surgical	abortion	
increased	from	31%	in	2010	to	47%	in	2014.(74)(77)	The	abortion	rate	was	estimated	
to	be	50	per	1,000	women	aged	15-44	using	data	extrapolated	from	a	survey	
conducted	in	2005.(80)	This	abortion	rate	was	estimated	in	a	subsequent	paper	using	
demographic	and	health	survey	and	national	prospective	data	to	be	21	per	1000	
women	in	2005	increasing	to	28	per	1,000	women	aged	15-44	in	2010.(81)		
The	2014	Cambodia	DHS	survey	reported	that	the	practice	of	abortion	occurs	
throughout	Cambodia	but	with	variation	by	residence	and	province.	The	proportion	of	
women	reporting	one	or	more	abortions	in	their	lifetime	was	17%	amongst	urban	
women	compared	to	11%	amongst	women	in	rural	areas;	19%	of	women	in	Phnom	
Penh	reported	ever	having	an	abortion	compared	to	3%	in	the	rural	Modul	Kiri	and	
Ratanak	Kiri	provinces.	Women	were	more	likely	to	report	having	had	an	abortion	if	
they	were	ever	married,	or	had	less	education.(74)		
The	same	survey	reported	that	44%	of	abortions	took	place	at	a	private	health	facility,	
compared	to	32%	at	the	respondent’s	home,	16%	in	a	public	health	facility	and	8%	at	
other	home.	The	proportion	of	women	using	a	health	facility	was	slightly	increased	
amongst	urban	women,	but	there	were	no	marked	differences	by	education.	Younger	
women	aged	15-34	were	less	likely	to	use	a	public	health	facility	compared	to	older	
women	(13%	vs.	19%),	more	likely	to	have	an	abortion	at	their	home	(35%	vs.	26%)	
with	no	apparent	difference	in	use	of	private	health	facilities	(45%	vs.	43%).(74)	
Despite	availability	of	safe	abortion,	some	women	continue	to	seek	abortion	from	
	
	
35	
unskilled	providers,	herbalists,	drug	sellers,	pharmacists	and	traditional	medical	
practitioners	or	induce	their	own	abortions.(82)(75)	This	could	be	due	to	lack	of	
awareness	of	the	legality	of	abortion	and	other	identified	barriers	such	as	shortages	of	
trained	healthcare	workers,	infrastructural	barriers,	provider	conscientious	objection	
or	expensive	fees.(82)(81)	
Fees	reported	to	be	charged	for	abortions	reported	in	a	study	conducted	by	Options	in	
2008	ranged	from	under	$10	for	an	abortificant	pill	to	$20-40	for	a	surgical	abortion	in	
the	first	trimester,	to	over	$100	for	an	abortion	at	the	“big	hospital”	in	the	second	
trimester.	The	study	authors	commented	that	the	price	of	abortion	should	not	be	seen	
as	a	simple	barrier	to	access	but	a	determinant	of	provider	and	method	choice.(73)	
Petitet	et	al	reported	that	the	recommended	retail	price	of	the	medical	abortion	
product	‘Medabon’	in	2012	was	$4.5	but	observed	to	be	sold	for	$10-15	per	pack	in	
pharmacies.(75)	A	study	conducted	by	Marie	Stopes	International	Cambodia	in	2009	of	
women	seeking	abortion	services	found	that	women	reported	spending	between	
$1.25	and	$15	for	medical	abortions	and	between	$10	and	$100	for	surgical	abortions	
with	prices	in	urban	areas	being	significantly	higher.(83)	Typical	user	fees	for	abortion	
as	part	of	a	comprehensive	abortion	service	package	including	consultation,	post-
abortion	care	and	post-abortion	family	planning	at	private/non-governmental	clinics	in	
2013	were	$20	for	medical	abortion	and	$25	for	surgical	abortion3.	In	contrast,	fees	for	
traditional	abortion	medicine	were	reported	in	Petitet’s	2011	study	to	be	around	
$3.(78)	In	addition	to	service	user	fees,	women	have	to	incur	travel	and	opportunity	
costs.	A	study	by	Potdar	et	al	in	2008	found	that	women	reported	losing	up	to	36	days	
of	their	own	productive	time	and	giving	up	as	much	as	$100	of	their	household	income	
																																																						
3	Source:	internal	Marie	Stopes	International	Cambodia	data	
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to	receive	appropriate	abortion	care,	in	a	country	with	a	gross	domestic	product	per	
capita	of	$306	at	the	time.(84)	
The	2008	Options	study	sought	to	learn	about	perceptions,	attitudes	and	behaviours	
relating	to	abortion	and	contraception	in	Cambodia	and	found	that	women	chose	to	
have	abortions	for	numerous	reasons	including	ill	health,	pre-marital	pregnancy,	to	
widen	birth	interval,	competing	family	responsibilities	and	poverty.(73)		
The	2010	Cambodia	Demographic	and	Health	Survey	(DHS)	reported	that	81%	of	
women	of	reproductive	age	wanted	to	delay	their	next	child	by	at	least	two	years,	or	
have	no	more	children,	with	only	35%	using	a	modern	contraceptive	method.(77)	In	
2014,	77%	of	women	reported	wanting	to	delay	a	pregnancy	by	at	least	two	years	with	
a	slight	increase	of	39%	using	a	modern	contraceptive	method.(74)	Table	1	shows	
estimates	of	contraception	use	in	2015	for	commonly	used	methods	worldwide	and	in	
Cambodia.	The	2014	Cambodia	DHS	reported	that	the	most	widely	used	method	was	
the	daily	pill	(18%),	followed	by	withdrawal	(15%)	and	injectables	(9%).(74)		
Table	1:	Estimates	of	contraceptive	prevalence	by	method	among	married	or	in-union	
women	aged	15-49,	2015	
	 Any	
method	
Female	
sterilisation	
Male	
sterilisation	
OC	 Injectable	 IUD	 Implant	 Condom	
World			 64%	 19%	 2.4%	 9%	 5%	 14%	 0.7%	 8%	
Cambodia	 58%	 3.1%	 0.1%	 19%	 10%	 5%	 2%	 2%	
Source:	Trends	in	Global	contraceptive	use	worldwide,	2015.	United	Nations,	Department	of	Economic	
and	Social	Affairs(9)	
The	observed	rise	in	induced	abortion	and	contraception	use	in	Cambodia	is	typical	of	
settings	where	fertility	levels	are	falling,(85)	and	suggests	unmet	need	for	
contraception.	Reducing	unmet	need	could	result	in	improved	health	indicators	in	
Cambodia,	where	despite	improvements,	maternal	and	child	mortality	remains	high.		
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Determinants	of	contraceptive	use	in	Cambodia	
Considering	Sheeran’s	model,	analyses	of	DHS	survey	data	on	contraception	use	in	
developing	countries	have	identified	background	factors	associated	with	contraceptive	
use.(86)(3)(16)	The	Cambodia	DHS	reported	increased	contraceptive	use	with	
increasing	parity,	wealth,	and	levels	of	educational	attainment.(77)	Whilst	few	data	
exist	on	post-abortion	contraception	use	from	DHS	surveys,	a	cross-sectional	study	in	
Cambodia	examined	determinants	of	contraceptive	acceptance	amongst	women	
seeking	abortion	services.	Factors	associated	with	contraceptive	acceptance	included	
increased	parity	and	range	of	available	contraceptive	methods	where	abortion	services	
are	provided.(82)	
An	analysis	of	52	developing	countries	with	surveys	since	2001,	including	Cambodia,	
examined	reasons	for	non-use	of	contraception	amongst	married	women	with	unmet	
need	for	contraception.(3)	These	reasons	can	be	organised	according	to	the	factors	
proposed	by	Sheeran	as	follows:	intrapersonal	e.g.	lack	of	knowledge	about	methods	
or	source	of	methods	or	concern	about	health	or	side-effects,	interpersonal	e.g.	
husband/partner	opposed	to	use,	and	situational	e.g.	reduced	exposure	to	sex	(for	
example	if	husband	or	partner	works	away),	fertility	related	(menopausal,	subfecund,	
postpartum	amenorrhoeic	or	breastfeeding)	or	other	(access,	cost,	convenience).	
Table	2:	Reasons	for	non-use	of	contraception	by	currently	married	women	
	 Exposure	 Fertility	
related	
Opposed	 Knowledge	 Health	
concerns	
Other	 Total	
Cambodia	2010	DHS	 23	 10	 12	 1	 48	 6	 100	
Total	(based	on	15	DHS	
surveys	conducted	in	Asia,	
North	Africa	&	Europe)	
28	 17	 19	 1	 29	 6	 100	
Adapted	from	Table	11:	Reasons	offered	for	non-use	of	contraception	by	currently	married	women	in	need	of	a	
modern	method	in	Westoff	C.	Unmet	Need	for	Modern	Contraceptive	Methods:	DHS	Analytical	Studies	No.	28.	
Calverton,	Maryland,	USA:	ICF	International;	2012.(3)	
The	findings	in	Table	2	are	consistent	with	the	discontinuation	literature	which	
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identifies	health	concerns,	including	side-effects	as	the	most	common	reasons	for	
discontinuation,	occurring	most	often	during	the	first	few	months	of	use.(16)(87)	
However,	health	concerns	are	particularly	prominent	in	Cambodia,	accounting	for	
almost	50%	of	non-use.	The	findings	are	supported	by	research	conducted	in	
Cambodia.	A	cross-sectional	study	reported	side-effects	as	the	most	important	reasons	
for	not	trying	or	discontinuing	contraception.(88)	A	focus	group	study	of	poor	married	
women	of	reproductive	age	found	that	women	reported	a	high	level	of	side-effects	
from	contraception.	Furthermore,	women	reported	switching	from	modern	methods	
to	less	effective	methods,	either	to	take	a	break	or	discontinue	modern	methods	
altogether.(89)	The	Options	study	also	reported	that	widespread	rumours	and	fears	
about	contraceptive	side-effects	presented	a	major	barrier	to	uptake,	continuation	and	
consistent	use.	The	authors	suggested	that	Cambodia	was	still	in	an	“early	adoption”	
stage	with	regards	to	perceptions	of	family	planning	and	behaviour	around	
contraceptives	characterised	by	low	levels	of	knowledge,	inaccessible	and	poor	quality	
services,	numerous	and	often	inconsistent	stories	and	rumours	about	side-effects,	
incorrect	use	of	contraceptives,	lack	of	choice,	and	sub-optimal	provision	by	
providers.(73)	
Experience	of	negative	side-effects	may	be	related	to	traditional	health	beliefs	in	
Cambodia.	An	anthropological	study	explored	practices	and	representation	related	to	
reproductive	health	and	contraceptive	methods	in	Cambodia.(78)	Petitet	reported	that	
in	Cambodia,	abundant	menstruation	(the	expulsion	of	‘bad	blood’)	is	viewed	as	a	sign	
of	good	health	and	fertility.	Contraceptive	methods	that	result	in	reduced	
menstruation	(for	example	the	injectable)	can	cause	women	to	worry	where	the	blood	
is	retained,	and	discontinue	the	method	to	wait	for	a	menstrual	period.	Many	women	
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reported	never	using	or	discontinuing	contraception	because	they	feared	or	
experienced	side-effects.	One	woman	who	had	five	previous	abortions	reported:		
“With	the	contraceptive	pill	we	always	have	problems,	bellyaches	for	two	months	or	
more,	headaches.	Abortion	only	takes	10	minutes	and	then	that’s	over.”	
Although	reported	less	than	health	reasons,	factors	related	to	knowledge,	access,	cost	
and	autonomy	are	important	reasons	for	non-use	of	contraception	in	Cambodia.	
Women	often	obtain	information	about	contraception	from	friends	and	relatives,	with	
myths	and	rumors	commonplace.(79)(90)	Furthermore,	not	all	women	have	full	
autonomy	over	health	care	decision	making.	The	Cambodia	DHS	reported	that	whilst	
45%	of	married	women	make	decisions	about	their	own	healthcare	by	themselves,	
45%	make	decisions	jointly	with	their	husbands,	and	in	9%	the	husband	decides.(77)	
Sex	workers	in	Cambodia	likely	have	even	less	autonomy,	with	a	cross-sectional	study	
reporting	that	about	half	of	women	interviewed	stated	having	been	coerced	by	clients	
into	unprotected	sex.(91)		
Finally,	access	and	cost	can	influence	choice	of	contraceptive	method,	particularly	for	
poor	women	living	in	rural	areas.	Women	have	to	consider	the	cost	of	transportation	
and	opportunity	cost	of	not	working	to	travel	to	provincial	towns	to	obtain	long-acting	
methods,	which	are	often	not	available	at	local	health	centres.(79)	
1.3	Interventions	to	improve	uptake	and	adherence	to	contraception	
Despite	the	significant	literature	on	determinants	of	contraception	use	and	evidence	
that	use	of	long-acting	reversible	contraception	can	reduced	subsequent	unintended	
pregnancies,	systematic	reviews	have	found	limited	evidence	for	interventions	to	
improve	use	of	contraception	and	PAFP.(92)(93)(94)		
A	systematic	review	of	randomised	controlled	trials	of	effectiveness	of	contraceptive	
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counselling	following	an	abortion	by	Ferreira	et	al	in	2009	identified	three	studies.(94)	
A	study	in	the	UK	in	2004	assessing	specialist	contraceptive	advice	and	enhanced	
provision	found	no	significant	difference	in	contraceptive	use	at	four	months	or	
abortion	rate	after	two	years.	However,	women	in	the	intervention	group	were	more	
likely	to	be	using	contraceptive	implants	at	four	months	(32%	vs.	6%;	p<0.001).(95)	A	
study	in	Iceland	in	2003	assessing	counselling	provided	by	a	specially	trained	family	
planning	nurse	found	no	significant	difference	in	contraceptive	use	between	the	two	
groups.(96)	A	study	in	Italy	in	2007	assessing	a	patient-centred	counselling	
intervention	found	increased	knowledge	and	attitudes	regarding	contraceptive	
methods	and	increased	use	of	effective	contraception	at	one	and	three	months.(97)	A	
meta-analysis	of	the	three	trials	found	no	difference	between	intervention	and	control	
groups	with	the	authors	concluding	that	there	was	no	evidence	indicating	that	
contraceptive	counselling	is	effective	in	increasing	contraceptive	use	after	an	
abortion.(94)		
A	systematic	review	of	post-abortion	family	planning	counselling	and	services	for	
women	in	low-income	countries	by	Tripney	et	al	in	2013	identified	15	studies.(93)	It	
was	not	possible	to	do	a	meta-analysis	due	to	differences	in	interventions	and	
outcomes.	Seven	of	the	studies	that	used	a	comparative	design	(pre-post	studies	with	
or	without	a	control	group)	reported	increased	use	of	modern	contraceptive	use	
compared	with	the	non-program	group.	One	study	assessed	repeat	pregnancy	and	
abortion,	a	matched	controlled	study	in	Zimbabwe,	and	reported	that	women	
receiving	counselling	and	free	contraception	prior	to	hospital	discharge	had	fewer	
unintended	pregnancies	(15%	vs.	34%;	p<0.001)	and	repeat	abortions	(2.5%	vs.	5.3%;	
p=0.23)	at	12	months	compared	with	standard	care.(98)	However,	given	the	paucity	of	
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high	quality	evidence,	the	review	authors	concluded	that	the	evidence	for	post-
abortion	family	planning	counselling	in	low-income	countries	to	address	the	problem	
of	unsafe	abortion	was	inconclusive.(93)		
Whilst	the	limited	evidence	for	interventions	to	increase	contraception	use	may	be	
partly	due	to	a	limited	number	of	high	quality,	adequately	powered	trials,	the	focus	of	
the	interventions	need	to	be	examined.	Interventions	have	often	focused	on	
adherence	to	a	specific	method,	often	OC,	which	may	be	less	effective	than	
interventions	that	anticipate	method-specific	discontinuation	and	facilitate	safe	
method	switching.(16)	Furthermore,	there	have	been	calls	for	increased	attention	to	
theory	of	behaviour	change	in	designing	and	evaluating	interventions	for	
contraception	use.(99)	It	is	important	to	distinguish	between	theories	of	behaviour	and	
theories	of	behaviour	change.	Whilst	Sheeran’s	framework	is	helpful	in	understanding	
factors	that	influence	contraception	use	(i.e.	existing	behaviour),	‘behaviour	change	
interventions’	can	be	considered	‘coordinated	sets	of	activities	designed	to	change	
specified	behaviour’.(100)	
Many	theories	or	models	of	change	are	used	in	the	health	behaviour	field.(101)	A	
systematic	review	in	2012	identified	83	behaviour	change	theories	developed	to	guide	
design,	implementation	or	evaluation	of	interventions.(102)(49)	Four	theories	
accounted	for	63%	of	articles	found;	the	Transtheoretical	Model	of	Change,	Theory	of	
Planned	Behaviour,	Social	Cognitive	Theory,	and	the	Information-Motivation-
Behavioural-Skills	Model.			
In	the	field	of	contraception,	a	Cochrane	review	of	trials	that	tested	a	theory-based	
intervention	for	improving	contraception	use	identified	17	trials,	most	of	which	
focused	on	adolescents	in	the	USA.(101)	Half	of	the	trials	addressing	contraception	use	
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showed	some	effect	and	used	several	different	theories	including	motivational	
interviewing,	social	cognitive	theory,	other	social	cognition	models	and	the	Health	
Belief	model.			
Given	this	plethora	of	theories,	intervention	designers	who	acknowledge	that	drawing	
on	theory	can	be	useful	are	faced	with	a	question	as	defined	by	Michie	et	al:	“for	
target	behaviour	X	for	population	Y,	in	context	Z	with	constrains	W	on	intervention	
delivery,	which	theory	is	likely	to	be	most	appropriate	and	informative?”,(49)	and	
sought	to	address	this	by	developing	a	simple	Behaviour	Change	Ontology	linking	five	
elements:	1)	behaviours,	2)	theories	and	constructs,	3)	behaviour	change	techniques	
(BCT),	4)	modes	of	delivery	and	5)	contexts	(setting	and	population).(103)	In	the	
context	of	this	thesis,	in	Figure	1,	the	target	behaviour	(box	1)	represents	
contraception	use,	the	mode	of	delivery	(box	4)	is	mobile	phone	and	the	context	(box	
5)	is	women	seeking	abortion	services	in	Cambodia.		
Figure	1:	Scheme	for	a	simple	behaviour	ontology	
	
Source:	Adapted	from	‘ABC	of	behaviour	change	theories’,	p473	(Michie	et	al,	2014)(49)	
	
Michie	et	al	conducted	a	systematic	literature	review	and	evaluation	of	existing	
frameworks	when	developing	the	‘Behaviour	Change	Wheel’.(100)	Unlike	other	
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theories	focusing	on	current	behaviour,	it	seeks	to	specify	how	to	bring	about	change	
in	behaviour.	A	review	of	existing	behaviour	change	frameworks	led	to	the	
development	of	the	behaviour	change	framework	that	considers	broader	individual,	
group	and	environmental	perspectives	that	influence	behaviour	change.(100)	At	its	
core	is	the	COM-B	model	(Capability,	Opportunity,	Motivation	–	Behaviour)	‘behaviour	
system’	involving	three	essential	conditions;	capability	(an	individuals	psychological	
and	physical	capacity	to	engage	in	the	activity	concerned),	motivation	(the	brain	
processes	that	energize	and	direct	behaviour	which	include	conscious	decision-making	
and	emotional	responding)	and	opportunity	(factors	that	lie	outside	the	individual	that	
make	behaviour	possible).(100)		
Interventions	can	be	characterized	in	terms	of	their	effective	components,	or	
‘techniques’.	Abraham	and	Michie	presented	a	taxonomy	of	behaviour	change	
techniques	used	in	interventions	in	2008,	identifying	26	BCTs,	for	example	provision	of	
information	on	risks,	consequences	of	actions,	or	conversely,	encouragement	and	goal	
setting.(104)	In	2013,	Michie	et	al	presented	a	more	exhaustive	taxonomy	of	93	
distinct	BCTs	clustered	into	16	groups	agreed	by	international	consensus.(105)	
We	considered	both	the	determinants	of	contraceptive	use	and	theory	of	behaviour	
change	when	developing	the	conceptual	framework	for	our	mobile	phone-based	
intervention	which	is	presented	in	Chapter	3,	and	coded	the	intervention	according	to	
Abraham	and	Michie’s	taxonomy	of	BCTs	in	Chapters	2	and	7.	
1.4	Overview	of	interventions	delivered	by	mobile	phone	‘mHealth’	
The	field	of	‘mHealth’	
Since	the	first	commercially	available	handheld	mobile	phone	was	officially	unveiled	in	
1983,(106)	worldwide	mobile	phone	subscriptions	grew	to	92	per	100	people	in	low-	
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and	middle-income	countries	and	122	per	100	people	in	high-income	countries	in	
2016.(107)	Mobile	phones	have	evolved	from	devices	to	make	phone	calls	and	text	
messages	in	the	1990’s,(108)	to	smartphone’s,	enabling	interactivity	and	exchange	of	
information,	text,	data	and	images	in	the	21st	century.(109)	
The	term	‘mHealth’	was	first	thought	to	have	been	coined	by	Robert	Istepanaian	and	
defined	in	2005	as	the	use	of	‘emerging	mobile	communications	and	network	
technologies	for	healthcare’.(110)	mHealth	was	subsequently	defined	at	the	inaugural	
mHealth	summit	in	2009	as	‘the	delivery	of	healthcare	services	via	mobile	
communication	devices’,(111)	in	2010	as	the	‘use	of	mobile	technologies	for	
health’,(112)	and	in	2011	by	the	WHO	as	‘medical	and	public	health	practice	supported	
by	mobile	devices,	such	as	mobile	phones,	patient	monitoring	devices,	personal	digital	
assistants	(PDAs),	and	other	wireless	devices’.(113)		
What	differentiates	‘mHealth’	from	interventions	delivered	by	landline	phones	or	call-
centres	is	the	‘mobile’	aspect.	Interventions	delivered	by	mobile	phone	have	
advantages	over	face-to-face	or	healthcare	delivery	by	landline	phone	as	support	can	
be	delivered	inexpensively	wherever	the	person	is	located,	when	it	is	needed.(114)	In	
particular,	interventions	delivered	by	mobile	phone	have	the	potential	to	reach	out	to	
youth	and	rural	populations,	where	geographical	distances	can	restrict	access	to	
services.	Behaviour	change	techniques	used	in	face-to-face	interventions	can	be	
modified	for	mobile	phones.(115)	Interventions	delivered	by	mobile	phone	can	utilise	
different	functions	of	mobile	phones	and	involve	different	modes	of	communication	
for	example,	text	message,	voice	messages,	and	smartphone	applications	and	may	
involve	one	direction	or	two-way	(interactive)	communication.(116)		
A	number	of	journals,	organisations	and	networks	have	been	created	within	the	
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discipline	of	mHealth.	mHealth	organisations	and	networks	include	the	‘mHealth	
working	group’	(created	in	2009’)	and	‘mHealth	knowledge’.(117)	mHealth	initiatives	
have	been	documented	in	the	‘mHealth	compendium’	and	on	websites	such	as	
mHealthevidence.org.(118)(119)	Academic	journals	include	The	Journal	of	mHealth	
(http://www.thejournalofmhealth.com;	first	issue	Feb	2014)	and	Journal	of	Mobile	
Technology	in	Medicine	(http://www.journalmtm.com;	first	issue	March	2012).	
Figure	2	shows	that	Google	searches	for	‘mHealth’	increased	significantly	in	the	years	
following	2008.	However,	it	would	appear	that	in	recent	years	the	term	‘Digital	health’	
is	gaining	more	popularity	if	compared	to	‘mHealth’.	An	example	of	this	would	be	the	
change	in	name	of	the	‘mHealth	working	group’	to	the	‘Global	Digital	Health	Network’	
to	encompass	mHealth,	eHealth	and	information	and	communications	technology	
(ICT).(120)		
Figure	2:	'mHealth',	'eHealth',	'Digital	health'	Google	searches:	interest	over	time	(2004-16)	
	
Data	source:	Google	Trends	(www.google.com/trends).	Numbers	represent	search	interest	relative	to	the	highest	
point	on	the	chart.	A	value	of	100	represents	the	peak	popularity	for	the	term,	a	value	of	50	means	that	the	term	is	
half	as	popular.	A	score	of	0	means	the	term	was	less	than	1%	as	popular	as	the	peak.		
	
	This	shift	in	terminology	from	‘mHealth’	to	‘Digital	health’	may	reflect	confusion	about	
what	is	and	is	not	‘mHealth’,	reflecting	increasing	use	of	internet	on	smartphones	and	
tablets	moving	away	from	the	traditional	focus	on	text	and	voice	messages	and	phone	
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calls.	For	the	purpose	of	this	thesis	I	refer	to	mHealth	as	‘interventions	delivered	by	
mobile	phone	to	improve	health’,	but	continue	to	use	term	‘mHealth’	when	describing	
use	in	contexts	where	the	term	‘mHealth’	is	commonly	used,	for	example	by	service	
providers.	
To	date,	interventions	delivered	by	mobile	phone	have	been	designed	to	improve	
health	service	delivery,	client	health	outcomes	and	as	tools	for	health	research.	
Interventions	can	be	designed	for	health	researchers,	healthcare	professionals,	
patients,	or	the	general	population,	as	per	Free	et	al’s	conceptual	framework	for	
mobile	electronic	device	intervention	classification	(Figure	3).(114)	Interventions	for	
patients	include	those	that	aim	to	improve	chronic	disease	management,	medication	
adherence,	appointment	attendance,	or	change	health	behaviour.(115)(121)	Labrique	
et	al	categorised	12	common	application	domains	for	mHealth	as	per	Figure	4.	The	
domains	most	relevant	to	this	PhD	are	those	focusing	on	improving	health	outcomes	
related	to	contraception	use;	thus	interventions	for	patients	and	the	general	
population	for	medication	adherence,	appointment	attendance,	and	behaviour	change	
(Figure	3)	and	client	education	and	behaviour	change	(Figure	4).	
Figure	3:	Conceptual	framework	for	mobile	electronic	device	intervention	classification	
Source:	The	effectiveness	of	M-health	technologies	for	improving	health	and	health	services:	a	
systematic	review	protocol	(Free	et	al,	2010)	
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Figure	4:	Twelve	Common	mHealth	and	ICT	Applications	
Source:	mHealth	innovations	as	health	system	strengthening	tools:	12	common	applications	and	a	visual	
framework	(Labrique	et	al,	2013)	
Evidence	for	interventions	delivered	by	mobile	phone	
A	number	of	systematic	reviews	in	recent	years	have	assessed	the	evidence	for	
interventions	delivered	by	mobile	phone,	either	looking	at	a	range	of	health	
outcomes,(115)(122)	or	specific	healthcare	fields	such	as	smoking	cessation	or	anti-
retroviral	therapy	(ART)	adherence.(123)(124)	Some	key	reviews	are	outlined	as	
follows.	
A	systematic	review	of	controlled	trials	of	interventions	delivered	by	mobile	phone	by	
Free	et	al	in	2013	identified	75	trials.	Four	trials	had	low	risk	of	bias.	Simple	text	
message	medication	reminders	had	at	best	small	effects	(Risk	Ratio	(RR)	1.00,	0.77–
1.30),	whilst	two	multi-faceted	interventions	were	shown	to	improve	health	
outcomes.(115)	The	txt2stop	intervention,	comprising	personalised	text	messages	was	
associated	with	increased	objectively	verified	smoking	cessation	in	the	UK	(10.7%	vs.	
4.9%;	RR	2.20,	1.80-2.68;	p<0.0001)	and	was	shown	to	be	cost-effective.(125)(126)	The	
WelTel	(Lester)	trial	in	Kenya	evaluated	a	multi-faceted	intervention	for	ART	
medication	adherence.(127)	Participants	were	sent	weekly	text	messages	in	the	local	
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language	asking	“How	are	you?”	and	were	instructed	to	respond	within	48-hours	if	
they	were	doing	well	or	if	they	had	a	problem.	Health	workers	would	then	phone	those	
who	said	they	had	a	problem	or	who	failed	to	respond.	Medication	adherence	was	
higher	in	the	intervention	group	(RR	for	non-adherence	0.81,	0.69-0.94).	The	
intervention	for	the	MOTIF	trial	used	a	similar	approach	to	Lester	and	is	discussed	
further	in	Chapter	3.	Free	et	al’s	systematic	review	found	that	interventions	for	other	
conditions	showed	suggestive	benefits	in	some	cases	but	the	results	were	not	
consistent.(115)		
A	systematic	review	by	Hall	et	al	in	2013	assessed	evidence	on	the	impacts	of	mobile	
technologies	on	health	outcomes	in	low-	and	middle-income	countries,	not	limited	to	
high-quality	trial	evidence.	The	review	identified	76	papers,	20	of	which	were	in	the	
domain	of	client	education	and	behaviour	change	in	areas	such	as	tuberculosis	and	
diabetes	management.(122)	One	paper	on	increasing	knowledge	and	changing	
behaviour	around	contraception	was	identified,	a	pilot	study	to	evaluate	the	
acceptability,	information,	access	and	potential	behavioural	impact	of	the	Mobile	for	
Reproductive	Health	(m4RH)	text	message	programme	in	Kenya.(128)	The	m4RH	
programme	was	subsequently	assessed	with	a	randomised	controlled	trial	discussed	in	
Section	2.8.	
A	systematic	review	by	Wald	et	al	in	2015	comparing	one-way	versus	two-way	text	
messaging	on	improving	medication	adherence	found	that	interactive	two-way	text	
messaging	was	associated	with	improved	medication	adherence	compared	with	one-
way	text	messaging.(129)	Three	studies	of	two-way	messaging	were	identified,	but	all	
of	the	interventions	also	involved	telephone	counselling.	One	of	these	studies	was	the	
WelTel	trial	described	above.	A	trial	by	Maduka	and	Tobin-West	also	evaluated	an	
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intervention	to	improve	HIV	medication	adherence	in	Nigeria.(130)	The	intervention	
comprised	bi-weekly	medication	reminder	text	messages	that	encouraged	participants	
to	acknowledge	receipt	of	the	message	and	indicate	if	they	required	further	
information	or	counselling.	In	this	case	researchers	would	provide	counselling	support	
as	required	by	telephone.	The	intervention	also	comprised	four	adherence	counselling	
sessions	lasting	between	45	and	60	minutes.	Medication	adherence	was	higher	in	the	
intervention	group	(77%	vs.	56%;	RR	0.75,	0.55-0.96;	p=0.022).				
The	third	study	identified	in	this	review	assessed	an	intervention	by	Wald	et	al	to	
improve	adherence	to	cardiovascular	treatment	in	the	UK.(131)	The	intervention	
comprised	text	messages	over	a	six-month	period	asking	participants	to	reply	
indicating	whether	they	had	taken	their	medication.	Patients	who	had	not	taken	their	
medication	or	not	responded	were	telephoned	to	determine	reasons	for	not	taking	
medication	and	discussing	with	view	to	resolving	the	issue.	The	authors	reported	a	
16%	absolute	improvement	in	non-adherence	(participants	taking	less	than	80%	of	
prescribed	regimen)	in	the	intervention	group	(9%	vs.	25%;	p<0.001).	
A	systematic	review	of	mobile	text	messaging	for	promoting	adherence	to	
antiretroviral	therapy	conducted	by	Horvath	et	al	in	2012	identified	two	RCTs	from	
Kenya,	one	of	which	was	the	Lester	trial.(132)	The	other	trial	by	Pop-Eleches	et	al	
compared	different	intervals	and	lengths	of	text	messaging	with	standard	care.(132)	
Adherence	of	greater	than	90%	was	higher	in	amongst	participants	receiving	weekly	
text	messages	compared	with	the	control	group	(53%	vs.	40%;	p=0.03).	The	systematic	
review	authors	concluded	that	there	is	high-quality	evidence	that	mobile	phone	text	
messaging	at	weekly	intervals	is	efficacious	in	enhancing	adherence	to	ART.(123)	
Subsequent	to	this	review	was	a	trial	to	improve	adherence	to	HIV	treatment	in	2014	
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in	India	by	Shet	et	al.(133)	The	intervention	was	described	as	being	interactive	in	that	
it	comprised	weekly	voice	messages	that	asked	participants	to	respond	if	they	were	
taking	their	medications	as	prescribed.	However,	the	intervention	did	not	involve	
phoning	participants	who	reported	not	taking	their	medication.	The	intervention	was	
not	associated	with	a	significant	difference	in	time	to	virological	failure.	
Some	observations	can	be	made	from	the	systematic	reviews	and	studies	described	in	
this	section.	The	area	of	interventions	delivered	by	mobile	phone	(mHealth)	is	a	
dynamic	one	with	a	growing	evidence	base	and	it	is	challenging	to	keep	up-to-date	
with	the	research	across	all	healthcare	fields,	study	designs	and	mHealth	domains.	The	
trials	of	ART	adherence	are	encouraging	in	that	they	demonstrate	that	interventions	
delivered	by	mobile	phone	can	be	delivered	to	a	group	in	which	confidentiality	and	
privacy	are	important.	In	general	it	can	be	observed	that	multifaceted,	more	intensive,	
interventions	delivered	by	mobile	phone	appear	to	be	more	effective	than	more	
simple	uni-faceted	interventions	such	as	one-way	medication	
reminders.(115)(123)(124)	This	is	consistent	with	adherence	research	demonstrating	
that	multifaceted,	more	intensive,	interventions	can	be	effective	but	uni-faceted	
interventions	have	modest	benefits.(134)		
Another	observation	concerns	the	description	of	the	interventions.	The	‘two-way	
messaging’	interventions	in	Wald’s	review	all	involved	contacting	patients	by	phone	for	
additional	support	depending	on	the	response	to	the	text	message	and	the	Lester	
intervention	was	also	described	by	the	authors	and	in	the	Horvath	review	as	a	text	
message	intervention	even	through	this	also	involved	contacting	patients	by	phone	for	
additional	support.(129)(127)(123)	The	finding	that	two-way	interactive	messaging	
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interventions	appear	to	be	more	effective	that	one-way	interventions	may	be	because	
several	of	these	interventions	have	involved	phone	counselling.		
Most	reviews	and	trials	focused	on	health	outcomes.	Whilst	evidence	for	interventions	
delivered	by	mobile	phone	on	health	outcomes	is	increasing,	few	studies	reported	on	
their	cost-effectiveness	which	may	be	a	contributing	factor	to	why	the	majority	of	
interventions	delivered	by	mobile	phone	have	not	been	scaled	up.(135)(136)(122)	
1.5	mHealth	in	Cambodia	
In	2012,	in	Cambodia,	there	were	an	estimated	19	million	mobile	subscriptions	
covering	a	population	of	14	million.(137)	Cambodians	do	appear	to	be	enthusiastic	
mobile	phone	users,	as	can	be	witnessed	during	daily	life	in	urban	and	rural	areas.	In	
2012	there	was	significant	interest	in	mHealth	in	Cambodia,	as	observed	by	a	number	
of	organisations	such	as	InSTEDD	South	East	Asia	and	the	Open	Institute	developing	
and	implementing	initiatives	utilising	mobile	phones.(138)(139)(140)	However,	a	
number	of	operational	challenges	facing	mHealth	programmes	in	Cambodia	have	been	
identified.(141)	Cambodian	mobile	phone	users	often	have	multiple	Subscriber	
Identification	Module	(SIM)	cards	and	share	phones	which	can	make	it	difficult	to	
maintain	contact	with	users.	Cambodians	often	prefer	to	use	their	mobile	phone	for	
voice	calls	rather	than	text	messages	for	two	reasons.	First,	whilst	literacy	levels	are	
90%	in	urban	areas,	this	figure	is	lower	(69%)	in	rural	areas.(77)	Second,	lack	of	Khmer	
(Cambodian)	language	capability	on	many	phones	means	that	even	if	users	can	read	
the	Khmer	script,	they	can	only	text	using	Roman	letters.	Despite	these	challenges,	
appropriately	designed	mHealth	interventions	have	potential	to	reach	out	to	the	80%	
of	Cambodians	living	rural	areas,	with	the	least	access	to	health	care.(77)		
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1.6	Literature	review	of	interventions	delivered	by	mobile	phone	for	
contraception	
As	of	2014,	no	systematic	reviews	had	examined	interventions	delivered	by	mobile	
phone	to	increase	contraception	use.	I	conducted	a	literature	review	during	February	
2014	for	my	PhD	upgrading	report	to	identify	randomised	controlled	trials	of	
interventions	delivered	by	mobile	phone	for	improving	uptake	and	adherence	of	
contraception	and	additional	relevant	literature	on	interventions	delivered	by	mobile	
phone	and	contraception.		
Three	trials	were	identified	that	fulfilled	the	inclusion	criteria	comparing	a	mobile	
phone	text	message	intervention	compared	to	standard	care	(Castano,	Hou	and	
Tsur).(142)(143)(144)	As	these	studies	were	also	identified	in	the	Cochrane	review	in	
Chapter	2	they	will	not	be	described	in	detail	here.		
One	ongoing	study	was	identified.	The	mAssist	trial	in	South	Africa	randomised	469	
women	seeking	medical	abortion	to	text	messaging	or	standard	care.	(145)	The	
intervention	comprised	a	series	of	text	messages	to	support	the	abortion	process	
(including	information	on	PAFP)	over	a	three-week	period.	The	authors	provisionally	
reported	increased	long-acting	reversible	contraception	uptake	at	seven-weeks	(21%	
vs.	13%).		
The	review	identified	a	number	of	other	mHealth	contraception	initiatives	that	have	
been	launched	and	scaled	up	in	low-income	settings,	but	not	subject	to	evaluation	of	
contraceptive	outcome	measures,	for	example,	Mobile	for	Reproductive	Health	
(m4RH)	and	the	Mobile	Alliance	for	Maternal	Action	(MAMA).(146)(147)	FamPlan	is	a	
Hotline	in	the	Philippines	that	allows	users	to	ask	questions	via	text	message.(148)	
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Examples	of	mobile	phone	applications	included	CycleTel	(using	the	standard	days	
method)	and	MyPill	(for	OC	reminders).(149)(150)		
The	review	concluded	that	‘although	a	number	of	other	initiatives	using	interventions	
delivered	by	mobile	phone	to	increase	contraception	use	have	been	launched	and	
scaled	up	in	low-income	settings,	to	date,	the	effect	of	mHealth	interventions	on	
contraceptive	uptake	or	adherence	have	not	been	reliably	established’	and	‘no	studies	
have	formally	reported	mHealth	PAFP	interventions’	and	that	‘there	is	therefore	a	need	
for	more	evidence	on	the	effectiveness	of	mHealth	interventions	for	contraception’.		
1.7	Aims	and	objectives	
The	aim	of	this	research	is	to	answer	the	broader	research	question:	Can	interventions	
delivered	by	mobile	phone	increase	contraception	use?	The	research	has	four	main	
objectives:	
1. Conduct	a	systematic	review	of	interventions	delivered	by	mobile	phone	for	
contraception:	to	complete	a	Cochrane	review	entitled	‘Mobile	phone-based	
interventions	for	improving	contraception	use’	
2. Develop	an	intervention	delivered	by	mobile	phone	to	support	PAFP	in	
Cambodia	
3. Evaluate	the	intervention	with	a	randomised	controlled	trial	including	analysis	
of	four	and	12-month	follow-up	data	
4. Conduct	a	mixed	methods	process	evaluation	
1.8	Thesis	structure	
The	following	research	paper	style	thesis	contains	eight	chapters	including	this	chapter	
addressing	the	objectives	of	the	thesis.	The	sequence	of	papers	follows	a	logical	
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sequence	starting	with	a	literature	review	and	progressing	to	the	intervention	
development,	trial	protocol	followed	by	the	trial	results	and	process	evaluation.	
However,	at	times	several	papers	were	being	worked	on	simultaneously,	and	some	
had	longer	peer-review	processes	than	others	meaning	that	the	papers	were	published	
in	a	slightly	different	order	than	as	presented.		
Chapter	1	presents	an	introduction	to	the	thesis	and	reviews	relevant	background	
literature,	on	contraception	trends,	theory	and	models	to	describe	and	predict	
contraceptive	use,	interventions	delivered	by	mobile	phone,	behaviour	change	theory,	
and	the	aims	and	objectives	of	the	thesis.		
The	next	6	chapters	are	research	papers.	The	division	of	labour	and	contribution	of	
others	to	these	publications	are	stated	in	the	research	paper	cover	sheets	for	each	
chapter.			
Chapter	2	is	a	systematic	literature	review	of	‘Mobile	phone-based	interventions	for	
improving	contraception	use’	(Cochrane	review).	This	chapter	builds	on	the	literature	
review	conducted	for	my	PhD	upgrade	as	discussed	in	Section	1.6.	After	approaching	
the	Cochrane	fertility	group	to	enquire	whether	I	could	conduct	a	Cochrane	review	on	
mobile	phone-based	interventions	to	increase	contraception	use,	the	provisional	title	
was	approved	and	published	in	2012.	The	protocol	was	published	in	2014	and	the	
search	strategy	used	for	my	PhD	upgrade	was	broadened	to	include	additional	
keywords,	electronic	databases	and	clinical	trials	registries.	The	review	was	conducted	
in	accordance	with	Cochrane	methodology	with	respect	to	data	extraction	on	
outcomes,	assessment	of	bias	and	methodological	quality,	calculation	of	measures	of	
effect,	presentation	of	results	and	discussion	using	Revman	software.	The	review	was	
published	in	2015	and	included	unpublished	four-month	follow	up	data	from	the	
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MOTIF	trial	(the	full	results	including	12-month	follow	up	are	presented	in	Chapter	5).	
The	division	of	labour	and	contribution	of	others	to	this	review	are	stated	in	the	
research	paper	cover	sheet	for	Chapter	2.	Although	the	protocol	was	a	separate	
publication	subject	to	peer	review	I	have	not	included	it	in	this	thesis	as	the	protocol	
was	incorporated	in	to	the	methods	section	of	the	main	review	paper.	In	addition	to	
the	published	Cochrane	review,	at	the	end	of	this	chapter	I	have	included	a	section	on	
trials	published	subsequent	to	conducting	the	database	searches	in	October	2014.	
Chapter	3	is	a	research	paper	describing	the	intervention	development	for	the	MOTIF	
trial.	Specifically	this	paper	comprises	reviews	of	relevant	literatures,	a	case	note	
review	of	clinic	data,	interviews	and	focus	groups	with	women	seeking	abortion	
services	and	consultation	with	clinicians	and	local	organisations	implementing	mHealth	
activities	and	presents	a	conceptual	framework	for	the	intervention.	I	presented	the	
intervention	development	at	the	International	Conference	on	Family	Planning	in	
Ethiopia	in	2012	and	this	paper	was	subsequently	prepared	and	accepted	for	
publication	after	the	conference.	
Chapter	4	is	a	research	paper	outlining	the	trial	protocol	and	a	subsequent	update	
publication	describing	some	amendments	that	was	submitted	after	my	PhD	upgrading	
seminar	on	2nd	April	2014.	The	papers	provide	detail	on	the	study	design,	intervention,	
study	hypothesis,	sample	size	calculation,	outcome	measures,	effect	measures	and	
proposed	statistical	analysis	methods.	Separately	a	detailed	trial	Statistical	Analysis	
Plan	was	written	and	sealed	prior	to	commencing	data	analysis	(Appendix	4).	
Chapter	5	is	a	research	paper	that	presented	the	results	of	the	MOTIF	randomised	
controlled	trial	and	includes	data	on	baseline	characteristics	of	participants,	primary	
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and	secondary	outcomes	collected	at	four	and	12-month	follow	up,	as	well	as	
subgroup	and	discontinuation	figures	for	the	12-month	follow	up	data.		
In	additional	to	the	published	trial	paper,	this	chapter	contains	three	additional	
analyses.	First	is	some	additional	trial	analysis,	which	includes	pre-specified	analyses	
that	could	not	be	included	in	the	main	trial	paper	due	to	word	count	limitations	as	well	
as	exploratory	analyses	of	the	dynamics	of	contraception	use	over	the	post-abortion	
period.	The	aim	of	this	analysis	is	to	further	understand	the	patterns	of	contraceptive	
use	over	the	post-abortion	period,	in	particular	differences	in	uptake,	discontinuation	
and	switching	between	the	intervention	and	control	groups.	Second	is	an	overview	of	
approaches	to	measuring	adherence	to	effective	contraceptive	methods	together	with	
an	analysis	assessing	the	validity	and	reliability	of	self-report	data	on	contraception	use	
collected	in	the	trial;	also	a	pre-specified	analysis	that	could	not	be	included	in	the	
main	trial	paper	due	to	word	count	limitations.	Third	is	an	exploratory	analysis	
assessing	factors	associated	with	loss	to	follow-up	in	the	trial	and	comparing	how	the	
result	might	have	varied	using	different	analysis	methods	such	as	multiple	imputation.	
Chapter	6	presents	a	quantitative	process	evaluation	assessing	response	to	the	
intervention	using	data	collected	during	the	intervention.	Specifically	this	paper	
includes	a	descriptive	analysis	to	assess	participants’	interaction	with	the	intervention,	
and	a	logistic	regression	analyses	to	assess	interaction	with	the	intervention	and	
subsequent	contraception	use.	The	paper	assesses	associations	between	baseline	
socio-demographic	factors	and	interaction	with	the	intervention	considering	the	public	
health	implications	of	the	intervention.	This	paper	is	being	reviewed	by	a	peer-review	
journal	as	of	August	2016.		
	
	
57	
Chapter	7	is	a	research	paper	reporting	women’s	views	and	experiences	of	receiving	
the	intervention.	The	study	comprised	15	qualitative	interviews	conducted	with	
women	that	received	the	intervention.	The	interviews	were	conducted	in	2013-14	and	
briefly	coded	at	the	time	and	I	undertook	more	thorough	analysis	in	2016.	This	paper	
identifies	key	themes	regarding	women’s	experiences	receiving	the	intervention,	and	
considers	the	mechanism	of	action	reflecting	on	the	theory	and	conceptual	framework	
presented	in	Chapter	3,	and	considers	how	the	intervention	could	be	improved.	The	
paper	was	submitted	to	a	journal	in	September	2016.		
In	Chapter	8	I	summarise	the	main	findings	of	the	thesis	and	its	overall	strengths	and	
limitations,	discuss	the	meaning	of	the	study	and	possible	mechanisms	of	action	in	
relation	to	other	studies	in	the	fields	of	contraception	and	interventions	delivered	by	
mobile	phone,	and	finally	discuss	recommendations	for	practice	and	further	research.		
1.9	Ethics	
The	trial	was	conducted	in	accordance	with	the	principles	of	Good	Clinical	
Practice,(151)	and	I	attended	an	Introduction	to	Good	Clinical	Practice	course	at	
Imperial	College	in	May	2012.	Ethical	approval	was	granted	by	the	LSHTM	ethics	
committee,	the	Marie	Stopes	International	ethics	committee	and	the	Cambodia	
National	Ethics	Committee	for	Health	Research	(NECHR)	for	the	formative	research	
(Phase	1),	the	trial	(Phase	2)	and	12-month	follow	up	(Phase	3).		
• Phase	1	approvals:	Cambodia	NECHR	(number:	C2/23	NECHR);	LSHTM	(number:	
6282);	MSI	(number:	013-12-FT-A)	
• Phase	2	approvals:	Cambodia	NECHR	(number:	0036	NECHR);	LSHTM	(number:	
6378);	MSI	(number:	002-13-E)	
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• Phase	3	approvals:	Cambodia	NECHR	(number:	0193	NECHR);	LSHTM	(number:	
6378-01);	MSI	(number:	002-13-Am14)		
The	MOTIF	trial	is	registered	with	ClinicalTrials.gov,	number:	NCT01823861.(152)		
1.10	Study	setting,	collaborations	and	funding	
The	idea	of	using	mobile	phone	communication	to	support	contraception	use	
originated	from	my	time	working	in	rural	Cambodia	as	an	international	fellow	to	the	
National	Health	Service	(NHS)	‘Improving	Global	Health’	scheme	in	2008-9.	During	this	
time	we	aimed	to	improve	healthcare	services	in	Samlaut	district	in	the	rural	North-
West	of	Cambodia,	supported	by	Maddox	Jolie-Pitt	(MJP)	foundation.(153)	In	order	to	
assess	priorities	we	conducted	a	household	survey	asking	what	services	people	
thought	should	be	provided	at	their	local	health	centre.	Many	of	the	women,	and	
some	men,	requested	improved	contraception	services	as	they	had	large	families	and	
didn’t	feel	able	to	support	more	children.	As	a	result	we	set	up	a	basic	family	planning	
service	from	the	local	health	post	providing	condoms,	pills	and	injectables.	However,	
several	months	later	when	we	evaluated	the	service	we	discovered	that	many	of	the	
women	had	discontinued	their	contraception	due	to	fear	or	experience	of	side-effects,	
for	example	amenorrhoea.	My	impression	was	that	there	was	a	lack	of	access	to	good	
quality	health	information	in	the	rural	areas	with	most	women	obtaining	information	
about	contraception	from	family	or	friends.	At	a	later	date	it	occurred	to	me	that	as	
most	people	had	mobile	phones,	albeit	simple	ones,	that	this	could	be	a	way	to	
communicate	health	information	to	populations	in	rural	areas.		
I	approached	the	innovation	and	research	teams	at	Marie	Stopes	International	and	
Caroline	Free	(CF)	at	LSHTM	with	the	idea	of	undertaking	a	PhD	research	project	on	
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the	topic	of	mHealth	and	contraception	in	late	2011.	Following	some	initial	exploratory	
discussions,	in	January	2012	I	visited	MSI	country	programmes	in	Kenya	and	Cambodia	
to	discuss	the	possibility	of	collaborating	on	an	application	for	an	internal	MSI	
Innovation	fund	project.	Whilst	both	country	programmes	expressed	an	interest	I	
decided	to	work	with	MSI	Cambodia	given	my	prior	experience	working	in	the	country.	
Independently,	Caroline	Free	and	Thoai	Ngo,	then	Head	of	Research	at	Maries	Stopes	
International,	had	discussed	developing	an	intervention	delivered	by	mobile	phone	to	
support	contraception	use	in	South	East	Asia.	The	MOTIF	project	successfully	obtained	
funding	(£146,736)	from	the	head	office	at	MSI	in	London	over	a	15-month	period	
from	October	2012-December	2013.	During	this	time	I	worked	together	with	a	
Cambodian	team	comprising	a	project	manager	(Uk	Vannak),	two	counsellors	(Ly	
Sokhey	and	Sieklot	Cheam)	and	four	research	assistants	to	develop,	implement	and	
evaluate	a	mobile	phone-based	intervention	to	support	PAFP	at	four	MSI	clinics	in	
Cambodia.	I	commenced	my	PhD	at	LSHTM,	registering	as	a	part-time	student	on	23rd	
November	2012.	During	October	2012	to	March	2013	we	conducted	formative	
research	to	develop	the	intervention.	My	supervisor	(CF)	visited	Cambodia	during	the	
week	commencing	25th	March	2013	and	we	had	meetings	with	the	team	at	MSI	
Cambodia	as	well	as	other	organisations	in	Cambodia.	We	decided	to	collaborate	with	
the	InSTEDD	South	East	Asia	iLab	as	our	tech	partner	to	deliver	the	intervention	as	we	
considered	their	‘Verboice’	voice-messaging	product	the	best	option	for	delivering	a	
voice-based	intervention.	During	March	and	April	2013	we	further	refined	the	
intervention,	obtained	ethical	approvals,	hired	additional	research	assistants	and	
developed	Standard	Operating	Procedures	(SOPs)	for	the	different	team	members.	We	
recruited	participants	to	the	trial	during	May	and	September	2013.	We	conducted	
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four-month	trial	follow	up	during	August	2013	and	January	2014,	having	been	granted	
a	one-month	no-cost	extension.	Qualitative	interviews	with	women	who	had	received	
the	intervention	were	conducted	between	October	30th	and	November	23rd	2013.		
I	was	awarded	a	three-year	Medical	Research	Council	Population	Scientist	Fellowship	
(grant	code:	MR/L012251/1)	commencing	1st	April	2014	that	included	costs	for	long-
term	trial	follow-up	and	funded	my	time	to	conduct	the	quantitative	and	qualitative	
analyses,	prepare	publications	and	write	up	my	PhD.		
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2.	Mobile	phone-based	interventions	for	improving	
contraception	use:	a	systematic	review	of	randomised	
controlled	trials	
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Mobile	phone-based	interventions	for	improving	contraception	use	
(review)	
Chris	Smith1,	Judy	Gold2,	Thoai	D	Ngo3,	Colin	Sumpter4,	Caroline	Free1		
1Clinical	Trials	Unit,	Department	of	Population	Health,	London	School	of	Hygiene	&	
Tropical	Medicine,	London,	UK.	2London,	UK.	3Research	and	Knowledge	Management	
Department,	Innovations	for	Poverty	Action,	New	Haven,	Connecticut,	CT,	USA.	
4London	School	of	Hygiene	and	Tropical	Medicine,	London,	UK		
2.1	Abstract		
Background		
Contraception	provides	significant	benefits	for	women’s	and	children’s	health,	yet	an	
estimated	225	million	women	had	an	unmet	need	for	modern	contraceptive	methods	
in	2014.	Interventions	delivered	by	mobile	phone	have	been	demonstrated	to	be	
effective	in	other	health	areas,	but	their	effects	on	use	of	contraception	have	not	been	
established.		
Objectives		
To	assess	the	effects	of	mobile	phone-based	interventions	for	improving	contraception	
use.		
Search	methods		
We	searched	for	randomised	controlled	trials	(RCTs)	of	client-provider	interventions	
delivered	by	mobile	phone	to	improve	contraception	use	compared	with	standard	care	
or	another	intervention.	We	searched	the	electronic	databases	Cochrane	Central	
Register	of	Controlled	Trials	(CENTRAL),	MEDLINE,	EMBASE,	Global	Health,	PsycINFO,	
POPLINE,	Africa-Wide	Information	and	Latin	American	Caribbean	Health	Sciences	
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Literature	(LILACS)	from	January	1993	to	October	2014,	as	well	as	clinical	trials	
registries,	online	mHealth	resources	and	abstracts	from	key	conferences.		
Selection	criteria		
Randomised	controlled	trials	of	mobile	phone-based	interventions	to	improve	any	
form	of	contraception	use	amongst	users	or	potential	users	of	contraception.	Outcome	
measures	included	uptake	of	contraception,	measures	of	adherence,	pregnancy	and	
abortion.		
Data	collection	and	analysis		
Two	review	authors	independently	screened	titles	and	abstracts	of	studies	retrieved	
using	the	search	strategy	and	extracted	data	from	the	included	studies.	We	calculated	
the	Mantel-Haenszel	risk	ratio	(RR)	for	dichotomous	outcomes	and	the	mean	
difference	(MD)	for	continuous	outcomes,	together	with	95%	confidence	intervals	
(CIs).	Differences	in	interventions	and	outcome	measures	did	not	permit	us	to	
undertake	meta-analysis.		
Main	results		
Five	RCTs	met	our	inclusion	criteria.	Three	trials	aimed	to	improve	adherence	to	a	
specific	method	of	contraception	amongst	existing	or	new	contraception	users	by	
comparing	automated	text	message	interventions	versus	standard	care.	Two	trials	
aimed	to	improve	both	uptake	and	adherence,	not	limited	to	one	method,	in	both	
users	and	non-users	of	contraception.	No	trials	were	at	low	risk	of	bias	in	all	areas	
assessed.		
One	trial	in	the	USA	reported	improved	self	reported	oral	contraceptive	(OC)	
continuation	at	six	months	from	an	intervention	comprising	a	range	of	uni-directional	
and	interactive	text	messages	(RR	1.19,	95%	CI	1.05	to	1.35).	One	trial	in	Cambodia	
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reported	increased	self	reported	use	of	effective	contraception	at	four	months	post	
abortion	from	an	intervention	comprising	automated	interactive	voice	messages	and	
phone	counsellor	support	(RR	1.39,	95%	CI	1.17	to	1.66).	One	feasibility	trial	in	the	USA	
reported	a	lower	mean	number	of	days	between	scheduled	and	completed	attendance	
for	the	first	but	not	subsequent	Depo-Provera	appointments	using	clinic	records	from	
an	intervention	comprising	reminders	and	healthy	self	management	text	messages	
(mean	difference	(MD)	-8.60	days,	95%	CI	-16.74	to	-0.46).	Simple	text	message	OC	
reminders	had	no	effect	on	missed	pills	as	assessed	by	electronic	medication	
monitoring	in	a	small	trial	in	the	USA	(MD	0.5	missed	pills,	95%	CI	-1.08	to	2.08).	No	
effect	on	self	reported	contraception	use	was	noted	amongst	isotretinoin	users	from	
an	intervention	that	provided	health	information	via	two	uni-directional	text	messages	
and	mail	(RR	1.26,	95%	CI	0.84	to	1.89).	One	trial	assessed	potential	adverse	effects	of	
the	intervention	and	reported	no	evidence	of	road	traffic	accidents	or	domestic	abuse.		
Authors’	conclusions		
Our	review	provides	limited	evidence	that	interventions	delivered	by	mobile	phone	
can	improve	contraception	use.	Whilst	evidence	suggests	that	a	series	of	interactive	
voice	messages	and	counsellor	support	can	improve	post-abortion	contraception,	and	
that	a	mixture	of	uni-directional	and	interactive	daily	educational	text	messages	can	
improve	OC	adherence,	the	cost-effectiveness	and	long-term	effects	of	these	
interventions	remain	unknown.	Further	high-quality	trials	are	required	to	robustly	
establish	the	effects	of	interventions	delivered	by	mobile	phone	to	improve	
contraception	use.		
2.2	Plain	language	summary	
Interventions	delivered	by	mobile	phone	to	support	client	use	of	family	
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planning/contraception		
Contraception	-	methods	or	devices	used	to	prevent	pregnancy	-	has	significant	
benefits	for	women’s	and	children’s	health.	Despite	these	benefits,	an	estimated	225	
million	women	in	developing	countries	were	not	using	a	modern	contraceptive	
method	in	2014	despite	wanting	to	avoid	pregnancy.	Expansion	of	mobile	phone	use	in	
recent	years	has	led	to	increased	interest	in	healthcare	delivery	via	mobile	phone	and	
the	potential	to	deliver	support	wherever	the	person	is	located,	whenever	it	is	needed,	
and	to	reach	populations	with	restricted	access	to	services.	Mobile	phone-based	
interventions	have	been	demonstrated	to	be	effective	in	other	health	areas,	but	not	
yet	in	the	field	of	contraception.		
In	2014,	we	undertook	computer	searches	for	randomised	trials	evaluating	mobile	
phone-based	interventions	to	increase	contraception	use.	We	found	five	trials.	Three	
trials	used	text	messaging	to	support	women	in	continuing	to	use	a	specific	method	of	
contraception.	Two	trials	aimed	to	improve	both	uptake	and	continued	use	of	
contraception	-	one	with	voice	and	one	with	text	messaging.	Our	review	provides	
limited	evidence	that	interventions	delivered	by	mobile	phone	improve	contraception	
use.	One	trial	in	the	USA	reported	that	women	were	more	likely	to	continue	to	take	
the	contraceptive	pill	from	an	intervention	comprising	a	range	of	educational	text	
messages.	One	trial	in	Cambodia	reported	increased	use	of	contraception	at	four	
months	post	abortion	from	an	intervention	comprising	voice	messages	and	phone	
counsellor	support.	Another	trial	in	the	USA	reported	improved	attendance	for	the	first	
but	not	subsequent	contraceptive	injection	appointments	from	an	intervention	
comprising	reminders	and	healthy	self	management	text	messages.	Simple	text	
message	contraceptive	pill	reminders	did	not	reduce	missed	pills	in	a	small	trial	in	the	
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USA.	No	difference	in	contraception	use	was	reported	amongst	users	of	isotretinoin	(a	
drug	used	for	acne)	from	an	intervention	that	provided	health	information	via	text	
messages	and	mail.		
In	conclusion,	evidence	indicates	that	a	series	of	voice	messages	and	counsellor	
support	can	improve	contraception	amongst	women	seeking	abortion	services	not	
wanting	to	get	pregnant	again	at	the	current	time,	and	data	suggest	that	daily	
educational	text	messages	can	improve	continued	use	of	the	contraceptive	pill.	
However,	the	cost	value	and	long-term	effectiveness	of	these	interventions	remain	
unknown.	More	good	quality	trials	are	needed	to	establish	the	effectiveness	of	
interventions	delivered	by	mobile	phone	to	increase	contraception	use.		
2.3	Background	
Rapid	expansion	in	the	use	of	mobile	phones	in	recent	years	has	had	a	dramatic	impact	
on	interpersonal	communication.	Within	the	health	domain,	phone	calls,	text	
messages	and	smartphone	applications	offer	new	means	of	communication	between	
service	providers	and	clients.	This	review	focuses	on	interventions	delivered	by	mobile	
phone	to	improve	contraception	use.		
Description	of	the	condition		
Contraception	-	methods	or	devices	used	to	prevent	pregnancy	-	provides	significant	
benefits	for	women’s	and	children’s	health.	Use	of	contraception	prevents	unintended	
pregnancies,	reduces	abortions	and	maternal	deaths	and	can	improve	perinatal	
outcomes	and	child	survival	by	widening	the	interval	between	successive	
pregnancies.(1)	Contraception	also	confers	substantial	social	and	economic	benefits	
such	as	improved	educational	and	employment	opportunities	for	women,	leading	to	
increasing	family	savings	and	economic	growth.(2)		
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Despite	these	benefits,	the	unmet	need	for	contraception	is	significant.	Unmet	need	
can	be	defined	as	women	not	using	a	modern	contraceptive	method	despite	wanting	
to	wait	two	or	more	years	to	give	birth,	or	wanting	no	more	children.(154)	The	total	
number	of	women	with	unmet	need	was	estimated	to	be	225	million	in	2014.(155)	
Women	report	not	using	contraception	for	many	reasons.	The	most	common	reasons	
for	non-use	are	concerns	about	health	and	side	effects	of	methods.(16)(87)(3)	Other	
important	barriers	include	lack	of	access	to	supplies	and	services,	as	well	as	factors	
outside	the	health	system	such	as	women’s	lack	of	education	or	empowerment.(155)		
If	the	unmet	need	for	modern	methods	of	contraception	were	met	amongst	women	in	
developing	countries,	the	number	of	unintended	pregnancies	would	be	reduced	by	52	
million	per	year.	This	reduction	in	unintended	pregnancies	would	avert	an	estimated	
24	million	abortions	(of	which	around	half	would	be	unsafe),	70,000	maternal	deaths	
and	500,000	newborn	deaths.(155)		
Description	of	the	intervention		
The	past	decade	has	seen	rapid	expansion	in	the	delivery	of	health-care	interventions	
via	mobile	phone.(112)	Interventions	delivered	by	mobile	phone	have	been	designed	
to	improve	health	outcomes	for	individuals	needing	acute	and	chronic	disease	
management	and	to	facilitate	health	promotion.	These	interventions	may	be	designed	
to	improve	medication	adherence,	encourage	appointment	attendance	or	promote	
behaviour	change.(115)(156)(124)	Interventions	delivered	by	mobile	phone	have	also	
provided	a	novel	means	of	delivering	patient	test	results.(157)	
Interventions	can	utilise	different	functions	of	mobile	phones	such	as	text	messages,	
voice	messages,	videos	and	applications;	may	involve	one-direction	or	two-way	
(interactive)	communication;(114)(116)	and	can	employ	single	functions	or	combined	
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functions	of	mobile	phones	such	as	interactive	text	message-based	support	or	voice	
messaging	combined	with	telephone	counselling.	Interventions	delivered	by	mobile	
phone	to	improve	contraception	use	could	be	provided	as	an	adjunct	or	alternative	to	
face-to-face	services	and,	for	non-users	of	contraception,	could	aim	to	increase	uptake	
of	contraception.	Interventions	for	existing	contraceptive	users	could	aim	to	improve	
adherence	to	contraception,	reduce	discontinuation	of	contraceptives	or	encourage	
switching	rather	than	stopping	contraceptives	if	the	individual	experiences	side	effects.		
How	the	intervention	might	work		
Interventions	delivered	by	mobile	phone	offer	potential	advantages	over	face-to-face	
or	landline	phone	healthcare	delivery,	as	support	can	be	delivered	wherever	the	
person	is	located,	and	whenever	it	is	needed.(158)	Such	interventions	can	facilitate	
confidential	access	to	healthcare	information	amongst	younger	populations,	who	are	
regular	mobile	phone	users.(159)(124)(160)	
Furthermore,	these	interventions	have	the	potential	to	reach	rural	populations,	for	
whom	geographical	distances	can	restrict	access	to	services.(161)	Intervention	content	
could	include	information,	pill	or	appointment	reminders	and/or	content	designed	to	
increase	or	maintain	motivation	to	use	contraception.	Behaviour	change	techniques	
used	in	face-to-face	interventions	can	be	modified	for	delivery	by	mobile	phone.(115)	
Interventions	could	utilise	a	range	of	behaviour	change	techniques,	such	as	
encouraging	women	to	make	a	clear	plan	about	when,	where	and	how	they	will	use	
contraception	(goal	setting).(104)	Multi-faceted	interventions	that	address	a	wide	
range	of	barriers	to	contraception	use	could	be	more	effective	than	those	targeting	
single	barriers	to	use.	Existing	adherence	research	suggests	that	multi-faceted	
interventions	can	be	effective	but	uni-faceted	interventions	provide	at	best	modest	
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benefits.(134)	Similarly,	no	evidence	indicates	that	medication	reminders	delivered	by	
mobile	phone	have	benefits	(pooled	risk	ratio	1.00,	95%	confidence	interval	0.77	to	
1.30),(115)	whilst	trials	of	more	complex	interventions	to	improve	adherence	to	
antiretroviral	medication	report	benefits.(115)(127)		
Several	potential	risks	are	associated	with	using	mobile	phones	to	improve	
contraception	use.	Road	traffic	accidents	are	the	only	adverse	health	effect	of	cell	
phone	use	for	which	evidence	is	available.(162)(163)(164)	However,	in	the	often	
sensitive	context	of	contraception,	the	potential	for	physical	or	psychological	adverse	
effects	could	arise	as	a	result	if	other	people	access	intervention	content	when	mobile	
phones	are	shared.	Further	risk	relates	to	the	opportunity	cost	of	investing	substantial	
resources	in	developing	a	technologically	focused	intervention	with	most	likely	a	
moderate	impact,	instead	of	investing	in	alternative	approaches.	Additional	challenges	
related	to	implementation	of	interventions	delivered	by	mobile	phone	include	limited	
literacy	of	target	populations,	incomplete	network	coverage,	phone	number	switching	
and	risk	of	incomplete	data	input	and	inaccurate	data	acted	upon.(141)(165)		
Why	it	is	important	to	do	this	review		
Interventions	delivered	by	mobile	phone	have	been	demonstrated	to	be	effective	in	
other	areas	such	as	smoking	cessation.(125)(123)(124)	When	interventions	delivered	
by	mobile	phone	have	been	shown	to	be	effective,	they	have	also	been	shown	to	be	
highly	cost-effective.(126)	However,	evidence	related	to	interventions	delivered	by	
mobile	phone	for	contraception	is	more	limited.		
In	recent	years,	interest	in	interventions	delivered	by	mobile	phone	has	been	growing,	
as	reflected	in	a	number	of	mobile	phone-based	contraception	initiatives	that	have	
been	launched,	and	in	some	cases	scaled	up,	such	as	Mobile	Technology	for	Improved	
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Family	Planning	(MOTIF),	mAssist,	Mobile	for	Reproductive	Health	(m4RH),	CycleTel	
and	Mobile	Alliance	for	Maternal	Action	(MAMA).(166)(149)(146)(147)(167)	Although	
these	initiatives	seem	promising,	each	uses	different	intervention	and	evaluation	
approaches,	and	the	effect	of	interventions	delivered	by	mobile	phone	on	
contraception	has	not	been	reliably	established.	Therefore	a	review	of	interventions	
delivered	by	mobile	phone	for	contraception	is	timely.		
Objectives	
To	assess	the	effects	of	mobile	phone-based	interventions	for	improving	contraception	
use.		
2.4	Methods	
Criteria	for	considering	studies	for	this	review		
Types	of	studies		
Randomised	controlled	trials	(RCTs).		
Types	of	participants		
Eligible	participants	were	men	or	women	of	reproductive	age	who	were	users	or	
potential	users	of	contraceptive	methods.	We	included	studies	in	all	settings	(e.g.	
primary	care	settings,	outpatient	settings,	community	settings,	hospital	settings).	We	
did	not	exclude	studies	according	to	the	types	of	healthcare	providers	who	
participated	(e.g.	doctor,	nurse,	allied	staff).		
Types	of	interventions		
We	included	studies	that	examined	any	type	of	client-provider	intervention	delivered	
by	mobile	phone	designed	to	improve	use	of	contraception	compared	with	standard	
delivery	of	care	or	another	intervention.	We	included	interventions	directed	at	both	
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users	and	non-users	of	contraception.	Eligible	interventions	included	those	designed	to	
do	the	following.	
• Improve	uptake	of	contraception	(including	post-abortion	and	post-partum	
contraception).	
• Promote	specific	methods	of	contraception.	
• Improve	adherence	to	contraception	(e.g.	interventions	to	support	individuals	
experiencing	side	effects,	reduce	discontinuation,	ensure	safe	method	
switching	or	send	pill	or	appointment	reminders).		
We	included	interventions	aimed	at	mobile	phone	users	delivered	by	mobile	phone	
that	included	some	degree	of	automation,	for	example,	text	message,	voice	message	
and	applications.	We	excluded	trials	in	which	mobile	phones	were	used	for	two-way	
voice	communication	(as	a	phone)	alone,	in	keeping	with	previous	reviews	of	mobile	
phone-based	interventions.(123)(124)	Web-based	interventions	often	can	be	accessed	
on	mobile	phones,	as	well	as	through	other	platforms,	but	in	practice	can	be	difficult	to	
access	via	mobile	phone	unless	they	are	adapted	for	mobile	phone	use.	We	excluded	
web-based	interventions	unless	study	authors	stated	that	they	had	been	intended	or	
adapted	for	mobile	phone	users.	We	excluded	trials	that	focused	only	on	preventing	
sexually	transmitted	disease	rather	than	providing	contraception.		
Types	of	outcome	measures		
Primary	outcomes		
• Uptake	of	contraception	(including	post-abortion	and	post-partum	
contraception).	
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• Uptake	of	a	specific	method	of	contraception	(e.g.	a	long-acting	method4).	
• Adherence	to	contraceptive	method	(e.g.	number	of	missed	pills,	attendance	
for	repeat	injection).	
• Safe	method	switching	(e.g.	from	one	effective	method	to	another	with	no	
gap).	
• Discontinuation	of	contraception.	
• Pregnancy	or	abortion	(objectively	measured	or	self	reported).		
Secondary	outcomes		
• Road	traffic	accidents	-	the	only	adverse	health	effect	of	cell	phone	use	for	
which	evidence	is	available.(164)	
• Any	physical	or	psychological	effect	reported.		
We	included	studies	that	assessed	any	form	of	contraceptive	use	and	trials	assessing	a	
range	of	outcome	measures	related	to	contraceptive	use,	including	uptake	of	
contraception,	selection	of	a	specific	method,	use	of	measures	of	adherence	(including	
discontinuation	and	safe	switching),	pregnancy	or	abortion.		
We	considered	sustained	and	point	prevalence	measures	as	well	as	subjective	(self	
reported)	and	objective	(e.g.	biochemically	verified,	electronic	medication	monitors	
used,	clinical	examination	performed)	assessment	of	contraception	use.		
Contraceptive	methods	can	be	classified	in	different	ways.	Contraception	can	be	
classed	as	modern	(e.g.	condom,	oral	contraceptive	pills,	injectables,	intrauterine	
device,	implant,	emergency	contraception)	or	traditional	(e.g.	rhythm	or	periodic	
abstinence,	withdrawal.(3)(6)	Furthermore,	distinctions	can	be	made	between	
hormonal	and	non-hormonal	methods,	and	between	short-acting	and	long-acting	or	
																																																						
4	The	definition	of	‘long-acting’	method	would	be	based	on	the	study	author’s	description	
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permanent	methods.	The	World	Health	Organization	(WHO)	classifies	methods	
according	to	effectiveness	on	the	basis	of	estimated	rates	of	unintended	pregnancy	
per	100	women	per	year.(6)	For	this	review,	we	define	effective	modern	methods	as	
those	associated	with	<	10%	12-month	pregnancy	rates;	commonly	used	methods	
include	oral	contraceptive,	injectable,	implant,	intrauterine	device	and	permanent	
methods.		
Search	methods	for	identification	of	studies		
Electronic	searches		
We	searched	the	following	electronic	databases	between	6	and	9	October	2014.		
• Cochrane	Central	Register	of	Controlled	Trials	(CENTRAL)	
• MEDLINE	using	Ovid	
• EMBASE	using	Ovid	
• Global	Health	using	Ovid	
• PsycINFO	using	Ovid	
• Population	Information	Online	(POPLINE)	
• Africa-Wide	Information	
• Latin	American	Caribbean	Health	Sciences	Literature	(LILACS)		
We	included	Africa-Wide	Information	and	LILACS,	given	the	proliferation	of	mobile	
phone-based	initiatives	in	low-	and	middle-income	regions.	We	searched	for	recent	
clinical	trials	separately	via	the	WHO	International	Clinical	Trials	Registry	Platform	
(www.who.int/trialsearch)	and	Current	Controlled	Trials	(www.controlled-trials.com),	
which	included	clinicaltrials.gov.		
We	searched	for	studies	published	in	all	languages	from	January	1993	until	the	present	
(i.e.	the	date	of	the	search),	as	the	first	text	message	was	sent	in	December	1992.(108)	
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We	presented	in	Table	9	the	electronic	database	search	strategies	that	we	used.		
Searching	other	resources		
We	wrote	to	the	contact	investigators	of	included	studies	to	request	additional	
information	about	studies	when	required,	as	well	as	information	about	trials	not	
discovered	in	our	search.	To	identify	completed	or	on-going	studies	that	had	not	been	
identified	in	the	electronic	searches,	we	reviewed	abstracts	from	the	mHealth	summit,	
Women	Deliver	and	the	International	Conference	on	Family	Planning.	We	also	
reviewed	online	repositories	of	mHealth	interventions	including	Health	Unbound,	
Royal	Tropical	Institute,	mHealthinfo,	K4Health	and	mHealth	Evidence.		
Data	collection	and	analysis		
Selection	of	studies		
We	exported	search	results	into	a	software	programme	for	bibliographic	citation	
management	and	excluded	duplicate	references.	Two	review	authors	independently	
screened	titles	and	abstracts	of	studies	retrieved	using	the	search	strategy.	We	
retrieved	full	articles	for	further	assessment	if	the	information	given	suggested	that	
the	study	(1)	included	participants	who	were	users	or	potential	users	of	contraception,	
(2)	compared	use	of	an	intervention	delivered	by	mobile	phone	versus	routine	
standard	of	care	or	another	intervention	or	(3)	assessed	one	or	more	relevant	
outcome	measures.	If	we	had	any	doubt	regarding	these	criteria	from	the	information	
provided	in	the	title	and	abstract,	we	retrieved	the	full	article	for	clarification.	Two	
review	authors	retrieved	the	full	text	of	potentially	eligible	studies	and	independently	
assessed	them	for	eligibility,	with	disagreements	resolved	through	discussion	with	a	
third	review	author.		
Data	extraction	and	management		
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Two	review	authors	independently	extracted	the	following	data	from	the	included	
studies	using	a	standardised	data	extraction	form.	
• General	information:	title,	study	authors,	complete	citation,	publication	status,	
date	published,	language,	review	author	information,	date	reviewed,	
sponsoring,	setting.	
• Study	characteristics:	study	design,	aim	of	study,	duration,	participant	
recruitment,	sampling,	inclusion	and	exclusion	criteria	including	numbers	
screened	and	eligible,	randomisation,	allocation	concealment,	method	of	
allocation	concealment,	blinding,	informed	consent,	power	analysis.	
• Risk	of	bias	(see	Table	4).	
• Participants:	description,	geographical	location,	setting,	number,	age,	ethnicity,	
socioeconomic	status	distribution.	
• Providers:	description,	geographical	location,	setting.	
• Intervention:	description,	aim	of	intervention,	any	behaviour	change	
intervention	(according	to	the	study	authors’	description	and	our	assessment	
according	to	an	established	typology	of	behaviour	change	techniques),(104)	
duration,	frequency	and	’dose’,	control	or	placebo	intervention,	technical	
specifications	including	device	and	mobile	phone	functions	used	(e.g.	text	
message,	voice	message),	message	content,	co-interventions.	
• Outcomes:	outcomes	as	specified	above,	other	outcomes	assessed,	length	of	
follow-up,	methods	used	to	assess	outcomes,	completeness	of	outcome	data,	
follow-up	for	non-respondents,	adverse	events.	
• Results:	outcomes	and	times	of	assessment,	intention-to-	treat	analysis	(when	
all	randomly	assigned	participants	are	included,	irrespective	of	what	happened	
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subsequently).(168)		
Review	authors	discussed	disagreements	and	resolved	them	through	discussion	with	a	
third	review	author	as	necessary.		
Assessment	of	risk	of	bias	in	included	studies		
Review	authors	assessed	studies	for	risk	of	bias	in	accordance	with	the	Cochrane	
Handbook	for	Systematic	Reviews	of	Interventions,(169)	across	the	following	domains:	
random	sequence	generation,	allocation	concealment,	blinding	of	outcome	
assessment,	incomplete	outcome	data,	selective	outcome	reporting	and	other	
potential	biases.	Two	review	authors	independently	assessed	risk	of	bias,	discussed	
disagreements	and	resolved	them	through	discussion	with	a	third	review	author	as	
necessary.	We	used	a	standardised	form	to	guide	assessment	of	risk	of	bias,	and	
judged	each	domain	as	having	’high’,	’low’	or	’unclear’	risk.	We	presented	all	included	
studies	by	study	type	and	risk	of	bias	level.	As	required,	we	contacted	study	authors	to	
ask	for	additional	information.	We	presented	the	results	of	the	risk	of	bias	assessment	
in	tables	in	Table	4,	and	as	a	systematic	narrative	description.		
Measures	of	treatment	effect		
We	used	risk	ratios	(RRs)	as	measures	of	treatment	effect	for	dichotomous	outcomes,	
and	mean	differences	(MDs)	for	continuous	outcomes.	We	reported	95%	confidence	
intervals	(CIs)	with	all	measures	of	effect.		
Unit	of	analysis	issues		
We	planned	to	take	into	account	unit	of	analysis	issues	resulting	from	cluster	RCTs,	
repeated	measurements	and	studies	with	more	than	one	treatment	group	and,	if	
appropriate,	to	analyse	data	in	accordance	with	recommendations	of	the	Cochrane	
Handbook	for	Systematic	Reviews	of	Interventions.(169)	However,	we	did	not	identify	
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any	unit	of	analysis	issues.		
Dealing	with	missing	data		
We	planned	to	assess	missing	data	on	individuals	as	guided	by	the	Cochrane	Handbook	
for	Systematic	Reviews	of	Interventions.	We	would	ignore	missing	data	if	they	were	
assumed	to	be	missing	at	random.	If	feasible,	we	planned	to	contact	study	authors	to	
ask	for	missing	data	when	it	was	assumed	that	they	were	not	missing	at	random,	for	
example,	if	some	randomly	assigned	participants	were	excluded	from	analyses.	If	
feasible,	we	planned	to	use	statistical	techniques,	as	appropriate	to	each	study,	to	
impute	missing	data	to	enable	an	available	case	or	intention-to-treat	analysis.(169)	For	
missing	summary	data,	if	feasible,	we	planned	to	approximate	the	correct	analyses	to	
impute	missing	summary	statistics	(e.g.	standard	deviations),	in	accordance	with	the	
Cochrane	Handbook	for	Systematic	Reviews	of	Interventions.(169)		
Assessment	of	heterogeneity		
We	did	not	undertake	a	meta-analysis,	as	the	studies	identified	were	so	different	in	
terms	of	both	interventions	and	outcome	measures.		
Assessment	of	reporting	biases		
We	did	not	assess	reporting	biases	statistically,	as	the	studies	identified	were	so	
different	in	terms	of	both	interventions	and	outcome	measures.		
Data	synthesis		
We	conducted	statistical	analysis	according	to	the	guidelines	provided	in	the	Cochrane	
Handbook	for	Systematic	Reviews	of	Interventions.(169)	We	presented	a	narrative	
overview	of	the	findings,	together	with	tabular	summaries	of	extracted	data.	
Differences	in	study	populations,	interventions,	comparators	and	outcomes	precluded	
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us	from	pooling	data	across	studies	to	estimate	summary	effect	sizes.	We	used	the	
Mantel-Haenszel	risk	ratio	fixed-effect	model	for	dichotomous	data	and	mean	
differences	(MDs)	for	continuous	data.	When	meta-analysis	was	not	possible,	we	
presented	summary	and	descriptive	statistics.		
We	summarised	the	quality	of	evidence	provided	by	studies	using	the	GRADE	(Grades	
of	Recommendation,	Assessment,	Development	and	Evaluation)	approach	while	
considering	factors	that	decrease	the	quality	level	of	a	body	of	evidence.(169)	
Randomised	controlled	trials	were	considered	of	high	quality	and	were	downgraded	by	
one	level	(serious)	or	two	levels	(very	serious)	for	each	of	the	following	reasons.	
• Limitations	in	design	and	implementation	(e.g.	lack	of	blinding,	large	losses	to	
follow-up).	
• Indirectness	of	evidence	(e.g.	trials	that	meet	eligibility	criteria	but	address	a	
restricted	version	of	the	main	review	question	in	terms	of	population,	
intervention,	comparator	or	outcomes).	
• Unexplained	heterogeneity	or	inconsistency	of	results	(e.g.	when	heterogeneity	
exists	and	affects	interpretation	of	results,	but	study	authors	fail	to	identify	a	
plausible	explanation).	
• Imprecision	of	results	(e.g.	when	studies	include	few	participants	and	thus	have	
wide	confidence	intervals).	
• High	probability	of	publication	bias	(e.g.	if	investigators	failed	to	report	studies	
or	outcomes	on	the	basis	of	results).		
Subgroup	analysis	and	investigation	of	heterogeneity		
We	planned	to	perform	subgroup	analyses	if	one	of	the	primary	outcome	parameters	
demonstrated	statistically	significant	differences	(at	P	value	<	0.01)	between	
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treatment	groups.	These	would	have	included	meta-analyses	on	studies	amongst	
specific	populations,	specifically,	younger	versus	older	women;	high-income	versus	
low-income	settings;	and	post	delivery	versus	post	abortion	versus	general	clinic	
attendees.	However,	we	did	not	identify	studies	appropriate	for	this	subgroup	analysis.	
We	did	not	identify	studies	promoting	traditional	contraceptive	methods;	therefore	we	
did	not	undertake	the	planned	subgroup	analysis	including	only	modern	methods,	or	
methods	considered	effective	or	very	effective	by	the	WHO.(6)		
Sensitivity	analysis		
We	did	not	identify	a	sufficient	number	of	studies	to	perform	the	following	sensitivity	
analyses.	
• Repeating	the	analysis	while	excluding	unpublished	studies	to	investigate	
potential	publication	bias	resulting	from	publication	or	non-publication	of	
research	findings,	depending	on	the	nature	and	direction	of	the	results.(169)	
• Repeating	the	analysis	while	taking	account	of	risk	of	bias	of	included	studies,	
as	specified	above.		
2.5	Results	
Description	of	studies		
Results	of	the	search		
We	conducted	searches	during	October	2014	and	produced	759	records	after	
removing	duplicates.	We	discarded	683	records	after	review	of	titles	and	abstracts.	We	
assessed	76	full-text	articles	for	eligibility.	See	Figure	5	for	the	study	flowchart.		
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Figure	5:	Study	flow	diagram	
	
We	identified	four	on-going	studies	(see	Table	3).	
Table	3:	Characteristics	of	on-going	studies	
Johnson	2014		 	
Trial	name	or	title		 Randomised	Controlled	Trial	Evaluation	of	m4RH		
Methods	 Randomised	Controlled	Trial	
Participants	 Users	or	potential	users	of	contraception	who	registered	for	m4RH	with	a	text	
message		
Interventions	 m4RH	text	messaging	intervention	
Outcomes		 Contraceptive	knowledge	and	use	
Starting	date	 2014	
Contact	information	 Pamela	Riley:	Pamela	riley@abtassoc.com		
Notes	 	
NCT01401816		 	
Trial	name	or	title	 Advanced	Provision	of	Emergency	Contraception:	Utilising	Technology	to	
Increase	Prescription	Fill	Rates		
Methods	 Pilot	randomised	controlled	trial	(n	=	60)	of	a	text	messaging	intervention		
Participants	 Sexually	active	female	adolescents	13	to	21	years	of	age	who	have	been	
provided	with	a	prescription	for	emergency	contraception		
Interventions	 Follow-up	text	message	on	the	phone	to	remind	them	to	fill	the	prescription		
Outcomes	 Primary	outcome:	prescription	fill	rates.	Secondary	outcomes:	sexual	activity,	
contraception	use,	risk	of	pregnancy,	knowledge	of	emergency	contraception	
Starting	date	 July	2011		
Contact	information	 Tracey.a.wilkinson@gmail.com	
1,488	records	
iden.ﬁed	through	
database	searching	
24	addi.onal	records	
iden.ﬁed	through	
other	sources	
759	records	a;er	
duplicates	removed	
759	records	screened	 683	records	excluded	
76	full-text	ar.cles	
assessed	for	eligibility	
71	full-text	ar.cles	
excludes	
5	studies	included	in	
qualita.ve	synthesis	
0	studies	included	in	
quan.ta.ve	synthesis	
(meta-analysis)	
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Notes		 	
NCT01545609		 	
Trial	name	or	title	 A	Text	Message	Support	System	for	Effective	Continuation	of	a	Birth	Control	
Method	in	Female	Adolescents:	’BC	2U’:	NCT01545609		
Methods	 Randomised	controlled	trial	(n	=	220)		
Participants	 Inner	city,	minority	adolescent	females	(15	to	19	years	of	age),	English	
speaking,	owner	of	a	working	cell	phone,	wanting	to	start	a	birth	control	
method	and	not	on	a	method	for	the	preceding	3	months,	no	
contraindications	to	initiating	a	birth	control	method		
Interventions	 Intervention:	tailored	text	messages	about	their	method	of	contraception		
Outcomes	 Primary	outcome:	continuation	of	a	birth	control	method	at	4	months.	
Secondary	outcomes:	change	in	birth	control	method	used,	pregnancy		
Starting	date	 March	2012		
Contact	information	 Jf2815@cumc.columbia.edu		
Notes	 Expect	publication	in	2015		
NCT02093884		 	
Trial	name	or	title	 A	Pilot	Study	Using	Text	Messaging	to	Communicate	With	Adolescent	Females	
in	the	Pediatric	Emergency	Department	T2	
Methods	 Pilot	randomised	controlled	trial	(n	=	100)	using	text	messaging	vs.	standard	
care	to	increase	contraceptive	use	
Participants	 Adolescent	females	at	high	risk	of	pregnancy	in	the	emergency	department	
who	are	potential	users	of	contraception	(high	risk	of	pregnancy	is	defined	as	
sexually	active	in	the	past	3	months	and	did	not	use	effective	contraception	at	
last	intercourse	and	is	not	on	it	now)	
Interventions	 Intervention:	3	months	of	31	random	text	messages	developed	from	
qualitative	interviews.	Standard	care:	paper	wallet	card	advertising	family	
planning	clinic		
Outcomes	 Primary	outcome:	initiation	of	highly	effective	contraception.	Secondary	
outcomes:	follow-up,	condom	use,	contraception	counselling	
Starting	date	 2014	
Contact	information	 Lauren	S	Chernick:	lc2243@cumc.columbia.edu	
Notes	 Expect	publication	in	2015	
Included	studies		
We	identified	five	randomised	controlled	trials	that	fulfilled	the	inclusion	criteria	
(Castano	2012;	Hou	2010;	Smith	2014;	Trent	2013;	Tsur	2008)	(see	Table	
4).(142)(143)(170)(144)(171)	Three	trials	were	conducted	in	the	USA	(Castano	2012;	
Hou	2010;	Trent	2013),	one	in	Israel	(Tsur	2008)	and	one	in	Cambodia	(Smith	2014).	
One	was	multi-site	(Smith	2014),	and	four	were	single-site	(Castano	2012;	Hou	2010;	
Trent	2013;	Tsur	2008).	Three	trials	recruited	participants	from	urban	clinics	(Castano	
2012;	Hou	2010;	Trent	2013),	one	trial	from	clinics	serving	both	urban	and	rural	
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populations	(Smith	2014)	and	one	trial	from	individuals	who	phoned	an	advice	line	
(Tsur	2008).	All	trials	included	only	female	participants.	Two	trials	focused	on	youth	
populations	(Castano	2012;	Trent	2013),	and	three	included	younger	and	older	women	
of	reproductive	age	(Hou	2010;	Smith	2014;	Tsur	2008).	Two	trials	recruited	new	users	
of	OC	(Castano	2012;	Hou	2010),	one	recruited	existing	injectable	users	(Trent	2013)	
and	two	recruited	both	users	and	non-users	of	contraception	(Smith	2014;	Tsur	2008).		
Table	4:	Characteristics	of	included	studies	
Castano	2012	
Methods	 Individual	randomised	controlled	trial.	Estimated	6-month	continuation	rate	in	
the	control	group	of	40%	and	that	a	sample	size	of	960	would	be	required	to	
detect	a	10%	change	in	OC	continuation,	with	80%	power	at	a	0.05	level	of	
significance,	anticipating	15%	loss	to	follow-up	
Participants	 962	sexually	active	females	13	to	25	years	of	age	electing	to	use	OC	at	a	
Planned	Parenthood	family	planning	health	centre	in	downtown	Brooklyn,	New	
York,	USA	
Interventions	 Control	group:	routine	care	including	contraceptive	counselling	by	staff	and	an	
educational	information	handout	detailing	use,	effectiveness,	benefits	and	
risks	Intervention	group:	routine	care	plus	automated	mobile	phone-based	
intervention	comprising	180	daily	text	messages	aiming	to	improve	OC	
continuation.	This	included	an	introductory	message,	3	reminders	of	how	to	
change	contact	information	or	message	time,	47	individual	educational	
messages,	repeated	up	to	4	times,	which	incorporated	6	domains	of	OC	
knowledge	(risks,	benefits,	side	effects,	use,	effectiveness	and	mechanisms	of	
action),	12	two-way	messages	for	quality	control	and	a	final	message.	
Intervention	duration	was	180	days	
Outcomes	 Primary	outcome:	self	reported	OC	continuation	(participant	had	taken	OC	
within	previous	7	days).	Secondary	outcomes:	missed	pills,	interruptions	in	OC	
use	>	7	days,	use	of	OC	at	last	sexual	intercourse.	All	outcomes	assessed	by	
phone	6	months	after	enrolment	
Behaviour	change	
techniques	
As	defined	by	study	authors:	The	educational	messages	incorporated	6	domains	
of	OC	knowledge:	risks,	benefits,	side	effects,	use,	effectiveness	and	
mechanisms	of	action	According	to	Abraham	and	Michie’s	typology:	4	
behaviour	change	techniques	used	(see	Table	5)	
Notes	 Loss	to	follow-up:	28%	in	the	intervention	group	and	30%	in	the	control	group	
Risk	of	bias	
Bias	 Authors’	
judgement	
Support	for	judgement	
Random	sequence	
generation	(selection	
bias)		
Low	risk	 Random	number	table	used	to	generate	the	sequence		
Allocation	
concealment	
(selection	bias)	
Low	risk	 Sequentially	numbered,	opaque,	sealed	envelopes	used		
Blinding	of	
participants	and	
High	risk	 No	blinding	possible;	outcome	may	have	been	influenced	by	
lack	of	blinding		
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personnel	
(performance	bias).	
All	outcomes		
Blinding	of	outcome	
assessment	
(detection	bias).	All	
outcomes	
High	risk	 Outcome	assessors	not	blinded,	as	participants	were	asked	
about	satisfaction	with	the	intervention	
Incomplete	outcome	
data	(attrition	bias)	
All	outcomes	
Low	risk	 Main	reason	for	incomplete	data	unlikely	to	be	related	to	
outcome	
Selective	reporting	
(reporting	bias)	
Unclear	risk	 Primary	outcome	of	contraceptive	continuation	stated	in	the	
clinicaltrials.gov	entry	but	insufficient	detail	on	pre-specified	
measurements	
Other	bias	 High	risk	 Possibility	of	detection	(social	desirability	or	recall)	bias	with	
self	report	measures	of	contraception	use	
Hou	2010	
Methods	 Individual	randomised	controlled	trial.	Estimated	an	average	of	2.6	missed	pills	
per	cycle	in	the	control	group,	and	that	a	sample	size	of	68	would	be	required	
to	detect	a	1.6	pill	improvement	with	standard	deviation	of	2	pills,	with	90%	
power	at	a	0.05	level	of	significance,	anticipating	15%	loss	to	follow-up	
Participants	 103	women	enrolled	to	the	study	and	82	randomly	assigned	after	a	1	month	
run-in	period.	82	sexually	active	females	electing	to	start	using	OC,	seeking	care	
at	Planned	Parenthood	League	of	Massachusetts,	USA.	Mean	age	of	22	years	
(range	18	to	31)	
Interventions	 Control	group:	routine	care	according	to	standard	clinic	protocol	(not	stated)	
during	1	month	run-in	period.	Women	in	the	control	group	did	not	receive	text	
message	reminders	Study	authors	reported	a	high	rate	of	reminder	system	use	
in	the	control	group,	particularly	electronic	systems	such	as	cell	phone	alarms	
that	mimicked	the	study	intervention.		
Intervention	group:	routine	care	according	to	standard	clinic	protocol	(not	
stated)	during	1	month	run-in	period	plus	an	automated	daily	text	message	
aiming	to	improve	OC	adherence,	“Please	remember	to	take	your	birth	control	
pill,”	sent	at	a	designated	time	chosen	by	the	participant	over	the	3	month	
study	period	
Outcomes	 Number	of	missed	pills	per	cycle	(assessed	over	3	months)	assessed	with	
electronic	monitoring	device	and	patient	diary	
Behaviour	change	
techniques	
As	defined	by	study	authors:	not	described	
	According	to	Abraham	and	Michie’s	typology:	3	behaviour	change	techniques	
used	(see	Table	5)	
Notes	 Loss	to	follow-up:	12%	intervention	and	10%	control	
Risk	of	bias	
Bias	 Authors’	
judgment	
Support	for	judgement	
Random	sequence	
generation	(selection	
bias)	
Low	risk	 Computer-generated	randomisation	
Allocation	
concealment	
(selection	bias)	
Low	risk	 Sequentially	numbered,	opaque,	sealed	envelopes	
Blinding	of	
participants	and	
personnel	
(performance	bias).	
High	risk	 No	blinding	possible;	outcome	may	have	been	influenced	by	
lack	of	blinding.	Increased	use	of	reminders	in	the	control	
group	suggests	that	allocation	to	intervention	or	control	group	
may	have	altered	behaviour	
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All	outcomes	
Blinding	of	outcome	
assessment	
(detection	bias).	All	
outcomes	
Low	risk	 Investigator	blinded	
Incomplete	outcome	
data	(attrition	bias)	
All	outcomes	
Low	risk	 Reason	for	missing	data	(mechanical	and	technological	issues)	
unlikely	to	be	related	to	true	outcome	
Selective	reporting	
(reporting	bias)	
Unclear	risk	 Primary	and	secondary	outcomes	stated	in	the	
clinicaltrials.gov	entry,	but	insufficient	detail	on	pre-specified	
measurements	and	subgroup	analyses	
Other	bias	 Low	risk	 Study	appears	to	be	free	of	other	sources	of	bias	(electronic	
medication	monitor	used	to	assess	outcome)	
Smith	2014	
Methods	 Individual	randomised	controlled	trial.	Estimated	that	use	of	effective	
contraception	at	4	months	would	be	35%	in	the	control	group,	and	a	sample	
size	of	500	would	be	required	to	detect	a	13%	improvement	in	contraceptive	
use,	with	90%	power	at	a	0·05	level	of	significance	
Participants	 500	participants;	females	18	years	of	age	or	older,	with	a	mobile	phone	
primarily	for	their	own	use,	reporting	not	wanting	to	be	pregnant,	willing	to	
receive	automated	voice	messages	related	to	contraception,	attending	for	
induced	abortion	at	4	Marie	Stopes	International	clinics	in	Cambodia	
Interventions	 Control	group:	routine	care,	which	included	post-abortion	family	planning	
counselling	at	the	clinic	in	accordance	with	national	guidelines,	the	offer	of	a	
clinic	follow-up	appointment,	the	clinic	phone	number	and	the	Hotline	number	
operated	by	counsellors	at	MSI	Cambodia		
Intervention	group:	routine	care	plus	a	mobile	phone-based	intervention	
aiming	to	improve	uptake	and	adherence	comprising	6	automated,	interactive	
voice	messages,	counsellor	delivered	phone	support	according	to	response	to	
messages	and	additional	reminder	messages	for	OC	or	injectable	users		
Outcomes	 Primary	outcome:	self	reported	effective	contraception	use	at	4	months	post	
abortion.	Secondary	outcomes:	use	of	long-acting	contraception	(intrauterine	
device,	implant,	permanent	method),	repeat	pregnancy,	abortion,	
contraceptive	use	over	the	4	month	post-abortion	period	>	80%,	road	traffic	
accident	and	domestic	abuse.	All	outcomes	assessed	by	phone	at	4	months	(12	
month	follow-up	is	planned)	
Behaviour	change	
techniques	
As	defined	by	study	authors:	Phone	calls	aimed	to	support	contraceptive	use	by	
addressing	participants’	capability	to	use	contraception	by	providing	
individualised	information	on	a	range	of	contraceptive	methods,	opportunity	to	
use	contraception	(e.g.	informing	participants	where	they	could	access	specific	
methods	near	to	their	residence)	and	motivation	by	re-enforcing	the	benefits	of	
contraception	use.		
According	to	Abraham	and	Michie’s	typology:	5	behaviour	change	techniques	
used	(see	Table	5)	
Notes	 Loss	to	follow-up:	15%	in	the	intervention	group	and	12%	in	the	control	group.	
Risk	of	bias	
Bias	 Authors’	
judgement	
Support	for	judgment	
Random	sequence	
generation	(selection	
bias)	
Low	risk	 Computer-based	randomisation	programme	used	
Allocation	
concealment	
Low	risk	 Web-based	allocation	performed	after	enrolment	
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(selection	bias)	
Blinding	of	
participants	and	
personnel	
(performance	bias).	
All	outcomes	
High	risk	 No	blinding	possible;	outcome	may	have	been	influenced	by	
lack	of	blinding	
Blinding	of	outcome	
assessment	
(detection	bias).	All	
outcomes	
Low	risk	 Researchers	who	undertook	data	collection	and	analysis	were	
masked	to	treatment	allocation	
Incomplete	outcome	
data	(attrition	bias)	
All	outcomes	
Low	risk	 Missing	outcome	data	balanced	in	numbers	across	
intervention	groups.	Reasons	for	missing	data	unlikely	to	be	
related	to	true	outcome	
Selective	reporting	
(reporting	bias)	
Low	risk	 Study’s	pre-specified	(primary	and	secondary)	outcomes	have	
been	reported	as	pre-specified	in	the	published	study	protocol	
Other	bias	 High	risk	 Possibility	of	detection	(social	desirability	or	recall)	bias	with	
self	report	measures	of	contraception	use	
Trent	2013	
Methods	 Pilot	individual	randomised	controlled	trial	(primarily	a	feasibility	and	
acceptability	trial)	
Participants	 100	female	adolescents	(13	to	21	years	of	age)	recruited	from	an	urban	
academic	practice	in	a	high	teen	and	unplanned	pregnancy	prevalence	
community	in	the	USA,	currently	using	Depo-Provera,	with	a	cell	phone	with	
text	messaging	capability	for	personal	use.	Most	participants	were	African	
American	and	resided	in	low	income,	single	parent,	mother-headed	households	
Interventions	 Control	group:	clinic	protocol	for	standard	care,	which	included	participant-
initiated	support	and	clinical	nursing	outreach	for	missed	
appointments	Intervention	group:	routine	care	plus	automated	intervention	
aimed	to	improve	follow-	up	Depo-Provera	clinic	attendance	and	comprised	a	
welcome	message,	daily	text	appointment	reminders	starting	72	hours	before	
the	clinic	visit	with	the	option	to	cease	messages	by	responding	(yes	or	no)	with	
their	plans	to	attend	the	visit.	Intervention	adolescents	also	received	
prescheduled	health	messages	over	the	course	of	the	3	month	enrolment	
period	regarding	condom	use	for	STI	prevention,	healthy	weight	management,	
encouragement	to	call	the	nurse	for	problems	and	an	STI	screening	reminder.	
All	message	signatures	indicated	that	they	were	from	the	nurse	case	manager	
to	build	relationships	with	the	clinical	team	
Outcomes	 Primary	outcome:	days	between	next	scheduled	appointment	and	attendance	
for	Depo-Provera	injection	over	3	cycles	(9	months).	Secondary	outcome:	on-
time	appointment	for	Depo-Provera	injection	over	3	cycles	(9	months)	
Behaviour	change	
techniques	
As	defined	by	study	authors:	not	described	
	According	to	Abraham	and	Michie’s	typology:	2	behaviour	change	techniques	
used	(see	Table	5)	
Notes	 Information	from	abstract	and	additional	communication	with	investigator.	Full	
text	not	yet	published		
Loss	to	follow-up:	12%	in	the	intervention	group	and	14%	in	the	control	group	
Risk	of	bias	
Bias	 Authors’	
judgment	
Support	for	judgment	
Random	sequence	
generation	(selection	
bias)	
Low	risk	 Randomisation	by	permitted	block	design	(according	to	
investigator’s	communication)	
Allocation	 Low	risk	 Allocation	sealed	in	envelope	for	nurse	until	informed	consent	
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concealment	
(selection	bias)	
to	participate	(according	to	investigator’s	communication)	
Blinding	of	
participants	and	
personnel	
(performance	bias).	
All	outcomes	
High	risk	 No	blinding	possible;	outcome	may	have	been	influenced	by	
lack	of	blinding	
Blinding	of	outcome	
assessment	
(detection	bias).	All	
outcomes	
Low	risk	 PI	blinded	to	allocation	(according	to	investigators’	
communication)	
Incomplete	outcome	
data	(attrition	bias)	
All	outcomes	
Low	risk	 Missing	outcome	data	balanced	in	numbers	across	
intervention	groups.	Reasons	for	missing	data	unlikely	to	be	
related	to	true	outcome	
Selective	reporting	
(reporting	bias)	
Low	risk	 Primary	outcome	pre-specified	in	the	clinicaltrials.gov	record	
Other	bias	 Low	risk	 Study	appears	to	be	free	of	other	sources	of	bias	
Tsur	2008	
Methods	 Individual	randomised	controlled	trial.	Estimated	that	use	of	contraception	
would	be	50%	in	the	control	group,	and	a	sample	size	of	100	would	be	required	
to	detect	30%	improvement	in	contraceptive	use,	with	80%	power	at	a	0·05	
level	of	significance	
Participants	 108	females	of	reproductive	age	(16	to	45	years	of	age),	some	users	and	some	
not	users	of	contraception,	using	or	planning	to	use	isotretinoin	(a	drug	for	
acne),	who	phoned	the	Drug	Consultation	Centre	at	Assaf	Harofeh	Medical	
Center	in	Israel	seeking	advice	regarding	isotretinoin	
Interventions	 Control	group:	Routine	care	comprised	information	on	Isotretinoin	including	
contraceptive	use	only	during	the	initial	interview.	Intervention	group:	
automated	intervention	aimed	to	increase	contraception	use	and	comprised	
routine	care	plus	additional	information	about	teratogenic	risk	and	the	
importance	of	contraceptive	use	in	mailed	written	form	and	by	text	messages	
sent	to	cellular	phones	1	month	and	2	months	after	the	initial	call	
Outcomes	 Primary	outcome:	contraceptive	use	in	women	taking	isotretinoin	(methods	of	
contraception	not	stated).	Secondary	outcomes:	use	of	2	contraceptives,	sexual	
activity,	contraceptive	use	amongst	sexually	active	participants.	All	outcomes	
assessed	by	phone	call	at	3	months	
Behaviour	change	
techniques	
As	defined	by	study	authors:	not	described	
According	to	Abraham	and	Michie’s	typology:	2	behaviour	change	techniques	
used	(see	Table	5)	
Notes	 5	participants	(5%)	lost	to	follow-up	at	3	months	and	not	included	in	the	final	
analysis.		
Differential	loss	to	follow-up	between	intervention	and	control	groups	not	
stated	
Risk	of	bias	
Bias	 Authors’	
judgment	
Support	for	judgment	
Random	sequence	
generation	(selection	
bias)	
Low	risk	 Computer-generated	random	numbers	kept	in	sealed	
envelopes	
Allocation	
concealment	
(selection	bias)	
Unclear	risk	 Method	of	allocation	concealment	not	described	in	adequate	
detail.	Sealed	envelopes	used,	but	unclear	whether	they	were	
sequentially	numbered	and	opaque	
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Blinding	of	
participants	and	
personnel	
(performance	bias).	
All	outcomes	
High	risk	 No	blinding	possible;	outcome	may	have	been	influenced	by	
lack	of	blinding	
Blinding	of	outcome	
assessment	
(detection	bias).	All	
outcomes	
Unclear	risk	 Insufficient	information	on	whether	outcome	assessors	were	
aware	of	allocation	
Incomplete	outcome	
data	(attrition	bias)	
All	outcomes	
Low	risk	 Missing	outcome	data	balanced	in	numbers	across	
intervention	groups	
Selective	reporting	
(reporting	bias)	
Unclear	risk	 Study	protocol	not	available.	The	primary	outcome	is	reported	
using	measurements	that	were	not	pre-specified	in	the	
Methods	section	of	the	paper	
Other	bias	 High	risk	 Possibility	of	detection	(social	desirability)	bias	with	self	report	
measures	of	contraception	use	
OC:	oral	contraceptive			
STI:	sexually	transmitted	infection		
	
Interventions		
Three	trials	aimed	to	improve	adherence	to	a	specific	method	of	contraception	by	
existing	or	new	contraception	users,	comparing	automated	text	message	interventions	
versus	standard	care.	Castano	2012	in	the	USA	randomly	assigned	962	new	OC	users	
13	to	25	years	of	age;	480	to	mobile	phone	text	messaging	and	482	to	standard	care.	
The	intervention	aimed	to	improve	OC	continuation	and	comprised	a	range	of	daily	
uni-directional	and	interactive	educational	text	messages	(e.g.	“The	pill	improves	
anaemia”)	for	180	days,	in	addition	to	standard	care	(face-to-face	counselling	and	
written	educational	hand-out).(142)	Hou	2010	in	the	USA	randomly	assigned	82	new	
OC	users	between	18	and	31	years	of	age:	41	to	mobile	phone	text	messaging	and	41	
to	standard	care.	The	intervention	aimed	to	improve	OC	adherence	and	comprised	a	
daily	text	message,	“Please	remember	to	take	your	birth	control	pill”,	sent	at	a	
designated	time	over	the	three-month	study	period.(143)	Trent	2013	in	the	USA	
randomly	assigned	100	current	Depo-Provera	users	between	13	and	21	years	of	age	to	
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mobile	phone	text	messaging	or	standard	care.	The	intervention	aimed	to	improve	
follow-up	Depo-Provera	clinic	attendance	and	comprised	a	welcome	message,	daily	
text	appointment	reminders	starting	72	hours	before	the	clinic	visit	and	healthy	self	
management	messages	sent	over	the	course	of	the	three-month	enrolment	
period.(171)		
Two	trials	aimed	to	improve	both	uptake	and	adherence,	not	limited	to	one	method,	in	
both	users	and	non-users	of	contraception.	Smith	2014	in	Cambodia	randomly	
assigned	500	women	>18	years	of	age	seeking	abortion	services	who	reported	not	
wanting	to	get	pregnant	again	at	the	current	time:	249	to	a	semi	automated	
intervention	delivered	by	mobile	phone	and	251	to	standard	care.	The	intervention	
aimed	to	increase	uptake	and	adherence	to	effective	contraception	(OC,	injectable,	
implant,	intrauterine	device	(IUD)	and	permanent	methods)	and	comprised	six	
interactive	voice	messages,	counsellor-delivered	phone	support	according	to	the	
response	to	messages	and	additional	reminder	messages	for	OC	or	injectable	
users.(170)	Tsur	2008	in	Israel	randomly	assigned	108	women	of	reproductive	age	(16	
to	45	years	of	age)	using	isotretinoin	(an	acne	treatment	that	is	contraindicated	in	
pregnancy):	50	to	mobile	phone	text	messaging	and	58	to	standard	care.	The	
intervention	was	automated	and	comprised	two	text	messages	(at	one	month	and	two	
months)	together	with	information	sent	via	mail,	in	addition	to	standard	care	
(information	given	once	during	a	phone	interview).(144)		
One	of	the	five	trials	provided	limited	details	of	the	intervention	(Tsur	2008).	No	trials	
reported	using	a	particular	behavioural	theory	to	underpin	the	intervention.	Smith	
2014	reported	a	conceptual	framework	for	the	intervention	in	the	study	protocol.(167)	
The	maximum	number	of	behaviour	change	techniques	according	to	our	assessment	
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using	Abrahams	and	Michie’s	typology,	(104)	for	any	intervention	was	six,	and	the	
median	was	three.	The	most	commonly	used	behaviour	change	techniques	were	the	
following:	provide	information	about	behaviour-health	link	(four	interventions),	
provide	information	on	consequences	(three	interventions)	and	provide	instruction	
(three	interventions)	and	prompt	practice	(three	interventions).	Behavioural	change	
techniques	identified	by	our	assessment	are	found	in	Table	5.		
Table	5:	Behaviour	techniques	used	in	interventions	
Behaviour	change	
technique	
Studies	
1.	Provide	information	
about	behaviour-health	
link	
Castano	2012	(e.g.	“The	pill	improves	anaemia”);	Smith	2014	(e.g.	
information	about	amenorrhoea);	Trent	2013	(healthy	self	management	
messages);	Tsur	2008	(informed	about	importance	of	contraceptive	use)	
2.	Provide	information	
on	consequences	
Castano	2012	(“The	pill	is	very	effective	at	preventing	pregnancy”);	Smith	
2014	(e.g.	“contraceptive	methods	are	an	effective	and	safe	way	to	prevent	
unintended	pregnancy”);	Tsur	2008	(informed	about	teratogenic	risk)	
3.	Provide	information	
about	others’	approval	
	
4.	Prompt	intention	
formation	
	
5.	Prompt	barrier	
identification	
Smith	2014	(If	client	received	a	phone	call,	counsellors	provided	reassurance	
regarding	side	effects	as	per	conceptual	framework	reported	in	the	study	
protocol)	
6.	Provide	general	
encouragement	
Castano	2012	(e.g.	“Welcome	to	our	study	and	thank	u	4	participating”)	
7.	Set	graded	tasks	 	
8.	Provide	instruction	 Castano	2012	(e.g.	“Tell	every	doctor	u	see	that	u	r	taking	the	pill”;	Hou	2010	
(if	“Please	remember	to	take	your	birth	control	pill”	is	considered	’telling	a	
person	how	to	perform	a	behaviour’);	Smith	2014	(e.g.	“press	1	if	you	would	
like	me	to	call	you	back	to	discuss	contraception”)	
9.	Model	or	
demonstrate	the	
behaviour	
	
10.	Provide	specific	goal	
setting	
	
11.	Prompt	review	of	
behavioural	goals	
	
12.	Prompt	self	
monitoring	of	
behaviour	
Hou	2010	(women	kept	a	diary	of	their	daily	pill	taking;	the	intervention	may	
have	prompted	this	behaviour)	
13.	Provide	feedback	
on	performance	
	
14.	Provide	contingent	
rewards	
	
15.	Teach	or	use	 	
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prompts	or	cues	
16.	Agree	on	
behavioural	contract	
	
17.	Prompt	practice	 Hou	2010	(“Please	remember	to	take	your	birth	control	pill”);	Smith	2014	
(participants	who	chose	to	receive	the	OC	or	injectable	could	receive	
additional	reminders	appropriate	to	their	method);	Trent	2013	(daily	text	
appointment	reminders	72	hours	before	the	clinical	visit)	
18.	Use	follow-up	
prompts	
	
19.	Provide	
opportunities	for	social	
comparison	
	
20.	Plan	social	support	
or	social	change	
Smith	2014	(If	client	received	a	phone	call	and	requested,	the	counsellor	
would	also	discuss	contraception	with	the	husband	or	partner)	
21.	Prompt	
identification	as	a	role	
model	
	
22.	Prompt	self-talk	 	
23.	Relapse	prevention	 	
24.	Stress	management	 	
25.	Motivational	
interviewing	
	
26.	Time	management	 	
	
Outcomes		
Primary	outcomes	were	reported	as	follows:	Three	trials	reported	on	adherence.	
Castano	2012	defined	OC	continuation	as	the	participant	taking	a	pill	within	the	
previous	seven	days,	assessed	at	six	months.(142)	Hou	2010	reported	missed	pills	per	
cycle	as	measured	by	electronic	monitoring	device	(EMD)	over	a	three-month	
period.(143)	Trent	2013	reported	days	between	next	scheduled	appointment	and	
attendance	for	Depo-Provera	injection	over	three	cycles	(nine	months).(171)	Two	trials	
reported	contraception	use.	Smith	2014	assessed	self-reported	use	of	effective	
contraception,	as	assessed	at	four	months	(12	month	follow-up	is	also	planned).(170)	
Effective	methods	were	considered	as	those	with	less	than	10%	failure	rates	as	
commonly	used:	OC,	injectable,	IUD,	implant.	Tsur	2008	assessed	self-reported	
contraceptive	use	(methods	not	defined)	at	three	months.(144)		
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Secondary	outcomes	were	as	follows:	adherence	(OC	use	at	last	sexual	intercourse,	
interruptions	in	OC	use	greater	than	seven	days,	no	missed	pills	during	the	past	month)	
(Castano	2012),	on-time	appointment	for	Depo-Provera	(Trent	2013),	discontinuation	
of	effective	contraception	(Smith	2014),	long-acting5	contraception	use	(Smith	2014),	
contraception	use	over	the	follow-up	period	>80%	(Smith	2014),	condom	use	for	at	
least	50%	of	coital	activity	during	the	study	(Hou	2010),	use	of	two	contraceptives	
(Tsur	2008),	sexually	active	and	not	using	contraception	(Tsur	2008),	emergency	
contraception	use	(Hou	2010),	pregnancy	(Hou	2010;	Smith	2014),	repeat	abortion	
(Smith	2014),	unintended	outcomes	(road	traffic	accident,	domestic	abuse)	(Smith	
2014)	and	measures	of	satisfaction	with	the	intervention	(Castano	2012;	Hou	2010).		
Excluded	studies		
We	excluded	three	studies	when	mobile	phones	were	used	for	two-way	voice	
communication	(as	a	phone)	alone;(172)(173)(174)	two	studies	when	the	intervention	
was	web-based	or	tablet-based	and	did	not	appear	to	have	been	adapted	for	mobile	
phone	users;(175)(176)	three	studies	that	did	not	have	relevant	outcome	
measures;(177)(178)(179)	five	studies	in	which	the	intervention	focused	on	preventing	
sexually	transmitted	disease	rather	than	on	providing	
contraception,(180)(181)(182)(183)(184)	and	four	studies	that	were	not	randomised	
controlled	trials.(146)(185)(186)(187)	We	provided	details	in	Table	6.		
	 	
																																																						
5	Intrauterine	device,	implant	or	permanent	method	
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Table	6:	Characteristics	of	excluded	studies	
Study	 Reason	for	exclusion	
Bannink	2014	 Web-based	intervention	that	does	not	appear	to	have	been	intended	or	adapted	
for	mobile	phone	users		
Berenson	2012	 Phone	call	only	intervention		
Bracken	2014	 No	relevant	contraception	outcome	measure		
Constant	2014	 Post-abortion	family	planning	not	the	main	focus	of	the	intervention	and	not	
reported		
Gold	2011	 Focus	on	preventing	sexually	transmitted	disease	rather	than	on	providing	
contraception	
Hall	2013	 Additional	analysis	of	Castano	2012	but	no	relevant	outcome	measure	(reported	
contraceptive	knowledge)	
Juzang	2011	 Focus	on	preventing	sexually	transmitted	disease	rather	than	on	providing	
contraception		
Kaoaiem	2012	 Focus	on	preventing	sexually	transmitted	disease	rather	than	on	providing	
contraception,	’quasi-experimental’	design		
Katz	2011	 Phone	call	only	intervention	
Kirby	2010	 Phone	call	only	intervention	
L’Engle	2013	 Not	a	randomised	controlled	trial	
Lim	2012	 Focus	on	preventing	sexually	transmitted	disease	rather	than	on	providing	
contraception	
Mackenzie	2009	 Not	a	randomised	controlled	trial	
O’Sullivan	2008	 Not	a	randomised	controlled	trial	
Sridhar	2013	 Tablet-based	application	for	contraceptive	counselling	not	adapted	for	mobile	
phone	users	
Suffoletto	2013	 Focus	on	preventing	sexually	transmitted	disease	rather	than	on	providing	
contraception		
Walakira	2013	 Not	a	randomised	controlled	trial	(longitudinal	comparison	study)	
	
Risk	of	bias	in	included	studies		
We	summarised	risk	of	bias	in	Figure	6	and	Figure	7.	For	Trent	2013,(171)	the	
conference	abstract	provided	insufficient	information	for	full	assessment	of	risk	of	
bias,	but	we	were	able	to	obtain	additional	data	from	the	study	investigator.		
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Figure	6:	Risk	of	bias	summary:	review	authors'	judgements	about	each	risk	of	bias	item	for	
each	included	study	
	
Figure	7:	Risk	of	bias	graph:	review	authors'	judgements	about	each	risk	of	bias	item	
presented	as	percentages	across	all	included	studies	
	
Allocation		
All	five	studies	specified	random	sequence	generation	methods.	Four	studies	used	
computer-generated	sequences	(Hou	2010;	Smith	2014;	Trent	2013;	Tsur	2008),	and	
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one	study	used	a	random	number	table	(Castano	2012).	Four	studies	specified	
adequate	allocation	concealment	methods	(Castano	2012;	Hou	2010;	Smith	2014;	
Trent	2013),	and	in	the	remaining	study	these	methods	were	unclear	(Tsur	2008).		
Blinding		
As	a	result	of	the	nature	of	the	interventions,	it	was	not	possible	to	blind	participants	
to	intervention	allocation;	therefore	the	outcome	could	have	been	influenced	by	lack	
of	blinding,	resulting	in	performance	bias.	Hou	2010	reported	that	68%	of	participants	
in	the	control	group	used	a	reminding	system	outside	of	the	study	protocol	(e.g.	alarm	
clock,	mobile	phone	alarm)	compared	with	36%	in	the	intervention	group	(P	value	=	
0.003).	This	could	have	occurred	in	response	to	participation	in	the	trial	or	frequent	
use	of	reminding	systems	in	general.	
Three	studies	reported	outcome	assessment	as	blinded	(Hou	2010;	Smith	2014;	Trent	
2013),	but	this	was	not	stated	in	two	studies	(Castano	2012;	Tsur	2008).	In	Castano	
2012	and	Hou	2010,	participants	were	asked	questions	regarding	their	satisfaction	
with	the	intervention.		
Incomplete	outcome	data		
One	trial	reported	loss	to	follow-up	of	20%	or	more	(Castano	2012):	28%	in	the	
intervention	group	and	30%	in	the	control	group.		
Selective	reporting		
One	trial	(Smith	2014)	pre-specified	primary	and	secondary	outcomes	in	its	study	
protocol	(Smith	2013).	Three	trials	provided	information	on	outcomes	on	a	clinical	
trials	registry	(Castano	2012;	Hou	2010;	Trent	2013).	For	one	trial,	we	were	unable	to	
locate	a	study	protocol	or	a	clinical	trials	registry	record	(Tsur	2008).		
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Other	potential	sources	of	bias		
Two	trials	used	objective	measures	for	the	primary	outcome	(Hou	2010;	Trent	2013).	
Hou	2010	assessed	mean	pills	missed	per	cycle	using	an	electronic	medication	
monitor,	in	addition	to	a	self-report	patient	diary.	The	overall	rate	of	missed	pills	was	
4.7	±	3.2	per	cycle	according	to	the	electronic	monitoring	device,	and	1.2	±	1.5	per	
cycle	according	to	the	patient	diary	(P	value	<0.001).	Trent	2013	assessed	attendance	
for	Depo-Provera	appointments	using	clinic	records.		
Three	studies	used	self-report	measures	for	the	primary	outcome	(Castano	2012;	
Smith	2014;	Tsur	2008).	Castano	2012	defined	adherence	as	participants	reporting	that	
they	took	OC	within	the	previous	seven	days.	Smith	2014	defined	self	reported	
contraception	use	according	to	one	of	these	methods:	Participants	currently	had	an	
implant	or	an	IUD	inserted;	participants	had	received	an	injection	within	the	previous	
three	months;	participants	or	husbands	or	partners	had	undergone	a	sterilisation	or	
vasectomy	procedure;	or	participants	reported	that	they	had	taken	OC	within	24	hours	
of	the	interview	or	according	to	instructions.	In	addition,	Smith	2014	attempted	to	
conduct	objective	measurements	amongst	50	participants	to	validate	self-report	
measures.	Tsur	2008	did	not	report	how	contraceptive	use	was	assessed.		
Effects	of	interventions		
See	Table	7.	
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Table	7:	Summary	of	findings	for	the	main	comparison	
	
Primary	outcomes		
Three	trials	assessed	adherence	to	a	specific	method	of	contraception.	In	Castano	
2012,	participants	receiving	daily	educational	text	messages	were	more	likely	to	report	
OC	continuation	at	six	months	(RR	1.19,	95%	CI	1.05	to	1.35)	(Figure	8).	In	Hou	2010,	
no	significant	difference	was	noted	in	the	mean	number	of	missed	pills	per	
contraceptive	pill	cycle	using	the	electronic	monitoring	device	between	the	text	
message	group	and	the	control	group	during	cycle	one	(MD	0.5	missed	pills,	95%	CI	-
1.08	to	2.08)	(Figure	9),	cycle	two	or	cycle	three	(MD	0.80	missed	pills;	95%	CI	-1.22	to	
2.82)	(Figure	10).	Trent	2013	reported	that	the	group	receiving	text	message	
	
	
98	
reminders	and	healthy	self	management	messages	had	a	lower	mean	number	of	days	
between	scheduled	appointment	and	actual	attendance	for	Depo-Provera	injection	for	
visit	one	(MD	-8.60	days,	95%	CI	-16.74	to	-0.46)	(Figure	11)	but	not	for	visit	two	or	
three	(Figure	12)	(data	obtained	from	study	investigator).	Two	trials	assessed	uptake	
and	adherence	to	more	than	one	method	of	contraception.	In	Smith	2014,	participants	
receiving	voice	messages	and	counsellor	support	were	more	likely	to	report	using	
effective	contraception	at	four	months	post	abortion	(RR	1.39,	95%	CI	1.17	to	1.66)	
(Figure	13).	In	Tsur	2008,	no	significant	difference	in	contraceptive	use	was	observed	
between	participants	receiving	text	messages	together	with	information	received	via	
mail	and	the	control	group	(RR	1.26,	95%	CI	0.84	to	1.89)	(Figure	14).	
Figure	8:	Comparison	1	Daily	educational	text	messages	vs.	no	messages,	Outcome	1	OC	use	
(continuation)	at	6	months	
	
	
	
99	
Figure	9:	Comparison	2	Daily	text	message	reminders	vs.	no	reminders,	Outcome	1	Mean	
number	of	missed	pills	(cycle	1)	
	
Figure	10:	Comparison	2	Daily	text	message	reminders	vs.	no	reminders,	Outcome	2	Mean	
number	of	missed	pills	(cycle	3)	
	
Figure	11:	Daily	text	message	appointment	reminders	vs.	standard	care,	Outcome	1	Mean	
number	of	days	between	schedules	appointment	and	completed	visit:	first	visit	
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Figure	12:	Daily	text	message	appointment	reminders	vs.	standard	care,	Outcome	2	Mean	
number	of	days	between	scheduled	appointment	and	completed	visit:	third	visit	
	
Figure	13:	Comparison	4	Voice	messages	and	counsellor	support	vs.	standard	care,	Outcome	
1	Effective	contraception	use	at	4	months	
	
Figure	14:	Comparison	5	Contraceptive	information	via	text	messages	and	mail	vs.	standard	
care,	Outcome	1	Contraceptive	use	during	treatment	with	isotretinoin	
	
Secondary	outcomes		
Four	trials	assessed	measures	of	adherence.	In	Castano	2012,	participants	receiving	
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the	intervention	were	more	likely	to	report	no	OC	interruptions	longer	than	seven	days	
at	six	months	(RR	1.22,	95%	CI	1.06	to	1.41)	(Figure	15),	more	likely	to	report	that	they	
had	missed	no	pills	in	the	previous	month	(RR	1.44,	95%	CI	1.16	to	1.79)	(Figure	16)	
and	more	likely	to	report	OC	use	at	last	sexual	intercourse	(RR	1.15,	95%	CI	1.03	to	
1.28)	(Figure	17).	In	Hou	2010,	participants	receiving	the	intervention	were	more	likely	
to	report	condom	use	for	at	least	50%	of	coital	activity	during	the	study	(RR	1.94,	95%	
CI	1.00	to	3.78)	(Figure	18).	In	Smith	2014,	participants	receiving	the	intervention	were	
more	likely	to	use	contraception	over	the	four-month	post-abortion	period	(>	80%,	RR	
1.35,	95%	CI	1.10	to	1.67)	(Figure	19)	and	less	likely	to	discontinue	effective	
contraception	if	they	had	started	a	method	during	the	first	four	weeks	post	abortion	
(hazard	ratio	0.45,	95%	CI	0.20	to	1.01).	For	Trent	2013,	the	abstract	reported	no	
overall	differences	among	those	who	received	injections	within	the	optimal	Depo-
Provera	window	due	to	additional	clinical	nursing	outreach	that	resulted	from	missed	
visits	per	the	existing	clinical	protocol	for	standard	care.		
Figure	15:	Comparison	1	Daily	educational	text	messages	vs.	no	messages,	Outcome	4	No	OC	
interruptions	>7	days	at	6	months	
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Figure	16:	Comparison	1	Daily	educational	text	messages	vs.	no	messages,	Outcome	5	
Missed	no	pills	in	last	month	
	
Figure	17:	Comparison	1	Daily	educational	text	messages	vs.	no	messages,	Outcome	6	OC	use	
at	last	intercourse	
	
Figure	18:	Comparison	2	Daily	text	message	reminders	vs.	no	reminders,	Outcome	3	Condom	
use	for	at	least	50%	of	coital	activity	during	the	study	
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Figure	19:	Comparison	4	Voice	messages	and	counsellor	support	vs.	standard	care,	Outcome	
3	Effective	contraception	use	over	4	month	post-abortion	period	
	
Three	trials	assessed	use	of	additional	contraceptive	methods.	In	Smith	2014,	
participants	receiving	the	intervention	were	more	likely	to	be	using	long-acting	
contraception	(IUD,	implant,	or	permanent	method)	at	four	months	(RR	3.35,	95%	CI	
2.07	to	5.40)	(Figure	20).	In	Hou	2010,	no	difference	was	noted	between	intervention	
and	control	groups	regarding	emergency	contraception	use,	but	few	events	were	
reported	(Figure	21).	In	Tsur	2008,	no	difference	was	observed	between	intervention	
and	control	groups	regarding	using	two	contraceptives	or	being	sexually	active	and	not	
using	contraception	at	three	months,	but	few	events	were	reported	(Figure	22;	Figure	
23).		
Figure	20:	Comparison	4	Voice	messages	and	counsellor	support	vs.	standard	care,	Outcome	
2	Long-acting	contraception	use	at	4	months	
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Figure	21	Comparison	2	Daily	text	message	reminders	vs.	no	reminders,	Outcome	4	
Emergency	contraception	use	during	the	study	
	
Figure	22:	Comparison	5	Contraceptive	information	via	text	messages	and	mail	vs.	standard	
care,	Outcome	2	Use	of	2	contraceptives	
	
Figure	23:	Comparison	5	Contraceptive	information	via	text	messages	and	mail	vs.	standard	
care,	Outcome	3	Sexually	active	and	not	using	contraceptive	
	
Two	trials	assessed	pregnancy,	and	one	trial	assessed	repeat	abortion.	In	Hou	2010,	no	
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pregnancies	were	reported	during	the	trial	period.	In	Smith	2014,	no	difference	was	
noted	between	intervention	and	control	groups	in	repeat	pregnancy	or	abortion	at	
four	months,	but	few	events	were	reported	(Figure	24;	Figure	25).	One	trial	assessed	
potential	unintended	outcomes.	In	Smith	2014,	no	road	traffic	accidents	or	domestic	
abuse	was	reported	(Figure	26;	Figure	27).		
Figure	24:	Comparison	4	Voice	messages	and	counsellor	support	vs.	standard	care,	Outcome	
4	Repeat	pregnancy	at	4	months	
	
Figure	25:	Comparison	4	Voice	messages	and	counsellor	support	vs.	standard	care,	Outcome	
5	Repeat	abortion	at	4	months	
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Figure	26:	Comparison	4	Voice	messages	and	counsellor	support	vs.	standard	care,	Outcome	
6	Road	traffic	accident	
	
Figure	27:	Comparison	4	Voice	messages	and	counsellor	support	vs.	standard	care,	Outcome	
7	Domestic	abuse	
	
Exploratory	analyses		
Castano	2012	undertook	an	exploratory	analysis	to	assess	whether	the	effect	of	the	
intervention	on	the	primary	outcome	differed	if	follow-up	occurred	whilst	the	
participant	was	still	receiving	the	intervention.	Participants	receiving	the	intervention	
were	more	likely	to	report	OC	continuation	if	follow-up	took	place	whilst	the	
intervention	was	on-going	(RR	1.41,	95%	CI	1.13	to	1.74)	(Figure	28),	and	no	evidence	
of	effect	was	found	if	follow-up	was	provided	after	the	intervention	ended	(RR	1.11,	
95%	CI	0.95	to	1.29)	(Figure	29).		
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Figure	28:	Comparison	1	Daily	educational	text	messages	vs.	no	messages,	Outcome	2	OC	use	
(continuation):	follow	up	187	days	or	less	
	
Figure	29:	Comparison	1	Daily	educational	text	messages	vs.	no	messages,	Outcome	3	OC	use	
(continuation):	follow	up	188	days	or	more	
	
2.6	Discussion	
Summary	of	main	results		
Our	review	provides	limited	evidence	that	interventions	delivered	by	mobile	phone	
improve	contraception	use.	We	identified	five	trials	-	three	assessing	adherence	to	a	
specific	method	of	contraception	and	two	assessing	both	uptake	and	adherence	to	
more	than	one	method.	Most	trials	were	conducted	in	high-income	countries.	
Differences	in	interventions	and	outcomes	measures	did	not	permit	us	to	undertake	
meta-analysis.		
Two	trials	reported	increased	self	reported	contraception	use.	One	trial	in	the	USA	
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reported	improved	OC	continuation	from	an	intervention	comprising	a	range	of	uni-
directional	and	interactive	text	messages	amongst	participants	who	were	still	receiving	
the	intervention	(Castano	2012).(142)	One	trial	in	Cambodia	reported	increased	use	of	
effective	contraception	at	four	months	post	abortion	from	an	intervention	comprising	
automated	interactive	voice	messages	and	phone	counsellor	support	(Smith	
2014).(170)	One	feasibility	trial	in	the	USA	reported	a	lower	mean	number	of	days	
between	scheduled	and	completed	attendance	for	the	first	but	not	subsequent	Depo-
Provera	appointments	using	clinic	records	from	an	intervention	comprising	reminders	
and	healthy	self	management	text	messages	(Trent	2013).(171)	Simple	text	messages	
as	OC	reminders	had	no	effect	on	missed	pills	assessed	by	electronic	medication	
monitor	in	a	small	trial	in	the	USA	(Hou	2010).(143)	No	effect	on	self	reported	
contraception	use	was	observed	amongst	isotretinoin	users	from	an	intervention	that	
provided	health	information	via	two	uni-directional	text	messages	and	mail	(Tsur	
2008).(144)	Only	one	trial	assessed	potential	adverse	effects	of	the	intervention	and	
reported	no	evidence	of	road	traffic	accidents	or	domestic	abuse	(Smith	2014).(170)		
Overall	completeness	and	applicability	of	evidence		
As	predicted	on	the	basis	of	previous	reviews	of	mobile	phone-based	
interventions,(123)(124)	we	identified	insufficient	high-quality	studies	to	address	the	
objectives	of	the	review,	and	thus	its	external	validity.	Evidence	is	insufficient	to	
recommend	a	particular	mode	or	frequency	of	communication.	We	cannot	draw	
conclusions	on	the	effectiveness	of	interventions	delivered	by	mobile	phone	among	
younger	or	older	populations,	in	high-	or	low-income	settings	or	among	different	
outcomes,	whether	they	involve	uptake	of	or	adherence	with	contraception.	However,	
we	identified	several	on-going	studies	that	may	be	included	in	future	updates	of	this	
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review.		
At	present,	interventions	delivered	by	mobile	phone	to	increase	contraception	use	are	
not	standard	practice	for	contraceptive	service	delivery	organisations.	Our	review	
findings	suggest	that	additional	mobile	phone-based	interventions	to	increase	
contraception	use	could	be	used	in	two	contexts.	First,	daily	educational	text	message	
reminders	can	improve	self-reported	OC	adherence	in	young	females	at	the	time	they	
are	receiving	the	intervention.	Second,	interactive	voice	messages	and	counsellor	
support	can	increase	self-reported	use	of	effective	contraception	at	four	months	post	
abortion.	However,	the	follow	caveats	should	be	considered.	First,	information	on	the	
cost-effectiveness	of	these	interventions	is	lacking	at	the	present	time.	None	of	the	
included	studies	presented	data	on	intervention	costs,	although	we	may	have	
identified	articles	if	we	had	explicitly	searched	for	cost-effectiveness	analyses.	Second,	
the	duration	of	follow-up	in	all	of	the	included	trials	ranged	between	three	months	and	
12	months,	and	the	long-term	effect	of	these	interventions	is	unclear.	Third,	it	is	likely	
that	these	interventions	would	require	adaptation	for	different	settings,	and	it	is	not	
clear	what	behaviour	change	techniques,	or	combinations	of,	are	effective.	Lack	of	
theory	in	the	interventions	was	a	limitation	of	all	included	studies.	We	used	Abraham	
and	Michie’s	typology	of	behaviour	change	techniques	to	code	intervention	content	
according	to	the	intervention	description	provided	in	the	papers	or	in	protocols,	which	
varied	in	the	level	of	detail	provided.	Three	trials	provided	details	of	specific	message	
content	(Castano	2012;	Hou	2010;	Smith	2014).(142)(143)(170)	Coding	of	the	
intervention	content	could	have	been	more	complete	and	accurate	if	additional	detail	
on	messages	and	other	intervention	content	had	been	provided.	The	effective	
interventions	used	four	(Castano	2012)	or	five	(Smith	2014)	behaviour	change	
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techniques,	whilst	the	interventions	that	were	not	reported	to	be	effective	used	two	
(Trent	2013;	Tsur	2008)	or	three	(Hou	2010)	behaviour	change	techniques	(Table	
5).(142)(143)(170)(144)(171)	An	inadequate	number	of	studies	assessed	associations	
between	use	of	particular	behaviour	change	techniques	and	effectiveness	of	
interventions.		
Our	review	excluded	studies	in	which	mobile	phones	were	used	for	two-way	voice	
communication	alone.	However,	some	of	the	excluded	studies	were	recent	and	utilised	
mobile	phones;	therefore	future	reviews	should	consider	inclusion	of	such	studies.	Our	
review	did	not	include	studies	that	aimed	to	increase	contraceptive	knowledge	alone.	
Interventions	that	increase	knowledge	of	contraception	may	lead	to	increased	uptake	
and	adherence,	and	future	reviews	should	consider	inclusion	of	such	studies.		
Quality	of	the	evidence		
We	summarised	the	quality	of	evidence	in	Table	8	using	the	GRADE	approach.	We	
downgraded	two	trials	because	of	limitations	in	design	and	implementation;	lack	of	or	
insufficient	information	on	blinding	(Castano	2012;	Tsur	2008);	or	large	losses	to	
follow-up	(Castano	2012).(142)(144)		
We	downgraded	one	trial	for	indirectness	of	evidence,	as	it	addressed	a	restricted	
version	of	the	main	review	question	by	including	only	participants	using	a	medication	
for	acne,	which	could	affect	the	generalisability	of	this	study	to	other	populations	(Tsur	
2008).(144)	We	downgraded	three	trials	with	small	sample	sizes	for	imprecision	of	
results	(Hou	2010;	Trent	2013;	Tsur	2008).(143)(171)(144)	Overall,	evidence	was	of	
high	quality	for	one	trial,	moderate	for	two	trials,	low	for	one	trial	and	very	low	for	one	
trial.		
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Table	8:	Results	by	quality	of	evidence	
Study	 Limitations	in	
design	and	
implementation	
Indirectness	
of	evidence	
Unexplained	
heterogeneity	
or	
inconsistency	
of	results	
Imprecision	
of	results	
High	
probability	
of	
publication	
bias	
Quality	of	
evidence	
Evidence	
of	effect	
Castano	
2012	
-2	 	 	 	 	 Low	 Yes	
Hou	
2010	
	 	 	 -1	 	 Moderate	 No	
Smith	
2014	
	 	 	 	 	 High	 Yes	
Trent	
2013	
	 	 	 -1	 	 Moderate	 Yes	
Tsur	
2008	
-1	 -1	 	 -1	 	 Very	low	 No	
Randomised	controlled	trials	were	considered	of	high	quality,	then	were	downgraded	by	one	level	(serious)	or	two	
levels	(very	serious)	for	each	of	the	following:	limitations	in	design	and	implementation	(e.g.	lack	of	blinding,	large	
losses	to	follow-up),	indirectness	of	evidence,	unexplained	heterogeneity	or	inconsistency	of	results,	imprecision	of	
results,	high	probability	of	publication	bias.	
No	trials	were	at	low	risk	of	bias	in	all	areas	assessed.	Performance	bias	may	have	
arisen	from	altered	behaviour	of	participants	based	on	allocation	to	the	intervention	
or	control	group.	Detection	bias	may	have	arisen	as	the	result	of	lack	of	outcome	
assessment	blinding,	which	was	not	apparent	in	all	of	the	trials.	Furthermore,	bias	may	
have	arisen	from	use	of	self-report	measures	of	contraception.	Although	the	standard	
in	contraceptive	research,	self	report	measures	have	been	shown	to	overestimate	
contraceptive	use	and	underestimate	abortion.(188)	Hou	2010	reported	increased	
poorer	OC	adherence	as	measured	by	electronic	medication	monitoring	compared	
with	the	patient	diary.(143)	However,	it	should	be	considered	that	no	gold	standard	
measure	of	OC	use	is	available,	and	objective	assessment	is	challenging,	as	biological	
measures	such	as	hormonal	assays	do	not	indicate	consistent	use.(189)	To	date,	
electronic	medication	monitors	have	been	costly,	and	the	appearance	of	the	devices	
themselves	could	interfere	with	the	intervention.		
Participants	randomly	assigned	to	the	intervention	may	have	shared	intervention	
content	with	participants	recruited	from	the	same	centre,	resulting	in	contamination	
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across	study	groups	and	weakening	of	overall	effect.	None	of	the	included	trials	
reported	on	this.	Three	trials,	all	of	which	found	no	effect,	included	small	sample	sizes,	
which	increased	the	possibility	of	Type	II	error	(Hou	2010;	Trent	2013;	Tsur	
2008).(143)(171)(144)		
Agreements	and	disagreements	with	other	studies	or	reviews		
To	our	knowledge,	this	is	the	first	systematic	review	of	mobile	phone-based	
interventions	to	improve	contraception	use.	Our	observation	that	interventions	found	
to	increase	contraception	use	were	multi-faceted	and	more	intensive	is	consistent	with	
evidence	on	strategies	to	improve	adherence	and	acceptability	of	hormonal	methods	
of	contraception.(92)	The	finding	that	simple	text	message	reminders	had	no	effect	is	
consistent	with	existing	mHealth	evidence	from	systematic	reviews	and	trials	that	
simple	text	message	reminders	have	at	best	small	effects	(pooled	RR	1.0,	95%	CI	0.77	
to	1.30),	as	well	as	findings	of	face-to-face	adherence	research.(134)(115)(133)		
Complex	interventions	delivered	by	mobile	phone	have	been	shown	to	be	effective	in	
other	conditions,	including	human	immunodeficiency	virus	(HIV)	medication	
adherence	and	smoking	cessation.(115)(123)(127)(132)(125)	Interventions	for	
different	conditions	should	be	compared	with	caution,	as	it	is	likely	that	factors	
influencing	contraception	use	will	be	different	from	those	influencing	adherence	to	
antiretroviral	therapy	or	smoking	cessation.	However,	mobile	phone-based	
interventions	for	HIV	medication	adherence	are	similar	to	those	for	contraception	in	
the	respect	that	they	include	populations	for	which	confidentiality	and	privacy	are	of	
particular	importance,	and	they	can	involve	similar	behaviours	(i.e.	taking	a	tablet).	A	
Cochrane	review	of	mobile	phone	text	messaging	for	promoting	adherence	to	
antiretroviral	therapy	reported	good	evidence	that	text	message	support	can	improve	
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adherence	to	treatment	compared	with	standard	care	(Horvath	2012).(123)	However,	
since	that	time,	Shet	2014	has	reported	no	effect	on	virologic	failure	at	two	years	
when	medication	reminders	were	delivered	by	mobile.(133)	Thus,	evidence	for	mobile	
phone-based	interventions	for	HIV	adherence	to	date,	as	for	contraception,	is	mixed	
and	is	likely	to	be	dependent	on	intervention	content,	as	well	as	the	mechanism	of	
delivery	(mobile	phone).	Shared	learning	between	researchers	in	different	fields	may	
occur	over	time.		
2.7	Authors’	conclusions		
Implications	for	practice		
At	the	present	time,	evidence	is	insufficient	to	support	widespread	implementation	of	
mobile	phone-based	interventions	to	increase	contraception	use.	Whilst	evidence	
indicates	that	a	series	of	interactive	voice	messages	and	counsellor	support	can	
improve	post-abortion	contraception,	and	that	a	mixture	of	uni-directional	and	
interactive	daily	educational	text	messages	may	improve	OC	adherence,	the	cost-
effectiveness	and	long-term	effects	of	these	interventions	remain	unknown.		
Interventions	delivered	by	mobile	phone	should	be	considered	as	part	of	the	wider	
health	service	delivery.	Future	mobile	phone-based	interventions	should	consider	the	
context	and	needs	of	the	population,	for	example,	literacy,	phone	use,	use	of	other	
services	and	what	behaviour	change	techniques	delivered	by	mobile	phone	are	likely	
to	be	effective.		
Implications	for	research		
Further	high-quality	trials	are	required	to	robustly	establish	the	effects	of	interventions	
delivered	by	mobile	phone	to	increase	contraception	use.	Larger	trials	could	be	
powered	for	pregnancy	and	abortion	outcomes.	Trials	should	be	complemented	by	
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process	evaluations	to	enhance	understanding	of	the	mechanism	that	explains	why	a	
certain	intervention	works	or	does	not	work.	The	cost-effectiveness	of	effective	
interventions	should	be	established.	To	build	the	evidence	base	regarding	which	
interventions	and	intervention	components	are	effective,	future	interventions	should	
be	described	in	detail	together	with	conceptual	frameworks	and	use	of	theory,	as	
appropriate.	This	would	enable	assessment	of	behaviour	change	techniques	and	
replication	or	modification	of	interventions	elsewhere.	In	areas	where	interventions	
have	yielded	inconclusive	evidence,	such	as	fully	automated	text	message	
interventions	for	OC	adherence,	future	research	should	focus	on	improving	
interventions	before	considering	future	evaluation	by	randomised	controlled	trials.	
Interventions	that	aim	to	improve	adherence	to	a	single	method	should	consider	
additional	facilitation	of	safe	method	switching,	given	that	side	effects	and	health	
concerns	leading	to	discontinuation	are	common.		
Consideration	should	be	given	to	choice	of	outcome	measures,	whether	measures	of	
uptake	or	adherence.	Use	of	consistent	outcome	measures	would	allow	pooling	of	
results	and	meta-analysis	in	future	reviews.	Trials	should	aim	to	objectively	assess	
contraception	use,	if	feasible.	If	self-report	measures	are	used,	outcome	assessment	
should	be	blinded	and	questions	carefully	considered	to	reduce	the	likelihood	of	
courtesy	bias.	For	long-acting	contraception,	objective	measures	of	use	such	as	clinical	
examination	to	assess	IUD	position	are	likely	to	be	more	robust	but	may	be	costly	and	
less	acceptable	to	patients,	resulting	in	increased	attrition.	If	appropriate,	data	on	
contraception	use	such	as	injectable	methods	could	be	obtained	from	clinical	records.	
To	assess	oral	contraceptive	use,	electronic	medication	monitors	that	have	the	same	
appearance	as	contraceptive	pill	blister	packs	should	be	considered.		
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Table	9:	Cochrane	review	search	strategies	
MEDLINE	via	Ovid	(date	of	search:	6	October	2014)		
(phone	adj3	call*).mp.	OR	((cell*	or	mobile	or	smart	or	Google	or	nexus	or	iPhone)	adj3	(phone*	or	
telephone*)).mp.	OR	smart-	phone*.mp.	OR	smart-phone*.mp.	OR	(blackberr*	not	extract).mp.	OR	
(black-berr*	not	extract).mp.	OR	((mobile	adj3	health)	not	(van*	or	unit*)).mp.	OR	mhealth.mp	OR	
m-health.mp	OR	e-health*.mp.	OR	eHealth*.mp.	OR	(electronic	adj	health).mp.	OR	(mobile	adj3	
technol*).mp.	OR	((mobile	or	smartphone	or	smart-phone	or	phone	or	software)	adj3	app*).mp.	
OR	MMS.mp.	OR	multimedia	messaging	service.mp	OR	SMS.mp.	OR	short	messag*	service.mp	OR	
(text*	adj	messag*).mp.	OR	text-messa*.mp.	OR	voice	messag*.mp.	OR	interactive	voice	
response.mp	OR	IVR.mp.	OR	Telemedicine/	OR	cellular	phone/	or	text	messaging/		
AND	(contracept*	or	(family	adj	planning)	or	(Birth	adj	control)).mp.	OR	condom.mp.	OR	(OC	adj	
pill).mp.	OR	(depot	medroxyprogest*	or	NET-EN	or	NET	EN	or	Mesigyna	or	Cyclofem).mp.	OR	
(intrauterine	system	or	intra-uterine	system	or	IUS	or	intrauterine	device	or	intra-uterine	device	or	
IUD).mp.	OR	(vasectomy	or	sterilisation	or	sterilization	or	(tubal	adj	ligation)).mp.	OR	((vaginal	adj	
ring)	or	cycletel	or	cycle-tel	or	abstain	or	abstinen*	or	lactational	amenorr*).mp	OR	(pregnan*	or	
abortion).mp	OR	exp	Contraception/	OR	exp	Contraceptive	Devices/	OR	exp	Pregnancy,	
Unplanned/	OR	exp	Pregnancy,	Unwanted/	OR	exp	Abortion,	Induced/	OR	(NORPLANT	or	implanon	
or	Femplant).mp.	Limit	to	yr=“1993-Current”	and	clinical	trial,	all		
Global	Health	via	Ovid	(date	of	search:	6	October	2014)		
(phone	adj3	call*).mp.	OR	((cell*	or	mobile	or	smart	or	Google	or	nexus	or	iPhone)	adj3	(phone*	or	
telephone*)).mp.	OR	smart-	phone*.mp.	OR	smart-phone*.mp.	OR	(blackberr*	not	extract).mp	OR	
(black-berr*	not	extract).mp	OR	((mobile	adj3	health)	not	(van*	or	unit*)).mp.	OR	mhealth.mp	OR	
m-health.mp.	OR	e-health*.mp.	OR	ehealth*.mp	OR	(electronic	adj	health).mp	OR	(mobile	adj3	
technol*).mp	OR	((mobile	or	smartphone	or	smart-phone	or	phone	or	software)	adj3	app*).mp.	OR	
MMS.mp	OR	multimedia	messaging	service.mp	OR	SMS.mp.	OR	short	messag*	service.mp	OR	
(text*	adj	messag*).mp.	OR	text-messa*.mp.	OR	voice	messag*.mp.	OR	interactive	voice	
response.mp	OR	IVR.mp	OR	Telemedicine/	OR	cellular	phone/	or	text	messaging/	OR	exp	mobile	
telephones/	AND	(contracept*	or	(family	adj	planning)	or	(Birth	adj	control)).mp.	OR	condom.mp	
OR	(OC	adj	pill).mp.	OR	(depot	medroxyprogest*	or	NET-EN	or	NET	EN	or	Mesigyna	or	
Cyclofem).mp.	OR	(intrauterine	system	or	intra-uterine	system	or	IUS	or	intrauterine	device	or	
intra-uterine	device	or	IUD).mp.	OR	(vasectomy	or	sterilisation	or	sterilization	or	(tubal	adj	
ligation)).mp.	OR	((vaginal	adj	ring)	or	cycletel	or	cycle-tel	or	abstain	or	abstinen*	or	lactational	
amenorr*).mp	OR	(pregnan*	or	abortion).mp	OR	exp	Contraception/	OR	exp	Contraceptive	
Devices/	OR	exp	Pregnancy,	Unplanned/	OR	exp	Pregnancy,	Unwanted/	OR	exp	Abortion,	Induced/	
OR	(NORPLANT	or	implanon	or	Femplant).mp.	OR	induced	abortion/		
Limit	to	yr=“1993-Current”		
PsycINFO	via	Ovid	(date	of	search:	6	October	2014)		
(phone	adj3	call*).mp.	OR	((cell*	or	mobile	or	smart	or	Google	or	nexus	or	iPhone)	adj3	(phone*	or	
telephone*)).mp.	OR	smart-	phone*.mp	OR	smart-phone*.mp.	OR	(blackberr*	not	extract).mp	OR	
(black-berr*	not	extract).mp	OR	((mobile	adj3	health)	not	(van*	or	unit*)).mp	OR	mhealth.mp.	OR	
m-health.mp.	OR	e-health*.mp.	OR	ehealth*.mp	OR	(electronic	adj	health).	OR	(mobile	adj3	
technol*).mp	OR	((mobile	or	smartphone	or	smart-phone	or	phone	or	software)	adj3	app*).mp.	OR	
MMS.mp.	OR	multimedia	messaging	OR	SMS.mp.	OR	short	messag*	service.mp	OR	(text*	adj	
messag*).mp	OR	text-messa*.mp	OR	voice	messag*.mp	OR	interactive	voice	response.mp	OR	
IVR.mp	OR	Telemedicine/	OR	cellular	phone/	or	text	messaging/		
AND	(contracept*	or	(family	adj	planning)	or	(Birth	adj	control)).mp	OR	condom.mp.	OR	(OC	adj	
pill).mp	OR	(depot	medroxyprogest*	or	NET-EN	or	NET	EN	or	Mesigyna	or	Cyclofem).mp	OR	
(intrauterine	system	or	intra-uterine	system	or	IUS	or	intrauterine	device	or	intra-uterine	device	or	
IUD).mp.	OR	(vasectomy	or	sterilisation	or	sterilization	or	(tubal	adj	ligation)).mp	OR	((vaginal	adj	
ring)	or	cycletel	or	cycle-tel	or	abstain	or	abstinen*	or	lactational	amenorr*).mp	OR	(pregnan*	or	
abortion).mp	OR	exp	Contraception/	OR	exp	Contraceptive	Devices/	OR	exp	Pregnancy,	
Unplanned/	OR	exp	Pregnancy,	Unwanted/	OR	exp	Abortion,	Induced/	OR	(NORPLANT	or	implanon	
or	Femplant).mp.	Limit	to	yr=“1993-Current”	and	clinical	trial,	all		
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EMBASE	via	Ovid	(date	of	search:	6	October	2014)		
(phone	adj3	call*).mp	OR	((cell*	or	mobile	or	smart	or	Google	or	nexus	or	iPhone)	adj3	(phone*	or	
telephone*)).mp.	OR	smart-	phone*.mp.	OR	smart-phone*.mp	OR	(blackberr*	not	extract).mp	OR	
(black-berr*	not	extract).mp	OR	((mobile	adj3	health)	not	(van*	or	unit*)).mp.	OR	mhealth.mp	OR	
m-health.mp.	OR	e-health*.mp.	OR	eHealth*.mp.	OR	(electronic	adj	health).mp	OR	(mobile	adj3	
technol*).mp.	OR	((mobile	or	smartphone	or	smart-phone	or	phone	or	software)	adj3	app*).mp	OR	
MMS.mp.	OR	multimedia	messaging	service.mp	OR	SMS.mp	OR	short	messag*	service.mp.	OR	
(text*	adj	messag*).mp	OR	text-messa*.mp.	OR	voice	messag*.mp	OR	interactive	voice	
response.mp.	OR	IVR.mp.	OR	Telemedicine/	OR	cellular	phone/	or	text	
messaging/	AND	(contracept*	or	(family	adj	planning)	or	(Birth	adj	control)).mp.	OR	condom.mp.	
OR	(OC	adj	pill).mp.	OR	(depot	medroxyprogest*	or	NET-EN	or	NET	EN	or	Mesigyna	or	
Cyclofem).mp.	OR	(intrauterine	system	or	intra-uterine	system	or	IUS	or	intrauterine	device	or	
intra-uterine	device	or	IUD).mp.	OR	(vasectomy	or	sterilisation	or	sterilization	or	(tubal	adj	
ligation)).mp.	OR	((vaginal	adj	ring)	or	cycletel	or	cycle-tel	or	abstain	or	abstinen*	or	lactational	
amenorr*).mp.	OR	(pregnan*	or	abortion).mp.	OR	exp	Contraception/	OR	exp	Contraceptive	
Devices/	OR	exp	Pregnancy,	Unplanned/	OR	exp	Pregnancy,	Unwanted/	OR	exp	Abortion,	Induced/	
OR	(NORPLANT	or	implanon	or	Femplant).mp.	Limit	to	yr=“1993-Current”,	clinical	trial,	all	and	
(clinical	trial	or	randomized	controlled	trial	or	controlled	clinical	trial	or	multicenter	study	or	phase	
1	clinical	trial	or	phase	2	clinical	trial	or	phase	3	clinical	trial	or	phase	4	clinical	trial)		
Cochrane	Central	register	of	Controlled	trials	(CENTRAL)	(date	of	search:	6	October	2014)		
(((phone	NEAR3	call*)	OR	((cell*	or	mobile	or	smart	or	Google	or	nexus	or	iPhone)	NEAR3	(phone*	
or	telephone*))	OR	(smartphone*)	OR	(smart-phone*)	OR	(blackberr*	NOT	extract)	OR	(black-berr*	
NOT	extract))	OR	((mobile	NEAR3	(health	NOT	(van*	or	unit*)))	OR	(mhealth)	OR	(m-health)	OR	(e-
health*)	OR	(eHealth*)	OR	(electronic	health)	OR	(mobile	NEAR3	technol*))	OR	((mobile	or	
smartphone	or	smart-phone	or	phone	or	software)	NEAR3	(app*))	OR	((MMS)	OR	(multimedia	
messaging	service)	OR	(SMS)	OR	(short	messag*	service)	OR	(text*	messag*)	OR	(text-messa*)	OR	
(voice	messag*)	OR	(interactive	voice	response)	OR	(IVR)))	OR	exp	Telemedicine	OR	exp	Cellular	
Phone	AND	(((contracept*)	OR	(family	planning)	OR	(Birth	control))	OR	(condom)	OR	((OC	pill))	OR	
((depot	medroxyprogest*)	OR	(NET-EN)	OR	(NET	EN)	OR	(Mesigyna)	OR	(Cyclofem))	OR	
((NORPLANT)	OR	(implanon)	OR	(Femplant))	OR	((intrauterine	system)	OR	(intra-uterine	system)	OR	
(IUS)	OR	(intrauterine	device)	OR	(intra-uterine	device)	OR	(IUD))	OR	((vasectomy)	OR	(sterilisation)	
OR	(sterilization)	OR	(tubal	ligation))	OR	((vaginal	ring)	OR	(cycletel)	OR	(cycle-tel)	or	(abstain)	OR	
(abstinen*)	OR	(lactational	amenorr*))	OR	((pregnan*)	OR	(abortion)))	OR	exp	Contraception	OR	
exp	Contraceptive	Devices	OR	exp	Pregnancy,	Unplanned	OR	exp	Pregnancy,	Unwanted	OR	exp	
Abortion,	Induced	Limit	to	1993-2014		
POPLINE	(date	of	search:	6	October	2014)		
Family	Planning	OR	Pregnancy	Unplanned	OR	Pregnancy	Unwanted	AND	Cellular	Phone	OR	Mobile	
Devices	OR	Text	Messaging	(1993-2014)		
Africa-Wide	Information	(date	of	search:	6	October	2014)		
((phone	n3	call*)	OR	((cell*	or	mobile	or	smart	or	Google	or	nexus	or	iPhone)	n3	(phone*	or	
telephone*))	OR	(smartphone*)	OR	(smart-phone*)	OR	(blackberr*	NOT	extract)	OR	(black-berr*	
NOT	extract))	OR	((mobile	n3	(health	NOT	(van*	or	unit*)))	OR	(mhealth)	OR	(m-health)	OR	(e-
health*)	OR	(eHealth*)	OR	(electronic	health)	OR	(mobile	n3	technol*))	OR	((mobile	or	smartphone	
or	smart-phone	or	phone	or	software)	n3	(app*))	OR	((MMS)	OR	(multimedia	messaging	service)	OR	
(SMS)	OR	(short	messag*	service)	OR	(text*	messag*)	OR	(text-messa*)	OR	(voice	messag*)	OR	
(interactive	voice	response)	OR	(IVR))		
AND	((contracept*)	OR	(family	planning)	OR	(Birth	control))	OR	(condom)	OR	((OC	pill))	OR	((depot	
medroxyprogest*)	OR	(NET-EN)	OR	(NET	EN)	OR	(Mesigyna)	OR	(Cyclofem))	OR	((NORPLANT)	OR	
(implanon)	OR	(Femplant))	OR	((intrauterine	system)	OR	(intra-uterine	system)	OR	(IUS)	OR	
(intrauterine	device)	OR	(intra-uterine	device)	OR	(IUD))	OR	((vasectomy)	OR	(sterilisation)	OR	
(sterilization)	OR	(tubal	ligation))	OR	((vaginal	ring)	OR	(cycletel)	OR	(cycle-tel)	or	(abstain)	OR	
(abstinen*)	OR	(lactational	amenorr*))	OR	((pregnan*)	OR	(abortion))		
LILACS	(date	of	search:	6	October	2014)		
(contracept$	OR	family	planning	OR	condom$	OR	pregnan$	OR	abortion$)	AND	(phone$	OR	text	
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messag$	OR	mobil$	health)		
WHO	international	trials	registry	(date	of	search:	9	October	2014)		
Condition	(family	planning)	intervention	(mHealth):	(family	planning	OR	contracept*	OR	pregnanc*	
OR	abortion*	OR	condom*)	AND	(phone	OR	text	messag*	OR	cellular	phon*	OR	mobile	phon*	OR	
mobile	devic*	OR	mobile	technol*		
Current	controlled	trials		
(family	planning	OR	contracept*	OR	unplanned	pregnanc*	OR	unintended	pregnanc*	OR	induced	
abortion*	OR	condom*)	AND	(phone	OR	text	messag*	OR	cellular	phon*	OR	mobile	phon*	OR	
mobile	devic*	OR	mobile	technol*)	
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participants	and	personnel,	blinding	of	outcome	assessment,	incomplete	outcome	
data,	selective	reporting	and	other	sources	of	bias.	
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2.8	Randomised	controlled	trials	identified	subsequent	to	systematic	review	
Background	
This	section	includes	a	review	of	trials	of	interventions	delivered	by	mobile	phone	to	
support	contraception	use	identified	subsequent	to	conducting	the	searches	for	the	
systematic	review	in	October	2014.	It	does	not	constitute	an	update	to	the	systematic	
review	as	I	have	not	replicated	the	search	methods	in	Section	2.4.	Trials	discussed	here	
have	been	identified	by	reviewing	the	on-going	studies	and	additional	relevant	
literature	identified	in	Chapters	1	and	2,	from	MEDLINE	(Ovid)	auto-alerts,	or	by	
discussions	with	colleagues	working	in	the	field	of	interventions	delivered	by	mobile	
phone	to	support	contraception	use.	The	long-term	follow	up	from	the	MOTIF	trial	will	
be	reported	and	discussed	in	Chapter	5.		
Findings	
Four	ongoing	studies	were	identified	in	the	systematic	review	(Table	3).	Evidence	of	
subsequent	reporting	of	results	was	sought	by	reviewing	the	clinical	trials	registry	and	
contacting	the	study	authors.		
The	Mobile	for	Reproductive	Health	(m4RH)	service	in	Kenya	has	subsequently	been	
evaluated	with	a	randomised	controlled	trial.(190)	New	consumers	who	accessed	the	
m4RH	service	were	randomly	assigned	to	either	full	access	or	limited	access	to	m4RH	
on	a	rolling	basis.	Participants	in	the	full-access	group	received	information	on	
benefits,	disadvantages	and	side-effects	of	nine	contraception	methods,	a	searchable	
database	of	clinics	offering	family	planning	services	and	serial	“role	model”	stories	
about	a	person	facing	a	difficult	family	planning	issue.	Participants	in	the	limited	access	
group	had	access	to	the	clinic	locator	along	with	general	motivational	messages	on	a	
variety	of	health	topics,	but	no	access	to	any	other	m4RH	content.	Outcome	data	was	
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assessed	by	sending	questions	by	text	message,	with	response	rates	to	the	surveys	
ranging	from	13.5	to	51.8%.	The	authors	reported	that	there	was	no	differential	loss	to	
follow-up.	Multiple	imputation	was	used	to	impute	missing	data.	Contraceptive	
knowledge	increased	by	14%	amongst	the	full-access	group	compared	to	the	limited	
access	group	(95%	CI:	9.9%-18.2%).	There	was	no	difference	in	use	of	contraception	
between	the	two	groups	(79.7%	full-access	vs.	79.6%	limited	access;	p=0.94).	The	
authors	concluded	that	text	messages	may	increase	family	planning	knowledge	but	do	
not,	by	themselves,	lead	to	behaviour	change.			
If	this	paper	were	to	be	included	in	a	subsequent	systematic	review,	it	is	possible	that	
it	would	be	at	risk	of	selection	bias	due	to	the	sequence	generation	procedures,	and	
attrition	bias	due	to	the	amount	of	incomplete	outcome	data.	Further	limitations	
include	that	the	study	population	comprised	participants	who	had	elected	to	enrol	in	
the	m4RH	programme	and	thus	might	already	have	been	motivated	to	use	
contraception.	In	addition,	the	intervention	compared	full	access	versus	limited	access	
to	m4RH,	but	did	not	compare	‘no	access’.	These	limitations	might	have	weakened	the	
effect	of	the	intervention.	
Additionally,	the	m4RH	programme	have	published	a	paper	exploring	strategies	for	
mHealth	programme	sustainability	using	operational	programme	data	considering	
three	strategies	for	cost-recovery	(user	pay-for-service,	text	message	cost	reduction,	
and	strategic	partnerships)	to	develop	four	different	cost-recovery	scenarios.(135)	In	
three	of	four	scenarios,	costs	exceeded	revenue.	Breaking	even	was	only	possible	in	
one	scenario,	in	which	the	lowest	text	message	rate	was	negotiated	and	users	paid	for	
all	text	messages	sent	or	received.	The	authors	commented	that	“while	this	strategy	
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was	sustainable	for	the	implementer,	a	central	concern	is	that	health	information	may	
not	reach	those	who	are	too	poor	to	pay,	limiting	the	programmes	reach	and	impact”.	
Trial	NCT01401816	was	a	pilot	RCT	(n=60)	in	the	USA	of	a	text	messaging	intervention	
to	remind	sexually	active	female	adolescents	to	fill	their	prescription	for	emergency	
contraception.(191)	The	study	authors	report	that	the	results	will	be	published	soon.	
(email	communication	with	study	author	(T.	Wilkinson),	October	2016).	
Trial	NCT01545609	was	a	RCT	(n=220)	in	the	USA	of	a	tailored	text	messaging	
intervention	for	inner	city	minority	adolescent	females	aged	15-19	years	wanting	to	
start	contraception	and	not	on	a	method.(191)	Half	received	an	intervention	
comprising	tailored	text	messages	about	their	method	of	contraception	and	half	
received	standard	care.	There	was	no	difference	in	adherence,	continuation	and	
pregnancy	between	the	intervention	and	control	groups	at	four-months.	However	the	
intervention	group	was	highly	satisfied	with	the	text	and	often	shared	messages	with	
friends.	Nonetheless,	most	did	not	continue	their	method	(email	communication	with	
study	author	(J.	Francis),	January	2015).	The	results	have	not	been	published	as	of	
October	2016.	
Trial	NCT02093884	was	a	pilot	RCT	(n=100)	in	the	USA	of	a	text	messaging	intervention	
for	adolescent	females	at	high	risk	of	pregnancy	in	the	emergency	department	who	are	
potential	users	of	contraception.(192)	The	study	authors	plan	to	submit	for	publication	
in	the	next	few	months	(email	communication	with	study	author,	(L.	Chernick)	October	
2016).	
Additional	ongoing	trials	
Two	additional	trials	assessing	interventions	delivered	by	mobile	phone	are	ongoing.		
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A	RCT	assessing	automated	voice	messages	linked	to	telephone	counselling	to	increase	
post-menstrual	regulation	contraceptive	uptake	and	continuation	(n=969)	is	being	
undertaken	in	Bangladesh.(193)	RCTs	assessing	interventions	delivered	by	mobile	
phone	by	text	message	or	instant	messaging	to	increase	the	acceptability	of	effective	
contraception	among	young	women	are	being	undertaken	in	Palestine,	Tajikistan	and	
Bolivia.(194)(195)(196)	
Additional	literature	
With	regards	to	other	opt-in	text	message	services	that	provide	information	on	
contraception	identified	in	section	1.6,	it	was	not	evident	that	the	Mobile	Alliance	for	
Maternal	Action	(MAMA),	FamPlan,	CycleTel	or	MyPill	initiatives	had	subsequently	
been	evaluated	with	randomised	controlled	trials.	A	formative	research	report	to	
inform	“Aponjon”,	the	Bangladesh	version	of	MAMA,	which	provides	health	
information	by	mobile	phone	to	expectant	and	new	mothers,	found	that	the	majority	
of	participants	choose	to	receive	voice	messages	rather	than	text	messages.	However,	
it	was	not	clear	from	the	report	whether	contraception	messages	were	included	in	the	
intervention.(197)	
The	mAssist	trial,	mentioned	in	section	1.6,	was	a	text	message	intervention	to	support	
the	home	phase	of	medical	abortion	in	South	Africa	and	was	demonstrated	to	reduce	
women’s	anxiety	and	stress.(178)	Increased	uptake	of	long-acting	reversible	
contraception	(21%	intervention	vs.	13%	control)	was	reported	in	a	project	brief,(198)	
but	the	study	author	reported	that	the	PAFP	data	was	not	rich	enough	to	constitute	a	
stand	alone	paper	(email	communication	September	2014).	
Conclusions	
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Only	one	of	the	previously	identified	ongoing	trials	has	reported	results,	the	m4RH	
evaluation.	However	this	trial	had	several	limitations	and	it	does	not	alter	the	
conclusion	of	the	systematic	review	that	further	high	quality	trials	are	required	to	
robustly	establish	the	effects	of	interventions	delivered	by	mobile	phone	to	increase	
contraception	use.	There	are	several	ongoing	trials	and	a	repeat	systematic	review	
could	be	considered	in	one	or	two	years.		
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3.	Development	of	a	mobile	phone-based	intervention	to	
support	contraception	use	in	Cambodia	
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paper	describing	the	intervention	development	for	the	MOTIF	trial.	This	paper	reviews	
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3.1	Abstract	
Background	
The	objective	of	this	paper	is	to	outline	the	formative	research	process	used	to	
develop	the	MOTIF	mobile	phone-based	(mHealth)	intervention	to	support	post-
abortion	family	planning	in	Cambodia.	
Methods	
The	formative	research	process	involved	literature	reviews,	interviews	and	focus	group	
discussions	with	clients,	and	consultation	with	clinicians	and	organisations	
implementing	mHealth	activities	in	Cambodia.	This	process	led	to	the	development	of	
a	conceptual	framework	and	the	intervention.	
Results	
Key	findings	from	the	formative	research	included	identification	of	the	main	reasons	
for	non-use	of	contraception	and	patterns	of	mobile	phone	use	in	Cambodia.	We	drew	
on	components	of	existing	interventions	and	behaviour	change	theory	to	develop	a	
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conceptual	framework.	A	multi-faceted	voice-based	intervention	was	designed	to	
address	health	concerns	and	other	key	determinants	of	contraception	use.	
Conclusions	
Formative	research	was	essential	in	order	to	develop	an	appropriate	mHealth	
intervention	to	support	post-abortion	contraception	in	Cambodia.	Each	component	of	
the	formative	research	contributed	to	the	final	intervention	design.	
3.2	Introduction		
Cambodia	is	one	of	the	poorest	and	least	developed	countries	in	Asia.	Eighty	percent	
of	Cambodians	live	in	rural	areas,	45%	are	under	the	age	of	20	and	approximately	28%	
live	below	the	poverty	line.	Despite	recent	improvements	in	health	indicators,	
maternal	mortality	remains	high	at	206	deaths/100,000	live	births.(77)	Although	the	
total	fertility	rate	declined	to	3.0	births	per	woman	in	recent	years,	there	remains	
unmet	need	for	contraception.	The	2010	Cambodia	Demographic	and	Health	survey	
(DHS)	reported	that	although	81%	of	women	of	reproductive	age	wanted	to	delay	their	
next	child	or	have	no	more	children,	only	35%	reported	using	a	modern	contraceptive	
method.(77)	
The	abortion	rate	in	Cambodia	has	been	estimated	to	be	50/1,000	women,	compared	
to	the	global	average	of	28/1,000.(80)	As	fertility	can	return	within	two	weeks	it	is	
important	to	start	contraception	as	soon	as	possible	after	abortion	if	the	woman	wants	
to	prevent	subsequent	unintended	pregnancies.(6)	In	Cambodia,	amongst	women	who	
have	had	an	abortion,	26%	have	had	more	than	one.(77)	This	suggests	there	is	a	need	
to	improve	contraception	uptake	and	continuation	post-abortion.			
Mobile	phone-based	interventions	(‘mHealth’)	refer	to	the	use	of	mobile	technologies	
for	health.(112)	mHealth	interventions	can	utilise	different	modes	of	communication;	
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for	example,	text-message,	voice	messages,	video	and	smartphone	applications	and	
may	involve	one-direction	or	two-way	(interactive)	communication.(116)	mHealth	
interventions	can	deliver	support	inexpensively	wherever	the	person	is	located,	
whenever	it	is	needed.	In	particular,	mHealth	has	the	potential	to	reach	out	to	youth	
and	rural	populations,	where	geographical	distances	can	restrict	access	to	
services.(115)		
Although	a	number	of	mHealth	contraception	initiatives	have	been	launched	and	
scaled	up	in	low-income	settings,	to	date,	the	effect	of	mHealth	interventions	on	post-
abortion	family	planning	PAFP	have	not	been	reliably	established.	There	is	therefore	a	
need	for	more	evidence	on	the	effectiveness	of	mHealth	interventions	for	PAFP.		
Formative	research	is	often	used	to	design	context-specific	interventions.	It	may	
involve	literature	reviews	and	research	with	the	target	population	and	other	key	
stakeholders.(199)	However,	the	process	is	rarely	reported.(200)	This	paper	outlines	
the	formative	research	process	we	used	to	inform	development	of	the	MOTIF	
intervention	to	support	PAFP	in	Cambodia.		
3.3	Methods	
The	MOTIF	study	was	conducted	at	four	Marie	Stopes	International	Cambodia	(MSIC)	
clinics	providing	comprehensive	sexual	and	reproductive	healthcare	services;	two	
serving	predominantly	urban	populations	around	Phnom	Penh	City,	and	two	serving	
predominantly	rural	populations	(Battambang	and	Siem	Reap).	Ethical	approval	was	
granted	by	the	LSHTM	ethics	committee,	the	MSI	ethics	committee	and	the	Cambodia	
Human	Research	ethics	committee.	
Development	of	the	MOTIF	intervention	was	iterative	and	included	processes	
recommended	for	the	development	of	complex	interventions.(201)	We	drew	on	
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existing	knowledge	and	reviewed	literature	(using	simple	keyword	searches)	in	the	
following	areas	with	particular	reference	to	Cambodia;	determinants	of	contraceptive	
use,	behaviour	change	theory,	interventions	delivered	by	mobile	phone	in	other	areas;	
interventions	for	improving	contraception	use.	
Research	conducted	in	Cambodia	included	a	case	note	review	of	clinic	data,	interviews	
and	focus	groups	discussions	(FGD),	consultation	with	clinicians	and	local	organisations	
implementing	mHealth	activities,	development	of	a	conceptual	framework,	and	testing	
the	intervention	with	the	target	group.	
The	case	note	review	of	100	MSIC	abortion	clients	was	conducted	during	October	and	
November	2012	using	routinely	collected	data	to	estimate	baseline	event	rates.	We	
identified	the	first	25	clients	seeking	abortion	services	at	each	of	the	four	clinics	
attending	sequentially	from	1st	September	2011	from	the	clinic	register.	Repeat	
attendances	over	subsequent	12-months	were	identified.	Where	available,	data	was	
collected	on	age	of	client,	residence,	provision	of	a	mobile	phone	number,	
contraceptive	history,	reason	for	abortion,	subsequent	follow-up	attendances,	
contraceptive	use	and	abortions.	The	data	was	summarised	using	simple	statistics.	
Table	10	contains	a	summary	of	characteristics	of	clients	from	the	case	note	review,	
interviews	and	FGDs.	
Following	the	case	note	review	we	conducted	interviews	and	FGDs	with	clients	seeking	
abortion	services.	Clients	attending	for	abortion	services	were	recruited	sequentially	
by	research	assistants	for	both	the	interviews	and	FGDs.	Potential	participants	were	
asked	if	they	would	like	to	participate	at	the	end	of	their	post-abortion	counselling	
session.	Clients	were	provided	with	an	information	sheet	to	read,	or	it	was	read	to	
them,	and	provided	signed	or	thumb-printed	consent.	Clients	were	either	interviewed	
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Table	10:	Characteristics	of	case	note	review	clients	and	interview	and	focus	group	
discussion	participants	
	
Characteristics	of	100	case	note	review	clients	
Age	(years)	 Average	 29.3	
	 Range	 18-46	
	 <25	 28	(28%)	
	 25	or	above	 72%	
Employment	status*	 Employed	 10	(10%)	
	 Factory	worker	 22	(22%)	
	 Self-employed	 12	(12%)	
	 Farmer	 23	(23%)	
	 Entertainment	worker	 2	(2%)	
	 Housewife		 31	(31%)	
Martial	status**	 Married	 100	(100%)	
*Self-reported	employment	status	according	to	MSIC	client	registration	form.	Categories	
may	not	be	mutually	exclusive	
**It	is	possible	that	women	do	not	disclose	being	single	given	that	pregnancy	outside	of	
marriage	is	not	socially	acceptable	in	Cambodia	
	
Characteristics	of	focus	group	discussion	(FGD)	participants	
FDG	 Location	 Participants	
1	 Urban	 Two	participants.	Limited	data	on	clients	that	
agreed	but	then	did	not	join	
2	 Urban	 Three	participants.	Conducted	on	a	Sunday.	
Possible	that	more	factory	workers	may	have	
attended	this	group	
3	 Rural	 Six	participants:	all	mainly	users	of	PAFP	and	
older	women	
4	 Rural	 Five	participants:	non-users	of	PAFP	and	
younger	if	compared	to	CBB	
	
	
	
	
Characteristics	of	interview	participants	
No.	 Age	 Occupation	 Marital	status	 Clinic	
1	 20	 Factory	worker	 Married	 Urban	
2	 32	 Business	 Married	 Urban	
3	 21	 Company	staff	 Married	 Urban	
4	 26	 NGO	staff	 Married	 Rural	
5	 26	 Housewife	 Married	 Rural	
6	 26	 Business	(sells	clothes)	 Married	 Rural	
7	 30	 Business	 Married	 Rural	
8	 36	 Farmer-migrant	 Separated	 Rural	
9	 21	 Student	 Married	 Rural	
10	 26	 Student-employment	 Married	 Rural	
11	 28	 Factory	worker	 Separated	 Urban	
12	 20	 Factory	worker	 Married	 Urban	
13	 34	 Factory	worker	 Married	 Urban	
14	 31	 Factory	worker	 Married	 Urban	
15	 24	 Working	in	bank	 Married	 Urban	
at	the	time	of	attending	for	abortion	services	or	when	attending	for	follow-up	
appointment,	according	to	their	preference.		
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Author	UV	conducted	15	semi-structured	interviews	with	clients	during	December	
2012	and	January	2013	across	the	four	study	clinics	by	in	the	Khmer	(Cambodian)	
language.	A	topic	guide	was	developed	containing	questions	to	explore	clients’	reasons	
for	seeking	abortion	services,	contraception	and	mobile	phone	use	and	to	seek	views	
on	the	proposed	intervention	(see	Table	11).		
Table	11:	Interview	and	focus	group	discussion	topic	guides	
Interview	topic	guide	
	
Demographics:	Questions	about	age,	residence,	distance	from	clinic,	literacy	
	
1)	Views	on	current	service	
• You	have	recently	used	the	Marie	Stopes	services.	Could	you	tell	me	about	your	experience	of	the	
services?		
• What	information	did	they	give	you	about	contraception?		
• What	did	you	think	about	any	advice	they	offered	about	contraception?		Prompt	for:	any	counselling	
offered,	acceptable	tone,	content	of	information,	relevant?	What	method	did	you	use?	What	
different	methods	of	contraception	did	the	staff	inform	you	about?	Were	the	staff	able	to	
answer	all	of	your	questions?	Did	the	staff	arrange	follow	up?		
• Have	you	used	the	Hotline	service	at	MSI?		
If	yes:	could	you	tell	me	about	your	experience	of	using	this	service?	
Prompt	for:	If	you	experienced	unexpected	effect’s	from	contraception	what	advice	
were	you	given?	Any	comments	about	privacy	and	confidentiality	when	discussing	
contraception	over	the	phone?	Do	you	have	any	suggestions	for	improvement?	
If	no:	any	reason	for	this	
	
2)	Contraception	use	
• Have	you	ever	used	contraception?	
If	yes:	when	was	the	last	time	you	used	contraception?	Which	method?	What	was	your	
experience	of	taking	contraception?	If	discontinued:	Why	did	you	stop	it?	Any	unexpected-	
effects?	Did	you	seek	advice,	if	so	from	whom?	Have	you	ever	used	other	methods	of	
contraception?	(if	yes,	repeat	above	questions)	
If	using	contraception	when	became	pregnant:	Why	do	you	think	you	became	
pregnant	even	whilst	you	were	using	contraception?	(probe	for	missed	pills	diarrhoea,	
or	other	cause	of	contraceptive	failure)	Where	would	you	obtain	contraception	
usually?	Motivation	for	using	contraception?	
If	no:	any	reason	for	this?		
• What	are	your	current	plans	for	contraception?	Ideally,	where	would	you	go	to	get	contraception?	
Probe	on	community	based,	fixed	clinic,	private	provider	and	why?	Do	you	have	any	children?	How	
many?	Desired	family	size?	
	
3)	Reasons	for	abortion	
If	not	already	raised:	
• When	did	you	realise	you	were	pregnant?	Had	you	wanted	to	be	pregnant?	
Prompt	for:	Reasons	for	abortion	(e.g.	medical,	social)?	Discussed	with	others?	
	
4)	Views	on	the	intervention	
•	What	do	you	think	about	receiving	text	messages	or	phone	calls	relating	to	contraception?	Prompt	for:	
preference	for	phone/text,	types	of	message,	frequency,	language	
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Mobile	phone	usage	
•	Do	you	have	access	to	a	mobile	phone?	
If	yes:	Prompt	for:	Network,	type	of	phone,	Smartphone.	Do	you	own	the	phone?	
• How	do	you	use	your	phone?	Prompt	for:	SMS/phone	call/internet/preferences	
If	no:	Prompt	for:	Any	reasons	why	not?	Any	future	plans	to	get	phone?	
	
Can	I	finally	ask	you	for	any	final	comments	that	have	not	been	covered	in	this	interview.	Thank	you	very	
much	for	helping	us	and	giving	up	your	time	
	
One-month	follow-up	phone	call	
• How	are	you?	Is	this	a	suitable	time	for	you	to	talk?		
• Are	you	currently	using	a	contraceptive	method?		
If	yes:		which	method?	How	are	you	taking	it?	Any	problems?	
If	no:	any	reason	for	this?	If	a	method	discontinued:	Why	did	you	stop	it?	Any	unexpected-	
effects?	Did	you	seek	advice,	if	so	from	whom?		
•	What	are	your	future	plans	for	contraception?		
	
Do	you	have	any	other	comments?	Thank	you	very	much	for	helping	us	and	giving	up	your	time	
	
FGD	topic	guide	
Mobile	phone	use	
• Do	you	have	a	mobile	phone?	Is	it	your	own	phone	or	shared?	Who	pays	for	credit?	
• How	do	you	use	your	phone?	Preference	for	SMS	vs.	Phone	(including	voicemail)	
• Literacy:	read	or	write	Khmer	or	English?	
• Privacy/confidentiality:	does	anyone	else	have	access	to	your	phone	(either	answer	the	phone	or	
check	SMS	messages)?	Is	this	a	problem?	Are	you	able	to	make	calls	in	private?	
	
PAFP	
• Current/future	plans	for	contraception	and	pregnancy.	Reasons	for	use/non-use;	where	do	you	plan	
to	go	to	get	contraception	in	the	future?	
• Disclosure	to	others	about	contraception	use	(?also	abortion);	reasons	
	
Views	on	the	proposed	new	service	
• Would	you	be	interested	in	receiving	a	service	provided	by	MSI	to	provide	support	via	your	mobile	
phone	for	contraception	after	abortion?	
• Do	you	have	any	suggestions	for	this	service?	
• Any	comments	if	we	were	sending	you	sensitive	messages	or	discussion	about	contraception	over	
the	phone?	Would	this	be	a	problem?	
If	relevant:	would	you	still	be	interested	in	the	service	even	if	you	haven’t	decided	to	use	
contraception	at	the	current	time?	
	
Scenarios		
(1)	Regular	communication	from	MSI	to	client	to	check	for	any	problems	or	provide	info	
• Comments	on	this		
• SMS	or	phone?		
• Automated	message	vs.	having	a	‘real	time’	conversation		
• If	a	pre-recorded	voice	message	(or	SMS)	do	you	have	any	suggestions	as	to	what		the	message	could	
say?	
If	no	suggestions	ask	for	feedback	on	the	following	3	messages	and	which		one	they	
prefer:		
	
1. “Hello,	how	are	you?	This	is	a	message	from	Marie	Stopes	to	check		how	you	are	
doing.	Press	1	if	you	are	fine,	or	2	if	you	have	a	problem	and	we	will	call	you	back”	
2. “Hello,	how	are	you?	This	is	a	message	from	Marie	Stopes	to	check		how	you	are	
doing.	If	you	have	any	questions	for	us	please	leave	a	message	after	the	beep	and	
we	will	respond	to	you	with	an	automatic	message	within	2	days”	
3. “Hello,	how	are	you?	This	is	a	message	from	Marie	Stopes	to	check	how	you	are	
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with	regards	to	contraception.	Press	1	if	you	are	fine,	or	2	if	you	have	a	problem.”	
If	 client	 presses	 2,	 then	 the	 client	 receives	 a	 series	 of	 options	 asking	 what	 the	
problem	is	1,2,3,4,5	etc.	to	identify	and	provide	a	response	straight	away	
	
• Any	comments	on	whether	we	should	mention	‘Marie	Stopes’	or	‘contraception’	or	your	name	in	the	
message?		
• If	a	VOICE	message	asked	for	a	response	e.g.	Press	1	if	you	are	fine,	or	2	if	you	have	a	problem,	would	
you	be	able	to	do	that?	Would	you	be	able	to	leave	a	voice	message	so	that	we	can	respond	
later?		
• If	a	simple	SMS	(e.g.	OK?)	that	required	the	client	to	press	1	if	you	are	fine,	or	2	if	you	have	a	
problem,	would	you	be	able	to	do	that?		
• Comments	on	the	frequency	of	messages	to	clients?			
	
(2)	Side-effect	from	contraception	(example	irregular	bleeding,	headache	from	pill	or	depot)		
i. What	would	you	do?	Would	you	consider	phoning	the	new	service	for	advice?	What		if	this	involved	
the	cost	of	a	local	call?	(explain	this	might	make	the	service	more		‘sustainable’)		
ii. Views	on	automated	response	(and	able	to	leave	a	message)	vs.	having	a	‘real	time’		conversation	
(explain	automated	might	also	make	the	service	more	‘sustainable’)		
iii. Views	on	instant	response	vs.	delay	of	1-2	days	
iv. How	about	if	we	linked	you	up	with	another	client	using	a	method	to	share	experience?	Would	you	
mind	sharing	experience	as	a	‘model	client’?	
	
(3)	Daily	pill	reminder	(additional	service	if	using	pill)	
• Opinions	on	this;	SMS	vs.	phone.	What	could	that	message	say?	(e.g.	*OK	PILL*)	
• Or	for	calendar	method?			
(4)	Appointment	reminder		
• Opinions	on	this;	SMS	vs.	phone.	What	could	that	message	say?	(e.g.	*Marie	Stopes	appointment	1	
week*)	
	
(5)	Problem	after	abortion	e.g.	bleeding	or	pain	
• Opinion	on	phone	 call	 or	 SMS	a	 few	days	or	 a	week	after	 abortion	 to	ask	how	 the	 client	 is	 after	
abortion	(as	well	as	asking	about	contraception)	
	
(6)	Other	scenarios?	
• Any	other	suggestions?	Any	other	information	that	clients	would	like	to	receive	via		mobile	phone?	
• Based	on	our	discussion	about	how	we	might	provide	the	service,	how	long	do	you	think	we	should	
provide	this	service	to	clients	after	they	have	an	abortion?			
	
Summing	up	
• Summarise	key	points	raised	in	the	FGD		
• Ask	if	anything	has	been	missed	or	participants	want	to	add	anything		
Clients	were	contacted	for	a	follow-up	phone	interview	after	one	month.	There	were	
three	refusals	because	clients	stated	that	they	didn’t	have	time.	Interviews	were	
recorded	and	transcribed	into	English	and	read	by	author	CS	to	identify	key	themes.	
Four	FGDs	were	conducted	during	January	and	February	2013;	two	at	urban	clinics,	
and	two	at	rural	clinics.	The	aim	of	the	FGDs	was	to	test	proposed	messages,	seeking	
clients’	feedback	and	suggestions	for	improvement.	The	FGD	topic	guide	was	informed	
by	the	interviews.	FGDs	were	conducted	by	authors	CS	and	UV	and	a	summary	of	the	
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discussion	transcribed	to	English.	Transcripts	were	read	by	CS	to	identify	key	themes.	
These	findings	were	used	to	guide	intervention	development.	We	also	consulted	with	
other	organisations	implementing	mobile	phone-based	interventions	in	Cambodia.			
We	developed	a	preliminary	intervention	based	on	these	activities.	The	messages	were	
then	tested	with	eleven	interview	and	FGD	participants	who	agreed	to	receive	
messages	on	their	mobile	phones.	Messages	were	modified	based	on	feedback	
received	on	content,	tone,	speed	of	voice,	and	sound	quality.		
3.4	Results	
Literature	on	determinants	of	contraceptive	use,	with	a	focus	on	Cambodia	
We	reviewed	literature	on	determinants	of	contraceptive	use	in	order	to	identify	areas	
amenable	to	an	intervention.	We	found	Sheeran’s	framework	to	be	useful	as	it	
combines	developmental	models	(describing	contraceptive	use	resulting	from	
transition	through	a	series	of	stages)	and	decision-making	models	(psychological	
factors	that	speed	up	or	delay	this	transition).	Sheeran’s	framework	considers	
contraceptive	use	as	a	product	of	background,	intrapersonal,	interpersonal	and	
situational	factors.(50)	The	2010	Cambodia	DHS	collected	data	on	background	factors	
associated	with	contraceptive	use	reporting	increased	contraceptive	use	with	
increasing	parity,	wealth,	and	levels	of	educational	attainment.(77)	Westoff	conducted	
additional	analysis	on	intrapersonal,	interpersonal	and	situational	reasons	for	non-use	
of	contraception.(3)	Globally,	health	concerns	including	side-effects	are	the	
commonest	reasons	for	non-use	of	contraception;	this	is	particularly	evident	in	
Cambodia,	with	health	concerns	accounting	for	almost	50%	of	non-use	of	
contraception.(3)(16)	
We	identified	qualitative	research	supporting	these	findings.	Experience	of	negative	
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side-effects	may	be	related	to	traditional	health	beliefs	in	Cambodia.(78)	Petitet	and	
Desclaux	reported	that	in	Cambodia,	abundant	menstruation	(the	expulsion	of	‘bad	
blood’)	is	viewed	as	a	sign	of	good	health	and	fertility.	Contraceptive	methods	that	
result	in	reduced	menstruation	can	cause	women	to	worry	about	blood	retention	
leading	to	discontinuation.		
Dingle	identified	factors	related	to	knowledge,	access,	cost	and	autonomy	as	
important	reasons	for	non-use	of	contraception	in	Cambodia.	Women	often	obtain	
information	about	contraception	from	friends	and	relatives,	with	myths	and	rumours	
commonplace.(79)	Furthermore,	not	all	women	have	full	autonomy	over	health	care	
decision-making.	The	Cambodia	DHS	reported	that	only	45%	of	married	women	make	
their	own	decisions	about	health	care.(77)	Sex	workers	in	Cambodia	have	even	less	
autonomy,	often	reporting	coercion	by	clients	into	unprotected	sex.(91)	Finally,	access	
and	cost	can	influence	choice	of	contraceptive	method,	particularly	for	poor	women	
living	in	rural	areas.	Women	have	to	consider	the	opportunity	cost	of	travelling	to	
provincial	towns	to	obtain	contraceptive	methods.(79)	
Behaviour	change	theory	
Lopez	highlighted	the	need	for	increased	attention	to	theory	of	behaviour	change	in	
designing	and	evaluating	interventions	for	contraception	use.(99)	In	addition	to	
understanding	existing	contraceptive	behaviour,	we	drew	on	behaviour	change	theory.	
Michie	defined	‘behaviour	change	interventions’	as	‘coordinated	sets	of	activities	
designed	to	change	specified	behaviour’	and	developed	a	taxonomy	of	behaviour	
change	techniques	included	in	interventions,	for	example	provision	of	information	on	
risks,	consequences	of	actions,	or	conversely,	encouragement	and	goal	setting.(100)	
We	applied	this	framework	as	its	development	involved	a	systematic	literature	review,	
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evaluation	of	existing	frameworks	and	reliability	testing.	At	its	core,	a	‘behaviour	
system’	involving	three	essential	conditions;	capability	(an	individuals	psychological	
and	physical	capacity	to	engage	in	the	activity),	motivation	(the	brain	processes	that	
direct	behaviour	which	include	conscious	decision-making	and	emotional	responding)	
and	opportunity	(factors	that	lie	outside	the	individual	that	make	behaviour	
possible).(100)		
Literature	on	interventions	delivered	by	mobile	phone	in	other	areas	
We	reviewed	evidence	from	systematic	reviews	of	mHealth	interventions.	Free,	et	al.’s	
systematic	review	of	mHealth	interventions	found	that	there	is	currently	no	evidence	
of	benefit	for	simple	text-message	medication	reminders	(RR	1.00,	0.77–1.30).(115)	
This	is	consistent	with	existing	adherence	research	demonstrating	that	multifaceted	
interventions	can	be	effective	but	uni-faceted	interventions	have	modest	
benefits.(134)	
Multi-faceted	mHealth	interventions	have	been	shown	to	increase	smoking	cessation	
in	a	high-income	setting	and	adherence	to	HIV	medication	in	a	low-income	
setting.(123)(125)	Of	particular	interest	was	the	WelTel	trial	in	Kenya,	evaluating	a	
multi-faceted	intervention	for	HIV	medication	adherence.(127)	Participants	were	sent	
a	weekly	text-message	in	the	local	language	asking,	“How	are	you?”	Therefore	if	the	
message	was	seen	by	a	third	person	it	was	not	obvious	that	that	it	was	sent	from	a	HIV	
clinic.	Health	workers	would	then	phone	clients	who	reported	a	problem.	Medication	
adherence	was	higher	in	the	intervention	group,	demonstrating	that	an	mHealth	
intervention	could	be	effective	when	confidentiality	and	privacy	are	important.	
Literature	on	mHealth	in	Cambodia	
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We	found	limited	published	literature	on	mHealth	in	Cambodia	although	Cambodians	
are	enthusiastic	mobile	phone	users,	as	can	be	witnessed	during	daily	life	in	both	
urban	and	rural	areas.	Although	mobile	phone	ownership	is	estimated	to	be	over	90%,	
most	Cambodians	use	simple	rather	than	internet-enabled	smartphones.(202)	There	is	
significant	interest	in	mHealth	in	Cambodia	among	an	increasing	number	of	
organisations.	
Bullen	identified	a	number	of	operational	challenges	facing	mHealth	programmes	in	
Cambodia.(141)	Cambodian	mobile	phone	users	often	have	multiple	Subscriber	
Identification	Module	(SIM)	cards	and	share	phones,	which	can	make	it	difficult	to	
maintain	contact	with	users.	Cambodians	often	prefer	to	use	their	mobile	phone	for	
voice	calls	rather	than	text-messages	as	many	phones	lack	Khmer	language	capability.	
Furthermore,	whilst	literacy	levels	are	90%	in	urban	areas,	this	figure	is	lower	(69%)	in	
rural	areas.(77)	
Literature	on	interventions	for	contraception	including	those	delivered	by	mobile	
phone	
We	next	reviewed	literature	on	behaviour	change	interventions	to	increase	
contraception	use.	Systematic	reviews	have	found	limited	evidence	for	interventions	
to	improve	contraception	and	PAFP.(92)(93)	We	identified	three	trials	of	mHealth	
interventions	aimed	at	increasing	use	of	contraception,	all	evaluating	text	message	
interventions.	The	two	trials	that	did	not	show	an	effect	both	evaluated	simple	uni-
faceted	text	message	interventions	(contraception	reminders).(143)(144)	The	
intervention	that	was	effective	comprised	a	variety	of	daily	educational	text	messages	
and	oral	contraceptive	(OC)	reminders.(142)		
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Other	mHealth	contraception	initiatives	that	have	been	launched	and	scaled	up	in	low-
income	settings	include	Mobile	for	Reproductive	Health	(m4RH)	and	Mobile	Alliance	
for	Maternal	Action	(MAMA).	m4RH	used	best	practices	from	health	communication	
programs	to	systemically	develop	family	planning	text	messages	and	MAMA	developed	
adaptable	messages	based	on	WHO	and	UNICEF	guidelines.(146)		
Findings	from	the	case	note	review	
The	case	note	review	found	uptake	of	effective	PAFP	either	immediately	after	abortion	
or	at	two-week	follow-up	to	be	40%	(n=40)	(OC,	intra-uterine	device,	implant,	
injection).	Over	50%	of	clients	did	not	return	to	the	MSIC	clinic	for	any	reason	within	
12-months	of	having	an	abortion.	4%	of	clients	returned	to	the	same	clinic	for	repeat	
abortion	within	12-months	with	8%	returning	with	repeat	pregnancy.	Over	80%	of	
clients	provided	a	mobile	phone	number.	
Findings	from	the	interviews	and	FGDs	
Interview	and	FDG	participants	reported	seeking	abortion	services	for	mainly	
economic,	or	less	commonly,	health	reasons	(Table	12).	Most	women	reported	
disclosing	having	an	abortion	with	their	husband	or	partner.	Many	women	reported	
side-effects	when	using	contraception	in	the	past.	Clients	reported	it	was	difficult	to	
make	PAFP	choices	at	the	time	of	abortion.	Reasons	for	this	included	wanting	to	wait	
for	their	health	to	improve	first,	having	to	wait	for	their	salary	or	needing	to	discuss	
with	their	husband.	Some	women	reported	they	were	unable	to	retain	sufficient	
information	about	contraception	they	were	given.	When	we	contacted	clients	for	the	
one-month	post-interview	phone	call	they	often	had	many	questions	relating	to	
contraception	and	side-effects.	
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Table	12:	Quotes	from	interviews	and	focus	group	discussions	with	clients	
Related	to	current	abortion	
“If	we	want	to	have	more	children,	those	who	go	to	school	must	drop	out	because	we	have	
no	enshrined	money	for	their	study”	(age	30,	married,	two	children)	
“We	do	not	have	enough	money	yet…my	husband	stays	far	away	from	me…he	always	goes	
to	province”	(age	24,	married,	no	children)	
“I	discussed	with	my	husband.	He	said	just	do	what	I	want	to	do”	(aged	34,	married,	one	
child)	
Reported	previous	experience	with	contraception	use	
“I	wasn’t	using	it	regularly	so	I	got	sick	because	of	it…it	felt	hot	inside	my	chest	and	I	felt	
exhausted…	Thus	I	changed	to	condom	but	difficulty	is	it	enables	cervicitis”	(aged	34,	
married,	one	child,	talking	about	previous	experience	with	OC)	
“Because	we	feel	so	tired	after	coming	back	from	the	business	and	we	don’t	take	it	regularly	
or	maybe	we	forget	to	take	it	one	evening,	so	we’re	lazy”	(aged	30,	married,	two	children	
talking	about	previous	experience	with	OC)	
“Husband	heard	from	a	friend	that	‘when	we	use	condom	a	girl	can	be	burned,	it	is	not	good	
for	both	husband	and	wife’.	So	I	followed	my	husband”	(aged	24,	married,	no	children,	
talking	about	previous	contraception	use)	
Reported	factors	influencing	use	of	post-abortion	family	planning	
“I	am	not	able	to	afford	any	of	these	methods	to	prevent	pregnancy.	If	I	could	afford	I	would	
practice	the	contraceptive	method…I	think	I	might	wait	for	my	monthly	salary”	(aged	28,	
separated,	no	children,	talking	about	PAFP)	
“Not	interested	in	contraception	yet…because	my	health	is	not	so	good”	(aged	21,	married,	
talking	about	plans	for	PAFP)	
“She	told	me	a	lot	but	I	forgot	some	because	there’re	a	lot	of	methods”	(aged	26,	married,	no	
children,	talking	about	PAFP	counselling	received)	
Reported	mobile	phone	use	
“Even	when	the	company	sends	messages	we	can’t	read	and	leave	alone	the	messages	sent”	
(aged	30,	married,	two	children)	
“I	don’t	really	understand	the	message	in	the	phone”	(aged	34,	married,	one	child)	
“My	older	 sister	 sent	a	message	and	 I	 got	my	husband	 to	 read	 it”	 (aged	30,	married,	 two	
children)	
“Husband	pays	bill	but	never	picks	up	my	phone	to	answer”	(aged	26,	married)	
Views	on	the	intervention	
“I	think	its	good	because	we	need	contraceptive	method	to	prevent	pregnancy,	so	we	need	
some	advice	to	do	this	or	that”	(aged	31,	married,	no	children)	
“Such	as	service	 is	 really	good…for	women	and	their	health	and	there	can	be	a	 lot	of	side-
effects	if	they	have	frequent	abortions…it	means	they	take	care	of	us”	(aged	21,	married)	
“We	talk	on	phone,	no-one	knows	our	face…If	anyone	said	that	they	saw	us	drive	here,	they	
would	 think	 that	 we	 didn’t	 come	 here	 to	 discuss	 but	 to	 do	 something,	 so	 if	 we	 have	 this	
programme	 I	 think	 that	 its	 very	 good…it	makes	 clients	 reduce	 the	 time	 to	 come	 directly”	
(aged	26,	married,	no	children)	
“We	are	ignorant	and	cannot	read	the	messages	so	we	leave	them	we	see	them,	so	I	suggest	
talking	directly	with	each	other”	(aged	30,	married,	two	children)	
Regarding	the	proposed	mHealth	intervention,	most	clients	said	they	preferred	to	
make	phone	calls	over	text	message.	Most	clients	could	not	read	and	many	had	never	
used	text	messaging.	However,	most	clients	reported	listening	to	voice	messages	
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received	on	their	phones.	All	clients	were	positive	about	the	proposed	new	MOTIF	
intervention.	Despite	sharing	of	phones,	privacy	was	not	mentioned	as	a	particular	
concern.	Most	clients	stated	that	messages	sent	to	their	phones	should	mention	the	
terms	‘Marie	Stopes’	and	‘contraception’	so	they	would	know	the	topic	of	the	message	
and	who	it	was	from.	Consultation	with	clinic	staff	and	organisations	implementing	
mHealth	activities	in	Cambodia	also	suggested	a	limited	likelihood	of	success	with	a	
text-message	intervention.	
Developing	a	conceptual	framework	and	the	final	intervention	
We	developed	a	conceptual	framework	(Figure	30)	for	the	intervention	that	
considered	determinants	of	contraceptive	use,	links	between	contraceptive	use	and	
fertility	and	theory	of	behaviour	change.		
Figure	30:	Conceptual	framework	for	the	MOTIF	intervention	in	Cambodia	
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MOBILE PHONE-BASED INTERVENTION 
 
Regular interactive phone communication between provider and clients: 
INFORMATION 
•  Availability of services 
•  Contraceptive methods 
REMINDERS 
•   Follow-up appointments 
•  Availability of phone based support (if experiencing side-effects) 
SUPPORT   
•  Motivation to use contraception  
•  Encourage continuation or safe switching 
            IMPACT 
 
REDUCED: 
•  Unmet need for 
     family planning 
•  Unintended pregnancy 
•  Repeat abortion  
     (including unsafe) 
         OUTCOMES 
 
INCREASED: 
•  PAFP uptake/use 
REDUCED: 
•  Discontinuation due 
     to health concerns,  
     side-effects, access,  
     user related) 
•  Unsafe method  
     switching 
FACTORS AFFECTING 
USE OF PAFP 
 
•  Health beliefs (e.g. 
     negative perception  
     of amenorrhea) 
•  Lack of knowledge 
     of methods  
     & side-effects 
•  Fear or experience 
     of side-effects 
•  Health concerns 
•  User related e.g.  
     missed pills or 
     appointments 
•  Boost motivation  
     to use PAFP 
•  Identify problems 
     early 
•  Reassure re side- 
     effects (if appropriate)  
     or facilitate safe 
     method switch 
	
	
141	
providing	information	about	contraceptive	methods,	opportunity	to	use	contraception	
i.e.	informing	clients	where	they	can	access	contraception	near	to	where	they	live,	and	
motivation	by	re-enforcing	the	benefits	of	contraception	use	and	providing	support	
relating	to	side-effects.(100)	
We	tested	the	messages	with	clients	and	made	final	modifications	based	on	their	
feedback.	See	Table	13	for	a	description	of	the	final	intervention.		
Table	13:	Final	MOTIF	intervention	
The	MOTIF	final	intervention	comprised	a	series	of	automated	voice	messages	to	participants’	
mobile	phones	over	the	three-month	period	following	their	abortion,	at	the	time	of	day	of	their	
preference.	Clients	received	the	first	message	within	one-week	of	receiving	abortion	services	and	
then	every	two-weeks,	with	a	total	of	six	messages.	The	main	message,	recorded	in	the	Khmer	
language,	was	as	follows:	
‘Hello,	this	is	a	voice	message	from	a	Marie	Stopes	counsellor.	I	hope	you	are	doing	fine.	
Contraceptive	methods	are	an	effective	and	safe	way	to	prevent	unplanned	pregnancy.	I	
am	waiting	to	provide	free	and	confidential	contraceptive	support	to	you.	Press	1	if	you	
would	like	me	to	call	you	back	to	discuss	contraception.	Press	2	if	you	are	comfortable	with	
using	contraception	and	you	do	not	need	me	to	call	you	back	this	time.	Press	3	if	you	would	
prefer	not	to	receive	any	messages	again’		
Clients	who	pressed	1,	or	who	did	not	respond	to	the	message	prompts,	received	a	phone	call	from	
a	counsellor.	The	phone	calls	aimed	to	support	contraceptive	use	by	addressing	clients’	capability	
to	use	contraception	by	providing	individualised	information	on	a	range	of	contraceptive	methods,	
opportunity	to	use	contraception	e.g.	informing	clients	where	they	could	access	specific	methods	
near	to	their	residence,	and	motivation	by	re-enforcing	the	benefits	of	contraception	use.	If	the	
client	requested,	the	counsellor	would	also	discuss	contraception	with	the	husband	or	partner.	
Follow-up	calls	to	clients	were	made	during	preferred	times	indicated	by	the	client	on	her	
registration	form.	Clients	were	also	able	to	call	the	MOTIF	service	at	any	time	to	request	to	speak	
with	a	counsellor.	Clients	that	chose	to	receive	the	OC	or	injectable	could	opt	to	receive	additional	
reminder	messages	appropriate	to	their	method	(e.g.	to	start	a	new	packet	of	pills	or	when	to	
receive	a	new	injection).	The	sixth	and	final	voice	message	provided	similar	information	to	the	first	
five,	but	also	reminded	the	client	that	this	would	be	the	last	message	they	will	receive.	
The	MOTIF	intervention	was	delivered	by	trained	counsellors	at	the	MSIC	head	office	in	Phnom	
Penh.	Voice	messages	were	scheduled	and	sent	using	the	open-source	software	programme	
‘Verboice’,	developed	by	InSTEDD	(instedd.org).	MSIC	incurred	the	cost	of	outgoing	communication	
from	the	provider	to	client,	and	clients	incurred	any	costs	calling	into	the	service	(the	cost	of	a	local	
call).	
	
Table	14	summarises	how	formative	research	findings	contributed	towards	the	
intervention	design.	
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Table	14:	Implications	of	key	formative	research	findings	for	intervention	design	
Formative	research	
component	
Key	findings	 Implication	for	intervention	design	
Insights	from	
contraception	
literature	
• Health	concerns	identified	as	
major	reason	for	non-use.	
Other	reasons	include	factors	
related	to	access,	cost,	
autonomy	
• Intervention	needs	to	address	
health	concerns	as	well	as	factors	
related	to	access,	cost	(by	
informing	clients	where	they	can	
access	contraception	near	their	
home)	and	autonomy		
	 • Limited	evidence	for	
interventions	to	improve	
adherence	to	specific	
contraceptive	methods	or	
uptake	of	PAFP	
• The	intervention	needs	to	
anticipate	some	discontinuation	
and	aim	to	facilitate	safe	method	
switching	and	well	as	support	
continuation	with	existing	method	
	 • Most	discontinuation	occurs	
within	the	first	few	months	
• Decided	to	provide	intervention	
for	three-months	
Insights	from	
mHealth	
intervention	and	
behaviour	change	
literature	
• Uni-facteted	adherence	
interventions	have	at	best	
modest	effects	
• Developed	a	multi-faceted	
intervention	providing	
information	reminders	and	
support	to	boost	motivation	to	
use	PAFP	
	 • A	semi-automated	mHealth	
intervention	increased	
adherence	to	HIV	treatment	in	
Kenya	
• A	similar	intervention	could	be	
adapted	for	PAFP	in	Cambodia	
Case	note	review	 • 40%	uptake	of	effective	PAFP	
at	the	time	of	seeking	abortion	
services	
• Over	50%	clients	did	not	return	
to	the	clinic	within	12-months		
• An	mHealth	intervention	is	an	
opportunity	to	maintain	contact	
with	clients	that	don’t	return	to	
the	clinic	for	contraception	after	
seeking	abortion	services		
Interviews	 • Side-effects	with	
contraception	common	
• Re-enforced	findings	from	
literature	that	intervention	should	
address	health	concerns	
	 • Clients	can	find	it	difficult	to	
make	decisions	about	PAFP	at	
time	of	seeking	abortion	
services		
• The	mHealth	intervention	is	an	
opportunity	to	maintain	contact	
and	remind	clients	about	available	
methods	
	 • Women	sometimes	have	to	
discuss	with	their	
husband/partner	before	using	
contraception	
• Re-enforced	findings	from	
literature	review	that	the	
intervention	take	into	account	
women’s	lack	of	autonomy,	
facilitating	a	discussion	with	
husband/partner	if	appropriate	
Focus	group	
discussions	
• Preference	for	voice	rather	
than	text-based	intervention	
• Intervention	used	voice	messages	
sent	to	clients	phone	instead	of	
text-messages	
	 • Many	clients	preferred	direct	
phone	call	to	automated	
message	
• Developed	a	semi-automated	
intervention	as	fully	counsellor	
delivered	intervention	would	be	
costly	to	scale	up	
	 • Clients	preferred	that	the	
messages	mentioned	the	
terms	‘Marie	Stopes’	and	
‘contraception’	
• Voice	message	mentioned	
‘contraception’	and	‘Marie	
Stopes’,	but	not	the	name	of	the	
client		
Consultation	with	
MSIC	staff	and	other	
• Text-message	interventions	
likely	to	have	limited	success	in	
• Re-enforced	findings	from	clients	
that	intervention	should	use	voice	
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organisations	 Cambodia		 rather	than	text	
	 • A	fully	counsellor	delivered	
intervention	would	be	costly	
and	hence	harder	to	scale-up		
• Intervention	was	semi-automated	
aiming	to	identify	clients	most	in	
need	of	additional	support	
*	A	unifaceted	interventions	refers	to	single-component	intervention.	A	multi-faceted	intervention	
refers	to	a	complex	intervention	using	a	range	of	behaviour	change	techniques	
3.5	Discussion	
We	used	a	wide	range	of	methods	to	inform	the	development	of	the	MOTIF	
intervention.	Our	literature	review	indicated	that	our	intervention	should	address	
intrapersonal	factors,	in	particular	health	concerns.	We	found	limited	evidence	on	
behaviour	change	interventions	to	increase	the	use	of	specific	contraceptives.	Whilst	
this	may	be	partly	due	to	a	limited	number	of	high	quality,	adequately	powered	trials,	
the	focus	of	the	interventions	needs	to	be	examined.	Interventions	often	focus	on	
adherence	to	a	specific	method,	which	may	be	less	effective	than	an	intervention	that	
anticipates	method-specific	discontinuation	and	facilitates	safe	method	switching.(16)	
We	designed	an	intervention	to	offer	to	all	women	seeking	abortion	services,	
regardless	of	the	immediate	plans	for	PAFP.	
A	key	finding	from	the	case	note	review	was	high	unmet	need	for	PAFP.	It	was	not	
known	if	clients	used	other	providers	to	obtain	contraception	as	most	women	did	not	
return	to	MSIC	clinics.	Most	clients	provided	a	mobile	phone	number,	which	led	us	to	
believe	that	a	mHealth	intervention	could	be	an	opportunity	to	maintain	contact	with	
clients.	Interviews	and	FGDs	supported	these	findings.	Health	concerns	related	to	
contraception	were	widely	reported.	Clients	also	stated	a	clear	preference	for	a	voice-
based	intervention.	In	developing	the	conceptual	framework	and	intervention	we	
hypothesised	that	a	multi-faceted	mHealth	intervention	would	remind	clients	about	
contraceptive	methods,	identify	problems	with	side-effects	early,	provide	support,	and	
boost	motivation	to	use	PAFP,	while	reducing	discontinuation	and	method	switching.	
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The	strength	of	this	paper	is	that	we	have	clearly	described	how	each	component	of	
the	formative	research	contributed	to	the	final	intervention	design.	Interventions	are	
often	developed	without	evidence	of	having	gone	through	a	formative	research	
process	or	without	clearly	describing	what	activities	the	formative	research	involved.	
Furthermore,	existing	behaviour	or	theoretically	predicted	mechanisms	of	action	are	
not	fully	described.(200)(100)	Our	research	allowed	us	to	gain	an	understanding	of	
what	types	of	interventions	had	been	successful,	and	to	avoid	repeating	mistakes	of	
unsuccessful	projects.	Our	limitations	were	mainly	due	to	time	and	resource	
constraints.	A	limitation	of	our	formative	research	is	that	analysis	of	the	interviews	and	
FGDs	was	not	undertaken	by	a	second	coder.	Furthermore,	the	literature	searches	
were	not	systematic.	However,	as	interventions	can	always	be	improved,	it	is	
important	to	consider	when	to	stop	the	development	process.(200)	The	formative	
research	period	including	obtaining	ethical	approval	was	seven-months.		
Using	a	similar	approach	to	Lester	et	al,	we	developed	a	semi-automated	intervention,	
which	sought	to	identify	clients	most	in-need	of	counsellor	delivered	support.(127)	
Where	the	MOTIF	intervention	differs	from	Lester	and	other	mHealth	contraception	
interventions	is	that	it	is	voice-based.	The	main	reasons	for	this	were	rural	literacy	
levels,	lack	of	functionality	of	Khmer	script	on	phones,	and	client	preference.	This	
study	provides	some	insights	into	mobile	phone-based	interventions	intervention	
development	in	low-literacy	settings.	
The	MOTIF	intervention	was	associated	with	an	increase	in	self-reported	contraception	
use	four	months	post-abortion	but	not	at	12	months.	The	intervention	was	associated	
with	increased	long-acting6	contraception	use	at	four	and	12	months.(167)(203)	A	
																																																						
6	Intrauterine	device,	implant	or	permanent	method	
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process	evaluation	will	explore	participants’	experience	and	cost	comparison	of	MOTIF	
with	other	interventions.	
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4.1	Abstract		
Background	
Providing	women	with	contraceptive	methods	following	abortion	is	important	to	
reduce	repeat	abortion	rates,	yet	evidence	for	effective	post-abortion	family	planning	
interventions	are	limited.	This	protocol	outlines	the	evaluation	of	a	mobile	phone-
based	intervention	using	voice	messages	to	support	post-abortion	family	planning	in	
Cambodia.		
Methods/Design	
A	single	blind	randomised	controlled	trial	of	500	participants.	Clients	aged	18	or	over,	
attending	for	abortion	at	four	Marie	Stopes	International	clinics	in	Cambodia,	owning	a	
mobile	phone	and	not	wishing	to	have	a	child	at	the	current	time	are	randomised	to	
the	mobile	phone-based	intervention	or	control	(standard	care)	with	a	1:1	allocation	
ratio.		
The	intervention	comprises	a	series	of	six	automated	voice	messages	to	remind	clients	
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about	available	family	planning	methods	and	provide	a	conduit	for	additional	support.	
Clients	can	respond	to	message	prompts	to	request	a	phone	call	from	a	counsellor,	or	
alternatively	to	state	they	have	no	problems.	Clients	requesting	to	talk	to	a	counsellor,	
or	who	do	not	respond	to	the	message	prompts,	receive	a	call	from	a	Marie	Stopes	
International	Cambodia	counsellor	who	provides	individualised	advice	and	support	
regarding	family	planning.	The	duration	of	the	intervention	is	three	months.	The	
control	group	receive	existing	standard	of	care	without	the	additional	mobile	phone-
based	support.		
We	hypothesise	that	the	intervention	will	remind	clients	about	contraceptive	methods	
available,	identify	problems	with	side	effects	early	and	provide	support,	and	therefore	
increase	use	of	post-abortion	family	planning,	while	reducing	discontinuation	and	
unsafe	method	switching.	Participants	are	assessed	at	baseline	and	at	four	months.	
The	primary	outcome	measure	is	use	of	an	effective	modern	contraceptive	method	at	
four	months	post	abortion.	Secondary	outcome	measures	include	contraception	use,	
pregnancy	and	repeat	abortion	over	the	four-month	post-abortion	period.	Risk	ratios	
will	be	used	as	the	measure	of	effect	of	the	intervention	on	the	outcomes,	and	these	
will	be	estimated	with	95%	confidence	intervals.	All	analyses	will	be	based	on	the	
‘intention	to	treat’	principle.		
Discussion	
This	study	will	provide	evidence	on	the	effectiveness	of	a	mobile	phone-based	
intervention	using	voice	messages	to	support	contraception	use	in	a	population	with	
limited	literacy.	Findings	could	be	generalisable	to	similar	populations	in	different	
settings.		
Trial	registration	number	
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ClinicalTrials.gov	Identifier:	NCT01823861		
Keywords	
Family	planning,	Post-abortion	family	planning,	Contraception,	mHealth,	Cambodia		
4.2	Background		
Globally,	an	estimated	44	million	pregnancies	end	in	abortion	each	year,	of	which	
nearly	half	are	unsafe,	resulting	in	47,000	maternal	deaths.(204)(205)	The	vast	
majority	of	unsafe	abortions	occur	in	developing	countries	and	account	for	one	in	eight	
maternal	deaths.	Around	80%	of	unintended	pregnancies	in	developing	countries	
occur	among	women	who	have	an	unmet	need	for	modern	family	planning	(FP).(204)	
Globally,	if	unmet	need	for	FP	were	met,	an	estimated	75%	of	unsafe	abortions	could	
be	avoided.(206)		
The	2010	Cambodia	Demographic	Health	Survey	(CDHS)	reported	that	81%	of	women	
of	reproductive	age	did	not	want	any	more	children,	or	wished	to	wait	at	least	two	
years	for	their	next	child,	but	only	35%	were	using	a	modern	method	of	
contraception.(77)	Modern	methods	include	condom,	oral	contraceptive	(OC),	
injectable,	implant,	intra-uterine	device	(IUD)	and	permanent	methods:	vasectomy	and	
sterilisation.	The	low	use	of	contraception	might	contribute	towards	the	high	abortion	
rate	in	Cambodia,	estimated	at	50	per	1,000	women,	well	above	the	global	average	of	
28	per	1,000.(80)	Furthermore,	among	women	who	have	had	an	abortion,	26%	have	
had	more	than	one.	This	highlights	the	need	for	more	effective	interventions	to	
support	clients	with	post-abortion	family	planning	(PAFP).		
There	has	been	widespread	uptake	of	mobile	phones	in	low-income	countries	
including	Cambodia,	with	an	estimated	19	million	mobile	subscriptions	covering	a	
population	of	approximately	14	million	in	2012.(137)	Marie	Stopes	International	
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Cambodia	(MSIC)	client	exit	surveys	have	estimated	that	over	80%	of	abortion	clients	
own	a	mobile	phone.	The	use	of	mobile	phones	to	deliver	healthcare	(‘mHealth’)	has	
the	advantage	over	face-	to-face	healthcare	delivery	in	that	support	can	be	delivered	
inexpensively	wherever	the	person	is	located,	when	it	is	needed.	This	is	of	particular	
relevance	in	Cambodia	where	the	women	least	likely	to	use	a	modern	method	of	
contraception	are	the	rural	poor.(77)	Behaviour	change	techniques	(BCTs)	used	in	face-
to-face	interventions	can	be	modified	for	delivery	via	mobile	phones.(115)		
Previous	trials	related	to	smoking	cessation	and	HIV	have	reported	objective	evidence	
of	altered	health	behaviour	leading	to	improved	health	outcomes,(125)(123)	yet	there	
is	more	limited	evidence	related	to	the	use	of	contraception.		
Of	the	three	previous	trials	in	the	USA	to	improve	contraceptive	use,	Kirby	(2010)	
reported	no	effect	on	contraception	use	with	phone	calls	using	motivational	
interviewing	techniques,(174)	and	Hou	(2010)	reported	no	significant	difference	in	
mean	numbers	of	missed	pills	with	simple	daily	SMS	reminders.(143)	However,	in	a	
larger	trial	(n	=	962),	Castano	(2010)	reported	that	participants	receiving	daily	
educational	text	messages	and	pill	reminders	remained	more	likely	to	continue	at	six	
months	(OR	1.41,	1.02-1.95).(142)		
There	is	even	less	evidence	for	PAFP.	No	studies	have	formally	reported	mHealth	PAFP	
interventions	in	low-	income	countries,	although	the	‘m-assist:	Mobile	in	Medical	
Abortion’	trial	has	provisionally	reported	increased	IUD	uptake	(21%	vs.	13%)	at	seven	
weeks	post	abortion	with	a	post-abortion	SMS-based	intervention	in	South	Africa.(145)	
Although	these	study	results	look	promising,	to	date,	the	effect	of	mHealth	
interventions	on	PAFP,	or	on	a	wider	range	of	contraceptive	methods,	has	not	been	
reliably	established.		
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The	MObile	Technology	for	Improved	Family	Planning	(MOTIF)	project	comprises	the	
development,	implementation	and	evaluation	of	a	mobile	phone-based	intervention	to	
support	PAFP	in	Cambodia.	This	protocol	outlines	our	proposed	evaluation	of	the	
intervention	developed.		
4.3	Methods/Design		
Study	design		
MOTIF	is	a	multisite	single-blind	randomised	controlled	trial	(RCT).	Participants	are	
randomised	to	the	mobile	phone-based	intervention	(voice	messages	and	follow-up	
phone	calls)	or	standard	of	care	(SOC)/control	(no	additional	mobile	phone-based	
support)	with	a	1:1	allocation	ratio	(see	Figure	31).		
Figure	31:	CONSORT	diagram	of	study	design	
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Setting	and	participants		
Participants	are	recruited	from	four	MSIC	clinics;	two	serving	predominantly	urban	
populations	around	Phnom	Penh	City	(Chbar	Ambov	and	Takmao),	and	two	based	in	
provincial	towns	serving	predominantly	rural	populations	(Battambang	and	Siem	
Reap).	Participants	are	eligible	for	the	trial	if	they	are	attending	for	induced	abortion,	
aged	18	years	or	over,	own	a	mobile	phone,	do	not	want	to	have	a	child	at	the	present	
time	and	are	willing	to	receive	simple	voice	messages	from	MSIC	related	to	
contraception.	Clients	are	eligible	regardless	of	whether	they	have	decided	to	adopt	
PAFP	after	their	abortion.	
Potential	trial	participants	are	identified	by	service	providers	in	the	clinics	who	ask	
whether	they	would	like	to	discuss	participation	in	the	trial	with	a	research	assistant	
(RA)	at	the	end	of	the	PAFP	counselling	session.	RAs	provide	further	information	
regarding	the	study.	Given	the	high	rates	of	illiteracy	in	Cambodia	(literacy	in	rural	
areas	was	69%	according	to	the	2010	Cambodia	DHS),	the	RA	verbally	explains	the	
study	by	reading	the	Participants	Information	Sheet.(77)	If	the	client	wishes	to	
participate,	they	sign,	or	thumbprint,	two	copies	of	the	consent	form.	RAs	collect	
baseline	data	from	participants	that	are	recruited.	The	RA	provides	a	written	list	of	all	
participants	recruited,	together	with	a	unique	trial	identification	(ID)	number,	to	the	
counsellor	delivering	the	intervention.	The	RA	sends	only	the	ID	number	together	with	
the	clinic	status	(‘urban’	or	‘rural’)	of	enrolled	participants	to	a	project	statistician	at	
the	London	School	of	Hygiene	and	Tropical	Medicine	(LSHTM)	via	email.	Participants	
are	stratified7	according	to	urban	or	rural	clinic	status	and	allocated	to	the	intervention	
or	control	group	using	a	remote	computer-based	randomisation	programme.	
																																																						
7	It	is	incorrectly	stated	that	participants	were	stratified	where	they	were	minimised.	For	further	discussion	on	this	
issue	see	section	8.2	
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Allocation	is	therefore	concealed	from	RAs	working	on	the	trial.		
Intervention		
The	intervention	was	developed	following	a	review	of	the	literature,	formative	
research	including	interviews	and	focus	groups	with	abortion	clients,	and	with	input	
from	clinicians	and	technology	partners	in	Cambodia.(141)	The	intervention	has	a	
similar	basis	to	the	approach	used	by	Lester	(2010)	in	Kenya	who	hypothesised	that	a	
structured	mobile	phone	protocol	to	keep	in	touch	with	patient	could	improve	HIV	
medication	adherence.(127)	Detailed	description	of	the	intervention	development	will	
be	reported	elsewhere.		
The	MOTIF	conceptual	framework	is	based	on	existing	literature	on	the	determinants	
of	contraceptive	use,	links	between	contraceptive	use	and	fertility,	and	effective	
adherence	interventions	(See	Chapter	3,	Figure	30).(51)(207)		
The	MOTIF	intervention	comprises	a	series	of	automated	voice	messages	to	
participants’	mobile	phones	over	the	three-month	period	following	their	abortion,	at	
times	of	their	preference.	Clients	receive	the	first	message	within	one	week	of	
receiving	abortion	services	and	then	every	two	weeks,	with	a	total	of	six	messages.	The	
messages	are	designed	to	remind	clients	about	FP	methods	available	to	them	and	
provide	a	conduit	for	additional	support.	A	typical	message,	recorded	in	the	
Cambodian	(Khmer)	language,	is	as	follows:		
‘Hello,	this	is	a	voice	message	from	a	Marie	Stopes	counsellor.	I	hope	you	are	doing	
fine.	Contraceptive	methods	are	an	effective	and	safe	way	to	prevent	unplanned	
pregnancy.	I	am	waiting	to	provide	free	and	confidential	contraceptive	support	to	you.	
Press	1	if	you	would	like	me	to	call	you	back	to	discuss	contraception.	Press	2	if	you	are	
comfortable	with	using	contraception	and	you	do	not	need	me	to	call	you	back	this	
time.	Press	3	if	you	would	prefer	not	to	receive	any	messages	again’	
Clients	who	indicate	they	would	like	to	talk	to	a	counsellor,	or	who	do	not	respond	to	
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the	message	prompts,	receive	a	call	from	an	MSIC	counsellor.	The	counsellors	provide	
individualised	information	on	contraceptive	methods	and	advice	if	the	client	is	
experiencing	side	effects	from	contraception.	Clients	are	advised	to	use	condoms	as	
dual	protection	from	HIV	and	sexually	transmitted	infections	as	appropriate.	Follow-up	
calls	to	clients	are	made	during	preferred	times	indicated	by	the	client	on	her	
registration	form.	Clients	in	the	intervention	arm	are	also	able	to	call	the	MOTIF	
service	at	any	time	to	request	to	speak	with	a	counsellor.	Clients	who	opt	to	receive	
the	OC	or	injectable	can	opt	in	to	receive	additional	reminder	messages	appropriate	to	
their	method	(that	is,	to	start	a	new	packet	of	pills	or	when	to	receive	a	new	injection).	
The	sixth	and	final	voice	message	provides	similar	information	to	the	first	five,	but	also	
reminds	the	client	that	this	will	be	the	last	message	they	will	receive.		
The	MOTIF	intervention	is	delivered	by	trained	counsellors	at	the	MSIC	head	office	in	
Phnom	Penh.	Voice	messages	are	scheduled	and	sent	using	the	open-source	software	
programme	‘Verboice’,	developed	by	InSTEDD	(instedd.org).	Verboice	has	functionality	
with	all	the	mobile	phone	network	operators.	MSIC	incurs	the	cost	of	outgoing	
communication	from	the	provider	to	client,	and	clients	incur	any	costs	calling	into	the	
service	(the	cost	of	a	local	call).	The	counsellor	records	information	on	the	voice	
messages	sent,	responses	to	messages	and	outcomes	of	follow-up	phone	calls.		
Control		
Participants	in	the	control	group	receive	the	current	existing	SOC,	but	not	the	voice	
messages	or	follow-up	phone	calls.	Existing	SOC	includes:	face-to-face	post-	abortion	
counselling;	a	clinic	follow-up	appointment	at	one	or	two	weeks;	the	clinic	phone	
number	and	hotline	phone	number:	a	toll-free	help	line	for	clients	staffed	by	trained	
counsellors	at	the	MSIC	head	office.		
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Objectives		
The	objective	of	the	study	is	to	test	whether	additional	regular,	structured,	interactive	
mobile	phone-based	support	improves	use	of	PAFP.	We	hypothesise	that	the	
intervention	will	remind	clients	about	contraceptive	methods	available,	identify	
problems	with	side	effects	early	and	provide	appropriate	support,	and	will	boost	
motivation	to	use	PAFP,	while	reducing	discontinuation	and	unsafe	method	switching.	
Therefore	we	hypothesise	that	the	intervention	will	increase	use	of	PAFP	compared	to	
clients	receiving	SOC	(control).		
Outcome	measures		
Baseline	characteristics	of	study	participants	in	both	the	intervention	and	control	
groups	will	be	compared	with	those	of	the	general	clinic	population.	We	will	assess	
recruitment	rates,	numbers	assessed	for	eligibility	compared	with	numbers	enrolled,	
and	completeness	of	follow-up.		
Primary	outcomes		
The	primary	outcome	measure	is	use	of	an	effective	modern	contraceptive	method	at	
four	months	post	abortion.	We	define	effective	modern	methods	to	be	those	
associated	with	<10%	12-month	pregnancy	rates,	as	commonly	used:	OC,	injectable,	
implant,	IUD,	or	permanent	methods.(6)	At	four	months,	all	trial	participants	will	be	
contacted	by	phone	to	collect	self-report	data	on	all	outcomes.		
Participants	are	considered	‘users’	or	‘non-users’	of	effective	modern	contraception	
according	to	method:	implant	(participant	currently	has	a	sub-dermal	implant);	IUD	
(participant	currently	has	IUD	inserted);	injectable	(client	has	received	injection	within	
the	previous	three	months);	permanent	method	(client,	or	husband/partner	has	had	
sterilisation	or	vasectomy	procedure);	OC	(participant	reports	having	taken	pill	within	
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24	hours	of	interview	or,	if	on	7-day	break,	took	the	last	pill	according	to	instructions).	
Although	self-reported	data	on	contraception	use	are	considered	less	reliable,	and	
prone	to	social	desirability	bias,	it	is	the	standard	approach	for	contraception	research	
and	it	will	provide	data	that	are	comparable	to	previous	studies.(189)(188)		
In	order	to	assess	the	validity	of	self-reported	data,	a	reliability	study	based	on	
approximately	50	participants	recruited	from	the	clinics	near	Phnom	Penh	will	be	
conducted.	Participants	who	have	already	provided	self-report	follow-up	who	were	
recruited	from	Chbar	Ambov	and	Takmao	clinics	will	be	contacted	in	sequential	order,	
and	requested	to	attend	the	clinic	of	their	choice	for	face-to-face	follow-up	for	
objective	measurement	on	all	contraception	outcomes.	This	will	include	urine	
pregnancy	testing	and	measures	of	contraceptive	adherence	(presence	of	sub-dermal	
implant,	or	documentary	evidence	of	insertion,	clinical	examination	to	identify	coil	
threads	or	documentary	evidence	of	insertion,	documentary	evidence	of	injection	
within	the	previous	three	months,	documentary	evidence	of	sterilisation,	pill	counts	
defined	as	>90%	of	pills	taken	since	last	prescription	dispensed).		
Secondary	outcomes		
Secondary	outcome	measures	include	self-reported	pregnancy,	repeat	abortion,	
contraception	use	over	the	four-month	post-abortion	period	(to	estimate	point	
prevalence	of	contraception	use	at	any	given	time	and	contraceptive	discontinuation	
rates),	and	involvement	in	any	domestic	abuse	or	road	traffic	accidents	(RTA).	RTAs	are	
rare,	but	the	only	adverse	health	effect	of	cell	phone	use	for	which	there	is	
evidence.(164)		
Sample	size		
Analysis	of	2011	MSIC	clinic	data	indicated	that	the	proportion	of	clients	using	an	
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effective	contraceptive	method	at	two	weeks	post	abortion	was	44%.	The	trial	will	
involve	the	same	population	so	it	is	reasonable	to	assume	similar	PAFP	use	in	the	
control	group.	Aggregate	demographic	and	health,	and	Cambodian,	survey	data	
indicate	that	around	30%	of	women	using	hormonal	methods	and	10%	using	the	coil	
discontinue	within	one	year,	many	before	three	months	of	use.(87)(88)	Contraception	
use,	repeat	pregnancy	or	abortion	rates	in	MSIC	clinics	after	two	weeks	are	not	known.	
Based	on	aggregate	data,	we	anticipate	20%	discontinuation	from	two-week	
acceptance,	and	therefore	35%	of	clients	will	be	using	an	effective	method	at	four	
months	post	abortion.		
The	trial	has	been	designed	to	detect	an	increase	of	13%	in	contraceptive	use	at	four	
months	as	results	from	previous	mHealth	HIV	adherence	and	face-to-face	
contraception	adherence	interventions	suggest	that	it	is	reasonable	to	anticipate	an	
effect	of	this	size.	Canto	De	Cetina	(2001)	reported	a	26%	decrease	in	injectable	
discontinuation	at	one	year	with	an	intervention	providing	structured	face-to-face	
counselling	versus	routine	information.(208)	Lester	(2010)	reported	a	12%	increase	in	
self-reported	adherence	among	those	receiving	the	mHealth	intervention	compared	to	
routine	care.(127)		
In	the	four	trial	clinics	there	were	over	1,500	abortions	during	a	three-month	period	in	
2011,	therefore	even	accounting	for	refusals	and	reduced	recruitment	due	to	clinic	
staff	time	pressure,	we	believe	it	will	be	possible	to	recruit	500	participants	over	a	
three-month	period.	A	trial	of	500	has	80%	power	to	detect	a	difference	in	
contraceptive	use	of	35%	vs.	48%	(that	is,	relative	risk	1.4)	at	the	5%	significance	level	
(that	is,	P	<0.05).	It	is	not	possible	to	adequately	power	the	study	for	the	rare	
secondary	outcomes	of	repeat	pregnancy	and	abortion.		
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Data	collection		
At	present,	around	50%	of	clients	do	not	return	to	the	clinic	for	any	reason	after	
attending	for	abortion,	therefore	all	trial	participants	will	be	actively	followed	up	by	a	
RA	to	assess	outcome	measures.	Data	collection	tools	include	baseline	and	follow-up	
questionnaires:	designed	in	English,	translated	to	Khmer	and	administered	by	local	RAs	
fluent	in	Khmer.	The	baseline	questionnaire	contains	questions	to	collect	information	
on	contact	details,	demographics,	reproductive	history	and	plans,	circumstances	of	
current	abortion	and	mobile	phone	use.		
The	follow-up	questionnaire	contains	questions	to	collect	information	on	changes	in	
demographics,	current	contraception	use,	contraception	use	over	the	four-month	
post-abortion	period,	and	any	reported	domestic	abuse	or	RTA	that	could	have	
resulted	from	mobile	phone	use.	In	addition	to	self-reported	measures,	clients	that	
attend	the	clinic	for	face-to-face	follow-up	will	be	offered	urine	pregnancy	testing	and	
objective	assessment	of	contraceptive	use	by	a	clinically	trained	RA.		
The	follow-up	questionnaire	assesses	births,	pregnancies,	contraceptive	use	and	
discontinuation	over	a	period	of	time	using	a	similar	format	to	that	used	in	the	CDHS.		
Analysis	plan		
Analysis	of	primary	and	secondary	outcomes		
We	will	report	the	trial	according	to	the	CONSORT	standards	for	reporting	RCTs.	This	is	
a	behavioural	intervention	unlikely	to	produce	adverse	effects,	so	analysis	will	be	
undertaken	once	the	four-month	follow-up	has	been	completed.		
Intention-to-treat	(ITT)	principles	will	be	used	for	primary	outcome	analysis;	therefore	
all	participants	will	be	analysed	according	to	the	arm	to	which	they	were	randomised.	
During	ITT	analysis,	participants	lost	to	follow-up,	resulting	in	missing	contraceptive	
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use	outcome	data	at	four	months,	will	be	considered	non-users.		
Sensitivity	and	per-protocol	analysis		
We	will	conduct	an	additional	sensitivity	analysis	including	only	participants	who	
completed	the	four-month	follow-up.	Per-protocol	analysis	will	be	undertaken	to	
assess	the	impact	of	the	intervention	among	those	who	actively	participated	in	the	
intervention.	Participants	who	respond	to	three	or	more	of	the	six	voice	messages	over	
the	intervention	period	will	be	considered	highly	protocol	adherent.	Participants	who	
respond	to	between	one	and	three	messages	will	considered	less	protocol	adherent.	
Those	who	never	responded	to	a	voice	message	will	be	considered	as	never	
responding	and	not	included	in	the	sensitivity	analysis.		
Sub-group	analysis		
We	will	undertake	exploratory	sub-group	analyses	to	assess	evidence	for	whether	the	
effect	of	the	intervention	varies	according	to	age,	urban	versus	rural	residence,	level	of	
education,	and	socioeconomic	status.	If	statistically	significant	overall	heterogeneity	is	
identified	then	relative	risks	and	99%	confidence	intervals	will	be	estimated.		
Statistical	methods		
For	the	primary	outcome	and	secondary	outcomes	we	will	estimate	risk	ratios	with	
95%	confidence	intervals.	We	will	calculate	the	sensitivity	and	specificity	of	self-	
reported	contraception	use	as	compared	to	objective	measurement,	and	comment	on	
any	limitations	of	the	respective	methods	of	data	collection.	We	will	undertake	Kaplan-
Meier	survival	analysis	to	compare	contraceptive	discontinuation	rates.	Analysis	will	be	
conducted	using	STATA	(Table	15).(209)		
	
	
161	
Table	15:	Outcome	measures	and	methods	of	analysis	
	
Additional	analysis		
Data	arising	from	the	intervention		
We	will	provide	a	descriptive	analysis	of	data	generated	by	the	intervention	to	include	
number	of	voice	message	and	phone	interactions,	response	to	voice	messages,	and	
time	spent	on	phone	calls,	to	facilitate	description	of	problems	and	issues.	
Additionally,	at	the	end	of	the	trial,	the	costs	of	the	intervention	(training,	human	
resources,	phone	costs	and	so	on)	will	be	estimated.		
Qualitative	interviews		
We	will	conduct	around	15	to	20	qualitative	interviews	with	participants	who	received	
the	intervention.	Participants	for	interview	will	be	selected	purposively	to	include	
those	who	did	or	did	not	appear	to	respond	to	the	intervention:	both	users	and	non-
users	of	contraception.	The	interviews	will	explore	participants’	experience	of	the	
intervention,	aiming	to	identify	active	components	of	the	intervention,	and	seek	
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recommendations	for	improvements.	Interviews	will	be	recorded	and	transcribed	and	
a	simple	thematic	analysis	undertaken.	We	will	use	the	findings	to	inform	any	
adjustments	to	the	intervention	after	the	trial.		
Analysis	of	long-term	follow-up	at	12	and	24	months		
The	main	purpose	of	taking	contraception	is	to	avoid	unwanted	pregnancy.	While	it	is	
likely	that	few	participants	will	report	repeat	pregnancy	and/or	abortion	at	four	
months,	differences	in	these	important	outcomes	may	become	apparent	over	a	longer	
period	of	time.	During	trial	recruitment,	participants	are	given	the	option	to	consent	
for	additional	follow-up	of	primary	and	secondary	outcomes	at	12	and	24	months.	This	
additional	follow-up	will	be	dependent	on	receiving	additional	funding	and	participants	
will	be	informed	whether	this	additional	follow-up	is	likely	to	occur	at	the	end	of	the	
study.		
Ethics		
The	trial	is	being	conducted	in	accordance	with	the	principles	of	Good	Clinical	
Practice.(151)	Ethical	approval	for	the	study	protocol	was	granted	by	the	LSHTM	ethics	
committee,	the	MSI	ethics	committee	and	the	Cambodia	Human	Research	Ethics	
Committee.	The	MOTIF	trial	is	registered	with	ClinicalTrials.gov,	number:	
NCT01823861.(152)		
All	participants	provide	written	consent	before	enrolling	in	the	trial	or	commencing	the	
follow-up	interview.	All	client	records,	written,	recorded	and	transcribed	data	are	
stored	securely.	No	names	of	participants	(or	others	mentioned)	or	locations	will	be	
used	in	the	analysis	or	report	writing.	Confidentiality	will	be	maintained	by	assigning	
coded	identifiers	to	participant	names	(with	a	master	list	stored	separately).	
Participants	are	able	to	withdraw	from	the	study	at	any	point.	Any	participants	raising	
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a	personal	sexual	issue	or	consequences	arising	from	other	people	listening	to	voice	
messages	(for	example,	an	argument	or	violence)	will	be	linked	into	appropriate	
services,	either	at	MSIC,	or	other	local	organisations.		
Participants	are	reimbursed	to	compensate	for	expenses	related	to	face-to-face	clinic	
follow-up,	but	not	for	participation	in	the	trial.	Participants	are	not	provided	with	
mobile	phones	or	airtime.		
4.4	Discussion		
The	MOTIF	trial	will	provide	rigorous	evaluation	of	a	novel	mobile	phone-based	
intervention	to	support	PAFP;	and	will	contribute	towards	the	evidence	base	on	
mHealth	interventions	for	contraception.	The	MOTIF	trial	is	unique	in	a	number	of	
ways.	First,	to	our	knowledge	this	is	the	first	RCT	of	a	mobile	phone-based	intervention	
using	voice	messages	to	support	PAFP.	Given	the	paucity	of	evidence	for	effective	
interventions	for	PAFP	in	low-income	settings,	further	research	in	this	area	is	
important.	The	MOTIF	trial	has	been	carefully	designed	to	minimise	bias	and	collect	
information	on	important	health	outcomes,	while	taking	into	account	the	sensitivities	
of	undertaking	research	with	post-abortion	clients.	Due	to	the	nature	of	the	
intervention,	the	trial	can	only	be	single-blind	and	study	participants	will	be	aware	of	
intervention	allocation.	However,	allocation	will	be	concealed	to	clinicians	and	RAs	
working	on	the	trial.	Second,	it	examines	the	interventions	effect	on	both	users	and	
non-users	of	contraception,	on	a	range	of	contraceptive	methods	over	a	period	of	
time.	Previous	mHealth	contraception	interventions	have	often	been	focused	on	one	
particular	method,	often	the	OC.	In	addition	to	the	OC,	the	MOTIF	intervention	will	
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promote	long-acting8	methods	which	are	associated	with	less	user-failure.	We	believe	
that	given	high	rates	of	dissatisfaction	with	methods,	leading	to	discontinuation,	
interventions	that	promote	safe	method	switching,	as	well	as	support	for	clients	
experiencing	side	effects,	will	lead	to	increased	contraceptive	use	overall	and	reduced	
unintended	pregnancy.	Third,	to	our	knowledge,	this	is	one	of	the	first	RCTs	of	a	
mobile	phone-based	intervention	to	support	contraception	use	in	a	low-income	
setting.	To	date,	most	RCTs	of	mHealth	interventions	to	support	contraception	use	
have	been	conducted	in	the	USA,	the	exception	being	the	mAssist	trial	in	South	
Africa.(145)	Other	mobile	phone-based	contraception	initiatives	that	have	been	
launched	and	scaled	up	in	low-income	settings	include	Mobile	for	Reproductive	Health	
(m4RH),	Cycle	Tel,	Mobile	Alliance	for	Maternal	Action	(MAMA),	each	with	different	
approaches	to	the	intervention	and	evaluation,	but	limited	evidence	of	health	impacts	
to	date.(146)(149)(147)		
No	single	trial	or	initiative	will	answer	the	question	of	whether	mHealth	interventions	
are	effective	in	supporting	contraception	use	and	we	also	recognise	that	mHealth	is	a	
dynamic	area,	with	rapid	changes	in	both	technology	and	the	techno-literacy	of	
populations;	hence,	what	works	or	does	not	work	now	may	not	hold	true	in	a	few	
years’	time.	The	MOTIF	trial	will	provide	evidence	on	the	effectiveness	of	voice	
messages	to	support	contraception	use	in	populations	with	limited	literacy,	and	
findings	could	be	generalisable	to	similar	populations	in	different	settings.	Therefore,	
in	addition	to	publishing	the	findings	from	our	statistical	analysis	we	intend	to	report	
on	our	analysis	of	why	the	intervention	did	or	did	not	work,	what	BCTs	appear	to	be	
the	‘active	components’	of	the	intervention,	technological	successes	and	challenges,	
																																																						
8	Intrauterine	device,	implant	or	permanent	method	
	
	
165	
and	cost	and	resource	implications	for	scale-up	of	the	intervention.	This	should	ensure	
that	the	learning	from	this	study	will	be	of	the	greatest	possible	value	to	other	
organisations	or	researchers	seeking	to	develop	similar	interventions.		
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4.5	MObile	Technology	for	Improved	Family	Planning:	update	to	randomised	
controlled	trial	protocol	
Chris	Smith1,	Thoai	D	Ngo2,	Phil	Edwards1,	Caroline	Free1	
1	Department	of	Population	Health,	London	School	of	Hygiene	and	Tropical	Medicine,	
London,	UK.	2	Research,	Monitoring	and	Evaluation	Team,	Marie	Stopes	International,	
London,	UK.		
4.5.1	Abstract	
Background	
This	update	outlines	changes	to	the	MObile	Technology	for	Improved	Family	Planning	
study	statistical	analysis	plan	and	plans	for	long-term	follow-up.	These	changes	result	
from	obtaining	additional	funding	and	the	decision	to	restrict	the	primary	analysis	to	
participants	with	available	follow-up	data.	The	changes	were	agreed	prior	to	finalising	
the	statistical	analysis	plan	and	sealing	the	dataset.	
Methods/design	
The	primary	analysis	will	now	be	restricted	to	subjects	with	data	on	the	primary	
outcome	at	four-month	follow-up.	The	extreme-case	scenario,	where	all	those	lost	to	
follow-up	are	counted	as	non-adherent,	will	be	used	in	a	sensitivity	analysis.	In	
addition	to	the	secondary	outcomes	outlined	in	the	protocol,	we	will	assess	the	effect	
of	the	intervention	on	long-acting	contraception	(implant,	intra-uterine	device	and	
permanent	methods).	
To	assess	the	long-term	effect	of	the	intervention,	we	plan	to	conduct	additional	12-
month	follow-up	by	telephone	self-report	for	all	the	primary	and	secondary	outcomes	
used	at	four	months.	All	participants	provided	informed	consent	for	this	additional	
follow-up	when	recruited	to	the	trial.	Outcome	measures	and	analysis	at	12	months	
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will	be	similar	to	those	at	the	four-month	follow-up.	The	primary	outcomes	of	the	trial	
will	be	the	use	of	an	effective	modern	contraceptive	method	at	four	months	and	at	12	
months	post-abortion.	Secondary	outcomes	will	include	long-acting	contraception	use,	
self-reported	pregnancy,	repeat	abortion	and	contraception	use	over	the	12-month	
post-abortion	period.	
Discussion	
Restricting	the	primary	analysis	to	those	with	follow-up	data	is	the	standard	approach	
for	trial	analysis	and	will	facilitate	comparison	with	other	trials	of	interventions	
designed	to	increase	contraception	uptake	or	use.	Undertaking	12-month	trial	follow-
up	will	allow	us	to	evaluate	the	long-term	effect	of	the	intervention.	
Trial	registration	
ClinicalTrials.gov	NCT01823861.	
4.5.2	Update	
Background	
This	update	outlines	changes	to	the	MObile	Technology	for	Improved	Family	Planning	
(MOTIF)	study	statistical	analysis	plan	and	plans	for	long-term	follow-up.	These	
changes,	subsequent	to	the	publication	of	the	protocol	in	Trials,(167)	result	from	
discussions	within	the	research	team,	recommendations	from	one	author’s	(CS)	PhD	
examiners,	and	procurement	of	additional	funding	to	conduct	further	follow-up.	The	
changes	were	agreed	and	we	informed	Trials	on	12	June	2014	prior	to	finalising	the	
statistical	analysis	plan	and	sealing	the	dataset.	
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Changes	to	four-month	analysis	
The	primary	analysis	will	be	restricted	to	participants	with	available	follow-up	data.	
This	is	a	more	common	approach	to	trial	analysis	and	is	standard	in	trials	of	
interventions	designed	to	increase	contraception	use.(143)(142)(144)	This	change	will	
therefore	facilitate	comparison	of	our	results	with	other	studies.	The	primary	outcome	
remains	the	same:	use	of	an	effective	modern	method	of	contraception	at	four	months	
post-abortion.	For	the	primary	analysis,	we	originally	planned	to	consider	all	
participants	lost	to	follow-up	as	non-users	of	contraception.	This	is	clearly	an	extreme-
case	scenario	and	is	likely	to	underestimate	contraceptive	rates,	as	it	is	unlikely	that	all	
subjects	lost	to	follow-up	will	be	non-users.	We	now	consider	that	this	would	be	more	
appropriate	for	a	sensitivity	analysis.	While	the	subset	of	subjects	with	follow-up	data	
might	not	be	representative	of	all	subjects,	comparison	across	arms	should	provide	an	
internally	valid	comparison,	providing	follow-up	rates	are	similar	in	the	intervention	
and	control	arms.	
In	addition	to	the	secondary	outcomes	outlined	in	the	protocol,	we	will	assess	the	
effect	of	the	intervention	on	long-acting	contraception.	Marie	Stopes	International	
Cambodia	considers	implant,	intra-uterine	device	and	permanent	methods	to	be	long-
acting	contraception.	We	anticipate	that	this	additional	secondary	analysis	will	be	of	
value	to	family	planning	service	providers.	The	researchers	conducting	the	data	
analysis	will	be	blind	to	treatment	allocation.	A	second	independent	researcher	will	
check	the	analyses.	
Long-term	trial	follow-up	
At	recruitment,	participants	were	given	the	option	to	consent	for	additional	self-report	
follow-up	of	primary	and	secondary	outcomes	at	12	and	24	months,	subject	to	the	
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trial’s	obtaining	additional	funding.	All	500	trial	participants	provided	consent	for	this	
potential	additional	follow-up.	Subsequently	CS	obtained	a	Medical	Research	Council	
Population	Scientist	Fellowship,	which	included	some	funds	for	long-term	MOTIF	trial	
follow-up.	
We	obtained	self-report	follow-up	data	on	86.2%	of	participants	at	four	months.	Six	
participants	withdrew	from	the	study.	This	follow-up	was	conducted	by	two	research	
assistants	over	a	five-month	period.	
To	assess	the	long-term	effect	of	the	intervention,	we	plan	to	conduct	12-month	trial	
follow-up	on	the	remaining	492	trial	participants,	commencing	July	2014.	The	follow-
up	questionnaire	will	be	similar	to	that	used	at	four	months.	We	will	collect	
information	on	current	contraceptive	use,	repeat	pregnancy	or	abortion,	and	
contraception	use	over	the	12-month	post-abortion	period.	In	addition,	we	will	ask	
participants	using	contraception	where	they	obtained	it.	We	anticipate	that	it	will	take	
several	months	to	conduct	12-month	follow-up.	Having	achieved	86.2%	follow-up	at	
four	months,	we	anticipate	increased	attrition	at	subsequent	follow-up.	Owing	to	
limited	resources,	we	will	not	complete	follow-up	at	24	months.	
Outcome	measures	and	analysis	will	be	similar	to	those	at	the	four-month	follow-up.	
The	primary	outcome	at	the	12-month	follow-up	will	be	use	of	an	effective	modern	
contraceptive	method	at	12-months	post-abortion.	This	will	be	considered	a	second	
primary	outcome,	in	addition	to	effective	modern	contraceptive	use	at	four	months.	
Secondary	outcomes	include	long-acting	contraception	use,	self-reported	pregnancy,	
repeat	abortion,	and	contraception	use	over	the	12-month	post-abortion	period	(to	
estimate	the	point	prevalence	of	contraception	use	at	any	given	time	and	of	
contraceptive	discontinuation	rates).	
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For	the	primary	outcomes	and	for	secondary	outcomes	with	binary	outcome	measures	
we	will	estimate	risk	ratios	with	95%	confidence	intervals	and	give	a	two-sided	P	value	
for	statistical	significance	using	the	chi-squared	test.	We	will	perform	Kaplan-Meier	
survival	analysis	to	assess	contraceptive	discontinuation	rates.	
We	will	perform	sub-group	and	sensitivity	analysis	as	per	the	four-month	analysis.	For	
sub-group	analysis,	we	will	assess	whether	the	effect	of	the	intervention	varies	
according	to	age,	urban	versus	rural	residence,	level	of	education	and	socioeconomic	
status.	We	will	use	the	chi-squared	test	for	heterogeneity	at	a	5%	level	of	significance.	
If	statistically	significant	overall	heterogeneity	is	identified,	relative	risks	and	99%	
confidence	intervals	will	be	estimated.	Sensitivity	analysis	will	include	counting	those	
lost	to	follow-up	as	non-users,	per-protocol	analysis,	and	analysis	of	clustering	among	
participants	from	each	clinic,	as	for	the	four-month	follow-up.	
Ethics	
Ethical	approval	for	this	additional	follow-up	has	been	granted	by	the	London	School	of	
Hygiene	and	Tropical	Medicine	ethics	committee	(reference	number	6378–01),	the	
Marie	Stopes	International	ethics	committee	(reference	number	002-13-Am14),	and	
the	Cambodia	Human	Research	ethics	committee	(reference	number	0193	NECHR).	
Conclusion	
Restricting	the	primary	analysis	to	those	with	follow-up	data	is	the	standard	approach	
for	trial	analysis	and	will	facilitate	comparison	with	other	trials	of	interventions	
designed	to	increase	contraception	uptake	or	use.	Undertaking	12-month	trial	follow-
up	will	allow	us	to	evaluate	the	long-term	effect	of	the	intervention.	
Abbreviation		
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Chapter	transition	notes	
The	previous	chapter	(Chapter	4)	described	the	trial	protocol.	This	chapter	(Chapter	5)	
is	a	research	paper	that	presents	the	results	of	the	MOTIF	randomised	controlled	trial	
and	includes	data	on	baseline	characteristics	of	participants,	primary	and	secondary	
outcomes	collected	at	four	and	12-month	follow	up,	as	well	as	subgroup	and	
discontinuation	figures	for	the	12-month	follow	up	data.		
In	additional	to	the	published	trial	paper,	this	chapter	contains	three	additional	
analyses.	This	includes	pre-specified	analyses	that	that	could	not	be	included	in	the	
main	trial	paper	due	to	word	count	limitations	such	as	additional	discontinuation	
figures	(Section	5.6),	an	analysis	assessing	the	validity	and	reliability	of	self-report	data	
on	contraception	use	collected	in	the	trial	(Section	5.7)	and	sensitivity	analyses	
(Section	5.8).		
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In	addition	I	have	undertaken	some	exploratory	analyses	not	originally	planned	for	the	
PhD	to	provide	additional	insights	into	the	mechanism	of	action	of	the	intervention,	
explore	follow	up	approaches	and	methods	of	dealing	with	missing	data.	These	include	
an	analysis	of	dynamics	of	contraception	use	over	the	post-abortion	period	(Section	
5.6),	an	overview	of	approaches	to	measuring	adherence	to	effective	contraceptive	
methods	(Section	5.7),	and	an	analysis	assessing	factors	associated	with	loss	to	follow-
up	in	the	trial	and	comparing	how	the	result	might	have	varied	using	different	analysis	
methods	such	as	multiple	imputation	(Section	5.8).	Whilst	I	conceived	the	idea	for	the	
paper	exploring	factors	associated	with	loss	to	follow-up	and	conducted	the	logistic	
regression	analysis,	a	statistician	(Christopher	Jarvis)	coded	the	multiple	imputation	
and	added	the	follow	text	to	the	paper:	“Logistic	regression	with	predictor	variables	
age	group,	socioeconomic	status,	and	education	was	used	for	univariate	imputation	of	
the	outcome.	Multiple	imputation	was	conducted	separately	for	the	outcome	at	4	and	
12	months	with	100	imputed	datasets	created	for	each	outcome	respectively”.	
Currently	the	additional	analyses	have	not	been	prepared	for	publication,	but	it	is	
possible	that	Sections	5.7	and	5.8	might	be	prepared	and	submitted	for	publication	in	
the	future.	
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Effect	of	a	mobile	phone-based	intervention	on	post-abortion	
contraception:	a	randomized	controlled	trial	in	Cambodia	
Chris	Smith,a	Thoai	D	Ngo,b	Judy	Gold,c	Phil	Edwards,a	Uk	Vannak,d	Ly	Sokhey,d	Kazuyo	
Machiyama,a	Emma	Slaymaker,a	Ruby	Warnock,d	Ona	McCarthya	&	Caroline	Freea	
a	Department	of	Population	Health,	London	School	of	Hygiene	&	Tropical	Medicine,	
Keppel	Street,	London,	WC1E	7HT,	England.	b	Innovations	for	Poverty	Action,	New	
Haven,	United	States	of	America.	c	Independent	consultant,	London,	England.	d	Marie	
Stopes	International,	Phnom	Penh,	Cambodia.		
5.1	Abstract	
Objective	
To	assess	the	effect	of	a	mobile	phone-based	intervention	(mHealth)	on	post-abortion	
contraception	use	by	women	in	Cambodia.		
Methods	
The	Mobile	Technology	for	Improved	Family	Planning	(MOTIF)	study	involved	women	
who	sought	safe	abortion	services	at	four	Marie	Stopes	International	clinics	in	
Cambodia.	We	randomly	allocated	249	women	to	a	mobile	phone-based	intervention,	
which	comprised	six	automated,	interactive	voice	messages	with	counsellor	phone	
support,	as	required,	whereas	251	women	were	allocated	to	a	control	group	receiving	
standard	care.	The	primary	outcome	was	the	self-reported	use	of	an	effective	
contraceptive	method,	four	and	12	months	after	an	abortion.		
Findings	
Data	on	effective	contraceptive	use	were	available	for	431	(86%)	participants	at	4	
months	and	328	(66%)	at	12	months.	Significantly	more	women	in	the	intervention	
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than	the	control	group	reported	effective	contraception	use	at	four	months	(64%	
versus	46%,	respectively;	relative	risk,	RR:	1.39;	95%	confidence	interval,	CI:	1.17–1.66)	
but	not	at	12	months	(50%	versus	43%,	respectively;	RR:	1.16;	95%	CI:	0.92–1.47).	
However,	significantly	more	women	in	the	intervention	group	reported	using	a	long-
acting9	contraceptive	method	at	both	follow-up	times.	There	was	no	significant	
difference	between	the	groups	in	repeat	pregnancies	or	abortions	at	four	or	12	
months.		
Conclusion	
Adding	a	mobile	phone-based	intervention	to	abortion	care	services	in	Cambodia	had	a	
short-term	effect	on	the	overall	use	of	any	effective	contraception,	while	the	use	of	
long-acting	contraceptive	methods	lasted	throughout	the	study	period.	
5.2	Introduction	
Unmet	need	for	contraception	can	result	in	unintended	pregnancy	and	avoidable	
maternal	and	infant	deaths.(1)	It	has	been	estimated	that,	if	the	need	for	modern	
contraception	methods	were	met,	52	million	unintended	pregnancies,	24	million	
abortions	(over	half	of	which	would	be	unsafe)	and	70	000	maternal	deaths	would	be	
prevented	among	women	in	low-income	countries	each	year.	Nevertheless,	225	
million	women	in	these	countries	had	an	unmet	need	for	contraception	in	2014.(155)	
Women	who	seek	an	abortion	are	likely	to	have	an	unmet	need	for	contraception	and	
the	time	after	an	abortion	provides	a	key	opportunity	to	offer	family	planning	
services.(29)	Typically,	women	are	counselled	on	family	planning	before	discharge	
from	clinical	care	aſter	seeking	abortion	services.(210)	However,	quality	of	service	
provision	varies	and	evidence	on	the	ability	of	enhanced	counselling	interventions	to	
																																																						
9	Intrauterine	device,	implant	or	permanent	method	
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improve	post-abortion	family	planning	is	inconclusive.(93)(94)	In	Cambodia,	despite	
the	total	fertility	rate	declining	from	3.4	births	per	woman	in	2005	to	3.0	births	per	
woman	in	2010,	there	remains	an	unmet	need	for	contraception:	in	2010,	81%	of	
women	of	reproductive	age	reported	wanting	to	delay	their	next	child	or	to	have	no	
more	children	but	only	35%	reported	currently	using	a	modern	contraceptive	
method.(77)	The	abortion	rate	in	the	country	was	estimated	to	be	50	per	1000	
women,	compared	to	a	global	average	of	28	per	1000,(80)	and	26%	of	women	who	
sought	abortion	services	had	had	more	than	one	abortion.(77)	Interventions	delivered	
by	mobile	phone	could	help	increase	the	uptake	and	continuation	of	post-abortion	
family	planning	in	countries	like	Cambodia	where	over	90%	of	the	2066	women	
surveyed	report	owning	a	mobile	phone.(211)	Health	interventions	delivered	by	
mobile	phone	can	utilize	different	approaches	(e.g.	text	messages,	voice	messages	or	
smartphone	applications)	depending	on	the	literacy	of	the	population	and	the	devices	
available.(116)	Compared	with	face-to-face	interventions,	mobile	phone-based	
interventions	have	the	advantage	that	they	can	provide	interactive,	personalized	
support	inexpensively	wherever	the	person	is	located	and	whenever	needed.	Our	
research	suggested	that	women	in	Cambodia	often	found	it	difficult	to	make	decisions	
about	contraception	at	the	time	of	seeking	abortion	services;	they	needed	more	time,	
to	wait	for	their	health	to	improve	or	to	speak	with	family	or	friends.(212)	Hence,	in	
this	setting,	where	80%	of	the	population	live	in	a	rural	area	and	geographical	
distances	can	restrict	access	to	services,	mobile	phone-based	interventions	may	
provide	an	effective	method	for	maintaining	communication	with	clients	after	they	
leave	the	clinic.(77)(115)	Interventions	delivered	by	mobile	phone	have	been	shown	to	
be	effective	in	other	health	areas,	such	as	smoking	cessation	and	adherence	to	
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treatment	for	human	immunodeficiency	virus	infection.(125)(123)	However,	the	
evidence	from	three	small	trials	in	which	a	mobile	phone-based	intervention	was	used	
to	increase	contraceptive	use	has	been	inconclusive.(142)(143)(144)	The	objective	of	
our	study	was	to	evaluate	the	effectiveness	of	a	mobile	phone-based	intervention	
designed	to	support	post-abortion	contraception	in	Cambodia.	The	specific	aims	were	
to	increase	the	uptake	of	effective	contraceptive	methods	and	to	reduce	contraceptive	
discontinuation.	
5.3	Methods	
Our	study	-	the	Mobile	Technology	for	Improved	Family	Planning	(MOTIF)	study	-	was	a	
single-blind,	randomized	trial	of	a	personalized,	mobile	phone-based	intervention	
designed	to	support	post-abortion	family	planning.	The	protocol	was	published	in	
2013.(167)(213)	The	trial	was	undertaken	at	four	Marie	Stopes	International	clinics	in	
Cambodia	that	provided	safe	abortion	services:	two	served	peri-urban	populations	
around	Phnom	Penh	city	(i.e.	Chbar	Ambov	and	Takmao)	and	two	served	provincial	
towns	with	a	predominantly	rural	population	(i.e.	Battambang	and	Siem	Reap).	All	
women	older	than	17	years	who	sought	an	induced	abortion	were	eligible	for	inclusion	
if	they	had	a	mobile	phone	primarily	for	their	own	use,	reported	not	wanting	to	
become	pregnant	and	were	willing	to	receive	automated	voice	messages	about	
contraception.	Research	assistants	interviewed	women	aſter	they	had	received	post-
abortion	family	planning	counselling	at	the	clinic	to	assess	their	eligibility	for	the	study	
and	to	collect	baseline	data.	Participants	provided	consent	by	written	signature	or	
thumbprint.	Ethical	approval	was	obtained	from	ethics	committees	at	the	London	
School	of	Hygiene	&	Tropical	Medicine	and	Marie	Stopes	International	and	the	
Cambodia	Human	Research	ethics	committee.	The	trial	was	registered	through	
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ClinicalTrials.gov	with	the	identifier	NCT01823861.	Research	assistants	provided	a	
written	list	of	participants,	each	with	a	unique	identification	number,	to	counsellors	
delivering	the	intervention.	The	project	statistician	at	the	London	School	of	Hygiene	&	
Tropical	Medicine,	London,	United	Kingdom	of	Great	Britain	and	Northern	Ireland,	
received	only	the	identification	number	and	the	urban	or	rural	clinic	classification	of	
each	participant.	The	statistician	allocated	participants	to	the	intervention	or	control	
group	on	a	1:1	basis	using	Minim	(https://www-users.york.ac.uk/~mb55/	
guide/minim.htm),	a	computer	randomization	program	that	stratified10	them	
according	to	whether	their	clinic	was	urban	or	rural.	The	identification	numbers	of	
participants	allocated	to	the	intervention	were	sent	to	the	counsellors	between	1	May	
and	27	September	2013.	Researchers	who	undertook	data	collection	and	analysis	were	
blinded	to	the	treatment	allocation.	
All	participants	received	existing	standard	care,	which	included	post-abortion	family	
planning	counselling	at	the	clinic	in	accordance	with	national	guidelines,	the	offer	of	a	
follow-up	appointment	at	the	clinic	and	details	of	the	clinic’s	phone	number	and	of	a	
hotline	number	operated	by	counsellors	at	Marie	Stopes	International	Cambodia.	
Those	allocated	to	the	intervention,	which	lasted	three	months,	also	received	six	
automated,	interactive	voice	messages	and	were	provided	with	phone	support	from	a	
counsellor	depending	on	their	responses	to	the	messages	(Table	16).	Participants	who	
chose	to	receive	oral	or	injectable	contraceptives	could	opt	for	additional	reminder	
phone	messages	appropriate	to	their	method.	Participants	in	the	control	group	did	not	
receive	voice	messages.		
																																																						
10	It	is	incorrectly	stated	that	participants	were	stratified	where	they	were	minimised.	For	further	discussion	on	this	
issue	see	section	8.2	
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The	intervention	was	delivered	by	trained	counsellors	at	Marie	Stopes	International	
Cambodia.	Voice	messages	were	scheduled	and	sent	using	the	open-source	software	
program	Verboice	(InSTEDD,	Palo	Alto,	United	States	of	America).	The	cost	of	outgoing	
communications	from	the	provider	to	the	participant	was	met	by	Marie	Stopes	
International	Cambodia	and	the	cost	of	calling	into	the	service	(i.e.	a	local	call)	was	
incurred	by	participants.	
Table	16:	The	mobile	phone-based	intervention	
The	conceptual	framework	for	the	intervention	used	in	the	MObile	Technology	for	
Improved	Family	Planning	(MOTIF)	study	was	based	on	literature	reports	on	the	
determinants	of	contraceptive	use	and	on	links	between	contraceptive	use	and	
fertility.18	The	intervention	comprised	six	automated	voice	messages	sent	to	
participants’	mobile	phones,	at	the	time	of	their	preference,	during	the	3	months	
following	an	abortion.	Participants	received	the	first	message	within	1	week	of	using	
abortion	services	and	every	2	weeks	thereafter.	The	message,	recorded	in	the	
Khmer	language,	was	as	follows:	Hello,	this	is	a	voice	message	from	a	Marie	Stopes	
counsellor.	I	hope	you	are	doing	fine.	Contraceptive	methods	are	an	effective	and	
safe	way	to	prevent	an	unplanned	pregnancy.	I	am	waiting	to	provide	free	and	
confidential	contraceptive	support	to	you.	Press	1	if	you	would	like	me	to	call	you	
back	to	discuss	contraception.	Press	2	if	you	are	comfortable	with	using	
contraception	and	you	do	not	need	me	to	call	you	back	this	time.	Press	3	if	you	
would	prefer	not	to	receive	any	more	messages.	Participants	who	pressed	1	or	who	
did	not	respond	received	a	phone	call	from	a	counsellor.	The	phone	calls	were	
intended	to	encourage	contraceptive	use	by	increasing	the	client’s	capability	of	
using	contraception	by:	(i)	providing	individualized	information	on	a	range	of	
contraceptive	methods;	(ii)	increasing	the	participant’s	opportunity	to	use	
contraception,	for	example,	by	informing	her	where	she	could	access	specific	
methods	near	her	residence;	and	(iii)	increasing	motivation	by	reinforcing	
knowledge	of	the	benefits	of	contraception.	At	the	participant’s	request,	the	
counsellor	would	also	discuss	contraception	with	her	husband	or	partner.	
Participants	were	also	able	to	call	the	service	and	ask	to	speak	to	a	counsellor.	Those	
who	chose	to	receive	an	oral	or	injectable	contraceptive	could	opt	to	receive	
additional	reminder	messages	appropriate	to	their	method	(e.g.	on	when	to	start	a	
new	packet	of	pills	or	when	to	receive	a	new	injection).	The	sixth	and	final	voice	
message	was	similar	but	also	reminded	the	participant	that	this	was	the	last	
message	they	would	receive.	The	intervention	was	delivered	by	trained	counsellors	
at	Marie	Stopes	International	Cambodia.	Voice	messages	were	scheduled	and	sent	
using	the	open-source	software	program	Verboice	(InSTEDD,	Palo	Alto,	United	
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States	of	America).	The	cost	of	outgoing	communications	from	the	provider	to	the	
participant	was	met	by	Marie	Stopes	International	Cambodia	and	the	cost	of	calling	
into	the	service	(i.e.	a	local	call)	was	incurred	by	participants.	
The	formative	research	carried	out	to	develop	the	intervention	will	be	reported	
elsewhere.	The	primary	outcome	was	the	self-reported	use	of	an	effective	
contraception	method,	four	and	12	months	after	an	abortion.	Effective	methods	were	
defined	as	those	that	have	been	associated	with	a	12-month	pregnancy	rate	below	
10%	(a	common	criterion	in	developing	countries),	such	as	oral	contraceptives,	three-
monthly	contraceptive	injections,	subdermal	implants,	intrauterine	devices	and	
permanent	methods,	such	as	sterilization	or	vasectomy.(7)(6)	A	participant	was	
regarded	as	using	an	effective	method	if	she	reported	that	she:	(i)	currently	had	a	
contraceptive	implant	or	an	intrauterine	device	in	place;	(ii)	had	received	a	
contraceptive	injection	within	the	previous	three	months;	(iii)	had	under-gone	
sterilization	or	her	husband	or	partner	had	had	a	vasectomy;	or	(iv)	had	taken	an	oral	
contraceptive	within	24	hours	of	the	interview	or	according	to	instructions.	Secondary	
outcomes	were:	(i)	use	of	a	long-acting	contraceptive	method	(i.e.	an	intrauterine	
device,	implant	or	permanent	method);	(ii)	repeat	pregnancy;	(iii)	repeat	abortion;	(iv)	
effective	contraceptive	use	for	more	than	80%	of	the	four	or	12	months	after	the	
abortion;	(v)	road	traffic	accidents	associated	with	the	intervention	(e.g.	caused	by	
driving	while	using	the	phone);	and	(vi)	domestic	abuse	associated	with	the	
intervention	(e.g.	after	the	woman’s	husband	or	partner	had	listened	to	the	
messages).	Research	assistants	contacted	participants	by	phone	and	collected	
information	on	these	outcomes	using	a	standardized	questionnaire.	The	effect	of	the	
intervention	was	examined	in	pre-specified	subgroups	categorized	by	age,	urban	or	
rural	residence,	educational	level	and	socioeconomic	status	–	access	to	a	motorized	
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vehicle	was	used	as	a	proxy	measure	of	socioeconomic	status.	The	four-month	follow-
ups	were	conducted	between	13	August	2013	and	31	January	2014	and	the	12-month	
follow-ups,	between	24	July	and	16	November	2014.	An	assessment	of	the	validity	of	
the	self-	reported	data	collected	after	four	months	in	50	participants	will	be	reported	
elsewhere.	
Statistical	analysis	
The	statistical	analysis	plan	was	specified	before	the	study	was	unblinded	and	was	
reported	in	the	trial	protocol.(167)	We	estimated	that	35%	of	the	control	group	would	
be	using	an	effective	contraception	method	after	four	months	and	that	a	sample	size	
of	500	would	be	required	to	detect	a	13%	increase	in	contraceptive	use	with	a	80%11	
power	at	the	5%	level	of	significance.(167)	Analyses	were	undertaken	on	an	intention-
to-treat	basis	using	Stata	version	13.1	(StataCorp.	LP,	College	Station,	United	States	of	
America).	The	effect	of	the	intervention	was	expressed	as	a	relative	risk	(RR)	or	hazard	
ratio	(HR);	a	95%	confidence	interval	(CI)	was	used	for	primary	and	secondary	
outcomes	and	a	99%	CI	for	subgroup	analyses.	The	contraceptive	discontinuation	rate	
was	assessed	using	Kaplan-Meier	survival	analysis	techniques:	for	four-month	follow-
up	data,	discontinuation	was	assessed	in	participants	who	started	using	an	effective	
contraception	method	during	the	first	four	weeks	after	an	abortion	and,	for	12-month	
follow-up	data,	discontinuation	was	assessed	in	those	who	started	the	method	during	
the	three	months	after	an	abortion.	Discontinuation	was	defined	as	stopping	the	
method	for	one	week	or	more	before	the	four-month	follow-up	or	for	one	month	or	
more	before	the	12-month	follow-up.	If	the	participant	switched	from	one	effective	
method	to	another	effective	method	this	was	not	considered	discontinuation.	
																																																						
11	In	the	published	paper	power	was	reported	as	90%	(typo	detected	at	the	PhD	viva)	
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5.4	Results	
We	excluded	199	potential	participants	because	they	did	not	own	a	mobile	phone.	Of	
the	500	participants,	249	were	assigned	to	the	intervention	group	and	251	to	the	
control	group	(Figure	32).	
Figure	32:	Flowchart	of	participants	
	
The	participants’	baseline	characteristics	are	shown	in	Table	17.	Data	on	the	primary	
outcome	were	available	for	431	(86%)	participants	at	four	months	and	for	328	(66%)	at	
12	months.	Over	75%	(133/172)	of	losses	to	follow-up	by	12	months	were	due	to	the	
participant’s	phone	being	either	switched	off	or	not	in	use,	as	indicated	by	an	
automated	message.	Less	frequently	the	phone	number	had	been	reassigned	to	
another	user	or	the	participant	had	reportedly	moved	abroad	for	work.	
The	proportion	of	women	in	the	intervention	group	who	reported	effective	
contraception	use	was	significantly	higher	than	in	the	control	group	at	four	months	
915 assessed for eligibility 
500 women randomized 
38 women lost to  
follow up 
•  3 withdrew 
•  35 could not be  
      reached 
Four months: 
•  211 women followed up 
and analyzed 
209 women did not meet inclusion criteria 
•  199 had no phone 
•  5 had miscarriage (not abortion) 
•  5 wanted to have another child 
206 women eligible but declined 
•  163 had no time 
•  14 separated from husband/partner 
•  11 husband/partner working away 
•  14 planning to work abroad 
•  3 no space to interview client 
•  1 deaf 
249 women allocated to intervention group 251 women allocated to control group 
31 women lost to 
follow up 
•  3 withdrew 
•  28 could not be 
reached 
Four months: 
•  220 women followed up 
and analyzed 
42 women lost to 
follow up 
•  42 could not be 
reached 
61 women lost to 
follow up 
•  2 withdrew 
•  59 could not be 
reached 
12 months: 
•  169 women followed up 
and analyzed 
12 months: 
•  159 women followed up 
and analyzed 
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Table	17:	Baseline	characteristics	of	participants	
Characteristic	 Intervention	
group	(n = 249)	
Control	group	(n = 251)	
No.	(%)	 No.	(%)	
Age,	years	 	 	
<	25	 88	(35)	 69	(27)	
≥	25	 161	(65)	 182	(73)	
Residence	 	 	
Rural	 164	(66)	 157	(63)	
Urban	 85	(34)	 94	(37)	
Educational	level	 	 	
None	or	primary	school	 93	(37)	 103	(41)	
Secondary	school	or	higher	 156	(63)	 148	(59)	
Socioeconomic	status	 	 	
Access	to	a	motorized	vehicle	 221	(89)	 214	(85)	
No	access	to	a	motorized	vehicle	 28	(11)	 37	(15)	
Marital	status	 	 	
Married	or	cohabiting	 231	(93)	 233	(93)	
Never	married	or	cohabited	 15	(6)	 14	(6)	
Divorced	or	separated	 3	(1)	 4	(2)	
Literacy	 	 	
Able	to	recognize	numbers	 246	(99)	 250	(100)	
Not	able	to	recognize	numbers	 3	(1)	 1	(<1)	
Number	of	living	children	 	 	
0	 79	(32)	 68	(27)	
1	or	2	 122	(49)	 131	(52)	
≥3	 48	(19)	 52	(21)	
Previous	abortions	 	 	
0	 144	(58)	 155	(62)	
1	 69	(28)	 65	(26)	
≥2	 36	(15)	 31	(12)	
Type	of	abortion	before	study	entry	 	 	
Medical	 102	(41)	 105	(42)	
Surgical	 147	(59)	 146	(58)	
Woman	planned	to	use	contraception	at	time	of	
randomization	
	 	
Yes	 91	(37)	 96	(38)	
No	 18	(7)	 24	(10)	
Undecided	 140	(56)	 131	(52)	
Woman’s	mobile	phone	access	 	 	
Shares	phone	 123	(49)	 118	(47)	
Never	shares	phone	 126	(51)	 133	(53)	
Inconsistencies	arise	in	some	values	due	to	rounding.	
(64%	versus	46%,	respectively;	RR:	1.39;	95%	CI:	1.17–1.66;	Table	18)	but	not	at	12	
months	(50%	versus	43%,	respectively;	RR:	1.16;	95%	CI:	0.92–1.47).	Significantly	more	
women	in	the	intervention	than	the	control	group	reported	using	a	long-acting	
contraceptive	method	at	four	months	(29%	versus	9%,	respectively;	RR:	3.35;	95%	CI:	
2.07–5.40;	Table	18)	and	at	12	months	(25%	versus	12%,	respectively;	RR:	2.08;	95%	
CI:	1.27–3.42).	In	addition,	significantly	more	women	in	the	intervention	than	the	
control	group	reported	effective	contraceptive	use	for	more	than	80%	of	the		
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Table	18:	Effect	of	a	mobile	phone-based	intervention	on	post-abortion	family	planning,	
Cambodia	2013-2014	
Outcome	 4-month	follow-up	 12-month	follow-up	
Interven
tion	
Control		 RR	(95%	CI)	 Interventi
on		
Control	 RR	(95%	CI)	
No.	(%)	 No.	(%)	 No.	(%)	 No.	(%)	
Primary	outcome	 	 	 	 	 	 	
Self-reported	use	of	
an	effective	
contraceptive	
method	
135/211	
(64)	
101/220	
(46)	
1.39	(1.17–1.66)	 84/169	
(50)	
68/159	
(43)	
1.16	(0.92–1.47)	
Secondary	outcome	 	 	 	 	 	 	
Use	of	a	long-acting	
contraceptive	
method	
61/211	
(29)	
19/220	
(9)	
3.35	(2.07–5.40)	 42/169	
(25)	
19/159	
(12)	
2.08	(1.27–3.42)	
Effective	
contraceptive	use	for	
>	80%	of	the	follow-
up	period	
108/200	
(54)	
81/203	
(40)	
1.35	(1.10–1.67)	 86/169	
(51)	
61/159	
(38)	
1.33	(1.04–1.70)	
Contraceptive	
discontinuation	
9/123	
(7)	
16/101	
(16)	
0.45a	(0.20–1.01)	 28/107	
(26)	
25/83	
(30)	
0.82b	(0.48–1.40)	
Repeat	pregnancy	 6/210	
(3)	
5/220	
(2)	
1.25	(0.39–4.06)	 22/169	
(13)	
28/159	
(18)	
0.74	(0.44–1.24)	
Repeat	abortion	 2/210	
(1)	
1/220	
(0.5)	
2.10	(0.19–22.9)	 8/169	(5)	 11/159	
(7)	
0.68	(0.28–1.66)	
Involvement	in	a	
road	traffic	accident	
0/210	
(0)	
0/220	
(0)	
NA	 ND	 ND	 NA	
Experience	of	
domestic	abuse	
0/210	
(0)	
0/220	
(0)	
NA	 ND	 ND	 NA	
Lost	to	follow-upb	 38/249	
(15)	
31/251	
(12)	
1.24	(0.80–1.92)	 80/249	
(32)	
92/251	
(37)	
0.88	(0.69–1.12)	
Withdrawal	from	
study	
3/249	
(1)	
3/251	
(1)	
1.01	(0.21–4.95)	 3/249	(1)	 5/251	
(2)	
0.60	(0.15–2.50)	
CI:	confidence	interval;	NA;	not	applicable;	ND:	not	determined;	RR:	relative	risk.	
a	The	value	for	contraceptive	discontinuation	is	the	hazard	ratio,	not	the	relative	risk.	
b	The	number	lost	to	follow-up	includes	participants	who	withdrew	from	the	study.	
four	months	after	the	abortion	(54%	versus	40%,	respectively;	RR:	1.35;	95%	CI:	1.10–
1.67)	and	for	more	than	80%	of	the	12	months	after	(51%	versus	38%,	respectively;	RR:	
1.33;	95%	CI:	1.04–1.70).	There	was	some	evidence	that	fewer	women	in	the	
intervention	than	the	control	group	had	discontinued	contraceptive	use	by	the	four-
month	follow-up	(7%	versus	16%,	respectively;	HR:	0.45;	95%	CI:	0.20–1.01;	Table	18)	
but	not	by	the	12-month	follow-up	(26%	versus	30%,	respectively;	HR:	0.82;	95%	CI:	
0.48–1.40;	Figure	33).			
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Figure	33:	Kaplan-Meier	survival	curves	for	contraceptive	discontinuation	
	
There	was	no	significant	difference	between	the	groups	in	the	proportion	of	women	
who	had	a	repeat	pregnancy	or	an	abortion	by	four	or	12	months	and	there	were	no	
reports	that	the	intervention	had	been	associated	with	a	road	traffic	accident	or	
domestic	abuse	at	four	months	(Table	18).		
The	subgroup	analysis	found	no	evidence	that	either	age,	urban	or	rural	residence,	
educational	level	or	socioeconomic	status	influenced	the	effect	of	the	intervention	on	
contraception	use	at	12	months	(Figure	34).		
5.5	Discussion	
Our	mobile	phone-based	intervention	was	associated	with	an	increase	in	the	self-
reported	use	of	an	effective	contraceptive	method	four	months	after	an	abortion	but	
not	12	months	after.	However,	more	participants	in	the	intervention	than	the	control	
group	reported	using	a	long-acting	contraceptive	method	at	four	and	12	months.	The	
intervention	had	no	significant	effect	on	the	repeat	pregnancy	or	abortion	rate	and	
	
	
190	
Figure	34:	Contraception	use	in	different	subgroups	at	12	months	
	
there	were	no	reports	of	adverse	effects.	This	study	has	several	strengths.	First,	all	
analyses	were	carried	out	on	an	intention-to-treat	basis.	Few	trials	of	post-abortion	
family	planning	have	a	longer	observation	period	than	our	study.(93)	The	follow-up	
rate	at	four	months	was	high	and	there	was	no	evidence	of	any	difference	in	losses	to	
follow-up	between	the	treatment	groups.	However,	the	follow-up	rate	at	12	months	
was	only	66%,	which	decreased	the	statistical	power	of	our	assessment	of	the	long-	
term	effects	of	the	intervention.	This	low	rate	was	probably	due	to	participants	
migrating	for	work	and/or	changing	phone	numbers,	which	is	recognized	as	a	
challenge	for	mobile	phone-based	interventions	in	Cambodia.(141)		
One	limitation	of	the	study	was	that,	since	the	intervention	involved	behavioural	
change,	it	was	not	possible	to	blind	participants	to	their	treatment	allocation	and	they	
may	have	passed	on	information	to	the	research	assistants	at	follow-up.	In	addition,	
the	use	of	self-report	measures	of	contraceptive	use	has	the	potential	for	detection	
Age group 
Age <25 
Age >=25 
Intervention 
(n=169) 
Control 
(n=159) 
Subgroup 
relative risk (99% CI)* 
Access to motorised  
transport 
Yes 
No 
Education 
None or primary 
Some secondary  
or above 
Overall 
20/53 (37.7) 
64/116 (55.2) 
1.15 (0.83–1.60) 
1.26 (0.50–3.17) 
1.47 (0.84-2.58) 
1.37 (0.62–3.06) 
1.15 (0.83–1.60) 
59/138 (42.8) 
9/21 (42.9) 
77/156 (49.4) 
7/13 (53.9) 
30/60 (50.0) 
38/99 (38.4) 
68/159 (42.8) 
11/40 (27.5) 
57/119 (47.9) 
Residence 
Rural 
Urban 
46/96 (47.9) 
22/63 (34.9) 
30/59 (50.9) 
54/110 (49.1) 
1.10 (0.77–1.57) 
1.24 (0.68–2.26) 
 
1.02 (0.64–1.62) 
1.28 (0.85–1.93) 
 
1.16 (0.92–1.47) 84/169 (49.7) 
Control better Intervention better 
 
 
61/116 (52.6) 
23/53 (43.4) 
0·75 1 2 3 4 
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bias.	Although	they	are	standard	in	contraceptive	research,	self-report	measures	have	
been	shown	to	overestimate	contraceptive	use	and	underestimate	abortion	
rates.(188)	However,	it	seems	unlikely	that	participants	would	over-report	using	one	
particular	long-acting	method	rather	than	another	(e.g.	intrauterine	devices	versus	
implants).	It	was	not	feasible	to	measure	objective	contraception	use	in	this	setting	
and	electronic	medication	monitors	and	hormonal	assays	have	limited	reliability	and	
validity.(214)(189)	Oral	and	injectable	contraceptives	can	be	obtained	from	
pharmacists	without	prescriptions	in	Cambodia,	so	clinic	records	may	not	accurately	
reflect	contraceptive	use.	The	most	commonly	reported	reason	for	ineligibility	was	not	
having	a	mobile	phone.	Although	we	did	not	record	the	characteristics	of	the	199	
potential	participants	in	our	study	who	did	not	have	a	phone,	it	is	a	concern	that	
mobile	phone-based	interventions	may	not	reach	the	people	most	in	need.	We	did	not	
give	participants	mobile	phones	because	of	possible	implications	for	the	sustainability	
of	the	intervention	and	because	there	could	have	been	negative	consequences	for	a	
participant	if	she	was	asked	where	she	obtained	a	new	phone.	Study	participants	were	
similar	to	clients	seeking	abortion	services	at	the	four	Marie	Stopes	International	
Cambodian	study	clinics	during	2013.	Most	of	these	women	are	married	and	
multiparous,	had	attended	secondary	school,	are	aged	over	25	years	and	have	
previously	paid	for	reproductive	health	services	at	a	clinic	run	by	a	nongovernmental	
organization.	However,	sex	workers	–	known	to	have	a	high	unmet	need	for	
contraception	and	a	high	abortion	rate(91)	–	and	young	women,	were	not	well	
represented	in	our	study	population.	The	effect	of	mobile	phone-based	interventions	
on	post-abortion	family	planning	among	these	groups	requires	further	evaluation.	
There	are	few	trials	of	mobile	phone-based	interventions	to	increase	contraception	
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use.	Two	small	trials	found	no	effect,(143)(144)	whereas	one	trial	found	improved	self-
reported	adherence	to	oral	contraceptive	use.(142)	Service	providers	often	define	
post-abortion	family	planning	as	the	initiation	of	contraceptive	use	within	two	weeks	
of	an	abortion	but	we	did	not	identify	any	trials	reporting	follow-up	at	this	time	point.	
We	decided	to	assess	contraception	use	at	four	months,	after	the	intervention	had	
been	completed,	because	we	recognized	that	side-effects	and	discontinuation	are	
common	in	the	first	few	months.(16)	The	12-month	follow-up	was	intended	to	assess	
the	long-term	effects	of	the	intervention.	Although	at	12	months	there	was	no	
evidence	of	increased	contraceptive	use	overall	or	of	less	frequent	discontinuation,	
our	intervention	was	associated	with	an	increase	in	the	use	of	long-acting	
contraceptive	methods	in	a	context	where	a	wide	range	of	post-abortion	family	
planning	methods	is	available	but	the	immediate	uptake	of	contraception	is	low	(data	
available	from	corresponding	author).	The	increase	occurred	because	participants	
returned	to	the	clinic	for	a	contraceptive	implant	or	an	intrauterine	device	and	is	
consistent	with	our	findings	that	some	clients	preferred	to	make	decisions	about	post-
abortion	family	planning	after	discharge	from	clinical	care.(212)	As	our	intervention	
was	complex,	it	was	not	clear	which	component	influenced	the	uptake	of	long-acting	
methods.	It	is	plausible,	though,	that	a	relatively	intensive	intervention	delivered	over	
a	short	period	of	time	could	influence	the	decision	to	adopt	a	long-acting	method	(i.e.	
a	single	behavioural	change)	but	be	less	effective	in	influencing	continued	adherence	
to	an	oral	contraceptive,	which	requires	sustained	repetitive	behaviour.	In	fact,	the	
literature	suggests	that	interventions	encouraging	medication	adherence	are	more	
effective	for	short-term	rather	than	long-term	treatments.	Furthermore,	long-acting	
contraceptive	methods	are	associated	with	lower	discontinuation	rates	than	short-
	
	
193	
acting	hormonal	methods.(16)(134)(215)	We	plan	to	publish	a	separate	report	on	the	
results	of	qualitative	interviews	with	participants	about	their	experience	of	the	
intervention.	Few	studies	have	examined	contraceptive	use	for	an	extended	period	
aſter	an	abortion	in	a	low-income	setting.	One	matched,	controlled	study	in	Zimbabwe	
assessed	the	effect	of	counselling	and	free	contraception	before	hospital	discharge.	At	
12	months,	effective	contraceptive	use	was	higher	in	the	intervention	than	the	control	
group	(84%	(227/271)	versus	64%	(165/258),	respectively;	P	<	0.001)	and	repeat	
unintended	pregnancy	was	lower	(15%	(42/276)	versus	34%	(96/281),	respectively;	P	<	
0.001)	but	repeat	abortions	were	not	significantly	lower	(3%	versus	5%;	P	=	0.23).(98)	
At	12	months	in	our	study,	13%	(22/169)	of	participants	in	the	intervention	group	
reported	a	repeat	pregnancy	compared	with	18%	(28/159)	in	the	control	group;	the	
corresponding	figures	for	a	repeat	abortion	were	5%	(8/169)	and	7%	(11/159),	
respectively.	However,	the	study	was	not	powered	to	detect	differences	in	these	
outcomes.	Nevertheless,	the	increased	use	of	long-acting	methods	and	the	increased	
duration	of	all	effective	contraceptive	use	would	be	expected	to	result	in	a	decrease	in	
unintended	pregnancies	and	repeat	abortions	over	time.	A	larger	study	may	be	able	to	
detect	differences	in	these	outcomes.	
Conclusion	
Our	results	indicate	that	the	addition	of	a	mobile	phone-based	intervention	to	existing	
abortion	care	services	could	increase	the	use	of	long-acting	contraceptives.	The	overall	
use	of	effective	contraceptive	methods	was	increased	four	months	after	an	abortion	
but	not	at	12	months.	In	practice,	the	duration,	language	and	mode	of	communication	
(i.e.	text	or	voice)	could	be	adapted	to	different	settings,	though	voice	messages	will	
be	most	useful	in	populations	with	limited	literacy.	We	estimated	the	main	cost	of	
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delivering	the	intervention	(i.e.	for	voice	messages,	phone	calls	and	the	counsellors’	
time)	to	be	6	United	States	dollars	per	client.	A	cost–effectiveness	analysis	will	be	
reported	elsewhere.	Although	our	intervention	was	delivered	in	addition	to	post-
abortion	family	planning	support	at	a	clinic,	future	research	could	assess	the	effect	of	a	
similar	intervention	in	settings	with	more	limited	support:	for	example,	where	medical	
abortions	are	provided	by	the	private	sector.	
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5.6	Additional	trial	analysis	
This	section	contains	additional	trial	analysis;	either	pre-specified	analysis	that	was	cut	
by	journals	due	to	word	count	limitations,	or	exploratory	analyses	of	the	dynamics	of	
contraception	use	over	the	post-abortion	period.	The	aim	of	this	analysis	is	to	further	
understand	the	patterns	of	contraceptive	use	over	the	post-abortion	period,	in	
particular	differences	in	uptake,	discontinuation	and	switching	between	the	
intervention	and	control	groups.	
General	trends	in	method	mix	
Figure’s	35-39	and	Table	19	are	exploratory	analyses	that	show	the	contraceptive	
method	mix	at	two	weeks	and	at	four	and	12	months.	Contraception	use	appears	to	be	
most	dynamic	during	the	first	10	weeks	post-abortion;	particularly	in	the	intervention	
group	where	use	of	effective	methods	increases	and	no/non-effective	method	use	
decreases.	Over	the	12-month	period,	no/non	effective	method	use	increases	in	both	
groups	as	use	of	effective	methods	are	stable	or	decreasing.		
Use	of	long-acting	methods	(IUD	and	implant12)	are	consistently	increased	in	the	
intervention	group	at	all	time	points.	Use	of	non-effective	methods	appear	to	be	
higher	in	the	control	group	at	four	and	12	months,	but	there	appears	to	be	little	
difference	between	use	of	no	method	at	four	and	12	months.	Injectable	use	is	similar	
at	two	weeks	post-abortion,	but	use	appears	higher	in	the	intervention	group	at	four	
and	12	months.	Conversely,	oral	contraceptive	use	in	the	intervention	and	control	
groups	is	similar	at	two	weeks	but	use	appears	higher	in	the	control	group	at	four	and	
12	months.	It	is	unclear	from	these	figures	and	tables	whether	women	who	
																																																						
12	Only	one	trial	participant	had	a	permanent	method	of	contraception	(in	the	control	group	and	hence	the	
discussion	of	‘long-acting’	methods	in	this	section	refers	to	IUD	and	implant)	
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discontinued	a	particular	method	such	as	OC	stopped	using	the	method	altogether	or	
switched	to	an	alternative	effective	method.		
Figure	35:	Contraception	use	over	the	4-month	post-abortion	period:	intervention	group	
	
Figure	36:	Contraception	use	over	the	4-month	post-abortion	period:	control	group	
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Figure	37:	Contraception	use	over	the	12-month	post-abortion	period:	intervention	group	
	
Figure	38:	Contraception	use	over	the	12-month	post-abortion	period:	control	group	
	
At	two	weeks,	overall	use	of	effective	contraception	was	39%	(Table	19)	which	is	similar	to	
the	40%	use	of	effective	contraception	at	two	weeks	found	in	the	case	note	review	as	part	
of	the	formative	research	to	develop	the	intervention.(212)		
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Figure	39:	Contraceptive	method	mix	at	2	weeks,	4	and	12	months	
	
Table	19:	Contraceptive	method	mix	at	2	weeks,	4	and	12	months	
	 Intervention		
No.	(%)	
Control		
No.	(%)	
P	
value	
Intervention		
No.	(%)	
Control		
No.	(%)	
P	
value	
Intervention		
No.	(%)	
Control		
No.	(%)	
P	
value	
	 2	weeks	 	 4	months	 	 12	months	 	
Oral	
contraceptive	
38	(18%)	 45	
(20%)	
0.006	
47	(22%)	 63	
(29%)	
<0.001	
25	(15%)	 41	
(26%)	
0.002	
Injection	 24	(11%)	 25	
(11%)	
27	(13%)	 19	(9%)	 17	(10%)	 8	(5%)	
Implant	 29	(14%)	 8	(4%)	 35	(17%)	 10	(5%)	 25	(15%)	 10	(6%)	
Intra-uterine	
device	
11	(5%)	 8	(4%)	 26	(12%)	 8	(4%)	 17	(10%)	 9	(6%)	
Permanent	
method	
0	(%)	 0	(0%)	 0	(0%)	 1	
(0.5%)	
0	(0%)	 0	(0%)	
Non-effective	
method	
15	(7%)	 24	
(11%)	
21	(10%)	 47	
(21%)	
26	(15%)	 40	
(25%)	
No	method	 94	(45%)	 110	
(50%)	
55	(26%)	 72	
(33%)	
59	(35%)	 51	
(32%)	
Total	
effective	
methods	
102	(48%)	 86	
(39%)	
	 135	(64%)	 101	
(46%)	
	 84	(50%)	 68	
(43%)	
	
Four	and	12-month	data	based	on	current	use	at	follow	up.	Method	mix	at	2	weeks	based	on	calendar	data	collected	at	
four-month	follow	up.	Non-effective	methods	included	condom,	withdrawal,	rhythm	(calendar)	and	other	traditional	
methods.	The	participant	that	reported	permanent	method	at	four	months	was	not	followed	up	at	12	months.		
Initiation	of	long-acting	contraception	
Figure	40	and	Table	20	are	exploratory	analyses	that	show	initiation	of	long-acting	methods	
(IUD	or	implant)	over	the	four-month	post-abortion	period.	The	data	was	obtained	
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retrospectively	at	four	months	asking	participants	about	weekly	contraceptive	use.	
Initiation	of	a	long-acting	method	during	the	first	four	weeks	post-abortion	was	higher	
amongst	women	receiving	the	intervention	compared	to	those	receiving	standard	care	
(59/211	(28%)	intervention	vs.	20/218	(9%)	control	(RR	3.05	(95%	CI	1.90	–	4.88);	p<0.001).	
Figure	40:	Initiation	of	long-acting	methods	(IUD/implant)	over	4-month	post-abortion	
period	
	
Table	20:	Initiation	of	long-acting	contraception	over	the	4-month	post-abortion	period	
Week	 Implant	 IUD	 Total	long-acting	contraception	(implant	+	IUD)	
	 Intervention	 Control	 Intervention	 Control	 Intervention	 Control	 RR	(95%	CI)	 P	value	
1	 20	 7	 8	 8	 28	 15	 	 	
2	 9	 1	 3	 0	 12	 1	 	 	
3	 1	 1	 4	 2	 5	 3	 	 	
4	 0	 0	 0	 0	 0	 0	 	 	
5	 1	 0	 2	 0	 3	 0	 	 	
6	 0	 0	 2	 0	 2	 0	 	 	
7	 0	 0	 0	 0	 0	 0	 	 	
8	 0	 0	 1	 0	 1	 0	 	 	
9	 0	 0	 1	 0	 1	 0	 	 	
10	 1	 1	 3	 0	 4	 1	 	 	
11	 1	 0	 2	 0	 3	 0	 	 	
12	 0	 0	 0	 0	 0	 0	 	 	
Total	 33	 10	 26	 10	 59/211	(28%)	 20/218	
(9%)	
3.05	(1.90-
4.88)	
<0.001	
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In	the	control	group	it	appears	that	initiation	of	long-acting	methods	occurred	mainly	
during	the	first	three	weeks.	In	the	intervention	group	initiation	of	long-acting	
methods	is	also	most	frequent	during	the	first	three	weeks,	but	continued	uptake	over	
the	12-week	period	can	be	observed.	The	finding	that	initiation	appeared	to	be	higher	
during	the	first	week	in	the	intervention	group	compared	to	the	control	group	could	be	
explained	by	women	returning	within	a	few	days	of	receiving	the	intervention	to	
initiate	methods.	However,	the	observed	increased	uptake	during	week	one	could	be	
due	to	recall	bias,	for	example,	if	initiation	was	after	one	to	two	weeks	but	recalled	to	
be	within	one	week.	
Discontinuation	
The	following	set	of	tables	and	figures	show	contraceptive	discontinuation	over	the	
follow	up	period.	Figure	41	shows	discontinuation	of	effective	contraception	over	the	
four-month	period;	a	pre-specified	analysis	cut	from	the	main	trial	paper	due	to	lack	of	
space.	Discontinuation	of	effective	contraception	over	the	12-month	period	was	
reported	in	the	main	trial	paper.	The	analysis	included	224	participants	starting	an	
effective	method	of	contraception	during	the	first	four	weeks	post-abortion	using	data	
collected	at	four-month	follow	up.	Discontinuation	was	defined	as	stopping	effective	
contraception	for	one	week	or	more	during	the	following	15	weeks.	If	the	participant	
switched	from	one	effective	method	to	another	effective	method	this	was	not	
considered	discontinuation.	There	was	some	evidence	of	reduced	discontinuation	
amongst	participants	receiving	the	intervention	(9/123	(7%)	vs.	16/101	(16%)	hazard	
ratio	0·45,	95%	CI	0·20-1·01;	p=0.053).	However,	the	extent	to	which	women	
discontinued	specific	methods	and	switched	between	methods	is	unclear	from	Figure	
41.	
	
	
201	
Figure	41:	Discontinuation	of	effective	contraception	over	the	4-month	post-abortion	period	
	
Kaplan-Meier	analysis.	Number	at	risk	refers	to	users	of	contraception	at	each	time	point.	Log-rank	test	for	equality	
of	survivor	functions	(compares	observed	and	expected	events)	p=0·048	
Method-specific	discontinuation	
Table	21	and	Figures	42	to	44	are	exploratory	analyses	that	show	method-specific	
discontinuation	during	the	four-month	post	abortion	period.	Although	not	statistically	
significant,	a	trend	can	be	observed	towards	increased	OC	discontinuation	in	the	
intervention	group	(22%	intervention	vs.	13%	control)	and	increased	injectable	
discontinuation	in	the	control	group	(14%	intervention	vs.	36%	control).	The	numbers	of	
IUD	discontinuation	are	too	small	to	comment	on	and	there	were	no	cases	of	implant	
discontinuation.		
Table	21:	Method	specific	discontinuation	at	4	months	
Outcome	 Overall	 Intervention	 Control	 Hazard	Ratio	 P	value	
OC	discontinuation	 18/106	(17%)	 11/50	(22%)	 7/56	(13%)	 1.82	(0.71-4.70)	 0.208	
Injectable	discontinuation	 14/56	(25%)	 4/28	(14%)	 10/28	(36%)	 0.39	(0.12-1.26)	 0.098	
Implant	discontinuation	 0/39	(0%)	 0/30	(0%)	 0/9	(0%)	 	 	
IUD	discontinuation	 4/25	(16%)	 1/15	(7%)	 3/10	(30%)	 0.17	(0.02-1.68)	 0.097	
Total	 36/226	(16%)	 16/123	(13%)	 20/103	(19%)	 	 	
*Includes	participants	that	started	method	during	first	4	weeks	post-abortion.	Discontinuation	defined	as	stopping	
the	method	for	one	week	or	more	during	the	following	15	weeks	
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Figure	42:	Oral	contraceptive	discontinuation	at	4	months	
	
Kaplan-Meier	analysis.	Number	at	risk	refers	to	users	of	oral	contraceptive	at	each	time	point.	Log-rank	p=0.224	
Figure	43:	Injectable	discontinuation	at	4	months	
	
Kaplan-Meier	analysis.	Number	at	risk	refers	to	users	of	injectable	at	each	time	point.	Log	rank	p=0.079	
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Figure	44:	IUD	discontinuation	at	4	months	
	
Kaplan-Meier	analysis.	Number	at	risk	refers	to	users	of	IUD	at	each	time	point.	Log	rank	p=0.107	
Table	22	and	Figures	45	to	48	are	exploratory	analyses	that	show	method-specific	
discontinuation	during	the	12-month	post	abortion	period.	Overall,	discontinuation	rates	
are	higher	for	OC	and	injectable	and	lower	for	implant	and	IUD.	These	rates	are	broadly	
consistent	with	the	approximate	30%	and	10%	discontinuation	for	hormonal	methods	
and	IUD	respectively	observed	elsewhere.(87)(16)		
Table	22:	Method	specific	discontinuation	at	12	months	
Outcome	 Overall	 Intervention	 Control	 Hazard	Ratio	 P	value	
OC	discontinuation	 33/86	(38%)	 17/38	(45%)	 16/48	(33%)	 1.46	(0.74-2.90)	 0.275	
Injectable	discontinuation	 30/48	(63%)	 16/29	(55%)	 14/19	(74%)	 0.57	(0.28-1.18)	 0.129	
Implant	discontinuation	 4/35	(11%)	 2/27	(7%)	 2/8	(25%)	 0.29	(0.04-2.04)	 0.213	
IUD	discontinuation	 3/24	(13%)	 2/16	(13%)	 1/8	(13%)	 0.94	(0.08-10.32)	 0.957	
Total	 70/193	(36%)	 37/110	(34%)	 33/83	(40%)	 	 	
*Includes	participants	that	started	method	during	first	4	months	post-abortion.	Discontinuation	defined	as	
stopping	effective	contraception	for	one	month	or	more	during	the	following	11	months	
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Figure	45:	Oral	contraceptive	discontinuation	at	12	months	
	
Kaplan-Meier	analysis.	Number	at	risk	refers	to	users	of	oral	contraception	at	each	time	point.	Log	rank	p=0.278	
Figure	46:	Injectable	discontinuation	at	12	months	
	
Kaplan-Meier	analysis.	Number	at	risk	refers	to	users	of	injectable	at	each	time	point.	Log	rank	p=0.093	
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Figure	47:	Implant	discontinuation	at	12	months	
	
Kaplan-Meier	analysis.	Number	at	risk	refers	to	users	of	implant	at	each	time	point.	Log	rank	p=0.189	
Figure	48:	IUD	discontinuation	at	12	months	
	
Kaplan-Meier	analysis.	Number	at	risk	refers	to	users	of	injectable	at	each	time	point.	Log	rank	p=0.942	
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Again,	although	not	statistically	significant,	a	trend	can	be	observed	towards	increased	
OC	discontinuation	in	the	intervention	group	(45%	intervention	vs.	33%	control)	and	
increased	injectable	discontinuation	in	the	control	group	(55%	intervention	vs.	74%	
control).	
Increased	injectable	discontinuation	can	be	observed	at	three-months	as	would	be	
expected	when	women	would	be	expected	to	return	for	a	repeat	injection.	The	
numbers	of	IUD	and	implant	discontinuation	are	too	small	to	comment	on.	However,	it	
remains	unclear	from	these	figures	and	tables	whether	women	who	discontinued	OC	
and	injectable	switched	to	an	alternative	effective	method.		
Switching	
Table	23	is	an	exploratory	analysis	that	shows	the	number	and	proportion	of	women	
that	discontinued	an	effective	method	and	switched	to	a	different	effective	method	at	
four	and	12	months.		
Table	23:	Method	switching	if	discontinued	an	effective	method	
	 4	months	 RR	(95%	CI)	 12	months	 RR	(95%	CI)	
	 Intervention	 Control	 	 Intervention	 Control	 	
OC	 3/11	(27%)	 0/7	(0%)	 	 6/17	(35%)	 3/16	(19%)	 	
Injectable	 3/4	(75%)	 2/10	(20%)	 	 5/16	(31%)	 5/14	(36%)	 	
Implant	 N/A	 N/A	 	 1/2	(50%)	 0/2	(0%)	 	
IUD	 1/1	(100%)	 2/3	(67%)	 	 0/2	(0%)	 1/1	(100%)	 	
Total	 7/16	(44%)	 4/20	(20%)	 2.19	(0.77-6.18)	 12/36	(33%)	 9/33	(27%)	 1.22	(0.59-2.52)	
	
During	the	four-month	post-abortion	period,	44%	of	women	who	discontinued	an	
effective	method	switched	to	a	different	effective	method	in	the	intervention	group	
compared	to	20%	in	the	control	group	(RR	2.19;	95%	CI	0.77-6.18).	During	the	12-
month	post-abortion	period,	33%	of	women	who	discontinued	an	effective	method	
switched	to	a	different	effective	method	in	the	intervention	group	compared	to	27%	in	
the	control	group	(RR	1.22;	95%	CI	0.59-2.52).	These	differences	are	not	statistically	
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significant	but	suggest	a	trend	towards	increased	safe-method	switching	amongst	
women	receiving	the	intervention.		
The	data	in	Table	23	suggests	a	trend	toward	increased	safe-switching,	at	four	and	to	a	
lesser	extent	12-months,	amongst	women	receiving	the	intervention.	Thus,	the	trend	
towards	decreased	OC	use	in	the	intervention	group	at	four	and	12	months	could	be	
explained	by	women	switching	to	other	more	effective	methods.	However,	it	is	also	
possible	that	the	increased	discontinuation	of	OC	in	the	intervention	group	was	due	to	
the	intervention	content	(voice	messages	and	phone	calls)	encouraging	use	of	longer-
acting	methods	in	preference	to	OC.	
Subgroup	analysis	
Figure	49	is	an	exploratory	analysis	showing	the	effect	of	intervention	on	primary	
outcome	amongst	different	subgroups	at	four-months,	expressed	as	a	relative	risk	with	
a	95%	confidence	interval.	The	pre-specified	analysis	included	only	age,	SES,	residence	
and	education	and	was	cut	from	the	main	trial	paper	due	to	lack	of	space.	The	effect	of	
the	intervention	amongst	pre-specified	subgroups	categorised	by	age,	residence,	
educational	level	and	socio-economic	status	analysis	at	12	months	was	reported	in	the	
main	trial	paper.(203)	
There	was	no	evidence	of	heterogeneity	(i.e.	that	the	effect	of	the	intervention	varied	
amongst	any	subgroups)	apart	from	PAFP	intentions	at	the	time	of	seeking	abortion	
services	(p=0.027);	the	intervention	was	associated	with	a	statistically	significant	
increase	in	effective	contraception	use	at	four-months	amongst	women	who	were	
undecided	about	PAFP	at	the	time	of	seeking	abortion	services,	which	suggests	that	
the	intervention	was	particularly	effective	amongst	this	group	of	women.	The	
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intervention	was	associated	with	a	smaller	increase	in	effective	contraception	use	at	
four-months	amongst	women	planning	to	use	PAFP	at	the	time	of	seeking	abortion		
Figure	49:	Effect	of	the	intervention	on	the	primary	outcome	at	4	months	amongst	different	
subgroups	
	
services,	but	this	was	not	statistically	significant.	Conversely,	there	was	no	evidence	
Title Verdana  
 Age group 
Age <25 
Age >=25 
Intervention 
(n=211) 
Control 
(n=220) 
Residence 
Rural 
Urban 
Access to motorised transport 
Yes 
No 
Education 
None or primary 
Some secondary or above 
Marital status 
Never married/living together 
Married/living together 
Divorced/separated 
Contraceptive decision-making 
Joint decision 
Mainly participant 
Mainly husband/partner 
Number of previous abortions 
0 
1 
2 or more 
Number of living children 
0 
1 or 2 
3 or more 
Mobile phone access 
Never shares 
Shares 
PAFP intentions 
No 
Undecided 
Yes 
Fertility plans 
Have a/another child 
No more/none 
Undecided 
Abortion method 
Medical 
Surgical 
Phone credit 
Always 
Usually 
Sometimes 
4/16 (25%) 
39/115 (34%) 
58/89 (65%) 
2/15 (13%) 
73/119 (61%) 
60/77 (78%) 
72/127 (57%) 
45/61 (74%) 
18/23 (78%) 
55/134 (41%) 
32/62 (52%) 
14/24 (58%) 
50/82 (61%) 
30/52 (58%) 
55/77 (71%) 
76/121 (63%) 
32/43 (74%) 
23/31 (74%) 
67/136 (49%) 
18/36 (50%) 
15/35 (43%) 
77/121 (64%) 
39/56 (70%) 
19/34 (56%) 
58/133 (44%) 
31/59 (53%) 
12/28 (43%) 
23/61 (38%) 
79/107 (74%) 
33/43 (77%) 
12/58 (21%) 
66/118 (56%) 
23/44 (52%) 
64/106 (60%) 
71/105 (68%) 
51/119 (43%) 
50/101 (50%) 
7/18 (39%) 
43/ 83(52%) 
46/85 (54%) 
89/126 (71%) 
39/93 (42%) 
62/127 (49%) 
4/13 (31%) 
131/196 (67%) 
0/2 (0%) 
1/10 (10%) 
100/207 (48%) 
0/3 (0%) 
53/81 (65%) 
82/130 (63%) 
43/87 (49%) 
58/133 (44%) 
123/190 (65%) 
12/21 (57%) 
90/191 (47%) 
11/21 (38%) 
97/142 (68%) 
38/69 (55%) 
69/137 (50%) 
32/83 (39%) 
34/67 (51%) 
101/144 (70%) 
20/58 (34%) 
81/162 (50%) 
32/76 (42%) 
27/50 (54%) 
42/94 (45%) 
1.48 (0.96-2.25) 
1.40 (1.16-1.69) 
0.838 
1.36 (1.11-1.66) 
1.42 (1.01-2.02) 
0.798 
1.37 (1.14-1.75) 
1.51 (0.83-2.73) 
0.772 
1.32 (1.02-1.73) 
1.45 (1.14-1.83) 
0.662 
3.08 (0.40-23.44) 
1.39 (1.16-1.64) 
(excluded) 
0.439 
1.41 (1.09-1.82) 
1.37 (1.08-1.73) 
0.863 
2.02 (1.06-3.83) 
1.27 (0.99-1.64) 
0.189 
1.29 (0.95-1.76) 
1.45 (1.17-1.79) 
0.547 
0.53 (0.11-2.50) 
1.81 (1.35-2.42) 
1.20 (0.99-1.45) 
0.027 
1.38 (1.07-1.78) 
1.43 (1.08-1.90) 
1.34 (0.90-2.00) 
0.966 
1.45 (1.06-1.99) 
1.07 (0.76-1.51) 
1.60 (1.23-2.09) 
0.187 
1.27 (1.02-1.59) 
1.49 (1.03-2.16) 
1.73 (1.12-2.68) 
0.427 
1.46 (1.15-1.85) 
1.33 (0.98-1.79) 
1.30 (0.78-2.20) 
0.853 
1.82 (1.00-3.31) 
1.32 (1.09-1.61) 
1.47 (1.06-2.04) 
0.541 
1.39 (1.17-1.66) 
Relative risk 
(95% CI) 
Control better Intervention better 
Overall 135/211 (64%) 101/220 (46%) 
0.1 1 2 5 25 
Disclosure of abortion to others 
No 
Yes 
11/14 (79%) 
60/91 (66%) 
Test of 
homogeneity 
Previous contraception use 
Yes 
No 
91/126 (72%) 
44/85 (52%) 
77/142 (54%) 
24/78 (31%) 
1.33 (1.11-1.60) 
1.68 (1.14-2.49) 
0.276 
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that	the	intervention	was	effective	in	women	who	were	not	planning	to	use	PAFP,	
although	the	confidence	interval	was	wide	for	this	group	due	to	few	numbers.		
There	are	several	reasons	why	the	intervention	might	not	be	effective	in	women	not	
planning	to	use	PAFP.	First,	it	is	possible	that	the	circumstances	of	the	pregnancy	
were	different,	for	example	that	they	were	seeking	abortion	services	because	of	a	
pregnancy	complication	rather	than	an	unintended	pregnancy	and	therefore	planned	
another	pregnancy	in	the	future.	Second,	it	is	possible	that	these	women	were	not	
planning	to	use	contraception	due	to	a	perceived	low	likelihood	of	subsequent	
pregnancy	because	their	circumstances	had	changed	perhaps	due	a	relationship	
breakdown	or	infrequent	sexual	intercourse.	Third,	it	is	possible	that	this	group	of	
women	included	those	who	preferred	not	to	use	contraception	and	opt	to	seek	
abortion	services	for	a	subsequent	pregnancy.	Further	research	could	examine	the	
characteristics	of	women	seeking	abortion	services	that	do	not	plan	to	use	PAFP.					
Comparing	baseline	characteristics	of	study	participants	with	MSI	clinic	population	
Table	24	compares	baseline	characteristics	of	trial	participants	with	MSI	Cambodia	
clinic	clients,	based	on	available	comparable	data.	Presentation	of	this	data	was	
suggested	by	a	peer-reviewer,	but	the	table	was	cut	from	the	main	trial	paper	due	to	
space	limitations.		
It	can	be	observed	that	the	study	population	was	of	similar	age	and	parity	compared	
with	MSI	clients	seeking	abortion	services	at	the	four	study	clinics	during	2013;	mainly	
married,	multiparous,	secondary	educated	women	aged	>25	paying	for	reproductive	
health	services	at	an	non-governmental	organisation	clinic.	The	study	population	and	
broader	MSI	population	were	similar	for	several	of	the	occupation	categories	such	as	
entertainment	worker,	factory	worker,	student,	farmer	and	unemployed	but	there	
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appeared	to	be	increased	proportions	of	employed	and	self-employed	and	a	decreased	
proportion	of	housewives	in	the	study	population.	This	may	have	been	because	
women	in	the	employed	and	self-employed	categories	were	more	likely	to	own	their	
own	phone	and	be	able	to	receive	the	intervention	and	hence	join	the	study,	but	this	
can	not	be	confirmed	from	the	available	data.	
Table	24:	Comparison	of	baseline	characteristics	of	trial	participants	with	Marie	Stopes	
International	(MSI)	Cambodia	clinic	clients	
	 Trial	intervention	group	 Trial	control	group	 MSIC	clients	
Age	(years)	 	 	 	
<25	 88/249	(35%)	 69/251	(27%)	 2159/6592	(33%)	
25	or	more	 161/249	(65%)	 182/251	(73%)	 4433/6592	(67%)	
Number	of	living	children	 	 	 	
0	 79/249	(32%)	 68/251	(27%)	 2248/6592	(34%)	
1-2	 122/249	(49%)	 131/251	(52%)	 2956/6593	(45%)	
3	or	more	 48/249	(19%)	 52/251	(21%)	 1389/6593	(21%)	
Previous	abortions	 	 	 	
0	 144/249	(58%)	 155/251	(62%)	 3302/6587	(50%)	
1	 69/249	(28%)	 65/251	(26%)	 1885/6587	(29%)	
2	or	more	 36/249	(14%)	 31/251	(12%)	 1400/6587	(21%)	
Type	of	abortion	 	 	 	
Medical	 102/249	(41%)	 105/251	(42%)	 2384/6594	(36%)	
Surgical	 147/249	(59%)	 146/251	(58%)	 4210/6594	(64%)	
Occupation	 	 	 	
Employed	 55/249	(22%)	 44/251	(18%)	 513/6594	(8%)	
Entertainment	worker	 11/249	(4%)	 16/251	(6%)	 341/6594	(5%)	
Factory	worker	 43/249	(17%)	 33/251	(13%)	 1181/6594	(18%)	
Farmer	 10/249	(4%)	 22/251	(9%)	 620/6594	(9%)	
Housewife	 47/249	(19%)	 55/251	(22%)	 2515/6594	(38%)	
Self-employed	 68/249	(27%)	 66/251	(26%)	 1068/6594	(16%)	
Student	 9/249	(4%)	 8/251	(3%)	 174/6594	(3%)	
Unemployed	 4/249	(2%)	 5/251	(2%)	 6/6594	(0.1%)	
Other	 2/249	(1%)	 2/251	(1%)	 176/6594	(3%)	
Summary	data	of	all	clients	seeking	abortion	services	during	2013	at	the	four	MSIC	study	clinics	(where	available	
and	comparable)	
	
Regarding	generalisability	beyond	MSI	clinics,	the	2014	Cambodia	DHS	reported	data	
on	where	there	most	recent	abortion	took	place	(public	health	facility,	private	health	
facility,	respondent	home,	and	other	home)	according	to	background	characteristics	of	
age,	pregnancy	duration,	residence	and	education.(74)	As	mentioned	in	Section	1.2,	
overall,	44%	of	women	used	a	private	facility,	compared	to	16%	who	used	a	public	
facility,	32%	who	had	an	abortion	at	home	and	8%	who	had	an	abortion	at	another	
home.	Private	facilities	include	both	non-governmental	organisation	clinics	and	those	
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operated	by	private	healthcare	workers,	and	thus	these	data	are	limited	in	terms	of	
providing	a	complete	picture	of	which	women	seek	abortion	services	where,	but	do	
however	provide	some	insights	regarding	generalisability	of	the	study	population	
beyond	MSI	clinics.	It	is	likely	that	a	significant	proportion	of	women	having	an	
abortion	at	a	home	were	using	medical	abortion	and	it	is	not	clear	from	the	DHS	data	
where	the	women	obtained	the	drugs.	However,	some	observations	can	be	made.	The	
proportion	of	women	having	an	abortion	in	a	private	health	facility	did	not	appear	to	
differ	markedly	by	age	(45%	aged	15-34	versus	43%	aged	35-49)	or	residence	(46%	
urban	versus	44%	rural)	but	did	appear	to	vary	by	education	(39%	no	education	versus	
45%	primary	and	higher).	There	was	a	trend	towards	younger	women,	rural	women	
and	those	with	increased	education	being	less	likely	to	use	a	public	health	facility	(13	
aged	15-34	versus	19%	aged	35-49;	15%	rural	versus	18%	urban;	19%	no	education	
versus	15%	primary	and	higher).	
These	data	suggest	that	the	trial	findings	are	likely	to	be	generalisable	to	MSI	clinics.	
However,	it	is	unclear	if	the	trial	findings	are	generalisable	to	other	settings	where	
women	seek	abortion	services	in	Cambodia	given	that	there	are	differences	in	
background	characteristics	in	women	seeking	abortions	in	different	settings.	Further	
research	is	recommended	prior	to	implementing	similar	interventions	in	different	
settings.		
Geographic	location	of	trial	participants	
Figure	50	shows	the	geographical	location	of	trial	participants	according	to	district	in	
Cambodia	and	is	shown	primarily	for	interest.	It	was	created	using	Geographic	
Information	System	(GIS)	Software	using	Cambodia	census	data	and	data	collected	on	
participants’	residence	collected	at	baseline.	Denser	colours	indicate	increased	
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numbers	of	participants	living	in	a	particular	district.	It	can	be	observed	that	
participants	are	more	geographically	dispersed	if	recruited	from	the	clinics	serving	
rural	areas	(Battambang	and	Siem	Reap)	if	compared	to	the	peri-urban	clinics.		
Figure	50:	Location	of	trial	participants	
	
Acknowledgement	to	Andrew	Shantz	for	helping	to	produce	this	figure	
	
Conclusions	
As	previously	reported,	at	four	months	the	intervention	was	associated	with	increased	
use	of	effective	contraception	(RR	1.39	(1.17-1.66))	and	long-acting13	contraception	
(RR	3.35	(2.07-5.40)).(203)	The	analysis	in	this	section	suggests	that	the	main	
contributing	factor	towards	this	finding	was	the	choice	of	contraceptive	method	rather	
than	use	of	any	method,	in	particular	increased	initiation	of	intrauterine	device	and	
implant	during	the	first	four	weeks	post-abortion	amongst	women	receiving	the	
intervention	(RR	3.05	(1.90-4.88)).	In	addition	there	was	some	evidence	of	reduced	
discontinuation	of	effective	methods	(HR	0.45	(0.20-1.01)),	due	to	trends	towards	
reduced	method	specific	discontinuation	and	safe-method	switching	in	the	
intervention	group.		
																																																						
13	Intrauterine	device,	implant	or	permanent	method	
Ba#ambang(
clinic(
Siem(Reap(
clinic(
Takmao(
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As	previously	reported,	at	12	months,	the	intervention	was	not	associated	with	
increased	use	of	effective	contraception	(RR	1.16	(0.92-1.47)	but	was	associated	with	
increased	use	of	long-acting	contraception	(RR	2.08	(1.27-3.42)).(203)	The	analysis	in	
this	section	suggests	that	the	main	contributing	factor	towards	this	was	the	
aforementioned	increased	initiation	of	intrauterine	device	and	implant	during	the	first	
four	weeks	post-abortion	amongst	women	receiving	the	intervention	followed	by	
increased	discontinuation	of	short-acting	methods	overall;	and	less	of	a	trend	towards	
safe-switching	in	the	intervention	group.	Hence	the	risk	ratio	for	long-acting	
contraception	use	remained	statistically	significant	whilst	the	risk	ratio	for	overall	
effective	contraception	use	reduced	and	lost	statistical	significance.		
Overall	discontinuation	at	12	months	was	higher	for	short-acting	methods,	consistent	
with	the	literature.(16)	There	was	a	trend	towards	increased	OC	discontinuation	in	the	
intervention	group	and	increased	injectable	discontinuation	in	the	control	group	at	
four	and	12	months.	There	was	a	trend	towards	increased	safe-method	switching	after	
discontinuing	a	method	amongst	women	receiving	the	intervention.		
There	was	no	evidence	that	the	intervention	effect	at	four-months	varied	amongst	any	
subgroup	apart	from	PAFP	intentions	at	the	time	of	seeking	induced	abortion	services	
for	unintended	pregnancy.	The	study	population	appeared	to	be	representative	of	MSI	
clients	seeking	abortion	services	at	the	four	study	clinics	during	2013	in	terms	of	
baseline	characteristics	and	PAFP	use	at	two	weeks.	
Implications	of	these	additional	pre-specified	and	exploratory	analyses	will	be	
discussed	further	in	Chapter	8.		
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5.7	Assessing	the	validity	and	reliability	of	self-report	data		
Background	
Contraception	use	can	be	measured	for	different	reasons,	for	example	to	collect	
information	on	general	patterns	of	contraception	use	over	several	years	using	
Demographic	and	Health	Surveys,	or	to	assess	the	impact	of	interventions	to	improve	
contraception	use,	often	focusing	on	specific	methods,	over	a	shorter	time	period.	A	
variety	of	different	approaches	to	measuring	contraceptive	use	have	been	used	or	
proposed,	either	to	assess	current	use	or	adherence	over	time,	using	subjective	or	
objective	measures.	This	paper	reports	an	overview	of	approaches	to	measuring	
adherence	to	the	oral	contraceptive	(OC),	intra-uterine	device	(IUD),	sub-dermal	
implant,	and	injectable	and	describes	how	we	assessed	contraception	use	in	the	
MObile	Technology	for	Improved	Family	Planning	(MOTIF)	trial	in	Cambodia.(203)		
Main	text	
Overview	of	measuring	adherence	to	common	contraceptive	methods	
The	majority	of	studies	assessing	contraception	use	have	relied	on	self-report	
measures,	which	are	relatively	simple	and	inexpensive	to	administer.	However,	
concerns	about	bias	associated	with	self-report	measures	leading	to	overestimation	of	
contraceptive	use	and	underestimation	of	abortion	have	led	to	calls	for	increased	rigor	
in	measuring	contraception	use.(188)(216)(217)	
For	fertility	surveys,	contraceptive	calendars,	such	as	those	used	in	Demographic	and	
Health	surveys,	have	been	found	to	generate	more	complete	and	accurate	data	on	
past	self-reported	contraceptive	use	than	other	questionnaire	formats.(218)(219)(220)	
These	methods	are	convenient,	inexpensive	to	administer	and	the	only	practical	way	
to	obtain	information	on	contraceptive	use	dating	back	several	years.	However,	in	
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clinical	trials,	objective	measures	are	generally	considered	preferable	to	subjective	
measures,	as	they	are	less	prone	to	bias.(169)	Table	25	summarises	approaches	to	
measuring	use	of	different	contraceptive	methods.		
Table	25:	Summary	of	approaches	to	measuring	adherence	to	different	contraceptive	
methods	
Contraceptive	
method	
Measurement	approach	 Advantages	 Disadvantages	
Oral	
Contraceptive	
Direct	observation	(clinician	
observes	ingestion	of	pill)	
Accurate	and	equates	to	
ingestion	
Impractical	
	 Self-reports	(self-completed	
or	interview	administered	
questionnaire)	
Simple,	inexpensive	and	
easy	to	administer.		
Requires	training	for	
administrators.	Subject	
to	recall	and	social	
desirability	bias.	
	 Clinic	/	pharmacy	records		 Can	help	to	correct	poor	
recall.	Simple,	inexpensive	
and	objective.	Usually	
easy	to	obtain	data.	Can	
measure	at	more	than	one	
point	in	time.		
Does	not	equate	to	
ingestion	and	requires	a	
closed	pharmacy	system	
	 Pill	counts	(individual	pill	or	
pill	pack	counts)	
Objective;	quantifiable	
and	easy	to	perform.		
However,	easily	altered	
by	participant	(e.g.	pill	
dumping),	cannot	assess	
timing	of	use	
	 Electronic	Monitoring	Devices	 Objective,	precise,	tracks	
patterns	of	use	over	time.		
Potentially	expensive	
and	may	require	return	
visits	to	download	data.	
Participants	may	not	
adhere	to	using	device,	
intervention	might	
improve	use	of	device	
rather	than	pill-taking	
behaviour.	
	 Blood	hepatic	binding	
globulin	levels	(Corticosteroid	
Binding	Globulin,	Thyroxine	
Binding	Globulin,	Lutenizing	
Hormone	and	Sex	Hormone	
Binding	Globulin)	
Objective.	Can	distinguish	
between	consistent	use	
and	non-use	
(Corticosteroid	Binding	
Globulin	and	Thyroxine	
Binding	Globulin	more	
discriminating).	
Inexpensive	compared	to	
measuring	contraceptive	
steroid	level		
Requires	specialist	
laboratory.	Can’t	
distinguish	between	
consistent	and	
inconsistent	users	
	 Blood	contraceptive	steroid	
level	(e.g.	Levonorgestrel	or	
Ethinylestradiol)	
Objective,	indicates	
indigestion.		
Difficult	test,	expensive	
therefore	limited	
potential	for	replication	
in	other	studies,	requires	
a	blood	test,	will	not	
distinguish	consistent	
from	inconsistent	users	
IUD	/	implant	 Self-report		 Simple,	inexpensive	and	 Subject	to	recall	bias	and	
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easy	to	administer.	 social	desirability	bias	
	 Clinical	examination	or	
ultrasound	
Simple,	inexpensive	and	
easy	to	administer.	
Intrusive,	has	to	be	
performed	in	clinic	
setting,	requires	skilled	
personnel/	equipment	
	 Clinic	or	client	record	 Objective	 Requires	a	closed	
pharmacy	system.	Self-
held	record	can	get	lost	
Injection	 Self-report	 Simple,	inexpensive	and	
easy	to	administer.	
Subject	to	recall	bias	and	
social	desirability	bias.	
	 Clinic	or	clinic	record	 Objective	and	indicates	
current	use	
Requires	a	closed	
pharmacy	system.	Self-
held	record	can	get	lost	
	
The	oral	contraceptive	is	probably	the	most	challenging	contraceptive	method	to	
measure.	The	combined	oral	contraceptive	pill	(COCP)	containing	oestrogen	and	a	
progestogen	is	taken	for	21	days,	with	a	7-day	break,	whereas	the	progesterone-only	
pill	(POP)	containing	one	hormone	is	taken	continuously.	One-year	pregnancy	rates	are	
estimated	to	be	0.3%	with	perfect	use,	but	7-8%	as	commonly	used,(6)	thus	measures	
that	assess	missed	pills	as	well	as	current	use	are	important.	
No	gold	standard	measure	of	OC	use	is	available.	The	ideal	measure	of	OC	would	be	
one	that	is	objective,	can	distinguish	reliably	between	non-users,	inconsistent,	and	
consistent	users,	does	not	rely	on	a	closed	pharmacy	system	(i.e.	accounts	for	people	
obtaining	contraception	in	different	settings);	is	inexpensive,	feasible	in	different	
settings,	is	acceptable	to	participants,	and	is	applicable	to	pills	containing	different	
hormones.	A	systematic	review	of	measurement	methods	for	OC	use	found	that	the	
majority	(71%)	of	research	studies	relied	solely	on	self-report	measures	(such	as	
interviewer	or	self-administered	questionnaires)	rather	than	objective	measures,	and	
the	terminology	used	to	describe	OC	use	(such	as	“continuation”,	“compliance”	and	
“adherence”)	varied	and	was	rarely	described.(189)		
Objective	measures	of	OC	use	include	biological	markers	or	electronic	medication	
monitors.	Biomarkers	can	either	directly	measure	the	hormones	in	the	pill	or	a	proxy	
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measure.	Direct	measurement	of	contraceptive	steroid	levels	(for	example,	
Ethinylestradiol	or	Levonorgestrel)	is	possible,	but	only	at	specialist	laboratories,	and	
thus	for	cost	and	logistical	reasons,	might	not	be	feasible	in	low-income	settings.	Other	
researchers	have	proposed	measurement	of	hepatic	binding	globulins,	which	are	
increased	by	Ethinylestradiol	(EE2).	Thyroxine	Binding	Globulin	(TBG)	and	
Corticosteroid	Binding	Globulin	(CBG)	were	found	to	distinguish	noncompliant	users	
from	compliant	users.(221)	In	one	study,	riboflavin	was	added	to	the	OC	as	a	urinary	
marker	and	assessed	by	urine	florescence.(222)	However,	the	addition	of	a	urine	
marker	to	a	pill	would	present	significant	challenges,	and	requires	a	closed	pharmacy	
system.	The	main	advantage	of	biological	measures	is	that	they	indicate	ingestion	of	
the	pill	and	are	good	at	assessing	current	use.	However,	disadvantages	are	that	they	
are	less	good	at	distinguishing	inconsistent	users	from	consistent	users,(214)(189)	and	
blood	tests	may	not	be	acceptable	to	study	participants.	It	is	theoretically	possible	to	
measure	EE2	in	urine	samples	by	enzyme-linked	immunosorbent	assay	(ELISA),	an	
assay	developed	for	detecting	EE2	in	animals	for	the	food	industry.	This	might	be	more	
acceptable	than	a	blood	test,	but	to	our	knowledge	this	test	has	not	been	validated	for	
human	urine.	
Electric	monitoring	devices	(EMDs)	can	be	used	to	measure	adherence	to	oral	
medication	by	recording	when	a	participant	opens	a	pill	box	or	blister	pack.	Such	
information	can	be	downloaded	periodically	or	transmitted	in	real-time.	EMDs	have	
been	shown	to	be	more	accurate	than	self-report	measures,	pill	counts,	and	
biomarkers	for	examining	antidepressant	adherence,(223)	and	used	in	low	income	
settings,	for	example	to	assess	anti-retroviral	adherence	in	Kenya.(132)	In	the	field	of	
contraception,	two	studies	reported	poorer	OC	adherence	as	measured	by	electronic	
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medication	monitoring	compared	with	self-report	measures.(214)(143)	Thus,	
advantages	of	EMDs	are	that	they	can	provide	more	detailed	information	of	patterns	
of	use	over	a	period	of	time	compared	with	self-report.	Limitations	of	EMDs	are	that	it	
can	be	difficult	to	distinguish	whether	interventions	improve	pill-taking	behaviour	or	
simply	improve	use	of	the	monitor,	that	opening	the	container	doesn’t	equate	to	
ingestion,	and	the	devices	themselves	could	interfere	with	the	intervention	if	the	
participant	has	to	transfer	pills	into	a	container.	Devices	that	mimic	pill	packets	would	
be	costly	and	require	a	closed	pharmacy	system.			
Measuring	use	of	other	contraceptive	methods	such	as	implant,	IUD	and	injectable	are	
somewhat	easier	compared	to	OC	as	it	is	not	necessary	to	assess	daily	adherence;	the	
women	is	either	protected	from	pregnancy	by	the	method,	or	not.	These	methods	can	
be	assessed	as	follows.	First,	by	self-report	(i.e.	asking	the	participant	if	they	are	using	
a	method)	but	this	method	is	subject	to	biases	already	mentioned.	In	particular	it	
might	be	difficult	to	recall	the	date	the	method	was	started	e.g.	date	of	injection.	
Second,	objectively	by	reviewing	clinic	records,	but	in	the	case	of	implant	and	IUD,	this	
does	not	indicate	continued	use	if	the	participant	had	the	device	removed	in	a	
different	clinic.	Finally,	current	use	of	IUD	or	implant	can	be	assessed	by	clinical	
examination;	by	palpating	the	sub-dermal	implant	or	visualising	the	IUD	threads	but	
this	entails	an	intimate	examination.	IUD	or	implant	use	could	also	be	assessed	by	
ultrasound	examination.		
Assessing	contraception	use	in	the	MOTIF	trial	
For	the	MOTIF	trial,	we	did	not	consider	it	feasible	to	measure	objective	contraception	
use	for	several	reasons.	We	were	concerned	that	participants	wouldn’t	be	able	to	
return	to	the	clinic	for	objective	follow-up	due	to	lack	of	time	as	many	lived	in	rural	
	
	
219	
areas	far	from	the	clinic.	Furthermore	we	were	concerned	about	whether	it	was	
appropriate,	potentially	a	betrayal	of	trust,	to	ask	women	to	return	to	clinic	for	
internal	examination	to	check	IUD	threads	simply	to	verify	self-report	information	
already	provided.	We	were	not	able	to	rely	on	clinic	records	of	contraception	use	as	
the	trial	was	not	operating	within	a	closed	pharmacy	system;	oral	and	injectable	
contraceptives	can	be	obtained	from	pharmacists	without	prescriptions	in	Cambodia,	
and	long-acting	reversible	methods	(intrauterine	device	or	implant)	could	be	removed	
in	other	clinics.	Therefore	assessment	of	the	primary	outcome,	use	of	effective	
contraception	at	four	and	12	months	post-abortion	for	the	MOTIF	trial	was	self-report	
by	phone	call.	The	questionnaire	was	designed	to	reduce	social	desirability	bias	by	first	
asking	participants	“Are	you	using	a	contraception	method?”	followed	by	“Which	
method	are	you	using?”	if	the	women	answered	“Yes”	(without	prompting	for	specific	
methods).	We	felt	it	was	unlikely	that	participants	would	over-report	using	one	
particular	contraception	method	over	another	e.g.	IUD	vs.	implant.	To	assess	reliability	
of	self-report	data	we	compared	calendar	data	collected	on	effective	contraception	
use	at	months	1-4	post-abortion,	collected	separately	at	four	and	12	months.	
Agreement	ranged	from	80-84%	with	a	kappa	statistic	ranging	from	0·59	to	0·67	
indicating	fair	to	good	agreement.		
We	aimed	to	assess	the	validity	of	the	four-month	data	with	50	participants,	
calculating	the	sensitivity	and	specificity	of	self-reported	data	compared	with	objective	
measurement	(considered	the	gold	standard).(167)	Consecutive	participants	recruited	
from	the	two	peri-urban	clinics	who	had	provided	self-report	follow	up	were	invited	to	
attend	for	objective	assessment	of	contraceptive	use	by	a	research	assistant	blinded	to	
treatment	allocation	as	follows:	assess	the	position	of	an	implant	or	IUD	(ultrasound	or	
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clinical	examination	according	to	participant	preference);	self-held	record	of	injection	
within	the	previous	three	months	or	permanent	method;	pill	counts	defined	as	>90%	
of	pills	taken	since	last	prescription	dispensed.	Those	attending	were	given	USD$4	for	
travel	expenses.	In	order	to	achieve	our	target	of	50	face-to-face	objective	
measurements	we	attempted	to	contact	94	participants	of	contraception	use;	thus	
achieving	a	53%	follow	up	rate	(compared	to	self-report	follow	up	of	86%	at	four	
months).	We	were	unable	to	contact	18	participants.	20	participants	declined	to	
attend	(the	most	common	reason	stated	was	lack	of	time).	Six	participants	agreed,	but	
then	did	not	attend.	We	obtained	valid	measurements	in	46	of	50	participants	who	
attended.	Three	participants	did	not	bring	OC	with	them	and	one	was	ineligible	as	she	
had	not	provided	self-reported	contraception	data.	Amongst	these	46	participants,	the	
sensitivity	and	specificity	was	100%	for	self-reported	IUD,	implant,	injectable	and	OC	
use	compared	to	objective	measurement	(Table	26).		
Table	26:	Objective	vs.	self-report	follow	up	at	four	months	
	 Self-report	(number)	 Objective	measurement	(number)	
Current	contraception	use	 	 	
IUD	 11	 11	
Implant	 4	 4	
Injectable	 3	 3	
Oral	contraceptive	 9	 9	
No	method/non-effective	method	 19	 19	
	 	 	
Total	effective	 27	 27	
Total	no/non-effective	method	 19	 19	
Total	measurements	included	in	analysis	 46	 46	
Amongst	the	46	participants	the	sensitivity	of	self-report	data	compared	to	objective	measurement	(gold	
standard)	was	100%	(27/27*100)	and	the	specificity	was	100%	(19/19*100)	
	
It	is	uncertain	if	this	validity	study	was	helpful.	Whilst	the	sensitivity	and	specificity	of	
objectively	measured	contraception	was	100%	in	those	attending	follow-up,	the	
response	rate	was	low	and	it	is	not	clear	that	those	who	attended	were	representative	
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of	the	wider	study	population.	For	example,	if	a	participant	provided	inaccurate	self-
report	data,	they	might	be	less	likely	to	attend	for	objective	assessment.			
Conclusion	
In	the	MOTIF	trial,	use	of	self-report	measures	resulted	in	higher	rates	of	follow	up	
compared	to	attempts	at	objective	measures.	Self-report	measures	showed	fair/good	
reliability	and	the	validity	study	did	not	identify	any	cases	of	misclassification.	
However,	the	method	for	verifying	self-reported	OC	use	by	pill	counts	was	also	prone	
to	detection	bias.		
There	is	no	perfect	method	of	assessing	contraception	use	and	researchers	designing	
future	studies	should	give	consideration	of	what	to	measure,	for	example	current	use	
or	detailed	patterns	of	use	over	time,	and	remain	mindful	of	what	will	be	feasible	and	
acceptable	to	the	study	population.	For	OC	use,	researchers	should	consider	using	the	
definitions	of	‘continuation’,	‘discontinuation’,	‘interrupted	use’	and	‘missed	pills’	as	
recommended	by	Hall	et	al.(189)	
Objective	measures	using	clinic	records	or	electronic	medication	monitors	might	be	
possible	if	there	is	a	closed	pharmacy	system.	EMDs	linked	to	mobile	devices	providing	
real-time	data	on	pill	taking	will	provide	the	most	detailed	information	on	OC	use.	
Biological	measures	or	clinical	examination	might	be	feasible	if	participants	are	willing	
and	able	to	return	to	the	clinic,	and	there	is	laboratory	capacity.	Self-report	measures	
can	be	optimised	by	careful	consideration	of	questions	to	avoid	response-style	bias.	
Although	self-reported	data	on	contraception	use	are	considered	less	reliable,	and	
prone	to	social	desirability	bias,	it	is	often	the	standard	approach	for	contraception	
research	and	provides	data	comparable	to	previous	studies.	(188)(189)	A	validity	study	
could	be	considered	to	verify	self-report	measures.	Future	research	could	explore	the	
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possibility	of	a	urine	EE2	assay	as	an	alternative	to	a	blood	test	to	distinguish	between	
users	and	non-users	of	OC.	
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5.8	Assessing	loss	to	follow	up	in	the	MObile	Technology	for	Improved	Family	
Planning	(MOTIF)	trial	
Background	
Loss	to	follow-up	(LTFU)	in	clinical	trials	is	an	important	source	of	bias	that	can	affect	
statistical	power	and	generalisability	of	findings	and	trials	with	large	LTFU	can	be	
downgraded	in	systematic	reviews.	Systemic	differences	in	LTFU	between	groups	can	
result	in	attrition	bias.(169)		
Successful	follow	up	requires	participants	to	be	found,	and	also	willing	to	participate	
with	the	data	collection	procedure.(224)	LTFU	can	be	classified	as	missing	at	random	
(MAR)	or	not	missing	at	random	(NMAR),	for	example	increased	attrition	in	younger	
people.	In	this	situation	a	complete	case	analysis,	restricted	to	participants	with	
available	follow	up	data,	may	produce	a	biased	estimation	of	the	true	effect.	A	
common	approach	to	dealing	with	missing	outcome	data	is	to	impute	outcomes	and	
treat	them	as	if	they	were	real	measurements,	known	as	multiple	imputation.(225)	
The	aim	of	this	paper	is	to	assess	factors	associated	with	LTFU	in	the	MObile	
Technology	for	Improved	Family	Planning	(MOTIF)	trial	in	Cambodia	and	compare	how	
the	result	might	have	varied	using	different	analysis	methods.	
Main	text	
For	the	MOTIF	trial,	the	primary	outcome,	self-reported	use	of	an	effective	
contraceptive,	was	assessed	by	attempting	to	contact	participants	by	phone	at	four	
and	12-months.	We	used	evidence-based	methods	to	try	and	reduce	the	chance	of	
LTFU	such	as	collecting	as	many	possible	phone	numbers	on	recruitment,	including	
those	of	friends	or	family	members,	with	consent	of	the	participant.(226)(167)	At	the	
time	of	the	trial	few	participants	used	email,	there	was	not	a	functioning	postal	system	
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in	rural	areas	in	Cambodia,	and	we	had	limited	resources	to	visit	participants	homes.	
At	four	months	we	obtained	primary	outcome	data	from	431	participants	(86%).	
Amongst	the	69	clients	LTFU,	six	withdrew	and	we	were	unable	to	contact	63	
participants.	At	12	months	we	obtained	primary	outcome	data	from	328	participants	
(66%).	Amongst	the	172	clients	LTFU,	eight	withdrew	and	RAs	were	unable	to	contact	
164	participants.		
For	the	primary	analysis	we	undertook	a	complete	case	analysis,	similar	to	the	
approach	used	in	similar	trials	of	interventions	of	interventions	delivered	by	mobile	
phone	to	increase	contraception	use.(143)(142)	Using	a	complete	case	analysis	the	
intervention	increased	self-reported	use	of	an	effective	contraception	method	at	four	
months	post-abortion	(64%	vs.	46%	risk	ratio	(RR)	1·39,	95%	CI	1·17-1·66;	p<0·001),	
but	not	after	12	months	(50%	vs.	43%	RR	1.16,	95%	CI	0.92-1.47;	p=0.208).			
Investigating	missing	data	
Reasons,	as	documented	by	the	research	assistants,	for	LTFU	at	12	months	amongst	
these	164	participants	were	as	follows:	76	(46%)	times	the	phone	was	switched	off,	57	
(35%)	times	there	was	an	automated	response	that	the	number	not	in	use	and	not	yet	
re-assigned,	16	(10%)	times	someone	else	answered	the	phone,	10	(6%)	cases	where	
the	participant	had	moved	abroad,	3	(2%)	cases	of	an	automated	response	that	the	
phone	couldn’t	receiving	incoming	calls,	and	2	(1%)	cases	where	the	participant	didn’t	
want	to	talk.	
We	conducted	an	exploratory	analysis	to	identify	predictors	of	LTFU	from	the	variables	
collected	at	trial	recruitment	to	assess	whether	data	were	missing	at	random	or	not.	
To	maximise	statistical	power,	binary	variables	were	created	from	some	of	the	
categorical	variables.	First	we	undertook	univariable	analysis	to	examine	the	crude	
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association	between	each	baseline	variable	and	LTFU.	In	the	univariable	analysis,	age	
<25,	lower	socio-economic	status	(i.e.	no	access	to	motorised	transport),	not	planning	
to	use	post-abortion	contraception	and	not	providing	an	additional	friend/family	
contact	number	were	associated	with	LTFU	at	four	months.	Age	<25,	lower	socio-
economic	status	and	usually	or	sometimes	having	phone	credit	were	associated	with	
LTFU	at	12	months.	There	was	no	evidence	of	differential	LTFU	between	those	
assigned	to	the	intervention	or	control	at	four	or	12	months.		
We	then	undertook	multivariable	analysis	to	explore	the	association	between	variables	
and	LTFU,	controlling	for	confounding,	using	logistic	regression	analysis.	Age	and	socio-
economic	status	are	associated	with	contraception	use	and	maybe	associated	with	
seeking	LTFU.	(74)(3)	We	therefore	considered	these	variables	as	confounders	in	the	
analysis.	In	the	multivariable	analysis,	aged	<25,	lower	socio-economic	status,	not	
planning	to	use	post-abortion	contraception	and	not	providing	an	additional	
friend/family	contact	number	remained	as	predictors	of	LTFU	at	four	months;	LTFU	
was	significantly	increased	amongst	women	aged	<25	years	compared	to	aged	>25	
(Odds	Ratio	(OR)	2.31;	p=0.002),	amongst	women	without	access	to	motorised	
transport	compared	to	women	with	access	to	motorised	transport	(adjusted	OR	2.44;	
p=0.008),	amongst	women	not	planning	to	use	post-abortion	contraception	compared	
to	women	planning	to	use	(OR	2.34;	p=0.05),	and	amongst	women	who	didn’t	provide	
additional	contact	numbers	compared	to	those	that	did	(OR	2.40;	p=0.002)	(Table	27).	
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Table	27:	Predictors	of	missing	data	at	four	months	
	
Followed	
up	 LTFU	 Crude	OR	
p	
value	 Adjusted	OR	 p	value	
	
N=431	 N=69	
	 	 	 	Age	group	
	 	 	 	 	 	Age	>25	(r)	 306	(89%)	 37	(11%)	 1.00	
	 	 	Age	<25	 125	(80%)	 32	(20%)	 2.12	(1.26-3.55)	 0.004	 2.31	(1.36-3.92)	 0.002	
Residence	
	 	 	 	 	 	Rural	(r)	 279	(87%)	 42	(13%)	 1.00	
	 	 	Urban	 152	(85%)	 27	(15%)	 1.18	(0.70-1.99)	 0.535	 1.11	(0.65-1.90)	 0.699	
Socio-economic	status	
	 	 	 	 	 	Access	to	motorised	transport	(r)	 381	(88%)	 54	(12%)	 1.00	
	 	 	No	access	to	motorised	transport	 50	(77%)	 15	(23%)	 2.12	(1.11-4.03)	 0.022	 2.44	(1.26-4.72)	 0.008	
Education	
	 	 	 	 	 	Secondary	or	above	(r)	 263	(87%)	 41	(13%)	 1.00	
	 	 	None	or	primary	 168	(86%)	 28	(14%)	 1.07	(0.64-1.79)	 0.800	 1.14	(0.64-2.02)	 0.665	
Marital	status	
	 	 	 	 	 	Married/living	together	(r)	 403	(87%)	 61	(13%)	 1.00	
	 	 	Never	married	or	living	together	 23	(79%)	 6	(21%)	 1.72	(0.67-4.40)	 0.255	 1.32	(0.51-3.43)	 0.573	
Divorced/separated	 5	(71%)	 2	(29%)	
2.64	(0.50-
13.92)	 0.252	 1.31	(0.22-7.75)	 0.769	
#	living	children	
	 	 	 	 	 	1	or	more	(r)	 312	(88%)	 41	(12%)	 1.00	
	 	 	0	 119	(81%)	 28	(19%)	 1.79	(1.06-3.03)	 0.030	 1.31	(0.71-2.42)	 0.382	
#	previous	abortions	
	 	 	 	 	 	0	(r)	 254	(85%)	 45	(15%)	 1.00	
	 	 	1	or	more	 177	(88%)	 24	(12%)	 0.77	(0.45-1.30)	 0.324	 0.91	(0.52-1.57)	 0.724	
Contraception	decision-making	
	 	 	 	 	Joint	decision	(r)	 257	(89%)	 33	(11%)	 1.00	
	 	 	Mainly	participant	 79	(82%)	 17	(18%)	 1.68	(0.89-3.17)	 0.112	 1.76	(0.91-3.37)	 0.091	
Mainly	husband/partner	 66	(85%)	 12	(15%)	 1.42	(0.69-2.89)	 0.340	 1.58	(0.76-3.26)	 0.220	
Mobile	phone	access	
	 	 	 	 	 	Never	shares	(r)	 225	(87%)	 34	(13%)	 1.00	
	 	 	Shares	 206	(85%)	 35	(15%)	 1.12	(0.68-1.87)	 0.651	 1.21	(0.72-2.03)	 0.474	
Disclosure	of	abortion	to	others	
	 	 	 	 	Yes	(r)	 174	(85%)	 30	(15%)	 1.00	
	 	 	No	 32	(86%)	 5	(14%)	 0.91	(0.33-2.51)	 0.850	 1.10	(0.39-3.16)	 0.853	
PAFP	intentions	
	 	 	 	 	 	Yes	(r)	 166	(89%)	 21	(11%)	 1.00	
	 	 	No	 31	(74%)	 11	(26%)	 2.80	(1.23-6.39)	 0.014	 2.34	(1.00-5.46)	 0.050	
Undecided	 234	(86%)	 37	(14%)	 1.25	(0.71-2.21)	 0.444	 1.13	(0.63-2.01)	 0.689	
Fertility	plans	
	 	 	 	 	 	No	more/none	(r)	 123	(88%)	 16	(12%)	 1.00	
	 	 	Have	a/another	child	 261	(85%)	 47	(15%)	 1.38	(0.75-2.54)	 0.293	 1.00	(0.50-1.96)	 0.990	
Undecided	 47	(89%)	 6	(11%)	 0.98	(0.36-2.66)	 0.971	 0.88	(0.32-2.45)	 0.810	
Abortion	method	
	 	 	 	 	 	Medical	(r)	 178	(86%)	 29	(14%)	 1.00	
	 	 	Surgical	 253	(86%)	 40	(14%)	 0.97	(0.58-1.62)	 0.909	 1.00	(0.59-1.70)	 0.990	
Phone	credit	
	 	 	 	 	 	Always	(r)	 158	(88%)	 21	(12%)	 1.00	
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Usually	 102	(80%)	 26	(20%)	 1.92	(1.02-3.59)	 0.042	 1.71	(0.90-3.24)	 0.101	
Sometimes	 171	(89%)	 22	(11%)	 0.97	(0.51-1.83)	 0.920	 0.88	(0.45-1.71)	 0.705	
Friend/family	contact	provided	
	 	 	 	 	Yes	(r)	 338	(88%)	 44	(12%)	 1.00	
	 	 	No	 93	(79%)	 25	(21%)	 2.07	(1.20-3.55)	 0.009	 2.40	(1.37-4.21)	 0.002	
#	phone	numbers	provided	
	 	 	 	 	Two	or	more	(r)	 128	(89%)	 16	(11%)	 1.00	
	 	 	One	 303	(85%)	 53	(15%)	 1.40	(0.77-2.54)	 0.269	 1.42	(0.77-2.59)	 0.261	
Randomisation	
	 	 	 	 	 	Intervention	(r)	 211	(85%)	 38	(15%)	 1.00	
	 	 	Control	 220	(88%)	 31	(12%)	 0.78	(0.47-1.30)	 0.346	 0.81	(0.48-1.37)	 0.431	
*Adjusted	for	age	and	SES.	P	values	less	than	0.05	were	regarding	as	being	significant.	Analyses	were	undertaken	
using	STATA	13.1.	
	
At	12	months,	aged	<25,	lower	socio-economic	status	and	phone	credit	remained	as	
predictors	of	LTFU;	LTFU	was	significantly	increased	amongst	women	aged	<25	years	
compared	to	aged	>25	(OR	1.59;	p=0.023),	amongst	women	without	access	to	
motorised	transport	compared	to	women	with	access	to	motorised	transport	(OR	2.04;	
p=0.009),	and	amongst	women	who	usually	(OR	1.85;	p=0.014)	or	sometimes	(OR	1.59;	
p=0.046)	have	phone	credit	compared	to	women	who	always	have	phone	credit	(Table	
28).	
Table	28:	Predictors	of	missing	data	at	12	months	
	
Followed	
up	 LTFU	 Crude	OR	
p	
value	 Adjusted	OR	 p	value	
	
N=328	 N=172	
	 	 	 	Age	group	
	 	 	 	 	 	Age	>25	(r)	 235	(69%)	 108	(31%)	 1.00	
	 	 	Age	<25	 93	(59%)	 64	(41%)	 1.50	(1.01-2.21)	 0.043	 1.59	(1.07-2.36)	 0.023	
Residence	
	 	 	 	 	 	Rural	(r)	 212	(66%)	 109	(34%)	 1.00	
	 	 	Urban	 116	(65%)	 63	(35%)	 1.06	(0.72-1.55)	 0.780	 1.04	(0.70-1.54)	 0.848	
Socio-economic	status	
	 	 	 	 	Access	to	motorised	transport	(r)	 294	(68%)	 141	(32%)	 1.00	
	 	 	No	access	to	motorised	transport	 34	(52%)	 31	(48%)	 1.90	(1.12-3.22)	 0.017	 2.04	(1.19-3.47)	 0.009	
Education	
	 	 	 	 	 	Secondary	or	above	(r)	 209	(69%)	 95	(31%)	 1.00	
	 	 	None	or	primary	 119	(61%)	 77	(39%)	 1.42	(0.98-2.07)	 0.065	 1.48	(0.98-2.23)	 0.060	
Marital	status	
	 	 	 	 	 	Married/living	together	(r)	 309	(67%)	 155	(33%)	 1.00	
	 	 	Never	married	or	living	together	 16	(55%)	 13	(45%)	 1.62	(0.76-3.45)	 0.212	 1.38	(0.64-2.99)	 0.416	
Divorced/separated	 3	(43%)	 4	(57%)	 2.66	(0.59-12.02)	 0.204	 1.51	(0.31-7.41)	 0.613	
#	living	children	
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1	or	more	(r)	 241	(68%)	 112	(32%)	 1.00	
	 	 	0	 87	(59%)	 60	(41%)	 1.48	(1.00-2.21)	 0.052	 1.29	(0.81-2.04)	 0.280	
#	previous	abortions	
	 	 	 	 	0	(r)	 201	(67%)	 98	(33%)	 1.00	
	 	 	1	or	more	 127	(63%)	 74	(37%)	 1.20	(0.82-1.74)	 0.351	 1.34	(0.91-1.98)	 0.136	
Contraception	decision-making	
	 	 	 	 	Joint	decision	(r)	 193	(67%)	 97	(33%)	 1.00	
	 	 	Mainly	participant	 63	(66%)	 33	(34%)	 1.04	(0.64-1.70)	 0.868	 1.06	(0.65-1.74)	 0.812	
Mainly	husband/partner	 53	(68%)	 25	(32%)	 0.94	(0.55-1.60)	 0.816	 0.99	(0.57-1.69)	 0.959	
Mobile	phone	access	
	 	 	 	 	Never	shares	(r)	 175	(68%)	 84	(32%)	 1.00	
	 	 	Shares	 153	(63%)	 88	(37%)	 1.20	(0.83-1.73)	 0.337	 1.25	(0.86-1.81)	 0.252	
Disclosure	of	abortion	to	others	
	 	 	 	 	Yes	(r)	 134	(66%)	 70	(34%)	 1.00	
	 	 	No	 19	(51%)	 18	(49%)	 1.81	(0.89-3.68)	 0.099	 1.97	(0.96-4.05)	 0.066	
PAFP	intentions	
	 	 	 	 	 	Undecided	(r)	 181	(67%)	 90	(33%)	 1.00	
	 	 	Yes	 120	(64%)	 67	(36%)	 1.12	(0.76-1.66)	 0.562	 1.20	(0.81-1.79)	 0.360	
No	 27	(64%)	 15	(36%)	 1.12	(0.57-2.21)	 0.749	 1.05	(0.53-2.10)	 0.886	
Fertility	plans	
	 	 	 	 	 	No	more/none	(r)	 90	(65%)	 49	(35%)	 1.00	
	 	 	Have	a/another	child	 197	(64%)	 111	(36%)	 1.03	(0.68-1.57)	 0.872	 0.87	(0.55-1.38)	 0.561	
Undecided	 41	(77%)	 12	(23%)	 0.54	(0.26-1.12)	 0.096	 0.51	(0.24-1.08)	 0.080	
Abortion	method	
	 	 	 	 	 	Medical	(r)	 138	(67%)	 69	(33%)	 1.00	
	 	 	Surgical	 190	(65%)	 103	(35%)	 1.08	(0.74-1.58)	 0.673	 1.09	(0.74-1.60)	 0.651	
Phone	credit	
	 	 	 	 	 	Always	(r)	 132	(74%)	 47	(26%)	 1.00	
	 	 	Usually	 75	(59%)	 53	(41%)	 1.98	(1.22-3.22)	 0.006	 1.85	(1.13-3.02)	 0.014	
Sometimes	 121	(63%)	 72	(37%)	 1.67	(1.07-2.60)	 0.023	 1.59	(1.01-2.51)	 0.046	
Friend/family	contact	provided	
	 	 	 	 	Yes	(r)	 250	(65%)	 132	(35%)	 1.00	
	 	 	No	 78	(66%)	 40	(34%)	 0.97	(0.63-1.50)	 0.896	 1.03	(0.66-1.60)	 0.897	
#	phone	numbers	provided	
	 	 	 	 	Two	or	more	(r)	 99	(69%)	 45	(31%)	 1.00	
	 	 	One	 229	(64%)	 127	(36%)	 1.22	(0.81-1.85)	 0.346	 1.22	(0.80-1.85)	 0.357	
Randomisation	
	 	 	 	 	 	Intervention	(r)	 169	(68%)	 80	(32%)	 1.00	
	 	 	Control	 159	(63%)	 92	(37%)	 1.22	(0.84-1.77)	 0.287	 1.25	(0.86-1.81)	 0.253	
*Adjusted	for	age	and	SES.	P	values	less	than	0.05	were	regarding	as	being	significant.	Analyses	were	undertaken	
using	STATA	13.1.	
We	then	undertook	two	different	analyses	to	compare	with	the	complete	case	
analysis.	First,	we	undertook	multiple	imputation	to	estimate	the	effect	of	the	
intervention	on	the	primary	outcome	at	four	and	12	months.	This	involved	replacing	
each	missing	primary	outcome	value	with	a	plausible	imputation	based	on	the	
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characteristics	of	missing	values	observed.	Logistic	regression	with	predictor	variables	
age	group,	socioeconomic	status,	PAFP	intentions	and	whether	an	additional	friend	or	
family	contact	was	provided	was	used	for	univariate	imputation	of	the	outcome	at	four	
months	and	predictor	variables	age	group,	socioeconomic	status	and	phone	credit	for	
imputation	of	the	outcome	at	12	months.	Multiple	imputation	was	conducted	
separately	for	the	outcome	at	4	and	12	months	with	100	imputed	datasets	created	for	
each	outcome	respectively.	Using	MI,	the	intervention	also	showed	an	effect	at	four	
months	(63%	vs.	45%;	risk	ratio	(RR)	1·42,	95%	CI	1·19-1·69;	p=0·001),	but	not	after	12	
months	(48%	vs.	43%;	RR	1.12,	95%	CI	0.89-1.40;	p=0.349).	Second,	we	conducted	
sensitivity	analyses	treating	all	participants	LTFU	as	non-users	of	contraception	
(extreme	case	scenario)	to	estimate	the	effect	of	the	intervention	on	the	primary	
outcome	at	4	and	12	months.(213)	In	this	analysis	self-reported	effective	
contraception	use	also	remained	significantly	increased	when	we	considered	
participants	LTFU	as	non-users	at	four	months	(54%	vs.	40%;	RR	1·35,	95%	CI	1·12-1·63;	
p=0·002)	but	not	at	12	months	(34%	vs.	27%;	RR	1·25,	95%	CI	0·95-1·63;	p=0·106).	
Table	29	shows	how	the	effect	measure	varies	according	to	the	analysis	method	used.	
Using	MI,	the	risk	ratio	was	slightly	increased	at	four	and	slightly	decreased	at	12	
months	compared	to	the	complete	case	analysis.			
When	counting	all	participants	LTFU	as	non-users	of	contraception	the	risk	ratio	was	
slightly	decreased	at	four	months	and	slightly	increased	at	12	months,	compared	to	
the	complete	case	analysis.	Despite	the	changes	in	the	risk	ratio,	use	of	the	different	
analysis	methods	did	not	result	in	an	effect	becoming	statistically	significant,	or	vice	
versa.	
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Table	29:	Effect	measure	variation	according	to	the	analysis	method	used	
Conclusions	
Factors	associated	with	LTFU	in	the	MOTIF	trial	were	young	age,	lower	SES,	not	
planning	to	use	post-abortion	contraception,	phone	credit	and	not	providing	additional	
contact	numbers.	Reasons	for	LTFU	amongst	younger	women	might	be	that	they	
changed	phone	number	(couldn’t	be	found)	or	perhaps	due	to	potential	stigma	of	
contraception	use	in	young	people	(no	longer	wanted	to	participate	in	the	trial).	
Younger	participants	were	also	found	to	be	at	increased	risk	of	LTFU	in	a	head	injury	
trial.(224)	LTFU	amongst	women	of	lower	SES	might	be	due	to	changing	phone	number	
or	no	longer	having	access	to	a	phone.	Women	not	planning	to	use	contraception	
might	have	been	less	motivated	to	participate	in	the	trial	follow	up.	The	finding	that	
LTFU	was	increased	in	those	not	providing	multiple	contacts	is	consistent	with	existing	
evidence.(226)	Although	the	risk	ratio	showed	slight	variation	using	multiple	
imputation	and	counting	those	LTFU	as	non-users,	there	was	no	significant	change	in	
the	principal	findings.	
Future	studies	assessing	contraception	use	might	anticipate	increased	attrition	
amongst	younger	participants	and	those	of	lower	SES	or	who	do	not	provide	additional	
	 Intervention	
group		
number	(%)	
Control	
group		
number	
(%)	
RR		
(95%	
CI)	
p	value	 Intervention	
group		
number	(%)	
Control	
group		
number	
(%)	
RR		
(95%	CI)	
p	value	
	 Four	months	 12	months	
Complete	
case	
analysis	
135/211	
(64%)	
101/220	
(46%)	
1.39	
(1.17	–	
1.66)	
<0.001	 84/169	
(50%)	
68/159	
(43%)	
1.16	(0.92	–	
1.47)	
0.208		
Counting	
participants	
LTFU	as	
non-users	
135/249	
(54%)	
101/251	
(40%)	
1·35	
(1·12	–	
1·63)	
0·002	 84/249	
(34%)	
68/251	
(27%)	
1·25	(0·95	–	
1·63)	
0·106	
Multiple	
imputation	
158/249	
(63%)	
114/251	
(45%)	
1.42	
(1.19-
1.69)	
0.000	 120/249	
(48%)	
108/251	
(43%)	
1.12	(0.89–
1.40)	
0.349	
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contact	details.	Attrition	could	be	reduced	by	collecting	as	many	contact	details	as	
possible,	providing	incentives,	and	possibly	enhanced	counselling	to	groups	at	higher	
risk	of	LTFU	on	recruitment.(226)	Multiple	imputation	should	be	considered	in	addition	
to	complete	case	analysis	if	LTFU	not	missing	at	random	is	expected	or	observed.	
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6.	Process	Evaluation	of	a	Mobile	Phone-Based	Intervention	to	
Support	Post-Abortion	Contraception	in	Cambodia	
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Chapter	transition	notes	
The	trial	results	and	additional	analyses	(Chapter	5)	comprised	analysis	of	trial	follow	
up	data	reporting	the	overall	effect	of	the	intervention,	but	provide	limited	insights	
into	the	mechanism	of	action	and	how	the	intervention	was	perceived	by	women.	
Chapters	6	and	7	report	the	process	evaluation.	This	chapter	(Chapter	6)	is	a	
quantitative	study	to	assess	participants’	interaction	with	the	intervention	from	a	
service	provider	perspective.	Chapter	7	is	a	qualitative	study	which	seeks	to	gain	
insights	into	how	the	intervention	was	perceived	by	women.	
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Process	Evaluation	of	a	Mobile	Phone-Based	Intervention	to	Support	
Post-Abortion	Contraception	in	Cambodia	
6.1	Abstract	
Background	
The	MObile	Technology	for	Improved	Family	Planning	(MOTIF)	trial	assessed	a	mobile	
phone-based	intervention	comprising	voice	messages	and	counsellor	support	to	
increase	post-abortion	contraception	at	four	Marie	Stopes	International	clinics	in	
Cambodia.	The	aim	of	this	process	evaluation	was	to	assess	participants’	interaction	
with	the	intervention	from	a	service	provider	perspective.		
Methods		
(1)	We	conducted	a	descriptive	analysis	to	assess	participants’	interaction	with	the	
intervention.	(2)	In	order	to	explore	how	the	intervention	might	work,	we	assessed	
associations	between	interaction	with	the	intervention	and	contraception	use	using	
logistic	regression	analysis.	(3)	We	undertook	a	logistic	regression	analysis	to	assess	
associations	between	baseline	socio-demographic	factors	and	ever	requesting	to	speak	
to	a	counsellor	(pressing	‘1’),	a	variable	found	to	be	associated	with	contraception	use.	
Results	
Amongst	249	women	that	received	six	interactive	voice	messages	+/-	counsellor	
support	for	contraception,	around	half	actively	requested	to	speak	to	a	counsellor	
(pressed	‘1’)	and	over	90%	spoke	to	a	counsellor	at	some	stage.	Women	who	spoke	to	
the	counsellor	having	requested	to	(by	pressing	‘1’)	were	more	than	four	times	as	
likely	to	be	using	effective	contraception	at	four	months	compared	to	women	who	
didn’t	request	or	speak	to	the	counsellor	(Odds	Ratio	4.39;	95%	CI:	1.15-16.71).	There	
was	a	small,	non-statistically	significant	increase	in	contraception	use	amongst	women	
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that	spoke	to	the	counsellor	without	requesting	a	call.	Increased	parity,	a	history	of	>2	
previous	induced	abortions,	lower	socio-economic	status,	and	medical	abortion	(after	
adjusting	for	age,	socio-economic	status	and	residence)	were	associated	with	
requesting	to	speak	to	a	counsellor.	
Conclusions	
The	interactive	message	can	identify	a	subgroup	of	women	in	whom	counselling	will	be	
more	effective	and	appears	to	be	equitable	in	terms	of	engaging	those	most	in-need.	
The	intervention	could	be	adapted	based	on	the	findings	of	this	study.	
6.2	Introduction	
The	past	decade	has	seen	rapid	expansion	in	delivery	of	health-care	interventions	by	
mobile	phone	(‘mHealth’).(112)	In	the	field	of	contraception,	mobile	phone-based	
interventions	have	been	developed	to	support	uptake	of	methods	or	reduce	
discontinuation,	for	example	by	providing	reminders,	or	support	for	clients	
experiencing	side-effects.(227)	However,	the	effects	of	interventions	delivered	by	
mobile	phone	for	improving	contraception	use	have	not	been	reliably	
established.(227)	
Our	trial,	MObile	Technology	for	Improved	Family	Planning	(MOTIF),	randomised	500	
women	seeking	elective	induced	abortion	services	aged	18	years	or	older	to	a	
personalised	mobile	phone-based	behaviour	change	intervention	or	to	a	control	group.	
The	trial	results	and	a	detailed	description	of	the	intervention	and	its	development	are	
reported	elsewhere.(203)(212)	In	brief,	the	intervention	comprised	a	series	of	
automated	interactive	‘real-time’	voice	messages	over	the	three-month	post-abortion	
period	in	addition	to	standard	care.	Women	would	receive	the	first	message	within	
one	week	of	attending	the	clinic,	and	then	every	two	weeks,	with	a	total	of	six	
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messages.	The	message	was	designed	to	remind	women	about	contraception	methods	
available	to	them	and	provide	a	conduit	for	additional	support.(167)	Women	could	
press	‘1’	to	request	to	speak	to	a	counsellor,	press	‘2’	if	they	did	not	require	a	call	back,	
or	press	‘3’	to	opt-out	of	receiving	further	messages.	Women	who	pressed	‘1’,	or	who	
did	not	respond,	received	a	phone	call	from	a	counsellor.	The	phone	calls	provided	
individualised	counselling	intending	to	encourage	contraception	use	by	reminding	
women	about	available	methods	and	providing	support	for	side-effects.	Counsellors	
could	make	appointments	for	implant	or	intra-uterine	device	insertions	or	women	
could	opt	to	receive	additional	oral	contraceptive	pill	or	injectable	reminder	messages.	
The	counsellor	could	discuss	contraception	with	the	husband	or	partner,	if	the	woman	
requested	or	women	could	call	in	to	the	service	to	request	to	speak	with	a	counsellor.		
The	intervention	increased	self-reported	use	of	an	effective	contraception	method	at	
four	months	post-abortion	(135/211	(64·0%)	vs.	101/220	(45·9%)	risk	ratio	(RR)	1·39,	
95%	CI	1·17-1·66;	p<0·001),	but	not	after	12	months	(84/	(49.7%)	vs.	68/	(42.8%)	RR	
1.16,	95%	CI	0.92-1.47;	p=0.208).	However,	self-reported	long-acting	contraception	
use	(intrauterine	device,	implant	or	permanent	method)	was	increased	at	four	and	12	
months.(203)	
As	a	complex	intervention	delivered	by	automated	voice	messages	and	phone	
counselling,	it	is	not	clear	what	components	of	the	intervention	resulted	in	behaviour	
change.	Our	intervention	was	based	on	literature	on	the	determinants	of	
contraceptive	use	and	a	similar	approach	to	Lester	(2010)	who	hypothesized	that	
regular	structured	mobile	phone-based	support	could	improve	HIV	medication	
adherence.(127)(212)	However,	for	research	conducted	in	‘real-life’	settings,	it	cannot	
be	assumed	that	the	delivery	of	a	complex	intervention	will	be	exactly	as	planned	in	
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the	design	stage	of	a	trial.	Process	evaluation	of	randomised	controlled	trials	can	lead	
to	a	greater	understanding	of	what	works,	and	provide	meaningful	interpretation	of	
the	effects	on	an	intervention	to	inform	future	implementation.(228)(201)	In	a	
subsequent	paper	we	will	report	findings	from	interviews	conducted	with	participants	
that	received	the	intervention.	The	aim	of	this	study	was	to	assess	participants’	
interaction	with	the	intervention	from	a	service	provider	perspective	and	to	consider	
how	the	intervention	could	be	improved.	Specific	objectives	were	to:	
1. Describe	the	response	to	voice	messages	and	number	of	counsellor	contacts	
over	the	intervention	duration	
2. Examine	associations	between	interaction	with	the	intervention	and	
subsequent	contraception	use	
3. Assess	associations	between	baseline	socio-demographic	factors	and	
interaction	with	the	intervention	
6.3	Methods	
This	quantitative	study	used	data	collected	during	the	intervention	and	trial.	First,	we	
undertook	a	descriptive	analysis	to	assess	how	participants	interacted	with	the	
intervention.	Counsellors	delivering	the	intervention	made	a	record	of	all	mobile	
phone	communications	with	participants.	We	report	the	response	to	voice	messages,	
the	number	and	type	of	counsellor	contacts	and	number	of	women	that	opted	out	of	
the	intervention	or	that	the	counsellor	was	unable	to	contact	using	descriptive	
statistics.	
Second,	in	order	to	explore	how	the	intervention	might	work,	we	assessed	associations	
between	interaction	with	the	intervention	and	effective	and	long-acting	contraception	
use	using	logistic	regression	analysis.	Using	data	collected	by	counsellors	delivering	the	
	
	
238	
intervention	we	created	variables	based	on	response	to	the	voice	messages	and	
whether	women	spoke	to	the	counsellor	or	received	pill	or	injection	reminder	
messages.	We	conducted	a	pre-specified	per-protocol	analysis	to	assess	the	impact	of	
the	intervention	among	participants	who	responded	to	at	least	one	voice	
message.(167)	We	estimated	odds	ratios	(OR)	with	95%	confidence	intervals	(CI).	
Third,	we	undertook	a	logistic	regression	analysis	to	assess	associations	between	
baseline	socio-demographic	factors	and	ever	requesting	to	speak	to	a	counsellor	
(pressing	‘1’),	a	variable	that	was	found	to	be	associated	with	contraception	use	in	the	
previous	analysis.	As	the	voice	message	stated	“Press	1	if	you	would	like	me	to	call	you	
back	to	discuss	contraception”	we	considered	plausible,	‘a	priori’	confounders	that	
might	be	associated	with	contraception	use	in	Cambodia.	Age,	socio-economic	status,	
residence,	education	and	number	of	living	children	are	associated	with	contraception	
use	in	Cambodia	and	were	included	in	the	adjusted	analysis.(77)(3)	As	almost	all	the	
women	in	the	trial	(>99%)	were	able	to	recognise	numbers	on	a	phone	and	spoke	
Khmer	as	their	mother	tongue,	we	did	not	consider	confounders	that	might	be	
associated	with	the	ability	to	understand	or	respond	to	a	voice	message.	For	
categorical	variables	in	the	adjusted	analysis,	we	assessed	the	statistical	significance	of	
the	crude	association,	controlled	for	the	effect	of	the	confounding	variables	using	the	
Likelihood	ratio	test.	Ethical	approval	for	the	MOTIF	study	was	obtained	from	ethics	
committees	at	the	London	School	of	Hygiene	and	Tropical	Medicine	and	Marie	Stopes	
International	and	the	Cambodia	Human	Research	ethics	committee.	
6.4	Results	
1.	Interaction	with	the	intervention	
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Figure	51	shows	the	response	to	voice	messages	over	time.	The	proportion	of	‘1’	
responses	(requesting	a	call)	decreased	from	27%	at	voice	message	one	to	8%	by	
message	six.		
Figure	51:	Interaction	with	intervention	over	time	
	
Overall,	49%	of	clients	ever	pressed	‘1’	(to	request	to	speak	to	the	counsellor).	The	
proportion	of	‘2’	responses	(not	requiring	a	call	back)	increased	from	26%	to	38%.	The	
proportion	of	‘call	failed’	(no	response	to	the	voice	message)	increased	from	35%	to	
53%	at	voice	message	six.	The	proportion	of	clients	that	spoke	to	a	counsellor	
decreased	from	64%	at	voice	message	one	to	26%	at	voice	message	six.	In	total,	there	
were	210	(15%)	‘1’	responses,	452	(32%)	‘2’	responses,	109	(8%)	‘3’	responses,	657	
(46%)	‘no	responses’,	613	calls	from	the	counsellor	to	client	(outgoing)	and	
approximately	100	calls	from	the	client	to	the	counsellor	(data	not	systematically	
recorded).	The	mean	number	of	outgoing	phone	calls	per	client	was	2·46	(standard	
deviation	1·48).	Overall,	92%	of	participants	ever	spoke	to	a	counsellor.	It	is	not	clear	
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how	often	the	counsellor	discussed	contraception	with	the	women’s	husband	or	
partner,	as	this	information	was	not	systematically	recorded.	
Twenty	per	cent	(49/249)	of	participants	receiving	the	intervention	opted	to	receive	
oral	contraceptive	or	injection	reminders	at	some	stage.	Of	the	24	women	that	
received	a	reminder	message	three	months	after	receiving	the	injectable,	83%	(20/24)	
reported	continued	use	at	four-month	follow	up.	Of	the	25	women	that	received	
monthly	oral	contraceptive	reminders,	68%	(17/25)	reported	continued	pill	use	at	four-
months.		
By	voice	message	six,	15	(6%)	clients	had	opted	out.	Reported	reasons	according	to	the	
counsellors	notes	were	that	they	were	‘too	busy’	and	had	‘no	time’,	or	the	‘phone	was	
answered	by	someone	else’.	Six	participants	(2%)	randomised	to	the	intervention	did	
not	receive	any	messages;	five	due	to	non-functioning	phone	number	and	in	one	case	
someone	not	known	to	the	participant	answered	the	phone.		
2.	Association	between	interaction	with	the	intervention	and	contraception	use	
Table	30	shows	associations	between	interaction	with	the	intervention	and	effective	
and	long-acting	contraception	use	at	four	months.	The	following	factors	were	
associated	with	effective	contraception	use	at	four	months:	Requesting	to	speak	to	a	
counsellor	(pressing	‘1’)	compared	to	not	pressing	‘1’	after	the	first	voice	message	(OR	
3.37;	95%	CI:	1.62-6.98);	ever	requesting	to	speak	to	a	counsellor	(pressing	‘1’)	
compared	to	never	requesting	to	speak	to	a	counsellor	(OR	2.51;	95%	CI:	1.41-4.47);	
speaking	to	the	counsellor	having	requested	to	(pressed	‘1’)	compared	to	never	
speaking	and	requesting	to	speak	to	the	counsellor	(OR	4.39;	95%	CI:	1.15-16.71)	or	
speaking	to	the	counsellor	having	not	requested	to	(OR	1.79;	95%	CI	0.47-6.79);	
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received	pill	or	injection	reminder	compared	to	not	received	a	pill	or	injection	
reminder	(OR	4.63;	95%	CI:	2.11-10.16).		
Table	30:	Association	between	interaction	with	the	intervention	and	effective	and	long-
acting	contraception	use	at	4	months	
	 Using	effective	
contraception		
OR	 p	
value	
Using	long-acting	
contraception		
OR	 p	value	
	 No/total	no.	of	
respondents	(%)	
	 	 No/total	no.	of	
respondents	(%)	
	 	
Per-protocol	
analysis	
	 	 	 	 	 	
Responded	to	1-2	
voice	messages	
(r)	
33/55	(60%)	 1.00	
	
18/55	(33%)	 1.00	 	
Responded	to	>2	
voice	messages	
89/124	(72%)	 1.70	(0.87-3.30)	 0.121	 40/124	(32%)	 0.98	(0.50-1.93)	 0.951	
Response	to	voice	message	1	 	 	 	 	 	
Call	failed	(r)	 40/69	(58%)	 1.00	 	 16/69	(23%)	 1.00	 	
1	 49/60	(82%)	 3.23	(1.44-7.26)	 0.005	 24/60	(40%)	 2.21	(1.03-4.73)	 0.041	
2	 36/58	(62%)	 1.19	(0.58-2.42)	 0.639	 18/58	(31%)	 1.49	(0.68-3.28)	 0.321	
3	 10/24	(42%)	 0.52	(0.20-1.33)	 0.171	 3/24	(12%)	 0.47	(0.12-1.79)	 0.271	
Response	to	voice	message	1	 	 	 	 	 	
Didn't	press	'1'	(r)	 86/151	(57%)	 1.00	 	 37/151	(25%)	 1.00	 	
Pressed	'1'	 49/60	(82%)	 3.37	(1.62-6.98)	 0.001	 24/60	(40%)	 2.05	(1.09-3.88)	 0.026	
Whether	participant	ever	pressed	
'1'	
	 	 	 	 	
Never	(r)	 53/100	(53%)	 1.00	 	 18/100	(18%)	 1.00	 	
1	or	more	 82/111	(74%)	 2.51	(1.41-4.47)	 0.002	 43/111	(39%)	 2.88	(1.52-5.45)	 0.001	
Spoke	to	counsellor	after	voice	
message	'1'	
	 	 	 	 	
	
No	(r)	 44/74	(59%)	 1.00	 	 20/74	(27%)	 1.00	 	
Yes	 91/137	(66%)	 1.35	(0.75-2.42)	 0.315	 41/137	(30%)	 1.15	(0.61-2.17)	 0.658	
Whether	participant	ever	spoke	to	
counsellor	
	 	 	 	 	
	
Never	(r)	 4/11	(36%)	 1.00	 	 1/11	(9%)	 1.00	 	
1	or	more	 131/200	(66%)	 3.32	(0.94-11.74)	 0.062	 60/200	(30%)	 4.29	(0.54-
34.23)	
0.170	
Whether	pressed	'1'	if	spoke	to	
counsellor	
	 	 	 	 	
	
Spoke	to	
counsellor	&	
never	pressed	'1'	
(r)	
49/90	(54%)	 1.00	 	 17/90	(19%)	 1.00	 	
Spoke	to	
counsellor	&	ever	
pressed	'1'	
82/110	(75%)	 2.45	(1.35-4.45)	 0.003	 43/110	(39%)	 2.76	(1.44-5.29)	 0.002	
Combinations	of	pressing	'1'	and	speaking	to	counsellor	 	 	 	 	
Never	pressed	'1'	
&	never	spoke	to	
counsellor	(r)	
4/10	(40%)	 1.00	 	 1/10	(10%)	
	
1.00	 	
Never	pressed	'1'	
&	spoke	to	
49/90	(54%)	 1.79	(0.47-6.79)	 0.390	 17/90	(19%)	 2.10	(0.25-
17.68)	
0.496	
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The	per-protocol	analysis	 included	179	participants.	Participants	were	categorised	as	 ‘highly	protocol	adherent’	 if	
they	responded	 (i.e.	pressed	number	 ‘1’	or	 ‘2’)	 to	more	than	three	messages	and	 ‘less	protocol	adherent’	 if	 they	
responded	to	three	or	fewer	messages	
The	following	factors	were	associated	with	long-acting	contraception	use	at	four	
months:	Requesting	to	speak	to	a	counsellor	(pressing	‘1’)	compared	to	not	pressing	‘1’	
after	the	first	voice	message	(OR	2.05;	95%	CI:	1.09-3.88);	ever	compared	to	never	
requesting	to	speak	to	a	counsellor	(OR	2.88;	95%	CI:	1.52-5.45);	speaking	to	the	
counsellor	and	ever	pressing	‘1’	compared	to	speaking	to	the	counsellor	and	never	
pressing	‘1’	(OR	2.76;	95%	CI:	1.44-5.29).	
3.	Association	between	baseline	variables	and	response	to	the	intervention	
Table	31	shows	the	association	between	socio-demographic	baseline	variables	and	
response	to	the	intervention.		
The	following	socio-demographic	factors	were	associated	with	ever	requesting	to	
speak	to	the	counsellor	(pressing	‘1’):	Age	greater	than	25	compared	to	less	than	25	
(unadjusted	OR	1.78;	95%	CI:	1.05-3.02)	but	not	after	adjusting	for	confounding	
variables;	lower	compared	to	higher	socio-economic	status	(unadjusted	OR	2.92;	95%	
CI:	1.23-6.90)	which	remained	statistically	significant;	being	married	or	living	together	
compared	to	never	married	or	living	together	(unadjusted	OR	4.25;	95%	CI:	1.17-15.46)	
counsellor	 	
Pressed	'1'	&	
spoke	to	
counsellor	
82/110	(75%)	 4.39	(1.15-16.71)	 0.030	 43/110	(39%)	 5.78	(0.71-
47.22)	
0.102	
Pressed	'1'	&	
never	spoke	to	
counsellor	
0/1	(0%)	 1.00	(.-.)	 .	 0/1	(0%)	 1.00	(.-.)	 .	
Whether	received	pill	or	injection	reminders	 	 	 	 	
Didn’t	receive	pill	
or	injection	
reminder	(r)	
96	(59%)	 1.00	 	 60	(37%)	 1.00	 	
Received	pill	or	
injection	
reminder	
39	(83%)	 4.63	(2.11-10.16)	 <0.00
1	
1	(2%)	 0.08	(0.01-0.62)	 0.015	
All	participants	 135/211	
(64%)	
	 	 61/211	(29%)	 	 	
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Table	31:	Association	between	baseline	variables	and	interaction	with	intervention	
	
Never	
pressed	'1'	
Ever	
pressed	'1'	 Crude	OR	
p	
value	 Adjusted	OR*	
P	
value	
	
N=127	 N=122	
	 	 	 	Age	group	
	 	 	 	 	 	Age	<25	(r)	 53	(60%)	 35	(40%)	 1.00	
	 	 	Age	>25	 74	(46%)	 87	(54%)	 1.78	(1.05-3.02)	 0.032	 1.06	(0.52-2.19)	 0.864	
Residence	
(urban/rural)	
	 	 	 	 	 	Urban	(r)	 48	(56%)	 37	(44%)	 1.00	
	 	 	Rural	 79	(48%)	 85	(52%)	 1.40	(0.82-2.36)	 0.215	 1.49	(0.86-2.59)	 0.153	
Socio-economic	status	
	 	 	 	 	 	Access	to	motorised	
transport	(r)	 119	(54%)	 102	(46%)	 1.00	
	 	 	No	access	to	motorised	
transport	 8	(29%)	 20	(71%)	 2.92	(1.23-6.90)	 0.015	 3.36	(1.35-8.40)	 0.009	
Education	
	 	 	 	 	 	Secondary	or	above	(r)	 85	(54%)	 71	(46%)	 1.00	
	 	 	None	or	primary	 42	(45%)	 51	(55%)	 1.45	(0.87-2.44)	 0.155	 1.02	(0.58-1.80)	 0.936	
Marital	status	
	 	 	 	 	 	Never	married	or	living	
together	(r)	 12	(80%)	 3	(20%)	 1.00	
	 	 	
Married/living	together	 112	(48%)	 119	(52%)	
4.25	(1.17-
15.46)	 0.028	
3.13	(0.76-
12.91)	 0.091	
Divorced/separated	 3	(100%)	 0	(0%)	 1.00	(.-.)	 .	 1.00	(.-.)	
#	living	children	
	 	 	 	 	 	0	(r)	 51	(65%)	 28	(35%)	 1.00	
	 	 	1	or	more	 76	(45%)	 94	(55%)	 2.25	(1.30-3.91)	 0.004	 2.24	(1.07-4.72)	 0.033	
#	previous	abortions	
	 	 	 	 	 	0	(r)	 81	(56%)	 63	(44%)	 1.00	
	 	 	1	or	more	 46	(44%)	 59	(56%)	 1.65	(0.99-2.74)	 0.053	 1.68	(0.96-2.94)	 0.067	
#	previous	abortions	
	 	 	 	 	 	0	 81	(56%)	 63	(44%)	 1.00	
	 	 	1	 36	(52%)	 33	(48%)	 1.18	(0.66-2.10)	 0.576	 1.26	(0.68-2.33)	 0.014	
2	or	more	 10	(28%)	 26	(72%)	 3.34	(1.50-7.44)	 0.003	 3.49	(1.45-8.40)	
Previous	contraception	
use	
	 	 	 	 	 	No	(r)	 57	(54%)	 49	(46%)	 1.00	
	 	 	Yes	 70	(49%)	 73	(51%)	 1.21	(0.73-2.01)	 0.452	 1.00	(0.57-1.74)	 0.997	
Contraception	decision-making	
	 	 	 	 	Joint	decision	(r)	 70	(51%)	 68	(49%)	 1.00	
	 	 	Mainly	participant	 26	(47%)	 29	(53%)	 1.15	(0.61-2.15)	 0.665	 0.89	(0.45-1.76)	
0.931	Mainly	
husband/partner	 17	(45%)	 21	(55%)	 1.27	(0.62-2.62)	 0.514	 1.06	(0.48-2.35)	
Mobile	phone	access	
	 	 	 	 	 	Never	shares	(r)	 65	(52%)	 61	(48%)	 1.00	
	 	 	Shares	 62	(50%)	 61	(50%)	 1.05	(0.64-1.72)	 0.852	 0.99	(0.59-1.68)	 0.979	
Disclosure	of	abortion	to	others	
	 	 	 	 	No	(r)	 10	(59%)	 7	(41%)	 1.00	
	 	 	Yes	 52	(49%)	 54	(51%)	 1.48	(0.53-4.19)	 0.457	 1.14	(0.36-3.56)	 0.825	
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PAFP	intentions	
	 	 	 	 	 	No	(r)	 14	(78%)	 4	(22%)	 1.00	
	 	 	
Undecided	 68	(49%)	 72	(51%)	
3.71	(1.16-
11.82)	 0.027	 2.69	(0.80-9.12)	 0.248	
Yes	 45	(49%)	 46	(51%)	
3.58	(1.09-
11.70)	 0.035	 2.46	(0.71-8.55)	
Fertility	plans	
	 	 	 	 	 	Have	a/another	child	(r)	 82	(53%)	 73	(47%)	 1.00	
	 	 	No	more/none	 34	(50%)	 34	(50%)	 1.12	(0.63-1.99)	 0.690	 0.67	(0.34-1.31)	 0.388	
Undecided	 11	(42%)	 15	(58%)	 1.53	(0.66-3.55)	 0.319	 1.15	(0.46-2.86)	
Abortion	method	
	 	 	 	 	 	Surgical	(r)	 80	(54%)	 67	(46%)	 1.00	
	 	 	Medical	 47	(46%)	 55	(54%)	 1.40	(0.84-2.32)	 0.196	 1.85	(1.06-3.22)	 0.030	
Phone	credit	
	 	 	 	 	 	Always	(r)	 53	(55%)	 44	(45%)	 1.00	
	 	 	Usually	 38	(58%)	 27	(42%)	 0.86	(0.45-1.61)	 0.631	 0.91	(0.47-1.77)	 0.480	
Sometimes	 36	(41%)	 51	(59%)	 1.71	(0.95-3.06)	 0.073	 1.35	(0.73-2.52)	
*Adjusted	for	age,	socio-economic	status,	residence,	education	and	number	of	living	children	
but	not	in	the	unadjusted	analysis;	having	one	or	more	compared	to	no	children	
(unadjusted	OR	2.25;	95%	CI:	1.30-3.91)	which	remained	statistically	significant;	having	
two	or	more	previous	abortions	as	opposed	to	none	(unadjusted	OR	3.34;	95%	CI:	
1.50-7.44)	which	remained	statistically	significant;	planning	to	use	(unadjusted	OR	
3.58;	95%	CI:	1.09-11.70)	or	being	undecided	about	PAFP	(unadjusted	OR	3.71;	95%	CI:	
1.16-11.82)	as	opposed	to	not	planning	to	use	PAFP	at	the	time	of	randomisation	but	
not	in	the	adjusted	analysis.	Medical	compared	to	surgical	abortion	became	associated	
with	requesting	to	speak	to	the	counsellor	(adjusted	OR	1.77;	95%	CI:	1.03-3.07)	after	
adjusting	for	the	confounding	variables.	
6.5	Discussion	
Summary	of	main	results	
In	summary,	amongst	249	women	that	received	six	interactive	voice	messages	+/-	
counsellor	support	for	PAFP,	around	half	actively	requested	to	speak	to	a	counsellor	
(pressed	‘1’)	and	over	90%	spoke	to	a	counsellor	at	some	stage.	Women	who	spoke	to	
the	counsellor	having	requested	to	(by	pressing	‘1’)	were	more	than	four	times	as	
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likely	to	be	using	effective	contraception	at	four	months	compared	to	women	who	
didn’t	request	or	speak	to	the	counsellor.	There	was	a	small,	non-statistically	
significant	increase	in	contraception	use	amongst	women	that	spoke	to	the	counsellor	
without	requesting	a	call.	Increased	parity,	a	history	of	>2	previous	induced	abortions,	
lower	socio-economic	status,	and	medical	abortion	were	associated	with	requesting	to	
speak	to	a	counsellor	(pressing	‘1’)	after	adjusting	for	age,	socio-economic	status	and	
residence,	education	and	number	of	living	children.		
Strengths	&	limitations		
A	strength	of	this	study	is	the	use	of	prospectively	collected	quantitative	data	on	
participant	characteristics	and	response	to	the	intervention	which	provides	some	
insight	into	the	active	components	of	the	intervention.	The	main	limitation	of	this	
study	is	that	it	only	considers	a	provider	perspective	and	does	not	consider	the	views	
and	experiences	of	users;	this	will	be	assessed	in	a	subsequent	paper.	The	main	
limitation	affecting	the	logistic	regression	analysis	was	the	relatively	small	sample	size,	
particularly	in	some	of	the	subgroups,	resulting	in	lack	of	statistical	power	to	detect	
differences.	Hence,	whilst	odds	ratios	may	appear	to	vary	greatly	between	subgroups,	
the	confidence	intervals	are	wide,	and	so	these	trends	should	be	interpreted	with	
caution.	It	was	not	possible	to	adequately	evaluate	the	effect	of	the	pill	or	injection	
reminders	as	they	were	sent	to	a	relatively	small	number	of	women,	without	a	control	
group,	and	part	of	a	complex	intervention.	A	further	limitation	concerns	the	
generalisability	of	this	study	and	the	findings	might	not	be	applicable	to	other	settings.		
Interpretation	&	comparison	with	existing	literature	
To	our	knowledge,	this	is	the	first	process	evaluation	of	an	interactive	mobile	phone-
based	intervention	for	contraception	that	includes	a	detailed	assessment	of	provider-
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participant	communication.	Other	trials	of	mobile	phone-based	interventions	to	
improve	contraception	use	have	involved	unidirectional	text	messages,	and	thus	
provide	limited	opportunity	for	comparison.(142)(143)(144)(229)	However,	some	
comparisons	can	be	made	with	other	studies,	in	particular	the	process	evaluation	of	
the	text	message	component	of	Lester’s	intervention	for	antiretroviral	medication	
adherence.(230)		
Response	to	the	intervention	
Despite	sending	the	messages	at	the	clients	preferred	time	(e.g.	morning	or	evening),	
the	proportion	of	participants	not	responding	to	voice	messages	(i.e.	pressing	‘1’	or	‘2’)	
was	greater	than	non-responses	to	interactive	text	messages	reported	in	trials	in	
Kenya	and	the	USA.(127)(229)		The	most	likely	explanation	for	this	is	that	our	‘real-
time’	voice	message	required	an	immediate	response	(there	was	no	voice-mail),	
whereas	clients	can	respond	to	a	text	message	at	their	convenience.	The	proportion	of	
women	actively	responding	to	voice	messages	decreased	over	time,	similar	to	
decrease	in	responses	observed	in	previous	trials	of	interactive	text	message	or	pager	
interventions.(231)(232)(230)		
More	women	requested	to	speak	to	a	counsellor	at	voice	message	one	than	at	
message	six	and	the	proportion	of	women	not	requesting	a	call	back	increased	over	
time,	which	might	be	expected	as	issues	were	resolved.	By	message	six,	15	(6%)	clients	
had	opted	out	mainly	because	they	reported	being	too	busy	or	shared	their	phone	
with	someone	else,	which	is	common	in	Cambodia.(141)	Six	participants	(2%)	
randomised	to	the	intervention	did	not	receive	any	messages	mainly	due	to	non-
functioning	phone	number.	A	text	message	trial	in	the	USA	reported	similar	
	
	
247	
intervention	discontinuation	(42/480;	9%)	and	number	of	participants	that	never	
received	messages	(4/480;	0.9%).(142)	
Previous	studies	have	reported	greater	than	40%	discontinuation	of	short-acting	
methods	by	12	months.(233)	In	our	study,	17%	of	women	that	received	an	injectable	
reminder	message	and	32%	of	women	that	received	a	pill	reminder	message	had	
discontinued	at	four-months.	It	is	not	possible	to	determine	the	added	value	of	these	
additional	messages	within	the	whole	intervention,	as	we	did	not	have	a	comparison	
group	of	women	using	pill	or	injectable	not	receiving	reminder	messages.	However,	
pooled	analysis	suggests	that	text	message	reminders	for	medication	adherence	have	
at	best	small	effects.(115)	Elsewhere,	a	trial	in	the	USA	reported	that	participants	
receiving	text	message	reminders	had	a	lower	mean	number	of	days	between	
scheduled	appointment	and	actual	attendance	for	contraceptive	injection	for	the	first,	
but	not	subsequent	appointments.(229)	
Assessing	associations	between	interaction	with	the	intervention	and	contraception	
use	provided	further	insights	regarding	possible	active	components	of	the	
intervention.	Compared	to	women	that	never	requested	a	call	(pressed	‘1’)	or	spoke	to	
the	counsellor,	women	who	pressed	‘1’	and	spoke	to	the	counsellor	were	over	four	
times	more	likely	to	be	using	effective	contraception	at	four	months.	In	contrast,	there	
was	a	lesser,	non-statistically	significant	increase	in	contraception	use	amongst	women	
that	spoke	to	the	counsellor	without	requesting	a	call.	We	did	not	find	evidence	that	
contraception	or	fertility	intentions	at	the	time	of	seeking	abortion	services	were	
associated	with	requesting	to	speak	to	a	counsellor,	after	adjusting	for	the	
confounding	variables.	The	finding	that	phoning	women	who	requested	a	call	is	
associated	with	subsequent	use	of	effective	contraception	suggests	that	the	
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interactive	message	can	identify	a	subgroup	of	women	in	whom	counselling	will	be	
more	effective.		
Public	health	implications	
Our	finding	that	women	were	more	likely	to	request	a	call	back	from	a	counsellor	
(pressing	‘1’)	if	they	were	of	lower	socio-economic	status	or	increased	parity	suggests	
that	the	intervention	is	equitable	in	terms	of	engaging	those	most	in-need	and	could	
have	public	health	benefits	at	scale.	Older	women	and	those	with	increased	parity	are	
at	greater	than	average	obstetric	risk	from	subsequent	unintended	pregnancies.(1)	
Poor	women	are	most	likely	to	experience	complications	related	to	unsafe	abortion	
from	subsequent	unintended	pregnancies.	(204)		
Age	was	associated	with	pressing	‘1’	in	the	unadjusted	analysis	was	because	older	
women	were	poorer,	less	educated,	had	more	children	or	previous	abortions	and	more	
likely	to	live	in	rural	areas.	In	contrast	to	other	studies,	we	didn’t	find	that	residence	
was	associated	with	response	to	the	voice	message.(230)	However,	it	is	possible	that	
lack	of	access	to	motorised	transport	(proxy	for	socio-economic	status)	was	a	barrier	
to	accessing	face-to-face	health	services.		
Women	with	one	or	more	child	might	have	requested	to	speak	to	a	counsellor	due	to	
increased	motivation	to	prevent	another	unintended	pregnancy.	Engagement	by	
women	who	have	had	several	abortions	could	reflect	problems	with	contraception	in	
the	past	or	post-abortion	health	concerns.	Women	opting	for	medical	abortion	might	
be	more	likely	to	request	to	speak	to	a	counsellor	for	support	regarding	managing	their	
symptoms	at	home.(178)	Although	it	is	safe	to	use	a	full-range	of	contraceptive	
methods	apart	from	intra-uterine	device	on	the	day	of	medical	(misoprostol)	
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treatment,(29)	some	women	might	want	to	postpone	decisions	about	contraception	
use	until	the	abortion	is	complete.	
Implications	for	practice/research		
First,	given	that	women	were	more	likely	to	subsequently	use	contraception	if	they	
requested	to	speak	to	a	counsellor	(i.e.	pressed	‘1’),	the	intervention	could	be	further	
refined	so	that	counsellors	only	phone	women	that	request	to	speak	to	a	counsellor.	
As	the	cost	of	counselling	is	likely	to	be	the	main	limitation	to	scaling	up	the	
intervention,	this	change	would	reduce	costs	but	any	effect	of	the	intervention	
amongst	women	that	speak	to	the	counsellor	without	requesting	a	call	would	be	lost.	
Second,	in	settings	where	smartphones	use	is	high,	the	intervention	could	be	adapted	
whereby	the	voice	message	is	sent	via	an	instant	messaging	application	and	listened	to	
at	the	woman’s	convenience,	and	can	be	listened	to	several	times.	This	might	increase	
the	response	rate	to	the	messages.	Use	of	such	applications	provides	additional	
opportunities	to	add	other	low-literacy	content	such	as	stickers/cartoons	and	future	
research	could	evaluate	such	interventions.		
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7.	Women’s	views	and	experiences	of	the	mobile	phone-based	
intervention	
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Chapter	transition	notes	
The	previous	chapter	(Chapter	6)	gained	insights	into	the	mechanism	of	action	of	the	
intervention	using	data	collected	during	the	intervention.	This	chapter	(Chapter	7)	is	a	
qualitative	interview	study	to	assess	women’s	views	and	experiences	of	receiving	the	
MOTIF	intervention,	gain	insights	into	the	mechanism	of	action	of	the	intervention	and	
seek	recommendations	for	improvements.	 	
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Women’s	views	and	experiences	of	the	mobile	phone-based	
intervention	
7.1	Abstract	
Background	
The	MObile	Technology	for	Improved	Family	Planning	(MOTIF)	trial	assessed	a	mobile	
phone-based	intervention	comprising	voice	messages	and	counsellor	support	to	
increase	post-abortion	contraception	at	four	Marie	Stopes	International	clinics	in	
Cambodia.	The	aim	of	this	process	evaluation	was	to	assess	women’s	views	and	
experiences	of	receiving	the	MOTIF	intervention,	gain	insights	into	the	mechanism	of	
action	of	the	intervention	and	seek	recommendations	for	improvements.	
Methods	
We	conducted	a	qualitative	study	comprising	15	semi-structured	interviews	with	
women	who	had	received	the	intervention	and	undertook	a	simple	thematic	analysis.	
Results	
We	identified	themes	relating	to	communication	via	mobile	phone,	supporting	
contraception	use,	broader	post-abortion	care,	interaction	with	family	and	friends	and	
suggestions	for	improvement.	The	majority	of	women	were	positive	about	the	mobile	
phone-based	intervention	to	support	contraception	use	and	reported	it	to	be	a	
convenient	way	to	ask	questions	or	get	advice	without	going	to	a	health	centre,	
although	a	few	women	found	the	voice	messages	intrusive.		
The	intervention	supported	contraception	use	by	provision	of	information,	
encouragement,	reminders	to	return	to	clinic,	reassurance	and	advice	for	problems	
and	had	a	positive	effect	on	contraceptive	uptake	and	continuation.	Women	reported	
a	sense	of	being	cared	for	and	received	support	for	additional	physical	and	emotional	
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issues.	Most	women	thought	that	the	duration	of	the	intervention	and	frequency	of	
messages	were	acceptable.	
Conclusions	
The	majority	of	women	were	positive	about	the	mobile	phone-based	intervention	
which	provided	support	for	contraception	use	as	well	as	additional	physical	and	
emotional	issues.	The	study	provides	some	insights	into	how	the	intervention	might	
have	worked	and	considers	how	the	intervention	could	be	improved.	
7.2	Introduction	
In	recent	years	several	randomised	controlled	trials	have	assessed	interventions	
delivered	by	mobile	phone	(‘mHealth’)	to	improve	contraception	use.(227)	
Interventions	have	sought	to	improve	adherence	to	specific	methods	of	contraception	
such	as	oral	contraceptive	or	injectable,(142)(143)(229)	or	improve	use	of	a	range	of	
contraceptive	methods.(203)(144)(190)	To	date,	the	trial	evidence	for	mobile	phone-
based	interventions	to	increase	contraception	use	is	mixed.	A	mixture	of	uni-
directional	and	interactive	daily	educational	text	messages	improved	oral	
contraceptive	adherence	at	six	months	in	the	USA.(142)	In	our	MObile	Technology	for	
Improved	Family	Planning	(MOTIF)	trial,	a	series	of	voice	messages	with	additional	
counsellor	support	improved	use	of	effective	post-abortion	contraceptive	in	Cambodia	
at	four	but	not	12	months.(203)	Automated	text	message	reminders	did	not	improve	
oral	contraceptive	or	injectable	adherence	in	two	small	trials	in	the	USA.(143)(229)	
Text	messages	and	role	model	stories	were	reported	to	be	associated	with	increased	
knowledge	but	not	behaviour	change	in	Kenya.(190)	Thus,	whilst	interventions	
delivered	by	mobile	phone	to	improve	contraception	use	show	promise,	greater	
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understanding	of	what	works,	for	whom	and	under	what	circumstances	is	required.	
Process	evaluation	alongside	randomised	controlled	trials	can	enhance	understanding	
of	why	a	certain	intervention	works	or	does	not	work.(228)(201)		
The	study	reports	women’s	views	and	experiences	of	receiving	voice	messages	and	
counsellor	support	for	post-abortion	contraception	in	the	MOTIF	trial.	The	MOTIF	trial	
protocol,	results	and	description	of	the	intervention	development	are	reported	
elsewhere.(203)(167)(212)	In	brief,	the	intervention	comprised	six	automated	
interactive	voice	messages	over	the	three-month	post-abortion	period.	Women	could	
press	‘1’	to	request	to	speak	to	a	counsellor,	press	‘2’	if	they	did	not	require	a	call	back,	
or	press	‘3’	to	opt-out	of	receiving	further	messages.	Phone	counselling	aimed	to	
increase	contraception	use	by	providing	information	about	a	range	of	methods	and	
advice	for	side-effects.	If	the	woman	requested,	the	counsellor	could	also	discuss	
contraception	with	the	husband	or	partner.14	Clients	that	chose	to	receive	the	oral	
contraceptive	or	injectable	could	opt	to	receive	additional	reminder	messages	
appropriate	to	their	method.	
Amongst	249	women	that	received	the	intervention,	around	half	actively	requested	to	
speak	to	a	counsellor	(pressed	‘1’)	and	over	90%	spoke	to	a	counsellor	at	some	stage.	
Women	who	spoke	to	the	counsellor	having	requested	to	(by	pressing	‘1’)	were	more	
likely	to	be	using	effective	contraception	at	four	months	compared	to	women	who	
didn’t	request	or	speak	to	the	counsellor	(Odds	Ratio	4.39;	95%	CI:	1.15-16.71).	
Increased	parity,	a	history	of	>2	previous	induced	abortions,	lower	socio-economic	
status,	and	medical	abortion	were	associated	with	requesting	to	speak	to	a	
counsellor.(234)	This	study	aims	to	explore	women’s	views	and	experiences	of	
																																																						
14	The	counselling	guide	is	shown	in	Appendix	6	
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receiving	the	MOTIF	intervention,	gain	further	insights	into	the	mechanism	of	action	of	
the	intervention	and	seek	recommendations	for	improvements.	
7.3	Methods	
This	qualitative	study	involved	15	semi-structured	interviews	with	women	within	a	few	
weeks	of	receiving	the	intervention.	Participants	for	interview	were	selected	
purposively	by	the	counsellor	(author	LS)	delivering	the	intervention	to	include	women	
from	urban	and	rural	areas	and	those	who	did	or	did	not	appear	to	respond	to	the	
intervention;	both	users	and	non-users	of	contraception.	The	counsellor	telephoned	
participants	to	ask	if	they	were	willing	to	participate	in	the	interview	study.			
The	topic	guide	was	developed	to	explore	women’s	experience	of	the	intervention,	
aiming	to	identify	active	components	of	the	intervention,	and	seek	recommendations	
for	improvements	(Figure	52).		
Figure	52:	Interview	topic	guide	
1.	MOTIF	mobile	phone-based	service		
You	recently	used	the	new	Marie	Stopes	mobile	phone	post-abortion	service.	Could	you	please	tell	
me	about	your	experience	of	the	service?		
a.	Voice	Messages	(outgoing)		
I	would	like	to	hear	your	experience	regarding	the	voice	messages.		
• Tell	me	what	it	was	like	when	you	received	the	VMs?	
• What	did	you	think	about	the	VMs?	/	How	did	it	make	you	feel?	
• Can	you	remember	what	were	you	told	about	the	VMs	when	you	signed	up?			
POSSIBLE	PROMPTS			
v. How	many	voice	messages	did	you	listen	to?			
vi. Do	you	recall	what	the	voice	messages	said?			
vii. What	was	your	understanding	of	the	VMs?			
viii. What	were	you	doing	at	the	time	you	received	the	VMs?			
ix. Any	comments	about	the	sound	quality	/	voice	of	the	message?			
x. What	did	you	expect	to	happen	if	you	pressed	‘1’,	‘2’	or	‘3’?			
xi. Did	you	respond	to	the	VM?			
1.	If	so,	what	number	did	you	press,	and	why?		
viii.	Did	anyone	else	listen	to	the	VM	instead	of	you?		
1.	Any	consequences	of	this?		
b.	Pill/injection	reminders	(if	relevant)		
i.	Did	you	receive	any	pill	or	injection	reminder	VMs?	
1.	If	so,	what	was	your	experience	of	this?		
	
c.	IVR	system	and	leaving	messages	(incoming)		
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i.	Did	you	ever	call	into	the	service?		
1.	If	so,	what	was	your	experience	of	this?		
d.	Counselling		
• Did	you	receive	any	direct	phone	calls	from	the	counsellor?		
If	yes,		
• What	was	it	was	like	when	you	spoke	to	the	counsellor?	
• What	did	you	think	about	speaking	to	the	counsellor?	/	How	did	it	make	you	feel?	
POSSIBLE	PROMPTS		
i. What	kind	of	information	were	you	given	from	the	counsellor?	
ii. What	support	do	you	receive	about	post-abortion	care?	(E.g.	medical,	emotional)	
iii. What	information	were	you	given	about	contraception?	
iv. What	did	you	think	about	any	advice	you	were	offered	about	contraception?		Any	conflict	
with	clinic	service	provider	advice?			
v. Any	counsellor	contact	with	husband/partner,	any	links	with	model	clients			
vi. Where	do	you	think	the	counsellor	is	based?	Do	you	think	she	is	old	or	young?	Would	
like	to	see	her	picture	before	participating	in	the	service?			
	
2.	Support/change	in	behaviour/unintended	consequences	from	intervention		
• In	general,	(thinking	about	VMs	and	counselling),	did	anything	happen	to	you	as	a	
consequence	of	receiving	the	service	(positive	of	negative)?	OR	did	you	do	anything	
different?	
• How	would	this	compare	to	if	you	hadn’t	received	the	service?			
POSSIBLE	PROMPTS			
i. Any	support	with	SE’s/	to	continue	using	method?	
ii. Any	support	starting	or	switching	to	a	new	method	
iii. Clinic	attendances	for	check	up’s/post-abortion	follow	up	appointment	avoided?	Any	
	time/money	saved?	
iv. Use	other	services	in	addition	to	MSI?	Why?	
v. Any	suggestions	for	the	service?			
	
Would	anything	else	have	worked	better	for	you?	Would	you	recommend	it	to	a	friend	seeking	
abortion	services?		
POSSIBLE	PROMPTS		
• Length	of	service,	voice	messages	versus	direct	calls	etc.	
• How	could	we	make	it	more	likely	for	you	to	listen	and	respond	to	VM?	
• Would	you	be	prepared	to	pay	an	additional	fee	for	the	service?	If	so,	how	much?			
	
3.	Views	on	trial		
• What	was	your	experience	of	participating	in	the	trial?	
POSSIBLE	PROMPTS:		
a. Any	comments	on	the	recruitment	process	(information	for	participants,	consent)?			
b. Any	comments	on	phone	follow	up?			
c. Any	comments	on	reimbursement	to	cover	time/costs	for	interviews?			
d. Any	suggestions	for	improvement?			
Can	I	finally	ask	you	for	any	final	comments	that	have	not	been	covered	in	this	interview?	
Questions	were	included	on	duration	and	frequency	of	messages,	content	of	the	
intervention	and	any	subsequent	behaviour	change.	Participants	were	also	asked	
about	their	experiences	of	participating	in	the	study	and	will	be	reported	elsewhere.		
Participants	that	attended	for	clinic	interview	were	given	$4	USD	to	compensate	for	
travel	expenses.		
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Interviews	were	conducted	between	30	October	and	23	November	2013.	Author	CS	
conducted	six	interviews	(four	at	the	clinic,	and	two	at	clients	houses)	with	author	UV	
interpreting,	author	RW	conducted	three	interviews	(at	the	clinic)	with	UV	
interpreting,	and	UV	conducted	six	interviews	(four	at	the	clinic,	and	two	by	phone).	
Participants	were	provided	with	an	information	sheet	to	read,	or	it	was	read	to	them,	
and	provided	signed	or	thumb-printed	consent,	or	recorded	verbal	consent	for	the	
phone	interviews.	Interviews	were	recorded	and	transcribed	by	Cambodian	research	
assistants	(medical	students)	to	English.	NVivo	11	software	was	used	to	store	and	code	
all	transcripts.(235)		
We	undertook	a	simple	thematic	analysis.(236)	This	involved	familiarization	with	the	
interview	transcripts,	identification	of	key	themes,	coding	the	data	according	to	
appropriate	thematic	references,	comparison	of	themes	across	and	within	cases.	CS	
and	CF	read	the	transcripts	to	identify	key	themes.	CS	coded	all	the	transcripts	and	
compared	themes	across	and	within	cases.	CF	and	UV	coded	some	transcripts.	Key	
themes	are	supported	with	quotations	which	have	not	been	edited	apart	from	obvious	
typos	to	avoid	unintentionally	changing	the	meaning.	Ethical	approval	was	obtained	
from	ethics	committees	at	the	London	School	of	Hygiene	and	Tropical	Medicine	and	
Marie	Stopes	International	and	the	Cambodia	Human	Research	ethics	committee.	
7.4	Results	
The	characteristics	of	the	15	interview	participants	are	shown	in	Table	32.		
Participants’	age	ranged	from	22	to	41.	Most	women	were	married	and	employed,	but	
we	also	interviewed	three	students	and	an	entertainment	worker.	Twelve	women	
were	using	a	contraception	method	at	the	time	of	interview,	eight	of	whom	were	using	
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long-acting	methods	(intrauterine	device	or	implant).	We	identified	themes	relating	to	
communication	via	mobile	phone,	
Table	32:	Characteristics	of	interview	participants	
No.	 Age	 Occupation	 Marital	status	 Residence	 Post-abortion	contraception	use	
1	 22	 Housewife	 Married	or	living	
together	
Urban	 Used	oral	contraceptive	post-
abortion	
2	 31	 Employed	 Married	or	living	
together	
Urban	 Didn’t	use	PAFP	then	had	IUD	
inserted	after	repeat	abortion	
3	 30	 Self-employed	 Married	or	living	
together	
Urban		 Returned	to	clinic	for	IUD	
insertion	
4	 24	 Housewife	 Married	or	living	
together	
Rural	 Used	oral	contraceptive	post-
abortion	but	discontinued	as	
husband	working	away.	Sent	oral	
contraceptive	reminder	message	
5	 33	 Housewife	 Married	or	living	
together	
Urban	 Used	IUD	post-abortion	
6	 34	 Self-employed	 Married	or	living	
together	
Rural	 Returned	to	clinic	for	implant	
insertion	
7	 34	 Self-employed	 Married	or	living	
together	
Urban	 Returned	to	clinic	for	IUD	
insertion	
8	 34	 Factory	worker	 Married	or	living	
together	
Rural	 Used	oral	contraceptive	post-
abortion	but	discontinued	as	
husband	living	away	
9	 25	 Student	 Married	or	living	
together	
Rural	 Advised	to	have	abortion	for	
medical	reasons	and	avoid	
pregnancy	for	a	year;	using	oral	
contraceptive.	Sent	oral	
contraceptive	reminder	message	
10	 25	 Factory	worker	 Married	or	living	
together	
Rural	 Returned	to	clinic	for	IUD	
insertion	
11	 22	 Student	 Married	or	living	
together	
Urban	 Using	oral	contraceptive.		Sent	
oral	contraceptive	reminder	
message	
12	 20	 Student	 Never	married	or	
living	together	
Urban		 Using	oral	contraceptive	
13	 38	 Self-employed	 Married	or	living	
together	
Urban	 Used	oral	contraceptive	post-
abortion	then	had	IUD	inserted		
14	 41	 Farmer	 Married	or	living	
together	
Rural	 Used	implant	post-abortion	
15	 25	 Entertainment	
worker	
Never	married	or	
living	together	
Rural	 Not	using	contraception	as	not	in	
relationship	
supporting	contraception	use,	broader	post-abortion	care,	interaction	with	family	and	
friends	and	suggestions	for	improvement.		
Communication	by	mobile	phone	
Most	women	reported	that	communication	via	mobile	phone	was	convenient.	Women	
reported	listening	to	the	voice	message	if	it	was	received	at	a	convenient	time	and	
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thought	the	message	was	easy	to	understand.	Whilst	most	women	had	forgotten	the	
content	of	the	voice	message,	most	recalled	the	concept	of	pressing	a	number	on	their	
keypad	and	reported	that	it	was	good	to	have	the	option	to	request	to	speak	to	a	
counsellor	or	not.	Women	reported	pressing	‘1’	if	they	had	a	question	or	health	
problem	or	pressing	‘2’	or	ending	the	call	if	they	were	busy,	had	no	problems,	or	did	
not	want	to	disturb	the	counsellors.	
“Sending	voice	message	wasn’t	the	disturbance	because	if	we	wanted	to	talk	to	
her,	we	just	talked	and	if	we	didn’t	want	to	talk,	we	just	pressed	number	2	or	3	
if	we	didn’t	want	her	to	call	us,	she	would	stop	calling	us”	(interview	11)	
“I	think	that	pressing	number	1	or	number	2	is	better	because	when	I	face	
problem,	I	just	press	number	1	or	number	2…	That’s	why	it	is	quite	important	for	
me”	(interview	9)	
Several	women	reported	that	receiving	messages	or	speaking	to	the	counsellor	was	a	
convenient	way	to	obtain	support	for	health	issues	or	remind	them	about	
contraception	and	saved	the	time	and	costs	of	clinic	attendance.	
	“These	messages	help	a	lot-especially	for	those	who	live	far	away	from	here	
like	me.	Because	of	busy,	I	might	forget	to	use	contraception	methods,	but	
when	I	listen	to	voice	messages,	I	can	remember.	If	do	not	want	to	have	
pregnant,	I	just	listen	to	it.	Voice	messages	always	remind	me…Whenever	I	
listen	to	voice	messages,	I	feel	like	someone	stays	next	to	me	and	supports	me	
about	using	contraceptive	methods”	(interview	9)	
“Counselling	via	phone	call	gives	advantage…because	we	don’t	have	to	come	to	
PET	[health	worker],	spend	money	to	clinic	directly,	and	we	discuss	with	her	and	
if	we	don’t	discuss	with	her	and	we	have	to	come	to	PET,	we	spend	money	first	
for	travel	fee	and	second	for	PET	fee”	(interview	6)	
Conversely,	a	few	women	reported	missing	calls	if	they	were	away	from	their	phone.	
Two	women	reported	that	messages	could	be	intrusive	if	received	at	an	inconvenient	
time	e.g.	when	busy	at	work.		
“The	message	just	tell	me	to	click	one	or	two	for	answer…	at	that	time	I	still	
work	but	if	I’m	busy,	it’s	ok	but	sometimes	when	I’m	very	busy	and	like	stress	
and	sometimes	it’s	annoying”	(interview	2)	
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Supporting	contraception	use	
Many	women	reported	receiving	information	and	increasing	their	knowledge	on	a	
range	of	contraceptive	methods.	Several	women	reported	that	the	counsellor	would	
ask	if	they	were	using	a	method,	and	the	phone	call	provided	an	opportunity	for	
women	to	ask	questions	about	contraception.		
“She	explained	even	about	drug,	IUD/implant,	injection,	oral	pill,	and	IUD,	and	
condom.	She	explained	all.	She	told	me	a	lot”	(interview	5)	
“The	message	ended	and	a	short	while,	she	would	call	me	back…	I	asked	her	
that,	for	example,	we	forgot	to	take	the	pill…	What	should	I	do	if	[I]	forgot	
taking	till	3	days?”	(interview	11)	
Some	women	reported	that	they	decided	to	adopt	a	long-acting	method	of	
contraception	after	speaking	to	the	counsellor.	A	few	women	described	being	given	
information	on	discounts	or	where	to	access	services.			
“After	I	got	information	from	counsellors	I	then	went	to	clinic	to	insert	IUD…I	
learnt	how	to	insert	IUD	and	taking	pills.	Inserting	of	IUD	is	much	more	easier.	
Talking	pill	has	to	be	on	time	and	take	it	daily	but	for	IUD	we	do	not	have	to	do	
like	this.		We	can	have	sex	whenever!	Counselling	service	made	me	feel	
confident	because	I	thought	that	medical	science	is	better	than	our	thought.	
Some	people	said	that	IUD	can	move	around,	but	when	I	came	to	ask	
counsellor,	she	said	that	IUD	did	not	have	legs	to	move	around….	I	also	told	
people	I	know	to	insert	IUD	as	well”	(interview	10)	
“She	explained	me	to	have	contraception	here,	use	implant	at	this	clinic,	there	
was	discount”	(interview	6)	
Several	women	reported	that	the	counsellor	provided	advice	if	they	were	experiencing	
side-effects	from	contraception;	either	advising	the	women	to	attend	the	clinic	for	
examination	or	providing	reassurance	which	led	to	the	women	continuing	to	use	the	
method.	
	“She	said	that	the	side	effects	of	IUD	lasted	3	months,	I	remember	that.	And	
after	these	3	months,	our	body	can	tolerate	with	it,	it	will	be	alright…and	now	I	
am	alright”	(interview	3)	
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Three	women	received	a	specific	pill	reminder	message	at	one-month,	but	only	one	
woman	recalled	receiving	this.	However,	several	women	using	oral	contraceptive	
reported	that	the	counsellor	had	emphasized	the	importance	of	taking	the	pill	
regularly	and	the	risk	of	consequent	pregnancy,	resulting	in	a	change	in	behaviour.	
“I	was	confident	because	she	said	that	when	we	took	the	pill,	we	had	to	take	
regularly.	If	we	didn’t	take	the	pill	regularly,	it	was	possible	to	be	pregnant…	so	I	
changed	my	habit	according	to	her”	(interview	1)	
Broader	post-abortion	care		
An	important	aspect	of	the	intervention	was	the	sense	of	care	and	emotional	support	
provided	as	well	as	support	for	specific	problems.	Many	women	reported	feeling	
happy	because	somebody	was	taking	care	of	them,	or	asked	about	their	health	or	
more	generally	about	what	they	were	doing.	Several	women	reported	that	the	
counsellor	provided	encouragement	and	that	they	gained	confidence	and	felt	less	
afraid.		
“For	that	voice	message	that	I	received,	I	think	that	it’s	good.	It’s	good	and	like	
makes	me	feel	warm	like	there’s	someone	take	care	about	us”	(interview	8)	
“When	I	received	that	voice	message,	I	felt	that…	she	encouraged	me	and	she	
loved	our	health	so	that	she	wanted	to	know	about	our	health	if	we	were	
healthy”	(interview	12)	
One	woman	reported	receiving	support	for	suicidal	feelings.	
	“Struggle	in	my	life,	because	sometimes	I	want	to	commit	suicide,	but	
counsellor	not	allow	me	to	do	this,	they	encourage	me	to	be	strong”	(interview	
15)	
The	counsellor	provided	support	for	post-abortion	health	concerns	such	as	abdominal	
pain,	vaginal	bleeding	or	discharge.	In	some	cases	the	counsellor	would	provide	
reassurance	or	otherwise	suggest	the	women	attend	the	clinic	for	a	check	up.	
“After	I	used	medicine	I	asked	her	my	problem	“why	around	my	abdominal	still	
painful?	Why	I	cannot	do	something?	Even	just	walking,	I	cannot	walk”.	
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Counsellor	said	that	bleeding	it	just	side	effect	of	medicine,	but	if	you	has	much	
bleeding	you	need	to	go	back	to	clinic.	I	followed	up	myself	and	I	found	that	
there	was	just	small	bleeding,	so	I	decided	not	coming	to	clinic”	(interview	9)	
A	few	women	reported	gaining	general	information	about	illnesses	and	health	
promotion.	
“If	I	make	comparison,	I	see	a	lot	of	changing.	Before	I	seldom	to	hear	
information,	by	the	time	I	have	started	to	use	services	here,	I	can	consult	at	
anytime	and	I	know	more	about	illness	problem	that	often	happen	to	women	
and	its	prevention”	(interview	9)	
Interaction	with	family	and	friends	
In	most	cases	women	listened	to	the	voice	messages	on	their	own.	Some	women	
reported	that	they	were	able	to	discuss	topics	in	confidence	that	they	couldn’t	discuss	
elsewhere	or	with	others,	for	example,	at	a	hospital	or	with	family	members.	
“The	reason	why	I	believe	her	because	she	encouraged	me	that	she	wouldn’t	tell	
other	about	my	secret	and	what	she	talked	with	me	she	kept	in	secret…I	believe	
that	they	can	help	a	lot	of	other	women,	sister,	because	woman	is	shy,	and	
sometimes	she	can’t	talk	to	other…	it	just	sometimes	we	felt	embarrassed.	
There’re	some	matters	that	we	don’t	want	other	to	know”	(interview	12)	
A	few	women	reported	that	they	would	hang	up,	or	arrange	to	speak	to	the	counsellor	
at	a	different	time	if	messages	were	received	or	the	counsellor	called	in	the	presence	
of	others.		
“Sometimes	there	was	my	mother;	I	didn’t	want	to	talk	because	I	was	shy	and	I	didn’t	
want	her	to	know.	But	if	I	stayed	with	my	family,	my	couple,	there	was	no	problem.	But	
sometimes…he	didn’t	stay	with	me	every	time,	but	we	didn’t	want	like	questioning	
words	like	I	was	sick	like	this	or	like	that	I	didn’t	want	to	talk	in	front	of	my	mother,	and	
my	younger	siblings.	But	she	called	me	when	I	was	alone	or	with	my	family,	I	would	talk	
and	there	was	no	problem”	(interview	8)	
If	few	women	reported	that	family	members	or	friends	might	ask	questions	after	
listening	to	a	voice	message	in	their	presence,	but	husbands’	were	generally	
supportive.		
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“No	one	listens	to	my	voice	messages	because	my	phone	stays	with	me	all	the	
time.	Even	my	husband,	he	also	does	not	hack	and	listen	alone.	When	new	
message	coming,	my	husband	told	me…	Moreover	my	husband	always	asks	me	
questions	when	I	finished	listen	to	messages	because	he	concerns	much	about	
my	health	condition”	(interview	9)	
In	other	cases,	women	reported	deliberately	sharing	intervention	content.	One	woman	
reported	using	the	speakerphone	so	that	others	could	listen	to	the	message.	There	
were	a	few	instances	where	women	reported	having	subsequent	conversations	with	
friends	or	family	members	to	recommend	Marie	Stopes	services	or	contraception	
methods.		
“I	never	let	anyone	listen	to	it	but	I	brought	my	younger	sister	who	wanted	to	use	IUD	
like	me.	I	always	told	her	that	I	felt	well”	(interview	3)	
There	were	a	few	instances	where	someone	else	listened	to	the	message	or	spoke	to	
the	counsellor	because	the	phone	had	been	shared	with	another	family	member	but	
there	were	no	reported	instances	of	harm	as	a	consequence.		
Suggestions	for	improvement	
All	of	those	interviewed	thought	that	the	service	should	be	offered	to	women	in	the	
future.	One	participant	suggested	focusing	on	less	educated	women.		
“I	do	not	have	any	request	because	it	is	good	enough	already.	I	rarely	to	see	
services	like	this	in	others	organization”	(interview	9)	
Most	women	were	positive	about	voice	messages,	although	a	few	women	expressed	a	
preference	for	direct	phone	calls	or	text	message.	Although	most	women	couldn’t	
remember	how	frequently	they	received	messages,	most	reported	that	a	frequency	of	
two	times	a	month	was	enough.	
“I	want	direct	phone	call…	I	am	not	interested	in	voice	message	at	all	because	it	
takes	long	time,	but	if	you	call	me,	I	once	pick	up	the	phone	call”	(interview	1)	
“Text	message.	Sometimes	when	I	go	bathroom	when	comeback,	I	can	see	
message	rather	than	missed	call.”	(interview	15)	
	
	
265	
Most	women	thought	that	the	intervention	duration	of	three-months	was	sufficient	
and	that	the	messages	were	no	longer	required	e.g.	“not	really	necessary	for	me	
because	I	do	not	have	any	problem	now”	(interview	14).	However,	a	few	women	
reported	that	they	would	have	liked	the	voice	messages	to	continue	beyond	three	
months	in	case	they	experienced	problems	in	the	future.		
“There	was	a	message	said	that	this	message	was	the	last	message.	To	me,	
when	the	message	said	that	it	was	the	last	message,	I	felt	regret	and	I	didn’t	
want”	(interview	3)	
“Sometimes	I	don’t	know	in	the	future	I	will	meet	what	problem,	sister,	so	I	am	
difficult	to	call	her.	When	she	sends	voice	message	to	me,	she	has	my	number	
and	that	number	is	easy	for	me	to	call	to	ask	her	too”	(interview	12)	
Most	women	reported	that	they	would	be	happy	to	pay	a	small	fee	(e.g.	$1-2USD)	for	
such	a	service,	but	a	few	thought	it	should	remain	free	of	charge.	A	few	women	
suggested	that	the	messages	support	other	health	topics.	
“We	go	to	small	pharmacies,	we	have	to	spend	the	money	too;	therefore,	I	
don’t	mind	about	paying	this	amount.	This	is	for	our	health	too”	(interview	3)	
“I	am	interested	in	general	health	short	voice	messages	if	we	send	you	weekly?	
For	example,	messages	tell	you	how	to	prevent	from	diseases,	how	prevent	
from	pregnancy,	STI	and	so	on…I	want	these	services	still	providing	for	long	
period”	(interview	14)	
7.5	Discussion	
Summary	of	main	results	
The	majority	of	women	were	positive	about	the	mobile	phone-based	intervention	to	
support	contraception	use	and	reported	it	to	be	convenient	in	a	number	of	ways.		
Most	women	liked	being	able	to	respond	to	the	voice	message	to	request	to	speak	to	a	
counsellor	or	not.	However	a	few	women	found	the	voice	messages	intrusive.	Phone	
counselling	was	a	convenient	way	to	ask	questions	or	get	advice	without	going	to	a	
health	centre.	Women	reported	that	the	intervention,	in	particular	phone	counselling,	
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supported	contraception	use	by	provision	of	information,	encouragement,	reminders	
to	return	to	clinic,	reassurance	and	advice	for	problems	and	had	a	positive	effect	on	
contraceptive	uptake	and	continuation.	Women	reported	a	sense	of	being	cared	for	
and	received	support	for	additional	physical	and	emotional	issues.	Counselling	allowed	
women	to	discuss	issues	with	the	counsellor	in	confidence,	although	in	some	cases	the	
intervention	content	was	shared	with	others,	either	deliberately	or	unintentionally.	
Most	women	thought	that	the	duration	of	the	intervention	and	frequency	of	messages	
were	acceptable.	
Strengths	&	limitations		
This	study	provides	insights	to	the	intervention	gained	by	in-depth	interviews	with	
women.	A	strength	of	our	methodology	is	that	most	of	the	interviews	were	conducted	
by	female	researchers,	which	is	considered	more	appropriate	for	reproductive	health	
research	in	order	to	minimise	‘social	distance’	between	researchers	and	subjects.(237)	
Our	study	also	has	some	limitations.	It	is	possible	that	women	would	have	been	more	
likely	to	agree	to	be	interviewed	if	they	had	had	a	positive	experience	of	the	
intervention.	We	did	not	document	if	any	women	refused	to	participate.	Most	of	the	
women	interviewed	were	using	a	contraceptive	method	and	hence	we	were	unable	to	
assess	differences	in	accounts	between	contraception	users	and	nonusers.	As	in	the	
trial,	most	of	the	women	interviewed	were	married,	and	single	women	and	
entertainment	workers	were	under-represented.(203)	The	interviews	may	have	been	
prone	to	social	desirability	bias,	particularly	as	some	were	conducted	by	western	
researchers,	although	it	is	encouraging	that	a	range	of	views	were	expressed.	Although	
small	numbers	of	women	were	interviewed,	few	new	ideas	resulted	from	the	later	
interviews,	and	a	degree	of	‘saturation’	was	reached.	
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Another	potential	limitation	is	that	it	wasn’t	always	clear	if	the	woman	was	referring	to	
voice	messages	or	counselling	when	analysing	the	interviews.	Hence	it	was	not	always	
possible	to	attribute	women’s	reports	to	the	automated	or	counsellor-delivered	
components	of	the	intervention.	As	a	consequence	of	these	potential	biases,	it	is	not	
possible	to	conclude	that	all	relevant	themes	were	identified.	
Interpretation	&	comparison	with	existing	literature	
To	our	knowledge,	this	is	the	first	in-depth	interview	study	reporting	participants’	
perceptions	of	a	mobile	phone-based	intervention	to	support	contraception	use	
alongside	a	randomised	controlled	trial,	although	participants	were	asked	questions	
regarding	their	satisfaction	in	two	RCTs	of	oral	contraceptive	adherence	interventions	
in	the	USA.(142)(143)	Our	finding	that	participants	were	positive	about	the	
intervention	is	consistent	with	previous	studies	assessing	participants	experience	of	
mobile	phone-based	interventions	in	other	areas	(e.g.	HIV	medication	adherence,	
maternal	and	child	health,	sexual	health,	smoking	
cessation).(142)(143)(230)(238)(239)(240).		
Communication	via	mobile	phone	was	a	convenient	way	to	discuss	contraception	or	
health	issues,	saving	money	and	time	in	comparison	to	going	to	a	health	centre,	as	
previously	reported.(230)	Our	previous	analysis	found	that	the	proportion	of	women	
that	requested	to	speak	to	a	counsellor	(pressing	‘1’)	decreased	from	message	one	to	
six,(234)	which	is	consistent	with	reports	from	the	interviews	that	health	issues	often	
resolved	over	time.		
Our	finding	that	messages	could	be	inconvenient	and	intrusive	for	some	women	
highlights	the	limitation	of	real-time	voice	messages	as	a	delivery	mechanism,	
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contrasting	with	other	studies	of	interventions	delivered	by	mobile	phone	where	
participants	could	check	messages	at	their	convenience.(239)(134)		
It	is	unclear	if	the	voice	messages	improved	contraceptive	use.	Participants	in	other	
trials	reported	that	daily	educational	text	messages	helped	them	remember	to	take	
oral	contraceptive	or	HIV	medication.(142)(143)(230)	However,	reviews	of	trials	of	text	
messages	for	medication	adherence	show	limited	evidence.(227)(115)	In	our	
intervention,	the	reminder	to	use	contraception	appeared	to	be	related	to	providing	
general	motivation	rather	than	a	daily	prompt.		
Interview	findings	suggest	that	the	intervention	included	components	identified	as	
best	practices	for	contraception	counselling	including	developing	close	personal	
relationships,	building	trust,	and	adequate	counselling	regarding	side-effects,(241)	
which	may	not	have	been	possible	with	a	fully	automated	intervention.	It	is	not	clear	
to	what	degree	provision	of	information	about	discounted	services	influenced	uptake	
as	clients	still	had	to	pay	a	user	fee	and	incur	associated	travel	and	opportunity	costs.	
All	women	would	have	received	contraception	counselling	at	the	time	of	seeking	
abortion	services,	as	per	current	recommendations.(29)	Findings	from	this	study	
indicate	some	benefits	to	providing	on-going	support	for	women	to	reconsider	their	
contraceptive	options	and	provide	support	for	side-effects	as	they	arise.		
The	intervention	provided	additional	benefits	that	were	broader	than	the	trial	
definition	of	success	(i.e.	contraception	use).	Our	findings	resonate	with	other	
qualitative	studies	of	mHealth	interventions	that	reported	a	feeling	that	someone	
cares.(230)(240)	The	action	of	sending	messages	(‘push’)	to	participants	may	
contribute	to	this	feeling,	as	previously	reported.(242)(239)		
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Our	finding	that	women	received	support	for	management	of	physical	and	emotional	
health	issues	is	consistent	with	studies	elsewhere;	post-abortion	mobile	phone	follow	
up	was	demonstrated	to	reduce	women’s	anxiety	and	stress	in	South	Africa,(178)	and	
be	acceptable	and	preferable	to	a	clinic	visit	in	the	UK.(177)	
Although	there	were	no	reports	of	any	adverse	advents	as	a	result	of	others	listening	
to	messages,	our	interview	participants	were	mostly	married	and	more	likely	to	have	
disclosed	having	had	an	abortion	to	others.	Women	concerned	about	others	listening	
to	messages	may	have	elected	not	to	receive	the	intervention.	Phone	sharing	is	
common	in	Cambodia	and	possible	unintended	consequences	should	be	considered	
when	developing	future	intervention	content.(141)		
Other	evaluations	of	text	message	interventions	for	contraception	and	sexual	health	
have	found	that	participants	would	re-read	messages	which	might	lead	to	
conservations	with	family	or	friends.(239)(146)	Although	this	was	not	possible	with	our	
voice	messages,	some	women	reported	recommending	long-acting	contraception	or	
Marie	Stopes	services	to	other	people.	This	additional	contraception	use	was	not	
captured	with	the	trial	follow	up	but	could	be	evaluated	in	further	studies.	
Mechanism	of	action	
This	study	provides	some	insight	into	the	mechanism	by	which	the	intervention	
resulted	in	behaviour	change.	The	voice	messages	appeared	to	act	as	a	conduit	for	
additional	support	rather	than	directly	influencing	behaviour	change,	but	may	have	
promoted	engagement	in	the	intervention,	as	previously	reported.(243)	
The	majority	of	support	for	contraception	uptake	and	continuation	and	other	post-
abortion	issues	appeared	to	be	provided	by	the	counsellor	calls	rather	than	the	voice	
message.	The	counselling	addressed	intrapersonal	determinants	of	contraceptive	use,	
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in	particular	health	concerns,	as	well	as	capability,	motivation	and	opportunity	to	use	
contraception,	as	per	our	conceptual	framework.(50)(3)(100)	The	relatively	intensive	
intervention	whereby	the	counsellor	could	develop	a	relationship	with	the	woman	and	
deliver	personalised	support	over	a	short	duration	likely	influenced	uptake	of	long-
acting	methods	such	as	intrauterine	device	and	implant,	but	was	less	effective	for	
continued	adherence	to	short-acting	methods.(203)		
The	intervention	included	five	behaviour	change	techniques;	two	could	be	attributed	
to	the	voice	messages	(provide	instruction,	and	prompt	practice)	and	three	to	the	
counselling	(provide	information	about	behaviour-health	link,	provide	information	on	
consequences,	prompt	barrier	identification.(227)(104)	Findings	from	this	study	
suggest	that	another	component	of	the	counselling	was	to	provide	general	
encouragement.	In	general	the	wider	literature	suggests	that	multi-faceted,	more	
complex	interventions	are	more	likely	to	be	effective.(244)(134)(115)	
Improving	the	intervention	
Most	women	thought	the	service	should	be	offered	to	women	in	the	future	with	few	
suggestions	for	improvement.	There	was	no	evidence	that	the	intervention	effect	
varied	by	level	of	education.(234)		
Some	women	expressed	a	preference	for	direct	phone	calls	or	text	message	but	this	
appeared	to	be	due	to	timing	of	the	message	and	concern	about	missing	the	call.	Most	
women	thought	that	the	frequency	of	messages	and	duration	of	the	intervention	were	
acceptable,	although	as	with	previous	trials	of	oral	contraceptive	reminders,	some	
would	have	liked	the	intervention	to	continue;(142)(143)	perhaps	more	as	a	‘safety	
net’	to	support	general	health.	
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Our	intervention	increased	effective	contraception	use	at	four-months,	soon	after	the	
intervention	had	ended,	but	an	effect	was	not	demonstrated	at	12	months	partly	due	
to	the	trial	not	being	powered	for	the	outcome	at	12	months	and	increased	attrition	at	
12	months.	A	previous	trial	of	text	message	reminders	for	OC	adherence	found	the	
intervention	effect	was	greater	whilst	the	intervention	was	on-going	rather	than	after	
the	intervention	ended.(142)	This	raises	the	question	of	whether	a	longer	intervention	
would	have	resulted	in	a	more	sustained	effect.	However,	evidence	that	interventions	
encouraging	medication	adherence	are	more	effective	for	short-term	rather	than	long-
term	treatments	suggests	only	modest	improvements	might	be	expected.(134)		
Implications	for	practice/research		
Findings	from	this	analysis	have	some	implications	for	practice	and	future	research.	
Our	findings	suggest	there	may	be	benefits	from	providing	this	intervention	(such	as	
increased	use	of	long-acting	methods)	but	the	long-term	effects	require	further	
evaluation.	Future	interventions	for	post-abortion	contraception	could	consider	
including	messages	to	support	comprehensive	post-abortion	care	more	broadly	and	
should	anticipate	that	women	may	have	a	range	of	issues	and	be	prepared	to	manage	
these	safely.	The	intervention	could	be	adapted	for	use	on	smart	phones	and	could	
utilise	password	protected	voice	or	text	messages	that	are	retained	on	the	participants	
phone.	This	might	improve	the	response	to	messages	and	facilitate	sharing	of	
intervention	content	with	others.	We	recommend	that	mobile	phone-based	
interventions	for	on-going	support	for	PAFP	should	be	integrated	with	counselling	at	
the	time	of	seeking	services.	Operational	research	could	examine	clients’	actual	
willingness	to	pay	for	such	interventions,	and	the	effect	of	varying	the	duration	of	the	
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intervention.	Further	adequately	powered	trials	of	mobile	phone-based	interventions	
to	support	contraception	use	are	needed.	
Conclusions	
The	majority	of	women	were	positive	about	the	mobile	phone-based	intervention	
which	provided	support	for	contraception	use	as	well	as	additional	physical	and	
emotional	issues.	The	study	provides	some	insights	into	the	possible	mechanism	of	
action	and	considers	how	the	intervention	could	be	improved.	
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8.	Discussion	and	conclusions	
Findings	from	each	research	component	of	this	thesis	have	been	discussed	in	each	of	
the	papers	in	Chapters	2-7.	The	discussion	section	of	each	of	the	papers	presenting	
research	findings	are	presented	according	to	the	author	guidelines	for	the	particular	
journal.	This	final	chapter	summarises	the	principal	findings,	presents	overall	strengths	
and	limitations	of	the	thesis,	synthesises	the	overall	study	findings	in	related	to	the	
original	conceptual	framework	and	existing	literature,	presents	an	updated	conceptual	
framework,	and	discusses	implications	for	future	research	and	practice.		
8.1	Principal	findings	
Findings	from	this	thesis	suggest	that	interventions	delivered	by	mobile	phone	can	
increase	contraception	use,	but	the	evidence	to	date	is	mixed.	The	first	objective	of	the	
thesis	was	to	conduct	a	systematic	review.	Five	trials	were	identified,	two	of	which	
increased	self-reported	contraception	use	(Chapter	2);	one	of	which	was	four-month	
data	from	the	MOTIF	trial.	However,	the	three	trials	that	did	not	report	an	effect	were	
small	and	potentially	underpowered.	A	meta-analysis	was	not	possible	due	to	differing	
interventions	and	outcome	measures,	with	insufficient	evidence	to	recommend	
particular	intervention	content	or	mode	of	communication.	The	trials	reporting	
increased	contraceptive	use	were	more	complex;	one	involving	a	range	of	educational	
text	messages	and	the	MObile	Technology	for	Improved	Family	Planning	(MOTIF)	trial	
comprising	interactive	voice	messages	with	counsellor	support.	However,	the	effect	of	
the	interventions	appeared	to	diminish	over	time.	Data	on	cost-effectiveness	was	
lacking.		
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Subsequent	to	conducting	the	systematic	review,	in	addition	to	the	12-month	MOTIF	
trial	follow	up,	only	one	of	the	previously	identified	ongoing	trials	has	reported	results;	
the	m4RH	evaluation	(see	Section	2.8).	However	this	trial	had	several	limitations	and	it	
is	unlikely	that	this	would	have	changed	the	conclusion	of	the	systematic	review.		
The	second	objective	of	the	thesis	was	to	develop	an	intervention	delivered	by	mobile	
phone	to	support	post-abortion	contraceptive	use	in	Cambodia.	In	developing	the	
conceptual	framework	and	intervention	it	was	hypothesised	that	a	multi-faceted	
intervention	delivered	by	mobile	phone	would	remind	clients	about	contraceptive	
methods,	identify	problems	with	side-effects	early,	provide	support,	and	boost	
motivation	to	use	PAFP,	while	reducing	discontinuation	and	unsafe	method	switching	
(Chapter	3).		
The	third	objective	of	the	thesis	was	to	evaluate	the	intervention	with	a	randomised	
controlled	trial.	The	study	protocol	and	update	describe	the	study	design	and	analysis	
plans	(Chapter	4).	The	intervention	was	associated	with	increased	self-reported	use	of	
effective	contraception	at	four	months	post-abortion	(64%	vs.	46%;	RR	1·39,	95%	CI	
1·17-1·66;	p<0·001),	but	not	at	12	months	(50%	vs.	43%;	RR	1.16,	95%	CI	0.92-1.47;	
p=0.208)	(Chapter	5).	The	intervention	was	associated	with	increased	self-reported	use	
of	long-acting	contraception	(IUD,	implant	or	permanent	method)	at	four	and	12	
months.	The	intervention	was	associated	with	increased	effective	contraceptive	use	
for	>80%	of	the	follow	up	period	at	four	and	12	months.	There	was	some	evidence	of	
reduced	discontinuation	of	effective	contraception	at	four,	but	not	12	months.	The	
intervention	had	no	significant	effect	on	the	repeat	pregnancy	or	abortion	rate.	There	
were	no	reports	of	adverse	effects.	
The	fourth	object	of	the	thesis	was	to	conduct	a	mixed	methods	process	evaluation.	
	
	
276	
Around	half	of	the	women	that	received	the	intervention	actively	requested	to	speak	
to	a	counsellor	(pressed	‘1’)	and	over	90%	spoke	to	a	counsellor	at	some	stage	
(Chapter	6).	Women	who	spoke	to	the	counsellor	having	requested	to	(by	pressing	‘1’)	
were	more	than	four	times	as	likely	to	be	using	effective	contraception	at	four	months	
compared	to	women	who	didn’t	request	or	speak	to	the	counsellor.	There	was	a	small,	
non-statistically	significant	increase	in	contraception	use	amongst	women	that	spoke	
to	the	counsellor	without	requesting	a	call.	Increased	parity,	a	history	of	>2	previous	
induced	abortions,	lower	socio-economic	status,	and	medical	abortion	were	associated	
with	requesting	to	speak	to	a	counsellor	(pressing	‘1’)	after	adjusting	for	age,	socio-
economic	status	and	residence.		
The	majority	of	women	were	positive	about	the	intervention	and	reported	it	to	be	a	
convenient	way	to	ask	questions	or	get	advice	without	going	to	a	health	centre	
(Chapter	7).	Women	reported	that	the	intervention,	in	particular	phone	counselling,	
supported	contraception	use	by	provision	of	information,	encouragement,	reminders	
to	return	to	clinic,	reassurance	and	advice	for	problems	and	had	a	positive	effect	on	
contraceptive	uptake	and	continuation	as	well	as	supporting	post-abortion	care	more	
broadly.	
8.2	Strengths	and	limitations		
The	strengths	and	limitations	of	each	of	the	research	components	are	discussed	in	
each	chapter.	In	this	section	I	will	discuss	and	expand	on	some	of	the	main	strengths	
and	weaknesses.		
Overall	strengths	
The	thesis	has	some	overall	strengths.	First,	to	my	knowledge,	this	was	the	first	trial	of	
an	intervention	delivered	by	mobile	phone	to	support	PAFP.	The	systematic	reviews	in	
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Chapters	1	and	2	identified	few	studies	of	interventions	delivered	by	mobile	phone	for	
contraception,	with	the	majority	in	high-income	settings.	Therefore	a	strength	was	
that	this	study	was	conducted	in	a	low-income	setting	where	consequences	of	unmet	
need	for	contraception	and	unsafe	abortion	are	greater,	and	hence	interventions	have	
significant	potential	public	health	benefits.	This	study	is	also	unusual	in	that	it	used	
voice	messages	rather	than	text	messages,	as	is	the	case	in	most	other	trials.	An	
additional	strength	concerns	the	completeness	and	transparency	of	reporting.	The	
intervention	development	(including	conceptual	framework)	was	fully	described.	The	
trial	protocol	was	published	setting	out	the	methods	and	changes	to	the	analysis	plan	
were	published.		
Strengths	of	the	Cochrane	systematic	review	
The	systematic	review	in	Chapter	2	was	rigorous	and	involved	an	extensive	search	
strategy	and	all	the	elements	that	are	required	for	a	Cochrane	review	including	data	
extraction	on	outcomes,	double	assessment	of	bias	and	assessment	of	quality.	In	
addition,	the	interventions	were	coded	according	to	their	behaviour	change	
techniques.	As	a	result	of	conducting	rigorous	systematic	review	searches	we	were	
confident	that	we	were	not	repeating	a	trial	already	undertaken.	
Strengths	of	the	intervention	development	
As	discussed	in	Chapter	3,	a	strength	of	the	intervention	was	that	it	was	developed	
with	significant	input	from	services	providers	and	service	users	in	Cambodia,	and	it	
also	considered	relevant	literature	on	theory	of	behaviour	and	behaviour	change.	As	
such	it	was	possible	to	gain	an	understanding	of	what	types	of	interventions	had	been	
successful,	and	avoid	repeating	mistakes	of	unsuccessful	projects.	Thus,	the	
intervention	was	delivered	to	both	users	and	non-users	of	contraception	on	a	range	of	
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contraceptive	methods	in	contrast	to	previous	mHealth	contraception	interventions	
focusing	on	one	particular	method,	often	the	oral	contraceptive.	Therefore	as	well	as	
proving	support	for	side-effects	to	reduce	discontinuation,	the	intervention	supported	
safe-method	switching.	The	finding	that	text	messages	were	unlikely	to	be	successful	
was	a	key	finding	from	the	formative	research	which	led	to	the	development	of	a	
voice-based	intervention.		
Strengths	of	the	trial	
The	trial	was	assessed	for	quality	of	evidence	and	risk	of	bias	in	Chapter	2,	and	further	
discussed	in	Chapter	5.	Overall,	the	quality	of	evidence	for	the	MOTIF	trial	using	the	
GRADE	approach	was	considered	high	and	not	downgraded	across	any	domains	(Table	
8).	Additional	strengths	were	that	the	statistical	analysis	plan	was	sealed	prior	to	
commencing	data	analysis	and	all	analyses	were	carried	out	on	an	intention-to-treat	
basis.	
In	terms	of	bias,	the	trial	was	at	low	risk	of	selection	bias	with	adequate	procedures	to	
ensure	random	sequence	generation	and	allocation	concealment;	allocation	was	
concealed	to	clinicians	and	RAs	working	on	the	trial.	The	trial	was	a	low	risk	of	
detection	bias	as	researchers	undertaking	data	collection	and	analysis	were	masked	to	
treatment	allocation.	The	possibility	of	social	desirability	or	recall	bias	is	discussed	in	
the	limitations	section.	The	follow	up	rate	at	four	months	was	high	and	there	was	no	
evidence	of	any	difference	in	loss	to	follow-up	between	the	treatment	groups	(Table	
18)	and	therefore	the	trial	was	a	low	risk	of	attrition	bias.	Few	trials	of	post-abortion	
family	planning	have	a	longer	observation	period	than	this	study.(93)	However,	we	
only	achieved	66%	follow	up	at	12	months;	this	will	be	discussed	in	the	limitations	
section.	
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Strengths	of	the	process	evaluation	
A	strength	of	the	process	evaluation	study	was	that	it	included	quantitative	and	
qualitative	components.	As	discussed	in	Chapter	6,	the	use	of	prospectively	collected	
quantitative	data	on	participant	characteristics	and	response	to	the	intervention	
provided	some	insight	into	the	active	components	of	the	intervention.	As	discussed	in	
Chapter	7,	the	interview	study	provided	additional	insights	to	the	intervention	gained	
by	in-depth	interviews	with	women.		
Overall	limitations	
This	thesis	is	subject	to	several	overall	limitations.	An	overall	limitation	concerns	the	
generalisability	of	this	study.	Although	the	study	population	appeared	to	be	
representative	of	MSI	clients	seeking	abortion	services	in	Cambodia	during	2013	
(section	5.6),	the	findings	might	not	be	applicable	to	other	settings.		
Limitations	of	the	literature	review	
The	literature	review	undertaken	for	my	PhD	upgrade	was	conducted	by	myself	and	
therefore	cannot	be	considered	a	systematic	review.	Furthermore,	due	to	time	
limitations	the	search	strategy	only	included	four	electronic	databases,	and	did	not	
search	clinical	trial	registries.	However,	the	Cochrane	review	did	fulfil	the	criteria	for	a	
systematic	review,	with	a	wider	search	strategy	and	a	second	review	author	to	screen	
and	extract	data.	
In	both	the	literature	review	in	Chapter	1	and	the	systematic	review	in	Chapter	2,	
studies	were	excluded	in	which	mobile	phones	were	used	for	two-way	voice	
communication	alone.	However,	some	of	the	excluded	studies	were	recent	and	utilised	
mobile	phones	for	voice	calls	alone,	such	as	the	Kirby	study	mentioned	in	the	
background	section	of	Chapter	4.(174)	By	only	including	interventions	delivered	by	
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mobile	phone	that	included	some	degree	of	automation,	such	as	text	message	or	
mobile	application,	the	literature	reviews	were	probably	more	focussed.	However	
future	reviews	should	consider	inclusion	of	studies	using	mobile	phones	more	broadly.	
Furthermore,	the	literature	reviews	did	not	include	all	of	the	non-trial	mobile	phone-
based	contraception	initiatives	that	have	been	launched	in	low-income	settings	such	as	
Mobile	for	Reproductive	Health	(m4RH),	Cycle	Tel,	Mobile	Alliance	for	Maternal	Action	
(MAMA).(146)(149)(147)	In	addition	to	systematic	reviews	of	trials	of	interventions	
delivered	by	mobile	phone	for	contraception,	a	review	of	non-trial	evidence	might	be	
useful.		
Limitations	of	the	intervention	development	
As	discussed	in	Chapter	3,	a	limitation	of	the	formative	research	is	that	analysis	of	the	
interviews	and	FGDs	was	not	undertaken	by	a	second	coder.	Furthermore,	I	could	have	
reviewed	each	aspect	of	the	literature	more	systematically.	Time	and	resource	
constraints	limited	the	time	I	could	spend	on	the	intervention	development.	
An	additional	limitation	of	the	intervention	development	paper	and	subsequent	
papers	is	that	beyond	describing	the	message	content,	context	and	software	
programme	used	to	send	messages,	there	is	limited	description	of	the	technical	
features	of	the	intervention	that	could	aid	replication	of	the	intervention	elsewhere.	
Subsequent	to	the	publication	of	the	intervention	development	paper,	the	World	
Health	Organization	mHealth	Technical	Evidence	Review	Group	(mTERG)	published	a	
proposed	mHealth	Evidence	Reporting	and	Assessment	(mERA)	checklist	to	improve	
reporting	of	mHealth	interventions.(245)	To	address	this	limitation,	the	MOTIF	
intervention	is	described	according	to	the	16	items	in	the	mERA	checklist	in	Table	33.	
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Table	33:	Reporting	of	the	MOTIF	intervention	according	to	the	mERA	checklist	
Criteria	 Item	
no	
Criteria	 Notes	
Infrastructure	
(population	
level)	
1	 Clearly	presents	the	availability	of	
infrastructure	to	support	technology	
operations	in	the	study	location.	This	
refers	to	physical	infrastructure	such	
as	electricity,	access	to	power,	
connectivity	etc.	in	the	local	context.	
Reporting	X%	network	coverage	rate	
in	the	country	is	insufficient	if	the	
study	is	not	being	conducted	at	the	
country	level	
The	intervention	was	delivered	to	
participants’	mobile	phones	meaning	
that	only	intermittent	access	to	
electricity/power	was	required	to	
charge	the	devices.	Electricity	was	
generally	reliable	at	the	site	of	
intervention	delivery,	with	a	back-up	
generator	available	if	required.	
Network	coverage	rate	in	the	specific	
areas	was	not	explicitly	stated.		
Technology	
platform	
2	 Describes	and	provides	justification	
for	the	technology	architecture.	This	
includes	a	description	of	software	
and	hardware	and	details	of	any	
modifications	made	to	publicly	
available	software	
Based	on	user	feedback	(see	Item	7)	
we	required	voice	message	software.	
The	only	two	options	we	were	aware	
of	were	FreedomFone	
(http://www.freedomfone.org/)	and	
Verboice	
(https://verboice.instedd.org/).		
Verboice	had	better	functionality	for	
sending	interactive	messages	and	
InSTEDD	had	a	support	office	in	
Phnom	Penh.	The	web-based	software	
was	connected	to	an	analogue	
modem	in	the	InSTEDD	office.			
Interoperability	
/	Health	
information	
systems	(HIS)	
context	
3	 Describes	how	mHealth	intervention	
can	integrate	into	existing	health	
information	systems.	Refers	to	
whether	the	potential	of	technical	
and	structural	integration	into	
existing	HIS	or	programme	has	been	
described	irrespective	of	whether	
such	integration	has	been	achieved	
by	the	existing	system	
The	Verboice	voice	messaging	system	
was	not	integrated	with	any	existing	
health	information	systems,	and	could	
be	considered	a	closed	system	at	
Marie	Stopes	International	Cambodia.	
Reporting	was	as	per	the	trial	and	
process	evaluation.	Further	
interoperability	could	be	considered	in	
the	future.		
Intervention	
delivery	
4	 The	delivery	of	the	mHealth	
intervention	is	clearly	described.	
This	should	include	frequency	of	
mobile	communication,	mode	of	
delivery	of	intervention	(that	is,	
SMS,	face	to	face,	interactive	voice	
response),	timing	and	duration	over	
which	delivery	occurred	
The	frequency/duration	of	messages	
(six	messages;	one	message	every	two	
weeks)	and	mode	of	delivery	
(interactive	voice	messages	with	
phone	call	depending	on	response	to	
message)	is	described	in	sections	3.4,	
4.3	and	5.3	
Intervention	
content	
5	 Details	of	the	content	of	the	
intervention	are	described.	Source	
and	any	modifications	of	the	
intervention	content	is	described	
The	content	of	the	voice	message	and	
aim	of	the	counselling	is	described	in	
sections	3.4,	4.3	and	5.3.	See	the	
counselling	guide	in	Appendix	6	for	
additional	details	of	the	phone	
counselling	content	
Usability	/	
content	testing	
6	 Describe	formative	research	and/or	
content	and/or	usability	testing	with	
target	group(s)	clearly	identified,	as	
appropriate	
The	formative	research	to	develop	the	
intervention	including	participant	
input	in	the	content	of	messages	and	
usability	testing	is	described	in	the	
intervention	development	paper	
(Chapter	3)	
User	feedback	 7	 Describes	user	feedback	about	the	 User	feedback	through	interviews	or	
	
	
282	
intervention	or	user	satisfaction	with	
the	intervention.	User	feedback	
could	include	user	opinions	about	
content	or	user	interface,	their	
perceptions	about	usability,	access,	
connectivity,	etc.	
focus	groups	was	used	as	part	of	
formative	research	to	develop	the	
intervention	(Chapter	3)	as	well	as	to	
assess	women’s	views	and	
experiences	of	receiving	the	
intervention	(Chapter	7).	
Access	of	
individual	
participants	
8	 Mentions	barriers	or	facilitators	to	
the	adoption	of	the	intervention	
among	study	participants.	Relates	to	
individual-level	structural,	economic	
and	social	barriers	or	facilitators	to	
access	such	as	affordability,	and	
other	factors	that	may	limit	a	user’s	
ability	to	adopt	the	intervention	
Participants	needed	to	have	a	mobile	
phone	to	receive	the	intervention	but	
affordability	was	less	of	issue	as	there	
was	no	cost	to	receive	or	respond	to	
messages.	Women	in	whom	abortion	
might	be	more	stigmatised	(e.g.	single	
women,	students)	may	be	less	likely	to	
adopt	the	intervention	due	to	
concerns	about	privacy	and	
confidentiality.	
Cost	
assessment	
9	 Presents	basic	costs	assessment	of	
the	mHealth	intervention	from	
varying	perspectives.	This	criterion	
broadly	refers	to	the	reporting	of	
some	cost	considerations	for	the	
mHealth	intervention	in	lieu	of	a	full	
economic	analysis.	If	a	formal	
economic	evaluation	has	been	
undertaken,	it	should	be	mentioned	
with	appropriate	references.	
Separate	reporting	criterion	are	
available	to	guide	economic	
reporting	
For	the	trial	results	paper	(section	5.5)	
we	estimated	the	main	cost	of	
delivering	the	intervention	(i.e.	voice	
messages,	phone	calls	and	counsellor	
time)	to	be	$6	per	participant.	A	cost-
effectiveness	analysis	is	being	
undertaken	and	will	be	reported	
elsewhere.	Verboice	is	open-source	
and	free	to	use,	but	organisations	with	
limited	technical	capacity	are	likely	to	
require	additional	expertise/support	
to	connect	Verboice	to	a	modem	to	be	
able	to	schedule	and	send	messages.	
Adoption	inputs	
/	programme	
entry	
10	 Describes	how	people	are	informed	
about	the	programme	including	
training,	if	relevant.	Includes	
description	of	promotional	activities	
and/or	training	required	to	
implement	the	mHealth	solution	
among	the	user	population	of	
interest	
During	the	trial,	potential	participants	
were	identified	by	service	providers	
and	information	about	the	
programme	was	provided	by	research	
assistants.	In	a	non-trial	
implementation	setting,	clinic	staff	
such	as	receptionist	or	service	
providers	would	need	to	provide	
information	about	the	programme,	
but	more	detailed	information	could	
be	provided	by	phone	counsellors		
Limitations	for	
delivery	at	scale	
11	 Clearly	presents	mHealth	solution	
limitations	for	delivery	at	scale	
The	analogue	modem	used	in	the	trial	
could	only	handle	one	message	at	a	
time.	Due	to	the	numbers	of	
participants	it	was	possible	to	
schedule	messages	one	at	a	time.	To	
deliver	the	intervention	at	scale	it	
should	be	possible	to	use	a	digital	
modem	capable	of	sending	multiple	
messages	simultaneously.	Additional	
limitations	to	scale	would	be	the	need	
to	have	additional	counsellors	and	
provide	training	to	clinic	staff	to	
recruit	participants	to	receive	the	
intervention.	
Contextual	
adaptability	
12	 Describes	the	adaptation,	or	not,	of	
the	solution	to	a	different	language,	
different	population	or	context.	Any	
For	our	study	population,	voice	
messages	in	the	Khmer	language	were	
required	due	to	limited	literacy	and	
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tailoring	or	modification	of	the	
intervention	that	resulted	from	pilot	
testing/usability	assessment	is	
described	
inability	to	text	in	Khmer	language.	
Participants	requested	that	the	terms	
‘contraception’	and	‘Marie	Stopes’	
were	used.	The	intervention	might	
require	adaptation	in	terms	of	mode	
of	delivery	and	terminology	in	other	
settings.		
Replicability	 13	 Detailed	intervention	to	support	
replicability.	Clearly	presents	the	
source	code/screenshots/	
flowcharts	of	the	algorithms	or	
examples	of	messages	to	support	
replicability	of	the	mHealth	solution	
in	another	setting	
The	content	of	the	voice	message	and	
aim	of	the	counselling	is	described	in	
sections	3.4,	4.3	and	5.3.	The	basic	
flowchart	for	the	interactive	voice	
message	is	shown	here.		
	
Data	security	 14	 Describes	the	data	security	
procedures/	confidentiality	
protocols	
The	Verboice	system	was	password	
protected	and	the	password	was	
changed	every	two	weeks.	No	client	
information	was	stored	on	the	
Verboice	system	apart	from	the	phone	
number	required	to	send	messages.	A	
password	protected	excel	form	was	
used	to	store	data	from	the	trial.	
Compliance	
with	national	
guidelines	or	
regulatory	
statutes	
15	 Mechanism	used	to	assure	that	
content	or	other	
guidance/information	provided	by	
the	intervention	is	in	alignment	with	
existing	national/regulatory	
guidelines	and	is	described	
The	counsellors	were	trained	
Cambodian	midwives	and	information	
provided	was	in	line	with	Cambodia	
Ministry	of	Health	guidance.	The	
intervention	was	discussed	with	the	
Reproductive	Health	National	
Programme	Manager	in	Cambodia	
and	local	ethical	approval	was	granted		
Fidelity	of	the	
intervention	
16	 Was	the	intervention	delivered	as	
planned?	Describe	the	strategies	
employed	to	assess	the	fidelity	of	
the	intervention.	This	may	include	
assessment	of	participant	
engagement,	use	of	backend	data	to	
track	message	delivery	and	other	
technological	challenges	in	the	
delivery	of	the	intervention	
There	were	no	major	issues	and	the	
intervention	was	broadly	delivered	as	
planned.	On	one	occasion	the	
Verboice	server	was	down,	but	this	
was	rectified	quickly	(within	24	hours)	
and	there	was	no	significant	
disruption	to	message	scheduling.	
The	process	evaluation	revealed	that	
there	was	often	no	response	to	the	
messages	(Section	6.4).	The	is	likely	
because	the	voice	message	was	live	
(i.e.	requiring	an	immediate	response)	
but	another	possible	reason	is	that	
due	to	the	analogue	modem	the	voice	
message	started	to	play	immediately	
after	being	sent.	This	meant	that	we	
had	to	create	a	30	second	countdown	
to	playing	the	message	in	case	the	
participant	did	not	pick	up	the	phone	
immediately.		
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This	additional	reporting	may	be	of	use	to	organisations	considering	implementing	
similar	interventions	and	use	of	the	mERA	checklist	should	be	considered	when	
describing	future	interventions.		
Limitations	of	the	trial	
The	trial	had	several	limitations	that	have	been	discussed	in	Chapters	2	and	5.		
The	first	limitation	pertains	to	the	sample	size	and	study	power	to	assess	longer-term	
trial	outcomes.	The	trial	with	500	participants	was	powered	to	detect	a	13%	
improvement	in	the	primary	outcome,	effective	contraception	use.	At	four	months	we	
achieved	86%	follow	up	and	there	was	an	18%	improvement	in	contraception	use	(64	
vs.	46%)	and	a	statistically	significant	effect	was	observed.	However,	at	12	months	
follow-up	was	66%	with	just	a	7%	improvement	in	use	of	effective	contraception	(50%	
vs.	43%)	and	hence	no	statistically	significant	effect	was	observed.	There	was	no	
evidence	of	differential	loss	to	follow-up	and	there	was	no	significant	change	in	the	
principal	findings	when	we	estimated	the	effect	of	the	intervention	on	the	primary	
outcome	at	12	months	using	multiple	imputation	(section	5.8).	Increased	attrition	at	
12	months	was	probably	due	to	participants	migrating	for	work	and/or	changing	
phone	numbers,	which	is	recognised	as	a	challenge	for	mobile	phone-based	
interventions	in	Cambodia.(141)	As	discussed	in	section	5.8,	future	trials	aiming	to	
assess	longer-term	outcomes	or	with	younger	participants	or	those	of	lower	socio-
economic	status	may	require	larger	sample	sizes	and	use	of	multiple	imputation	
methods	to	assess	outcomes.			
In	terms	of	bias,	the	trial	was	at	high	risk	of	performance	bias	as	the	outcome	may	
have	been	influenced	by	lack	of	blinding.	The	trial	had	a	high	risk	of	social	desirability	
and	recall	bias	due	to	self-report	measures	of	contraception	use.	For	the	trial,	we	did	
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not	consider	it	feasible	to	measure	objective	contraception	use,	for	example	using	
biomarkers	or	with	electronic	medication	monitors,	for	several	reasons	as	discussed	in	
Chapter	5.	Therefore	assessment	of	the	primary	outcome,	use	of	effective	
contraception	was	self-report	by	phone	call.	Self-report	measures	showed	fair/good	
reliability	when	comparing	the	four	and	12-month	data,	and	the	objective	
measurement	validity	study	did	not	identify	any	cases	of	misclassification.	However,	
the	method	for	verifying	self-reported	OC	use	by	pill	counts	was	also	prone	to	
detection	bias.	Although	self-reported	data	on	contraception	use	are	considered	less	
reliable,	and	prone	to	the	aforementioned	biases,	it	is	the	standard	approach	for	
contraception	research	and	provided	data	comparable	to	previous	studies.(189)(188)	
An	additional	limitation	is	that	the	method	to	restrict	randomisation	to	balance	
prognostic	factors	across	treatment	groups	was	poorly	described	in	trial	protocol,	
statistical	analysis	plan	and	results	paper.	It	was	incorrectly	stated	that	we	stratified	
participants	according	to	urban	or	rural	clinic	status.	In	fact,	minimisation	was	used.	To	
clarify,	stratification	involves	grouping	participants	into	strata	defined	by	baseline	
characteristics	and	performing	block	randomisation	within	each	stratum	whereas	with	
minimisation	participants	are	not	grouped	into	different	strata.	With	minimisation,	for	
each	new	participant	entering	a	trial,	the	baseline	characteristics	of	participants	in	the	
treatment	groups	are	summarised	and	the	participant	is	allocated	to	the	group	that	
would	provide	the	best	marginal	balance	in	terms	of	prognostic	factors.(246)(247)	
As	balanced	randomisation	introduces	correlation	between	treatment	groups,	
violating	the	statistical	assumption	that	all	participants	are	independent,	it	has	been	
recommended	that	variables	used	in	the	randomisation	process	should	subsequently	
be	adjusted	for	in	the	analysis.	However,	the	extent	to	which	that	occurs	or	is	
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discussed	is	variable.(248)	Unadjusted	analyses	after	stratification	or	minimisation	can	
lead	to	confidence	intervals	that	are	too	wide,	p	values	that	are	too	large,	and	a	
reduction	in	power	resulting	in	results	that	are	likely	to	be	overly	conservative	with	
less	chance	of	a	false	positive	result	or	type	1	error.	This	is	likely	to	be	issue	if	the	
balancing	factor	is	associated	with	the	outcome	and	whilst	unlikely	to	affect	trials	that	
show	a	large	treatment	effect,	could	affect	interpretations	where	there	is	moderate	
evidence.	It	has	been	argued	therefore	that	adjusting	for	balancing	factors	in	the	
analysis	is	necessary	to	obtain	correct	P	values	and	avoid	a	loss	in	power	i.e.	to	show	a	
statistically	significant	result	if	one	exists.	Furthermore,	rather	than	undertaking	
exploratory	analyses	to	determine	if	the	selected	balancing	factors	are	associated	with	
the	outcome,	trial	protocols	and	statistical	analysis	plans	should	pre-specify	that	all	
balancing	factors	are	adjusted	for	the	in	the	analysis.(248)		
Although	not	described	in	the	trial	protocol	or	results	paper,	the	reason	that	we	did	
not	undertake	simple	randomisation	was	due	to	concern	that	this	could	result	in	a	
chance	imbalance	in	participants	reporting	to	live	in	urban	or	rural	residence,	a	
suspected	important	prognostic	factor	that	could	be	associated	with	the	outcome	as	
distance	to	access	services	could	affect	uptake	of	contraception	services.	Therefore	
participants	were	allocated	to	the	intervention	or	control	group	using	minimisation	by	
self-reported	urban	or	rural	residence.	However,	there	was	no	discussion	in	the	trial	
protocol	or	results	regarding	whether	the	minimisation	variables	analysis	should	be	
adjusted	for	in	the	analysis.	This	raises	the	question	of	whether	an	adjusted	analysis	
should	have	been	undertaken	to	take	into	account	that	we	used	minimisation	to	
balance	urban/rural	residence	across	treatment	groups.	Based	on	the	literature	
summarised	above,	strong	consideration	should	have	been	given	to	pre-specifying	that	
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urban/rural	status	should	have	been	adjusted	for	in	the	analysis.	However,	it	is	unclear	
that	an	adjusted	analysis	would	have	resulted	in	a	significant	change	to	the	principal	
findings	which	if	anything	were	likely	to	be	overly	conservative,	particularly	the	
statistically	significant	effect	observed	at	four-months.	Furthermore,	we	only	
minimised	for	one	variable	and	it	has	been	reported	that	minimisation	balances	
baseline	variables	marginally.(249)	Careful	consideration	with	regards	to	balancing	
prognostic	factors	across	treatment	groups	and	subsequent	analysis	is	required	for	
future	trials.	
Limitations	of	the	process	evaluation	
As	discussed	in	Chapter	6,	the	main	limitation	affecting	the	logistic	regression	analysis	
was	the	relatively	small	sample	size,	particularly	in	some	of	the	subgroups,	resulting	in	
lack	of	statistical	power	to	detect	differences.	Furthermore,	it	was	not	possible	to	
adequately	evaluate	the	effect	of	the	pill	or	injection	reminders	as	they	were	sent	to	a	
relatively	small	number	of	women,	without	a	control	group.	
As	discussed	in	Chapter	7,	the	process	evaluation	interviews	were	subject	to	social	
desirability	bias.	Additionally	it	is	possible	that	women	would	have	been	more	likely	to	
agree	to	be	interviewed	if	they	had	had	a	positive	experience	of	the	intervention.	Most	
of	the	women	interviewed	were	using	a	contraceptive	method	and,	as	in	the	trial,	
most	of	the	women	interviewed	were	married,	and	single	women	and	entertainment	
workers	were	under-represented.(203)	It	was	not	possible	to	improve	reliability	of	
language	transcription	by	getting	sections	translated	by	an	independent	translator	due	
to	resource	limitations.			
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Differences	between	women	seeking	medical	vs.	surgical	abortion	
An	additional	potential	limitation	of	this	thesis	is	that	potential	differences	between	
women	seeking	medical	versus	surgical	abortion	were	given	little	consideration	during	
the	intervention	development.	It	is	possible	that	there	are	differences	in	baseline	
characteristics	and	post-abortion	family	planning	intentions	in	women	who	opt	for	a	
medical	abortion	compared	to	a	surgical	abortion.	In	the	subgroup	analysis	in	Figure	
49,	there	was	no	evidence	of	heterogeneity	(i.e.	that	the	effect	of	the	intervention	
varied	amongst	women	having	either	a	medical	or	surgical	abortion).	It	is	safe	to	use	a	
full	range	of	contraceptive	methods	apart	from	the	intra-uterine	device	on	the	day	of	
medical	(misoprostol)	treatment	and	therefore	the	content	of	the	counselling	in	terms	
of	contraception	advice	could	have	been	similar	whether	women	had	medical	or	
surgical	abortion.	
Medical	compared	to	surgical	abortion	was	associated	with	increased	odds	of	
requesting	to	speak	to	the	counsellor	(adjusted	OR	1.77;	95%	CI:	1.03-3.07)	after	
adjusting	for	the	confounding	variables	which	may	have	been	related	to	seeking	
support	regarding	managing	their	symptoms	at	home,	i.e.	broader	post-abortion	care.	
An	additional	analysis	of	the	trial	dataset	assessing	differences	in	contraception	use	
and	subsequent	pregnancies	and	abortions	comparing	women	who	had	medical	
compared	to	surgical	abortion	could	be	useful	to	aid	future	intervention	design.		
Lack	of	cost	data	
A	final	important	overall	limitation	of	this	thesis	is	that	it	does	not	include	a	cost-
effectiveness	analysis.	As	mentioned	in	Chapter	5,	the	main	cost	of	delivering	the	
intervention	(i.e.	for	voice	messages,	phone	calls	and	the	counsellors’	time)	was	
estimated	to	be	6	United	States	dollars	per	client.	This	was	based	on,	as	yet	
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unpublished,	data	collected	during	the	intervention	on	voice	message,	phone	call	and	
human	resource	costs.		
A	cost-effectiveness	analysis	of	the	MOTIF	intervention	is	currently	being	undertaken	
and	will	be	published	separately.	It	will	assess	the	cost-effectiveness	of	mobile	phone-
based	support	in	addition	to	standard	care	versus	standard	care	alone	by	calculating	
the	incremental	cost	effectiveness	ratio	(ICER)	under	different	scenarios,	where	Cm	is	
the	mean	cost	of	the	MOTIF	intervention	alongside	standard	care,	Cs	is	the	mean	cost	
of	standard	care,	Em	is	the	mean	effect	of	MOTIF	being	available	alongside	standard	
care	and	Es	is	the	mean	effect	of	standard	care.	The	main	measure	of	effect	will	be	
Couple	Year	of	Protection	(CYP),	a	commonly	used	measure	of	family	planning	
performance	that	equates	to	one	year	of	contraceptive	protection	per	couple.	CYP	is	
calculated	by	multiplying	the	number	of	clients	attending	for	services	by	corresponding	
conversion	factors	to	estimate	the	total	amount	of	contraceptive	protection	provided	
and	enables	comparison	with	other	analyses.(250)(251)	A	sensitivity	analysis	will	
consider	different	user	and	provider	perspectives	and	uncertainties	with	respect	to	
effectiveness.	More	information	on	the	cost-effectiveness	of	the	intervention	is	likely	
to	be	useful	for	service	providers	and	funders	when	considering	implementation	of	
interventions	delivered	by	mobile	phone.	
As	discussed	in	Chapter	2,	none	of	the	studies	identified	in	the	systematic	review	
included	data	on	intervention	costs,	although	we	may	have	identified	articles	if	we	had	
explicitly	searched	for	cost-effectiveness	analyses.	It	has	been	suggested	that	one	of	
the	reasons	that	many	mHealth	interventions	fail	to	continue	beyond	the	pilot	stage	is	
the	limited	data	on	cost-effectiveness	of	programmes	and	mechanisms	for	financial	
sustainability.(121)(122)(135)	For	implementing	organisations,	evidence	of	
	
	
290	
effectiveness	in	terms	of	health	outcomes	alone	is	unlikely	to	be	enough	when	
deciding	what	activities	and	interventions	to	prioritise.	The	m4RH	study	mentioned	in	
section	2.8	exploring	sustainable	cost	models	for	mHealth	at	scale	is	a	valuable	
contribution	to	the	literature,(135)	but	further	evidence	on	the	cost-effectiveness	of	
interventions	delivered	by	mobile	phone	is	required.		
8.3	Meaning	of	the	study:	possible	mechanisms	in	relation	to	other	studies	
I	will	now	discuss	the	findings	of	the	trial	and	process	evaluation	with	reference	to	the	
study	hypothesis,	conceptual	framework	(displayed	again	in	Figure	53),	and	existing	
literature.	I	will	first	consider	impact	(the	contribution	of	the	intervention	towards	
sustained	significant	change),	then	outcomes	(medium/long-term	results)	and	then	the	
mechanism	of	action	of	the	intervention.		
Impact	of	the	intervention	
The	conceptual	framework	hypothesised	that	the	intervention	would	reduce	unmet	
need	for	family	planning	and	reduce	repeat	unintended	pregnancy	and	abortion.	
Findings	from	the	trial	suggested	reduced	unmet	need	for	family	planning	as	
evidenced	by	increased	effective	contraception	use	at	four-months,	increased	self-	
reported	use	of	long-acting	contraception	(in	particular	IUD	and	implant)	at	four	and	
12	months,	and	increased	effective	contraceptive	use	for	>80%	of	the	period	at	four	
and	12	months.	However,	the	statistically	significant	increase	in	follow	up	use	of	
effective	contraception	was	not	demonstrated	at	12	months.	Reports	from	the	process	
evaluation	interviews	supported	the	trial	findings	that	the	intervention	reduced	unmet	
need	for	contraception	by	providing	information,	encouragement,	and	reassurance	
and	support	for	side	effects.		
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Figure	53:	Conceptual	framework	for	intervention	
	
The	intervention	had	no	significant	effect	on	the	repeat	pregnancy	or	abortion	rate	but	
the	trial	was	not	powered	for	these	outcomes.	A	larger	trial	might	have	detected	a	
difference	in	the	repeat	pregnancy	rate	observed	in	the	trial	(13%	intervention	vs.	18%	
control).	As	previously	discussed,	previous	studies	have	shown	that	post-abortion	use	
of	long-acting	contraception	is	associated	with	reduced	unintended	
pregnancies.(36)(37)(38)	
Outcomes	of	the	intervention	
The	conceptual	framework	hypothesised	that	the	outcomes	of	the	intervention,	
contributing	to	impact,	would	be	increased	PAFP	uptake/use	and	reduced	
discontinuation	and	unsafe	method	switching.	Findings	from	the	additional	trial	
analysis	in	section	5.6	provided	further	insights	on	contraception	use	with	regards	to	
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differences	in	uptake,	discontinuation	and	switching	over	the	post-abortion	period	
between	the	intervention	and	control	groups.	
This	analysis	suggested	the	intervention	effect	was	primarily	due	to	increased	initiation	
of	long-acting	methods	(IUD	and	implant)	whilst	receiving	the	intervention	over	the	
three-month	post-abortion	period.	The	increase	in	long-acting	method	use	was	
sustained	at	12	months	as	women	were	more	likely	to	continue	using	these	methods,	
which	is	consistent	with	existing	literature	that	short-acting	methods	have	higher	
discontinuation	rates.(16)	Increased	continuation	of	long-acting	methods	in	this	
context	might	reflect	increased	satisfaction	with	the	method,	but	also	that	the	oral	
contraceptive	and	injectable	can	be	easily	discontinued	by	the	user,	whereas	intra-
uterine	device	and	implant	require	removal	at	a	clinic.		
The	relatively	intensive	intervention	whereby	the	counsellor	could	develop	a	
relationship	with	the	woman	and	deliver	personalised	support	over	a	short	duration	
likely	influenced	uptake	of	long-acting	methods	but	was	less	effective	for	continued	
adherence	to	short-acting	methods.(203)	Other	studies	of	interventions	of	enhanced	
counselling	for	women	at	the	time	of	seeking	abortion	services	in	the	UK	and	New	
Zealand	have	also	shown	that	increases	in	long-acting	reversible	contraception	use	can	
be	achieved.(95)(252)		
In	contrast	to	the	evidence	of	increased	uptake	of	contraception,	there	was	limited	
evidence	that	the	intervention	reduced	discontinuation	or	supported	safe	method-
switching.	There	was	some	evidence	of	reduced	discontinuation	of	effective	methods	
during	the	first	four-months	(HR	0.45	(0.20-1.01)),	due	to	trends	towards	reduced	
method	specific	discontinuation	and	safe-method	switching	in	the	intervention	group.	
However,	at	12	months,	discontinuation	and	patterns	of	safe-switching	in	the	
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intervention	and	control	groups	were	more	similar.	There	was	a	trend	towards	
increased	oral	contraceptive	discontinuation	in	the	intervention	group	which	was	
difficult	to	explain.	The	trend	towards	increased	injectable	discontinuation	in	the	
control	group	at	four	and	12	months	could	reflect	concerns	about	amenorrhoea,	which	
appears	to	be	a	particular	issue	in	Cambodia,	although	there	was	no	evidence	of	this	
from	the	process	evaluation	interviews.(78)(6)	The	high	discontinuation	rates	observed	
appear	to	support	the	recommendation	by	Ali	and	Cleland	that	“the	prudent	course	of	
action	is	for	family	planning	service	providers	to	anticipate	that	substantial	minorities	
of	couples	will	cease	use	of	a	chosen	method,	usually	within	a	few	months	of	adopting	
it,	and	will	need	to	switch	promptly	to	an	alternative	if	an	unintended	pregnancy	is	to	
be	averted”.(16)	
Achieving	sustained	behaviour	change	
The	finding	that	the	intervention	effect	was	greatest	during	and	shortly	after	the	
intervention	completed,	and	less	so	when	assessed	several	months	later,	highlights	the	
challenge	of	achieving	sustained	behaviour	change.	As	Ogden	noted,	“even	though	
many	people	show	initial	changes	in	their	health-related	behaviours,	rates	of	sustained	
behaviour	change	are	poor”.(50)	This	has	been	demonstrated	in	other	healthcare	fields	
such	as	with	interventions	for	weight	loss	and	smoking	cessation	where	relapses	have	
been	observed	over	the	longer	term.(50)(253)	A	Cochrane	review	found	that	
interventions	encouraging	medication	adherence	are	more	effective	for	short-term	
rather	than	long-term	treatments.(134)	This	short-lived	behaviour	change	was	also	
observed	in	the	Castano	trial	identified	in	the	systematic	review	(Chapter	2)	where	oral	
contraceptive	continuation	was	highest	in	the	intervention	group	if	follow	up	took	
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place	while	the	intervention	was	ongoing,	compared	to	after	the	intervention	
ended.(142)		
A	study	in	2008	sought	to	explore	the	mechanisms	behind	sustained	behaviour	change	
by	conducting	qualitative	interviews	with	34	‘success	stories’	who	had	lost	weight	or	
stopped	smoking	and	maintained	the	change	for	at	least	three	years.(254)	The	results	
showed	that	in	the	majority	of	cases	sustained	behaviour	change	was	triggered	by	a	
significant	life	crisis	such	as	a	health	scare,	a	salient	milestone	(such	as	turning	30),	or	a	
relationship	break	up.	The	study	authors	proposed	that	mechanisms	underlying	longer	
term	changes	may	be	different	to	those	identified	as	central	to	changes	in	the	shorter	
term	and	recommended	further	research	to	explore	whether	a	crisis	is	necessary	for	
sustained	behaviour	change.(254)	
In	the	context	of	post-abortion	contraception,	it	is	possible	that	having	an	abortion	
represents	a	life	crisis,	an	‘epiphany’	or	a	time	to	‘see	the	light’,	leading	to	long-term	
contraception	use,	but	this	may	not	be	the	case	for	other	women.		
Successful	behaviour	change	in	the	field	of	contraception	is	likely	to	be	related	to	a	
range	of	factors,	including	those	background,	intrapersonal,	interpersonal	and	
situation	factors	proposed	by	Sheeran.(254)(52)	According	to	the	Subjective	Expected	
Utility	Theory,	the	basis	of	most	decision-making	models	introduced	in	Section	1.1,	
decision-making	around	post-abortion	contraception	is	likely	to	involve	weighing	the	
costs	and	benefits	of	contraception	use	against	those	of	a	repeat	pregnancy,	factoring	
in	the	perceived	likelihood	of	getting	pregnant.(50)	The	challenge	of	sustaining	
behaviour	change	is	particularly	relevant	for	short-acting	contraception	methods	like	
the	daily	oral	contraceptive	that	require	continued	behaviour	compared	to	long-acting	
methods	like	the	intra-uterine	device	and	could	be	explored	in	future	studies.	
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Mechanism	of	action	of	intervention	
The	mixed	methods	process	evaluation	presented	in	Chapters	6	to	7	provided	
additional	insights	into	the	mechanism	by	which	the	intervention	resulted	in	behaviour	
change	and	how	it	was	perceived	by	the	women.	The	mechanism	by	which	the	
intervention	resulted	in	behaviour	change	can	be	considered	in	terms	of	the	different	
components	of	Michie’s	scheme	for	a	simple	behaviour	ontology	introduced	in	
Chapter	1,	shown	again	here	in	Figure	54.	
Mode	of	delivery	
The	mode	of	delivery	was	interactive	voice	messages	and	counsellor	support	delivered	
by	mobile	phone.	Many	of	the	women	interviewed	reported	that	support	by	mobile	
phone	was	a	convenient	way	to	ask	questions	or	get	advice	without	going	to	a	health	
centre.	The	interactive	voice	message	appeared	to	act	as	a	conduit	for	additional	
support	rather	than	directly	influencing	behaviour	change,	but	may	have	promoted	
Figure	54:	Scheme	for	a	simple	behaviour	ontology	
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engagement	in	the	intervention.	The	review	comparing	one-way	versus	two-way	text	
messaging	discussed	in	Section	1.4	found	that	two-way	messaging	was	more	effective,	
although	the	identified	trials	also	involved	phone	counselling.(129)	Around	half	of	the	
women	that	received	the	intervention	actively	requested	to	speak	to	a	counsellor	
(pressed	‘1’)	and	those	who	spoke	to	the	counsellor	having	requested	to	(by	pressing	
‘1’)	were	more	likely	to	subsequently	use	effective	contraception	compared	to	women	
who	didn’t	request	or	speak	to	the	counsellor.		
The	majority	of	support	for	contraception	use	and	other	post-abortion	issues	appeared	
to	be	provided	by	the	counsellor	calls	rather	than	the	voice	message.		
There	was	evidence	from	interviews	that	the	counselling	provided	support	for	
intrapersonal	determinants	of	contraceptive	use,	as	defined	in	Sheeran’s	model,	such	
as	health	concerns,	fear	or	experience	of	side-effects.(52)	Phone	counselling	enables	
more	personalised	support	to	be	delivered	as	well	as	increased	amount	of	content.	
Counsellors	are	able	to	assess	particular	concerns	and	tailor	content	accordingly	in	a	
way	that	is	not	possible	with	automated	messages.	As	reported	in	the	qualitative	
interviews,	phone	counselling	enabled	the	counsellor	to	develop	a	relationship	with	
the	client	and	convey	empathy	and	a	sense	of	being	cared	for	that	would	be	harder	to	
achieve	with	an	automated	message.		
Behaviour	change	techniques	
The	intervention	can	also	be	characterised	in	terms	of	individual	behaviour	change	
techniques.	Recoding	the	intervention	using	Abraham	and	Michie’s	typology	in	
Chapter	7	suggested	that	the	intervention	likely	included	six	behaviour	change	
techniques;	two	related	to	the	voice	messages	(provide	instruction,	and	prompt	
practice)	and	four	related	to	the	counselling	(provide	information	about	behaviour-
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health	link,	provide	information	on	consequences,	prompt	barrier	identification	and	
provide	general	encouragement).(227)(104)	The	finding	that	the	intervention	included	
several	behaviour	change	techniques	is	consistent	with	the	previously	discussed	
adherence	research	showing	that	multifaceted	interventions	are	likely	to	be	more	
effective	compared	to	uni-faceted	interventions.(134)	
Mechanism	of	action	(theory)	
The	qualitative	interviews	provided	insights	regarding	mechanisms	of	behaviour	
change	which	can	be	conceptualised	in	terms	of	the	capability,	motivation	and	
opportunity	components	of	Michie’s	COB-B	‘behaviour	system’.(100)	
Capability	in	the	behaviour	system	refers	to	the	individual’s	psychological	and	physical	
capacity	to	engage	in	the	activity	concerned	and	includes	having	the	necessary	
knowledge	and	skills.(49)	An	example	from	the	interviews	where	the	intervention	may	
have	increased	the	women’s	capability	to	use	contraception	would	be	the	provision	of	
individualised	information	on	contraceptive	methods	via	phone	counselling	with	
women	reporting	increased	knowledge.		
Motivation	in	the	behaviour	system	refers	to	those	brain	processes	that	energise	and	
direct	behaviour	and	includes	habitual	processes,	emotional	responding	as	well	as	
analytical	decision-making.	It	includes	reflective	processes	(involving	plans)	and	
automatic	processes	(involving	emotions	and	impulses).(49)	An	example	from	the	
interviews	where	the	intervention	may	have	increased	the	women’s	motivation	to	use	
contraception	could	be	the	counsellor	emphasizing	the	importance	of	taking	the	pill	
regularly	to	avoid	getting	pregnant	again	leading	to	the	women	changing	her	habit	(the	
behaviour	change	technique	of	‘providing	information	on	consequences’).		
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Opportunity	in	the	behaviour	system	refers	to	factors	that	lie	outside	the	individual	
that	make	the	behaviour	possible	or	prompt	it	and	includes	physical	opportunities	
(such	as	time,	financial	resources	and	access)	and	social	opportunities	created	by	the	
cultural	environment.(49)	An	example	from	the	interviews	where	the	intervention	may	
have	increased	the	women’s	opportunity	to	use	contraception	could	be	the	provision	
of	information	on	where	to	access	contraception	and	available	discounts.	
Updating	the	conceptual	framework	
Figure	55	shows	an	updated	conceptual	framework	which	seeks	to	better	describe	the	
intervention,	based	on	findings	from	the	trial	and	process	evaluation.	This	framework	
could	serve	as	a	starting	point	for	future	intervention	development	for	interventions	
delivered	by	mobile	point	to	support	post-abortion	contraception.		
Aspects	of	the	conceptual	framework	in	italics	are	more	speculative	and	require	
further	formative	research.	The	main	difference	is	that	the	updated	conceptual	
framework	includes	broader	post-abortion	care	(PAC),	not	limited	to	post-abortion	
family	planning,	as	there	was	evidence	that	the	intervention,	in	particular	the	phone	
counselling,	provided	support	for	additional	physical	and	emotional	issues.			
When	describing	the	intervention	in	this	updated	framework,	the	automated	
interactive	message	is	separated	from	the	phone	counselling.	The	interactive	message	
is	considered	a	way	of	reminding	clients	about	availability	of	support	and	a	way	to	
identify	women	most	likely	to	benefit	from	additional	support	for	contraception	or	
other	issues.	It	is	not	clear	whether	the	pill	or	injectable	reminder	messages	were	
effective	and	therefore	this	intervention	component	is	in	italics.	Furthermore,	there	
was	insufficient	evidence	from	the	interviews	that	the	intervention	identified	problems	
early.	As	the	messages	was	sent	to	women	(“push”)	every	two	weeks,	and	the	majority	
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Figure	55:	Updated	conceptual	framework	
	
of	calls	were	outgoing,	it	is	not	clear	what	women	would	do	if	they	had	a	more	urgent	
problem	and	therefore	‘identify	problems	early’	has	been	removed	in	the	updated	
framework.	
The	phone	counselling	is	expected	to	provide	personalised	support	for	clients	to	
support	contraception	use	and	other	post-abortion	care	issues.	Phone	counselling	
would	aim	to	increase	women’s	capability,	motivation	and	opportunity	to	use	
contraception.		
In	terms	of	outcomes	and	impact,	the	intervention	could	reduce	unmet	need	for	
contraception	by	increasing	uptake	of	long-acting	methods,	in	particular	IUD	and	
implant.	As	these	methods	are	associated	with	reduced	discontinuation	this	might	
reduce	unintended	pregnancies	and	abortions	over	time	although	this	was	not	
demonstrated	in	our	trial,	perhaps	due	to	lack	of	power.	In	the	short-term	the	
INTERVENTION DELIVERED BY MOBILE PHONE 
Regular interactive automated phone communication 
•  To remind clients about availability of additional support 
•  To identify clients most likely to benefit from additional phone counselling 
•  Reminders for follow-up appointments (OC and injectable) 
Phone counselling  
•  Capability to use contraception (e.g. personalised information on methods) 
•  Opportunity to use contraception (e.g. information about availability of services) 
•  Motivation to initiate contraception methods (addressing intrapersonal factors)  
•  Support concerns or experience of side effects of contraception (reassure, refer or 
support safe switching) 
•  Support for broader post-abortion care physical or emotional health issues (advice, 
reassure or refer for further assessment) 
            IMPACT 
 
REDUCED: 
•  Unmet need for 
family planning 
•  Unintended 
pregnancy 
•  Repeat abortion  
     (including unsafe) 
•  Maternal mortality 
         OUTCOMES 
 
INCREASED: 
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long-acting methods) 
REDUCED: 
•  Discontinuation and unsafe 
method switching (in the short-
term) 
•  Adverse health outcomes from 
incomplete abortion 
POST-ABORTION CARE ISSUES 
 
•  Physical health issues (e.g. pain, 
ongoing bleeding) 
•  Emotional health issues (e.g. 
isolation) 
•  Lack of knowledge of 
contraceptive methods  
•  Fear or experience of side-effects 
considering health beliefs (e.g. 
negative perception of 
amenorrhoea) 
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intervention	might	reduce	discontinuation	and	unsafe	switching.	The	intervention	
might	contribute	towards	reduced	maternal	mortality	and	morbidity	through	
supporting	broader	physical	and	emotional	issues	but	this	requires	further	evaluation.	
8.4	Implications	for	service	delivery	
Findings	from	this	thesis	have	potential	implications	for	service	delivery	and	have	been	
described	in	Chapters	5,	6	and	7.		
Implementing	the	current	intervention	
Overall,	the	findings	from	this	trial	and	process	evaluation	suggest	that	the	
intervention	comprising	six	interactive	voice	messages	+/-	counsellor	support	for	a	
range	of	contraceptive	methods	could	be	delivered	as	it	was	in	the	trial,	at	non-
governmental	clinics	such	at	Marie	Stopes	International	in	Cambodia	but	further	
formative	research	is	recommended	prior	to	implementing	similar	interventions	in	
other	settings.	Given	that	some	women	will	choose	to	discontinue	methods,	the	
intervention	should	support	use	of	a	range	of	methods	rather	than	focus	on	adherence	
to	one	particular	method.	The	intervention	might	be	expected	to	influence	
contraception	use	by	increasing	uptake	of	long-acting	methods	and	increase	safe-
method	switching	during	the	three-month	post-abortion	period	whilst	the	intervention	
is	being	delivered.	After	this	time	the	effect	of	the	intervention	is	likely	to	diminish	and	
normal	patterns	of	contraception	discontinuation	would	be	expected;	with	increased	
discontinuation	of	short-acting	methods	but	less	discontinuation	of	long-acting	
methods	(IUD/implant).	The	intervention	as	implemented	in	the	trial	is	likely	to	be	
positively	received	by	most	women	as	a	convenient	way	to	ask	questions	and	get	
support	for	additional	post-abortion	physical	and	emotional	issues	without	having	to	
return	to	the	clinic.	The	intervention	could	be	offered	to	all	women,	with	the	
	
	
301	
intervention	likely	to	have	greatest	effect	amongst	women	undecided	about	PAFP	at	
the	time	of	seeking	abortion	services.	However,	not	all	women	are	likely	to	want	to	
enrol	to	receive	the	intervention,	and	amongst	those	that	do,	a	minority	are	likely	to	
find	the	voice	messages	intrusive.	Although	there	were	no	reports	of	any	adverse	
advents	of	the	intervention,	phone	sharing	is	common	in	Cambodia	and	possible	
unintended	consequences	should	be	considered	if	someone	other	than	the	intended	
client	answers	a	call.		
Service	providers	would	need	to	consider	the	cost-implications	of	implementing	the	
intervention,	balanced	against	potential	benefits	such	as	increased	client	loyalty	and	
reputation	of	the	organisation.	It	is	unclear	whether	women	would	pay	for	the	
intervention	and	therefore	the	implementation	costs	would	need	to	be	budgeted	by	
the	organisation	or	a	third-party	funder.	In	contrast	to	the	trial	where	women	were	
recruited	by	research	assistants,	service	providers	or	clinic	staff	would	need	to	enrol	
women	to	the	intervention,	or	at	least	obtain	consent	for	a	counsellor	to	call	the	
women	to	enrol	them	to	the	intervention.	The	intervention	for	on-going	support	for	
post-abortion	family	planning	should	not	distract	from	counselling	and	the	opportunity	
to	initiate	contraceptive	methods	at	the	time	of	seeking	abortion	services.	
Adapting	the	intervention	
Findings	from	the	process	evaluation	in	Chapters	6	and	7	suggest	several	ways	in	which	
the	intervention	could	be	improved.	The	duration,	language	and	mode	of	
communication	(i.e.	text	or	voice)	could	be	adapted	to	different	settings,	though	voice	
messages	will	be	most	useful	in	populations	with	limited	literacy.	A	longer	intervention	
or	a	“booster”	message	at	a	later	date	could	be	evaluated.	In	settings	where	
smartphone	use	is	high,	the	intervention	could	be	adapted	whereby	voice	or	text	
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messages	are	sent	via	an	instant	messaging	application	and	listened	to	at	the	woman’s	
convenience.	This	might	increase	the	response	rate	to	the	messages.	The	content	
could	be	password	protected,	retained	on	the	participants	phone	and	listened	to	
several	times	and	shared	with	others	if	the	participant	wished.	Use	of	such	applications	
provides	additional	opportunities	to	add	other	low-literacy	content	such	as	
stickers/cartoons	and	future	research	could	evaluate	such	interventions.	
Given	that	women	were	more	likely	to	subsequently	use	contraception	if	they	
requested	to	speak	to	a	counsellor	(i.e.	pressed	‘1’),	the	intervention	could	be	further	
refined	so	that	counsellors	only	phone	women	that	request	to	speak	to	a	counsellor.	
As	the	cost	of	counselling	is	likely	to	be	the	main	limitation	to	scaling	up	the	
intervention,	this	change	would	reduce	costs	but	any	effect	of	the	intervention	
amongst	women	that	speak	to	the	counsellor	without	requesting	a	call	would	be	lost.		
Future	interventions	for	post-abortion	contraception	could	consider	including	
messages	to	support	comprehensive	post-abortion	care	more	broadly	and	should	
anticipate	that	women	may	have	a	range	of	issues	and	be	prepared	to	manage	these	
safely.	Possible	unintended	consequences	should	be	considered	when	developing	
future	intervention	content	in	settings	where	phone	sharing	is	common.	Some	women	
will	have	repeat	unintended	pregnancies	and	counsellors	should	be	prepared	to	
provide	advice	on	emergency	contraception,	where	appropriate,	or	availability	of	safe-
abortion	services.	
8.5	Recommendations	for	future	research	
Findings	from	this	thesis	have	potential	implications	for	future	research	and	have	been	
described	in	Chapters	5,	6	and	7.		
Repeat	systematic	review	
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Subsequent	to	the	publication	of	the	systematic	review	of	mobile	phone-based	
interventions	to	improve	contraception	use	(Chapter	2),	one	study	has	reported	
findings	that	would	likely	meet	the	inclusion	criteria	for	the	review;	the	evaluation	of	
m4RH	in	Kenya,	described	in	Section	2.8.(190)	At	the	time	of	writing,	other	trials	of	
interventions	delivered	by	mobile	phone	are	being	conducted	in	Bangladesh,	Palestine,	
Tajikistan	and	Bolivia.	In	the	light	of	this	emerging	evidence,	an	update	to	the	
systematic	review	is	recommended	in	one	or	two	years.	Future	reviews	could	include	
trials	using	mobile	phones	for	voice	calls	alone	as	well	as	non-trial	mobile	phone-based	
contraception	initiatives	and	include	a	meta-analysis	comparing	automated	
interventions	with	those	that	include	phone	counselling.		
Trials	
Future	studies	could	assess	similar	interventions	delivered	by	mobile	phone	to	
increase	contraception	use	including	more	automated	interventions,	interventions	
delivered	by	smartphone	as	outlined	above	or	the	effect	of	varying	the	duration	of	the	
intervention.	Larger	studies	could	be	powered	to	detect	differences	in	repeat	
pregnancy	and	repeat	abortion.	Objective	measures	of	contraception	use	such	as	use	
of	electronic	monitoring	devices	should	be	considered	if	appropriate	(discussed	in	
section	5.7).	Attempts	could	be	made	to	measure	additional	use	of	services	resulting	
from	participants	sharing	intervention	content	with	other	people	such	as	family	and	
friends	(discussed	in	Chapter	7).	Future	studies	could	assess	interventions	to	increase	
contraception	use	and	support	post-abortion	care	more	broadly	and	could	assess	
health	outcomes	related	to	post-abortion	care.	Interventions	should	be	clearly	
described	and	process	evaluations	conducted	to	gain	insights	into	their	mechanism	of	
action.		
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As	discussed	in	Chapter	5,	most	women	participating	in	the	MOTIF	trial	were	married,	
multiparous,	had	attended	secondary	school,	were	aged	over	25	years	and	had	paid	
for	reproductive	health	services	at	a	clinic	run	by	a	nongovernmental	organisation.	The	
effect	of	interventions	delivered	by	mobile	phone	on	PAFP	amongst	youth	and	
marginalised	populations	such	as	sex	workers,	known	to	have	high	unmet	need	for	
contraception	and	a	high	abortion	rate,(91)	requires	further	evaluation.	Future	
research	could	assess	the	effect	of	similar	interventions	in	settings	with	more	limited	
support:	for	example,	where	medical	abortions	are	provided	by	the	private	sector.	
Recruitment	of	participants	might	be	more	challenging	in	this	setting,	but	important	
given	the	trend	towards	medical	abortion	in	Cambodia	and	globally.(74)(20)	Trials	
assessing	longer	term	outcomes	or	with	younger	populations	or	those	of	lower	socio-
economic	status	might	expect	increased	attrition	and	require	imputation	of	outcome	
data.		
Finally,	further	research	is	required	on	cost-effectiveness	and	sustainability	models	of	
interventions	delivered	by	mobile	phone	to	increase	contraception	use.	In	addition	to	
the	planned	cost-effectiveness	of	the	MOTIF	trial,	operational	research	could	examine	
clients’	actual	willingness	to	pay	for	such	interventions.	
8.6	Conclusions	
With	reference	to	the	over-arching	research	question,	findings	from	this	thesis	suggest	
that	interventions	delivered	by	mobile	phone	can	increase	contraception	use,	but	the	
evidence	to	date	is	mixed.		
The	trials	identified	in	a	systematic	review	reporting	increased	contraceptive	use	were	
more	complex;	one	involving	a	range	of	educational	text	messages	and	the	MObile	
Technology	for	Improved	Family	Planning	(MOTIF)	trial	comprising	interactive	voice	
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messages	with	counsellor	support.	The	MOTIF	intervention	was	associated	with	
increased	self-reported	use	of	effective	contraception	at	four	months	post-abortion	
but	not	at	12	months,	but	use	of	long-acting	contraception	(IUD,	implant,	permanent	
method)	was	increased	at	four	and	12	months.	The	intervention	effect	was	primarily	
due	to	increased	initiation	of	long-acting	methods	whilst	receiving	the	intervention	
over	the	three-month	post-abortion	period;	and	appear	to	support	aspects	of	the	
original	study	hypothesis	that	‘the	intervention	will	remind	clients	about	contraceptive	
methods	available,	identify	problems	with	side	effects	early	and	provide	appropriate	
support,	and	will	boost	motivation	to	use	PAFP,	while	reducing	discontinuation	and	
unsafe	method	switching’	as	summarised	in	the	conceptual	framework.	Process	
evaluation	findings	indicated	that	the	intervention	provided	support	for	post-abortion	
care	more	broadly.	Women	were	more	likely	to	request	to	speak	to	a	counsellor	if	they	
were	of	lower	socio-economic	status	or	increased	parity	which	suggests	that	the	
intervention	is	equitable	in	terms	of	engaging	those	most	in-need	and	could	have	
public	health	benefits	at	scale.	The	MOTIF	intervention	could	be	implemented	in	
current	form,	however	cost-effectiveness	analysis	is	still	ongoing.	The	intervention	
could	potentially	be	improved	so	that	counsellors	only	phone	women	that	request	to	
speak	to	the	counsellor,	and	the	duration	and	mode	of	communication	could	be	
adapted	to	different	settings.	Further	high-quality	adequately	powered	trials	of	
interventions	delivered	by	mobile	phone	to	increase	contraception	use	are	required.	
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9.	APPENDICES	
Appendix	1:	Additional	outputs	&	dissemination	
In	addition	to	submission	of	papers	to	open-access	peer-reviewed	journals,	additional	
dissemination	of	this	research	has	included:	
Conference	presentations	
• Society	of	Academic	Primary	Care	(SAPC)	Annual	Scientific	Meeting,	‘Effects	of	
a	mobile	phone-based	intervention	to	support	post-abortion	family	planning	in	
Cambodia’,	10/7/15	
• UCL	Global	mHealth	conference	2015,	‘Effect	of	a	mobile	phone-based	
intervention	to	support	post-abortion	family	planning’,	28/1/2015	
• Global	mHealth	forum	2014,	Washington	DC,	‘Mobile	Technology	for	Improved	
Family	Planning	(MOTIF)’,	10/12/14	
• International	Conference	on	Family	Planning	2013,	Ethiopia,	‘Development	of	
the	MOTIF	intervention’,	2013	
Presentations	at	other	meetings	
• ‘Contraception	after	medical	abortion	meeting’,	Santa	Monica,	‘Effect	of	a	
mobile	phone-based	intervention	on	post-abortion	contraception	in	Cambodia’,	
March	2016	
• Post-abortion	care	(PAC)	consortium	meeting	(linked	to	ICFP	2016,	Indonesia),	
‘Effect	of	a	mobile	phone-based	intervention	on	post-abortion	contraception	in	
Cambodia’,	23/1/16	
• Research	dissemination	presentation	to	LSHTM	alumni	Cambodia	(25/2/15)	
• Research	dissemination	webinar	to	MSI	Pakistan	and	other	country	
programmes,	5/11/14	
• Research	dissemination	presentation	to	Marie	Stopes	International	London	
staff,	3/11/14	
• Research	dissemination	presentation	to	MSI	USA	staff,	Washington	DC,	
10/12/14	
• WHO	health	partners	meeting,	Cambodia,	research	dissemination	
presentation,	28/8/14	
• Research	dissemination	presentation	to	MSI	Vietnam	office	staff,	Hanoi,	
14/8/14	
Internal	presentations	at	LSHTM	
• Abortion	related	research:	where	are	we	at	and	where	are	the	gaps?,	LSHTM	
seminar	presentation,	‘Effect	of	a	mobile	phone-based	intervention	on	post-
abortion	contraception	in	Cambodia’,	20/6/16	
• Feedback	from	the	International	Conference	on	Family	Planning,	presentation	
at	MARCH			seminar,	4/2/16	
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• Presentation	to	clinical	trials	unit	‘critical	mass’	meeting,	‘Effect	of	a	mobile	
phone-based	intervention	on	post-abortion	contraception	in	Cambodia’,	
23/1/15	
• Presentation	to	MARCH	seminar	at	LSHTM,	‘Effect	of	a	mobile	phone-based	
intervention	on	post-abortion	contraception	in	Cambodia;	methodological	
issues’,	26/1/15	
• Presentation	at	MARCH	seminar,	‘Loss	to	follow	up	and	dealing	with	missing	
data	in	contraception	trials:	experience	from	the	MObile	Technology	for	
Improved	Family	Planning	(MOTIF)	trial’,	1/10/15	
Other	media	
• Interviewed	for	New	Scientist	article	‘Women	in	Oregon	can	now	get	the	pill	
over	the	counter’	(5	January	2016):	
https://www.newscientist.com/article/dn28726-women-in-oregon-can-now-
get-the-pill-over-the-counter/		
• Interviewed	for	Phnom	Penh	Post	article	‘Kingdom’s	contraception	demand	
‘unmet’	(31	Dec	2015):	http://www.phnompenhpost.com/national/kingdoms-
contraception-demand-unmet		
• Video	‘How	Marie	Stopes	International	Uses	Verboice	to	Deliver	Sexual	Health	
Information	in	Cambodia’	(2015):	http://www.ilabsoutheastasia.org/news-
media/video/how-marie-stopes-international-uses-verboice-to-deliver-sexual-
health-information-in-cambodia/			
• Interviewed	for	Medical	Research	Council	network	publication	‘Mobile	
medicine’	(Winter	2014/15):	https://www.mrc.ac.uk/news/magazine/network-
winter-2014-15/		
• Interviewed	for	Phnom	Penh	Post	article	‘On	the	phone’	(31	Jan	2014):	
http://www.phnompenhpost.com/7days/phone	
• Facilitated	session	of	‘Talent	Development	Program’	to	build	capacity	for	
young	talent	in	ICT	and	technology	in	Cambodia,	USAID	Cambodia	
Development	Innovations	Project,	Cambodia,	15/9/14	
• Provided	informal	advice	to	the	following	PhD	students	working	on	e/mHealth	
and	sexual	and	reproductive	health:	Kate	Reiss	(LSHTM),	Ona	McCarthy	
(LSHTM),	Emma	Wilson	(LSHTM/Kings),	Emma	Rezel	(Kings/LSHTM),	Sharmani	
Barnard	(Kings/LSHTM)	
• Preparation	of	study	newsletters,	research	summary	documents,	and	reports	
for	Marie	Stopes	International	
During	my	PhD	I	have	undertaken	the	following	research	training:	
• Analysing	Survey	and	Population	Data	(attended	lectures),	2016	
• STATA	programming:	creating	beautiful	tables,	LSHTM,	Sept	2015	
• MRC	fellows	induction	workshop,	MRC,	April	2015		
• Producing	a	research	poster,	LSHTM,	8/1/15		
• Demographic	methods	(attended	lectures/practicals),	Oct/Nov	2014	
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• Writing	for	non-scientific	audiences	(MRC	workshop),	1/10/14	
• Introduction	to	STATA,	LSHTM,	Feb	2014	
• Statistical	Methods	for	Epidemiology,	LSHTM,	(D/L),	2013	
• Introduction	to	Good	Clinical	Practice	(GCP),	2012	
I	(or	my	research	team)	have	won	or	been	shortlisted	for	the	following	awards:	
• 120	under	40:	The	New	Generation	of	Family	Planning	Leaders,	Nominee,	2016	
• Max	Perutz	Science	Writing	Award	shortlist:	‘Mobile	phones	for	family	
planning’,	2014	
• MRC	Population	Scientist	Fellowship,	2014	
• 2014	Communication	for	Social	Change	Award,	University	of	Queensland.	
Marie	Stopes	International	MOTIF	project.	Finalist	//	Cambodia,	2014	
• Marie	Stopes	CEO	pick	of	Innovation	Fund	projects	for	MOTIF	project,	2013	
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Appendix	2:	Ethical	approvals	
Figure	56:	Ethical	approval	for	formative	research	(NECHR)	
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Figure	57:	Ethical	approval	for	formative	research	(LSHTM)	
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Figure	58:	Ethical	approval	for	formative	research	(MSI)	
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Figure	59:	Ethical	approval	for	trial	(NECHR)	
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Figure	60:	Ethical	approval	for	trial	(LSHTM)	
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Figure	61:	Ethical	approval	for	trial	(MSI)	
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Figure	62:	Ethical	approval	for	12-month	follow	up	(NECHR)	
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Figure	63:	Ethical	approval	for	12-month	follow	up	
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Figure	64:	Ethical	approval	for	12-month	follow	up	(MSI)	
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Appendix	3:	Study	consent	forms	and	questionnaires	
	
Figure	65:	Participant	information	sheet	for	interview	
Participant’s	Information	Sheet	for	Interview	
We	are	inviting	you	to	take	part	in	a	research	study.	Before	you	decide	whether	or	not	to	participate,	
it	is	important	that	you	know	why	we	are	doing	the	study	and	what	is	involved.	Please	read	the	
following	information	carefully.	If	you	are	unable	to	read	it	we	will	read	it	to	you.		
What	is	the	study?		
We	are	asking	Marie	Stopes	service	users	to	help	us	develop	a	mobile	phone-based	service	to	support	
contraception	use	for	women	who	have	recently	had	an	abortion.	We	would	like	to	ask	your	views	in	
order	to	develop	this	service.		
Why	are	we	doing	the	study?		
We	want	to	find	out	if	a	mobile	phone-based	service	to	support	contraception	use	for	women	who	
have	recently	had	an	abortion	can	be	supportive	and	acceptable.		
Why	have	I	been	chosen?		
You	are	have	attended	the	MSI	clinic,	which	provides	abortion	and	other	reproductive	health	services	
for	women.		
Do	I	have	to	take	part?		
No,	it	is	up	to	you	to	decide	whether	to	take	part.		
What	will	happen	if	I	take	part?		
The	researcher	will	arrange	a	time	for	an	interview.	We	will	ask	you	about	your	reasons	for	deciding	
to	have	an	abortion,	previous	contraceptive	use,	views	on	the	Marie	Stopes	service,	your	mobile	
phone	usage,	and	views	on	the	proposed	intervention.	With	your	permission,	we	will	record	the	
interview.	The	interview	will	take	about	an	hour.	With	your	permission	we	will	contact	you	by	phone	
one	month	after	the	interview	to	ask	about	your	current	use	of	contraception,	and	subsequently	by	
email	or	phone	according	to	your	preference,	to	ask	for	your	feedback	about	any	new	messages	
developed	after	the	interview.		
Will	you	recompense	me	for	the	time	this	takes?		
We	will	give	you	$5	to	cover	travel	expenses	to	attend	the	interview.	We	will	give	you	$5	to	cover	the	
expenses	of	giving	feedback	on	any	new	messages	developed	after	the	interview.		
What	do	I	have	to	do?	If	you	agree	to	take	part	you	will	need	to	and	sign	the	consent	form.		
What	are	the	alternatives?	You	do	not	have	to	take	part.	It	will	not	affect	any	of	the	services	that	you	
receive		
What	are	the	possible	disadvantages	in	taking	part?		
The	study	will	take	some	of	your	time.	We	cannot	promise	that	your	health	will	benefit.		
What	are	the	possible	benefits	of	taking	part?		
Your	views	can	affect	the	information	and	support	service	users	receive.		
What	will	happen	if	I	don’t	want	to	carry	on	with	the	study?		
You	can	withdraw	from	the	study	at	any	time	by	letting	the	researcher	conducting	the	interview	
know	and	the	data	collected	from	you	will	not	be	used		
What	if	there	is	a	problem?		
You	can	discuss	this	with	the	researcher	present	or	call	us	on	xxxxxxx.	If	you	want	to	make	a	
complaint,	please	call	us.	If	you	would	like	to	make	a	formal	complaint	write	to	Dr.	Chris	Smith	who	
will	follow	the	complaints	procedure.		
Will	my	taking	part	in	this	study	be	kept	confidential?		
Yes.	Your	comments	will	be	identified	by	a	research	number	only	and	all	your	comments	will	be	made	
anonymous.		
What	will	happen	to	the	results	of	the	research	study?		
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We	will	use	your	views	to	develop	the	mobile	phone-based	service.	Once	we	have	developed	a	
mobile	phone-based	service	that	service	users	like	and	find	helpful	we	will	test	them	on	a	larger	
group	of	service	users	to	see	if	they	can	improve	contraception	use	after	an	abortion.		
Who	is	organising	and	funding	the	research?		
The	study	is	being	run	by:	Dr.	Chris	Smith	(lead	investigator),	a	collaboration	between	Marie	Stopes	
International	and	the	University	of	London.	Marie	Stopes	International	is	funding	the	study.		
Who	has	reviewed	the	trial?		
The	London	School	of	Hygiene	and	Tropical	Medicine	(LSHTM)	ethics	committee,	Marie	Stopes	
International	Ethics	Committee,	Cambodia	Ethics	Committee		
The	team	contact	details:	Tel	xxxxxxxxxxxx	email:	chris.smith@xxxxxxxxxx,	LSHTM	,	Keppel	St,	
London,	WC1E	7HT		
Thank	you	for	taking	the	time	to	consider	taking	part.		
If	you	would	like	further	information	please	speak	to	the	research	present	or	ring	the	study	team	
on	xxxxxxxxxx	
	
Figure	66:	Participant	information	sheet	for	focus	group	
Participant’s	Information	Sheet	for	Focus	Group	
We	are	inviting	you	to	take	part	in	a	research	study.	Before	you	decide	whether	or	not	to	participate,	
it	is	important	that	you	know	why	we	are	doing	the	study	and	what	is	involved.	Please	read	the	
following	information	carefully.	If	you	are	unable	to	read	it	we	will	read	it	to	you.		
What	is	the	study?		
We	are	asking	Marie	Stopes	service	users	to	help	us	develop	a	mobile	phone-based	service	to	support	
contraception	use	for	women	who	have	recently	had	an	abortion.	We	would	like	to	ask	your	views	
about	what	should	be	in	the	messages.	We	would	like	your	help	and	comments	to	make	the	
messages	supportive,	helpful	and	easy	to	understand.		
Why	are	we	doing	the	study?		
We	want	to	find	out	if	a	mobile	phone-based	service	to	support	contraception	use	for	women	who	
have	recently	had	an	abortion	can	be	supportive	and	acceptable.		
Why	have	I	been	chosen?		
You	are	have	attended	the	MSI	clinic,	which	provides	abortion	and	other	reproductive	health	services	
for	women.		
Do	I	have	to	take	part?		
No,	it	is	up	to	you	to	decide	whether	to	take	part.		
What	will	happen	if	I	take	part?		
The	researcher	will	arrange	a	time	for	a	group	discussion.	Groups	will	comprise	clinic	staff	and	around	
four	service	users.	We	will	ask	you	about	your	mobile	phone	usage,	and	views	on	the	proposed	
intervention	and	messages	developed.		
With	your	permission,	we	will	record	the	group	discussion.	The	discussion	will	take	about	an	hour.	
With	your		
permission	we	will	contact	you	(by	email	or	phone	according	to	your	preference)	to	ask	for	your	
feedback	about	any	new	messages	developed	after	the	discussion.		
Will	you	recompense	me	for	the	time	this	takes?		
We	will	give	you	$5	to	cover	travel	expenses	to	attend.	We	will	give	you	$5	to	cover	the	expenses	of	
giving	feedback	on	any	new	messages	developed	after	the	meeting.		
What	do	I	have	to	do?	If	you	agree	to	take	part	you	will	need	to	and	sign	the	consent	form.		
What	are	the	alternatives?	You	do	not	have	to	take	part.	It	will	not	affect	any	of	the	services	that	you	
receive		
What	are	the	possible	disadvantages	in	taking	part?		
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The	study	will	take	some	of	your	time.	We	cannot	promise	that	your	health	will	benefit.		
What	are	the	possible	benefits	of	taking	part?		
Your	views	can	affect	the	information	and	support	service	users	receive.		
What	will	happen	if	I	don’t	want	to	carry	on	with	the	study?		
You	can	withdraw	from	the	study	at	any	time	by	letting	the	researcher	conducting	the	group	
discussion	know	and	the	data	collected	from	you	will	not	be	used.		
What	if	there	is	a	problem?		
You	can	discuss	this	with	the	researcher	present	or	call	us	on	xxxxxxx.	If	you	want	to	make	a	
complaint,	please	call	us.	If	you	would	like	to	make	a	formal	complaint	write	to	Dr.	Chris	Smith	who	
will	follow	the	complaints	procedure.		
Will	my	taking	part	in	this	study	be	kept	confidential?		
Yes.	Your	comments	will	be	identified	by	a	research	number	only	and	all	your	comments	will	be	made	
anonymous.		
What	will	happen	to	the	results	of	the	research	study?		
We	will	use	your	views	to	develop	the	mobile	phone-based	service.	Once	we	have	developed	a	
mobile	phone-based	service	that	service	users	like	and	find	helpful	we	will	test	them	on	a	larger	
group	of	service	users	to	see	if	they	can	improve	contraception	use	after	an	abortion.		
Who	is	organising	and	funding	the	research?		
The	study	is	being	run	by:	Dr.	Chris	Smith	(lead	investigator),	a	collaboration	between	Marie	Stopes	
International	and	the	University	of	London.	Marie	Stopes	International	is	funding	the	study.		
Who	has	reviewed	the	trial?		
The	London	School	of	Hygiene	and	Tropical	Medicine	(LSHTM)	ethics	committee,	Marie	Stopes	
International	Ethics	Committee,	Cambodia	Ethics	Committee		
The	team	contact	details:	Tel	xxxxxxxxxxxx	email:	chris.smith@xxxxxxxxxxx,	LSHTM	,	Keppel	St,	
London,	WC1E	7HT		
Thank	you	for	taking	the	time	to	consider	taking	part.		
If	you	would	like	further	information	please	speak	to	the	research	present	or	ring	the	study	team	
on	xxxxxxxxxx		
	
Figure	67:	Consent	form	for	interview	
Consent	Form	for	Interview	
MOTIF:	MObile	Technologies	for	Improved	Family	Planning	
Developing	a	mobile	phone-based	post-abortion	contraception	service	
	
I	______________	have	read	and	understood	the	participants’	information	sheet	(or	it	has	been	read	
to	me).	You	have	explained	what	you	are	trying	to	find	out	and	why	you	would	like	to	talk	to	me.		
Please	put	a	mark	in	the	box	to	the	right	if	you	think	the	sentence	is	true:		
I	have	asked	all	the	questions	that	I	need	to	and	I	am	happy	with	the	answers	you	have	given	me.		
I	allow	you	to	write	about	what	I	have	said	during	our	talk	and	I	understand	that	you	won’t	be	using	
my	real	name.		
I	understand	that	I	don’t	have	to	talk	about	things	that	I	don’t	want	to	talk	about.	I	know	that	I	can	
stop	our	talk	at	any	time	and	without	giving	a	reason	for	this	and	the	data	collected	from	me	will	not	
be	used		
I	am	happy	for	you	to	record	our	talk.		
I	am	happy	for	you	to	contact	me	by	phone	one	month	after	the	interview	to	ask	me	about	my	
current	contraceptive	use		
I	understand	that	I	can	take	a	look	at	the	draft	report	for	this	study	if	I	want	to.		
I	would	like	to	take	part	in	the	study.	I	can	still	change	my	mind	at	any	time.		
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My	questions	have	been	answered	by	______________________________________	
Participant	(name	in	BLOCK	CAPITALS)	_____________________________________		
Telephone	number	___________________________________	
	Signed	_____________________________________________		
Date	______________		
Researcher	(name	in	BLOCK	CAPITALS)	________________________________	
Signed	___________________________________________________________	
Date	______________		
If	you	need	more	information	to	help	you	decide,	call	xxxxxxxxxx	email	chris.smith@xxxxxxxxxxxx		
	
Figure	68:	Consent	form	for	focus	group	
Consent	Form	for	Focus	Group	
I	________________________	have	read	and	understood	the	participants’	information	sheet	(or	it	
has	been	read	to	me).	You	have	explained	what	you	are	trying	to	find	out	and	why	you	would	like	to	
talk	to	me.		
Please	put	a	mark	in	the	box	to	the	right	if	you	think	the	sentence	is	true:		
MOTIF:	MObile	Technologies	for	Improved	Family	Planning		
Developing	a	mobile	phone-based	post-abortion	contraception	service		
I	have	asked	all	the	questions	that	I	need	to	and	I	am	happy	with	the	answers	you	have	
given	me.		 		
I	allow	you	to	write	about	what	I	have	said	during	the	group	discussion	and	I	understand	
that	you	won’t	be	using	my	real	name.		 			
I	understand	that	I	don’t	have	to	talk	about	things	that	I	don’t	want	to	talk	about.	I	know	
that	I	can	withdraw	from	the	group	discussion	at	any	time	and	without	giving	a	reason	
for	this	and	the	data	collected	from	me	will	not	be	used		
	
I	don’t	mind	that	you	record	the	group	discussion.		 		
I	understand	that	I	can	take	a	look	at	the	draft	report	for	this	study	if	I	want	to.		 		
I	would	like	to	take	part	in	the	study.	I	can	still	change	my	mind	at	any	time.		 	 		
My	questions	have	been	answered	by	____________________________________________		
Participant	(name	in	BLOCK	CAPITALS)	_____________________________________		
Telephone	number	______________________________________________________	
Signed	________________________________________________________________	
Date	______________		
Researcher	(name	in	BLOCK	CAPITALS)	_____________________________________		
Signed	____________________________________________________________________		
Date	______________		
If	you	need	more	information	to	help	you	decide,	call	xxxxxxxxxx	email	chris.smith@xxxxxxxxxx		
	
Figure	69:	Participant	information	sheet	for	trial	
Participant’s	Information	Sheet	for	Trial	
We	are	inviting	you	to	take	part	in	a	research	trial.		Before	you	decide	whether	or	not	to	participate,	
it	is	important	that	you	know	why	we	are	doing	the	trial	and	what	is	involved.	Please	read	the	
following	information	carefully.	If	you	are	unable	to	read	it	we	will	read	it	to	you.	
What	is	the	study?	
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MOTIF	is	a	mobile	phone-based	service	for	Marie	Stopes	service	users	who	have	recently	had	an	
abortion	to	support	contraception	use.		
Why	are	we	doing	the	study?			
We	want	to	find	out	if	a	mobile	phone-based	service	to	support	contraception	use	for	women	who	
have	recently	had	an	abortion	can	be	supportive,	acceptable	and	effective.		
Why	have	I	been	chosen?	
You	have	attended	the	MSI	clinic,	which	provides	abortion	and	other	reproductive	health	services	for	
women.			
Do	I	have	to	take	part?	
No,	it	is	up	to	you	to	decide	whether	to	take	part.		
What	will	happen	if	I	take	part?	
The	study	team	will	phone	you	to	collect	some	information.	We	will	then	put	you	into	one	of	two	
groups	by	chance	(randomly).	One	group	will	get	the	MOTIF	(mobile	phone-based	service)	and	the	
other	will	not	(the	control	group).	Participants	in	the	MOTIF	group	will	receive	a	phone	call	within	a	
few	days	to	further	introduce	the	service	which	will	involve	regular	SMS,	voice	message	or	direct	call	
communication	to	you	according	to	your	situation	and	preferences.	Also,	you	will	be	able	to	contact	
the	service	for	support.	The	control	group	will	receive	standard	care.	This	includes	face-to-face	post-
abortion	counselling,	follow-up	at	two	weeks,	the	clinic	phone	number,	and	Hotline	phone	number	
for	support.	We	will	contact	you	in	four	months	time	by	phone	to	find	out	what	contraception	you	
are	using.	We	may	ask	you	to	return	to	the	clinic	for	face-to-face	follow	up.	We	may	also	attempt	to	
contact	you	after	one	year	and	two	years	to	find	out	about	contraception	use	and	subsequent	
pregnancies/abortions.				
What	do	I	have	to	do?		
If	you	agree	to	take	part	you	will	need	to	read	the	consent	form	(or	have	it	read	to	you)	and	sign	the	
consent	form.	The	consent	form	does	not	have	to	be	signed	immediately.	You	can	take	your	time	
before	you	decide	whether	to	participate	or	not.	
What	are	the	alternatives?		
You	do	not	have	to	take	part.	It	will	not	affect	any	of	the	services	that	you	receive	
What	are	the	possible	disadvantages	in	taking	part?		
The	study	will	take	some	of	your	time.	We	cannot	promise	that	your	health	will	benefit.	The	support	
could	make	some	participants	aware	that	they	are	in	abusive	relationships.	The	service	or	research	
team	will	be	able	to	provide	information	about	how	to	access	appropriate	counselling	services	for	
people	in	abusive	relationships.		
What	are	the	possible	benefits	of	taking	part?	
Being	involved	in	the	trial	will	give	you	the	chance	to	receive	additional	support	for	contraception	and	
to	reduce	repeat	abortion.	
What	happens	when	the	research	trial	stops?	
We	will	compare	contraception	use	in	the	two	different	groups	to	see	which	group	did	better.	If	the	
MOTIF	programme	is	effective,	then	we	will	consider	conducting	a	larger	study	or	providing	the	
service	more	widely.	
What	will	happen	if	I	don’t	want	to	carry	on	with	the	study?	
You	can	withdraw	from	the	study	at	any	time	by	calling,	texting,	or	emailing	us	
What	if	there	is	a	problem?	
Please	call	us	and	we	will	do	our	best	to	sort	it	out.	If	you	would	like	to	make	a	formal	complaint	write	
to	Dr.	Chris	Smith	who	will	follow	the	complaints	procedure.		
Will	my	taking	part	in	this	trial	be	kept	confidential?	
Yes.	
What	will	happen	to	the	results	of	the	research	study?	
The	results	will	be	used	to	support	post-abortion	family	planning	for	other	clients.	The	results	will	be	
published	in	a	scientific	journal	so	that	other	doctors	know	about	it.	If	you	would	like	a	copy	of	the	
results	please	contact	us.			
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Will	you	recompense	me	for	the	time	this	takes?	
We	will	give	you	$4	to	cover	travel	expenses	if	you	are	asked	to	attend	for	face-to-face	follow	up.		
Who	is	organising	and	funding	the	research?	
The	study	is	being	run	by:	Dr.	Chris	Smith	(lead	investigator),	a	collaboration	between	Marie	Stopes	
International	and	the	University	of	London.	Marie	Stopes	International	is	funding	the	study.	
Who	has	reviewed	the	trial?	
The	London	School	of	Hygiene	and	Tropical	Medicine	(LSHTM)	ethics	committee,	Marie	Stopes	
International	Ethics	Committee,	Cambodia	Ethics	Committee	
The	team	contact	details:	
Tel	xxxxxxxxxxxx	email:	chris.smith@xxxxxxxxxx,	LSHTM,	Keppel	St,	London,	WC1E	7HT	
You	should	not	use	your	phone	while	driving	a	vehicle	
Thank	you	for	taking	the	time	to	consider	taking	part.	
If	you	would	like	further	information	please	speak	to	the	research	present	or	ring	the	study	team	on	
XXXXXXXXXX	
	
Figure	70:	Consent	form	for	trial	(English	version)	
Consent	Form	for	Trial	
	
	
	
	
	
I	________________________	have	read	and	understood	the	participants’	information	sheet	(or	it	
has	been	read	to	me).	You	have	explained	what	you	are	trying	to	find	out	and	why	you	would	like	me	
to	participate	in	the	trial.	
Please	put	a	mark	in	the	box	to	the	right	if	you	think	the	sentence	is	true:	
I	have	asked	all	the	questions	that	I	need	to	and	I	am	happy	with	the	answers	you	have	
given	me.	
	
I	understand	that	there	is	only	a	50%	chance	that	I	will	receive	the	mobile	phone-based	
service	
	
I	allow	you	to	contact	me	at	four	months	by	phone	call	to	conduct	a	questionnaire	and	
ask	about	my	contraception	use	and	views	on	the	service	
	
I	understand	that	some	participants	will	be	asked	to	attend	the	clinic	for	face-to-face	
follow	up	at	four	months		
	
I	allow	a	member	of	clinic	staff	to	view	my	clinic	record	and	inform	the	research	team	
about	my	contraception	use	(this	only	applies	if	I	return	for	face-to-face	follow	up)	
	
I	allow	you	to	attempt	to	contact	me	after	one	and/or	two	years	by	phone	call	to	ask	
about	my	contraception	use		
	
I	allow	you	to	write	about	the	communication	between	myself	and	the	service	and	I	
understand	that	you	won’t	be	using	my	real	name.	
	
I	understand	that	I	can	request	to	withdraw	from	the	study	without	giving	a	reason	for	
this	and	additionally	I	can	request	the	data	collected	from	me	will	not	be	used	
	
I	understand	that	I	can	take	a	look	at	the	draft	report	for	this	study	if	I	want	to.	 	
I	would	like	to	take	part	in	the	study.	I	can	still	change	my	mind	at	any	time.	 	
	
My	questions	have	been	answered	by		____________________________________________	
Participant	(name	in	BLOCK	CAPITALS)		_____________________________________	
Telephone	number		________________________________________________________	
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Signed		____________________________________________________________________	
Date		______________	
Researcher	/	clinic	staff	(name	in	BLOCK	CAPITALS)		_____________________________________	
Signed		____________________________________________________________________	
Date		______________	
If	you	need	more	information	to	help	you	decide,	call	XXXXXXXXXX	email	chris.smith@	XXXXXXXXXX	
	
Figure	71:	Participant	information	sheet	for	process	evaluation	(English	version)	
Participant’s	Information	Sheet	for	Interview	(process	evaluation)	
We	are	inviting	you	to	take	part	in	an	interview	study.		Before	you	decide	whether	or	not	to	
participate,	it	is	important	that	you	know	why	we	are	doing	the	study	and	what	is	involved.	Please	
read	the	following	information	carefully.	If	you	are	unable	to	read	it	we	will	read	it	to	you.	
What	is	the	study?	
We	are	asking	Marie	Stopes	service	users	who	received	the	mobile	phone-based	(MOTIF)	service	for	
feedback	to	help	us	evaluate	the	service.	
Why	are	we	doing	the	study?			
We	want	to	find	out	if	a	mobile	phone-based	service	to	support	contraception	use	for	women	who	
have	recently	had	an	abortion	can	be	supportive	and	acceptable.		
Why	have	I	been	chosen?	
You	received	the	mobile	phone-based	service	to	support	post-abortion	contraception.			
Do	I	have	to	take	part?	
No,	it	is	up	to	you	to	decide	whether	to	take	part.		
What	will	happen	if	I	take	part?	
The	researcher	will	arrange	a	time	for	an	interview.	We	will	ask	you	about	your	contraception	and	
mobile	phone	use,	and	views	on	the	Marie	Stopes	MOTIF	service.	With	your	permission,	we	will	
record	the	interview.	The	interview	will	take	about	30	minutes.		
Will	you	recompense	me	for	the	time	this	takes?	
We	will	give	you	$4	to	cover	travel	expenses	to	attend	the	interview.		
What	do	I	have	to	do?	If	you	agree	to	take	part	you	will	need	to	read	the	consent	form	(or	have	it	
read	to	you)	and	sign	the	consent	form.	The	consent	form	does	not	have	to	be	signed	immediately.	
You	can	take	your	time	before	you	decide	whether	to	participate	or	not.	
What	are	the	alternatives?	You	do	not	have	to	take	part.	It	will	not	affect	any	of	the	services	that	you	
receive	
What	are	the	possible	disadvantages	in	taking	part?		
The	study	will	take	some	of	your	time.	We	cannot	promise	that	your	health	will	benefit.			
What	are	the	possible	benefits	of	taking	part?	
Your	views	can	affect	the	information	and	support	service	users	receive.	
What	will	happen	if	I	don’t	want	to	carry	on	with	the	study?	
You	can	withdraw	from	the	study	at	any	time	by	letting	the	researcher	conducting	the	interview	
know	and	the	data	collected	from	you	will	not	be	used	
What	if	there	is	a	problem?	
You	can	discuss	this	with	the	researcher	present	or	call	us	on	089940679.	If	you	want	to	make	a	
complaint,	please	call	us.	If	you	would	like	to	make	a	formal	complaint	write	to	Dr.	Chris	Smith	who	
will	follow	the	complaints	procedure.		
Will	my	taking	part	in	this	study	be	kept	confidential?	
Yes.	Your	comments	will	be	identified	by	a	research	number	only	and	all	your	comments	will	be	made	
anonymous.	
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What	will	happen	to	the	results	of	the	research	study?	
We	will	use	your	views	to	evaluate	the	mobile	phone-based	service.	The	results	will	be	used	to	
support	post-abortion	family	planning	for	other	clients.	The	results	will	be	published	in	a	scientific	
journal	so	that	other	doctors	know	about	it.	If	you	would	like	a	copy	of	the	results	please	contact	us.			
Who	is	organising	and	funding	the	research?	
The	study	is	being	run	by:	Dr.	Chris	Smith	(lead	investigator),	a	collaboration	between	Marie	Stopes	
International	and	the	University	of	London.	Marie	Stopes	International	is	funding	the	study.	
Who	has	reviewed	the	trial?	
The	London	School	of	Hygiene	and	Tropical	Medicine	(LSHTM)	ethics	committee,	Marie	Stopes	
International	Ethics	Committee,	Cambodia	Ethics	Committee	
The	team	contact	details:	
Tel	XXXXXXXXXX	email:	chris.smith@XXXXXXXXXX,	LSHTM,	Keppel	St,	London,	WC1E	7HT	
Thank	you	for	taking	the	time	to	consider	taking	part.	
If	you	would	like	further	information	please	speak	to	the	research	present	or	ring	the	study	team	
on	XXXXXXXXXX	
	
Figure	72:	Consent	form	for	process	evaluation	interview	(English	version)	
Consent	Form	for	Interview	
	
	
	
	
	
I	________________________	have	read	and	understood	the	participants’	information	sheet	(or	it	
has	been	read	to	me).	You	have	explained	what	you	are	trying	to	find	out	and	why	you	would	like	to	
talk	to	me.	
Please	put	a	mark	in	the	box	to	the	right	if	you	think	the	sentence	is	true:	
I	have	asked	all	the	questions	that	I	need	to	and	I	am	happy	with	the	answers	you	have	
given	me.	
	
I	allow	you	to	write	about	what	I	have	said	during	our	talk	and	I	understand	that	you	
won’t	be	using	my	real	name.	
	
I	understand	that	I	don’t	have	to	talk	about	things	that	I	don’t	want	to	talk	about.	I	know	
that	I	can	stop	our	talk	at	any	time	and	without	giving	a	reason	for	this	and	the	data	
collected	from	me	will	not	be	used	
	
I	am	happy	for	you	to	record	our	talk.	 	
I	understand	that	I	can	take	a	look	at	the	draft	report	for	this	study	if	I	want	to.	 	
I	would	like	to	take	part	in	the	study.	I	can	still	change	my	mind	at	any	time.	 	
My	questions	have	been	answered	by		____________________________________________	
Participant	(name	in	BLOCK	CAPITALS)		_____________________________________	
Telephone	number		________________________________________________________	
Signed		____________________________________________________________________	
Date		______________	
Researcher	(name	in	BLOCK	CAPITALS)		_____________________________________	
Signed		____________________________________________________________________	
Date		______________	
If	you	need	more	information	to	help	you	decide,	call	XXXXXXXXXX	email	chris.smith@	XXXXXXXXXX	
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Figure	73:	Trial	registration	form	(English	version)	
Trial	registration	Form	
To	be	completed	by	either	research	assistant	or	clinic	staff	that	have	been	given	training.	There	is	an	
additional	form	for	baseline	data	collection	because	clinic	staff	will	not	have	the	time	to	collect	
detailed	baseline	data	
Part:	1	Eligibility	
• Purpose:	to	check	eligibility	
Client	is	eligible	to	participate	in	the	trial:	
☐			Client	is	aged	18	or	over																			
☐			Is	attending	for	abortion																				
☐			Doesn’t	want	to	have	a	child	at	the	moment																
☐			Has	a	mobile	phone																										
☐			Is	willing	to	provide	informed	consent		
	
If	all	boxes	are	checked	then	the	client	is	eligible	for	the	trial.		
• Provide	 ‘Information	for	Participants’	and	obtain	consent	 if	 the	client	wishes	to	proceed.	Allow	
client	to	take	time	if	required	before	providing	consent.	Offer	client	opportunity	to	discuss	with	
research	assistant	on	phone	if	appropriate.	
Part	2:	Contact	details	
• Purpose:	 to	 collect	 contact	 details	 so	 that	 research	 assistant	 can	 contact	 client	 by	 phone	 to	
collect	baseline	data	
Date	/	time:					
Name:																														
Preferred	name	to	use:							
Mobile	number(s):		
Email:		
Address:		
Preferred	time	to	contact:	
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Figure	74:	Trial	baseline	data	collection	form	
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Figure	75:	4-month	trial	follow	up	questionnaire	
NAME	OF	PARTICIPANT:																	 	 	 	 	 TRIAL	NUMBER:		
1. “Are	you	currently	using	a	contraceptive	method?”	
a. If	YES,	“which	method	(or	methods)	are	you	currently	using?”	
2. “Have	you	become	pregnant	again	since	having	your	abortion?”	
a. Yes	
b. No	
3. Have	you	had	another	abortion	since	your	abortion	(four	months	ago)?	
a. Yes	
b. No	
4. Have	you	had	any	involvement	in	road	traffic	accident	as	a	result	of	mobile	phone	use?	
a. Yes	
b. No	
5. Did	anything	happen	to	you	as	a	consequence	of	participating	in	the	trial,	good	or	bad?	
a. None	
b. Argument	
c. Violence/domestic	abuse	
d. Other	
6. Did	you	know	any	other	women	who	took	part	in	the	study	(not	a	researcher)?	
a. Yes	(if	yes,	provide	details)	
b. No	
7. Contraception	use	following	abortion	(complete	table	below)	–	week	1:	“Did	you	start	using	
a	contraception	method	immediately	after	your	abortion?”.	Continue	for	each	week	until	
the	present	time	
Contraceptive	discontinuation	following	abortion	(complete	table	below).	If	the	participant	stopped	
using	a	method,	ask	why	she	stopped	
	
DATE	 WEEK	SINCE	ABORTION	
1	
REQUIRES	A	CODE	FOR	
EVERY	MONTH	
2	
CODE	IF	METHOD	
DISCONTINUED	
	 1	 	 	
	 2	 	 	
	 3	 	 	
	 4	 	 	
	 5	 	 	
	 6	 	 	
	 7	 	 	
	 8	 	 	
	 9	 	 	
	 10	 	 	
	 11	 	 	
	 12	 	 	
	 13	 	 	
	 14	 	 	
	 15	 	 	
	 16	 	 	
	
COLUMN	1:	CONTRACEPTIVE	USE,	
PREGNANCY,	REPEAT	ABORTION	
	
0	NO	METHOD	
1	FEMALE	STERILISATION	
2	MALE	STERILISATION	
3	IUD/COIL	
4	INJECTABLE	
COLUMN	2:	DISCONTINUATION	OF	CONTRACEPTIVE	
USE	
	 	
0	INFREQUENT	SEX/HUSBAND/PARTNER	
AWAY	
1	BECAME	PREGNANT	WHILST	USING	
2	WANTED	TO	BECOME	PREGNANT	
3	HUSBAND/PARTNER	DISAPPROVED	
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5	IMPLANT	
6	PILL	
7	CONDOM	
8	FEMALE	CONDOM	
9	DIAPHRAGM	
J	FOAM	OR	JELLY	
K	LACTATONAL	AMENORRHEA	
L	RHYTHM	METHOD	
M	WITHDRAWAL	
X	OTHER	MODERN	METHOD	
Y	OTHER	TRADITIONAL	METHOD	
	
P	PREGNANCY	
A	REPEAT	ABORTION	(INDUCED)	
M	MISCARRIAGE	
4	WANTED	MORE	EFFECTIVE	METHOD	
5	SIDE	EFFECTS/HEALTH	CONCERNS	
6	LACK	OF	ACCESS/TOO	FAR	
7	COSTS	TOO	MUCH	
8	INCONVENIENT	TO	USE	
F	UP	TO	GOD/FATALISTIC	
A	DIFFICULT	TO	GET	
PREGNANT/MENOPAUSAL	
D	MARITAL	DISSOLUTION/SEPARATION	
X	OTHER	(SPECIFY)	
Z		DON’T	KNOW	
	
	
Figure	76:	12-month	trial	follow	up	questionnaire	
Are	you	currently	using	a	contraceptive	method?	
Y	 	 N	 	
	
If	yes,	which	method	are	you	using?	
	 Pill	 	
	 Injection	 	
	 Implant	 	
	 Coil/IUD	 	
	 Female	sterilisation	 	
	 Male	sterilisation	 	
	 Non-effective	method	 	
	
Have	you	become	PREGNANT	again	since	your	abortion	(12	months	ago)?		
Y	 	 N	 	
	
Have	you	had	another	ABORTION	since	your	abortion	(12	months	ago)?		
Y	 	 N	 	
	
Contraception	calendar	data	
Date	 Month	
since	
abortion	
Column	1	
Requires	a	code	for	
every	month	
Column	2	
Code	for	non-use	or	if	
method	discontinued	
Column	3	
Code	for	every	month	of	
initiation	of	method	
	 1	 	 	 	
	 2	 	 	 	
	 3	 	 	 	
	 4	 	 	 	
	 5	 	 	 	
	 6	 	 	 	
	 7	 	 	 	
	 8	 	 	 	
	 9	 	 	 	
	 10	 	 	 	
	 11	 	 	 	
	 12	 	 	 	
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	 13	 	 	 	
	 14	 	 	 	
	
Column	1:	Contraceptive	use,	
pregnancy,	repeat	abortion	
0. No	method	
1. Female	sterilisation	
2. Male	sterilisation	
3. IUD/coil	
4. Injectable	
5. Implant	
6. Pill	
7. Condom	
8. Female	condom	
9. Diaphragm	
10. Foam	or	jelly	
11. Lactational	amenorrhoea	
12. Rhythm	method	
M.	Withdrawal	
X.	Other	modern					method	
Y.	Other	traditional	method	
P.	Pregnancy	
A.	Abortion		
Column	2:	Non-use	or	
discontinuation	
0. Infrequent	sex,		
husband/partner	away	
1. Became	pregnant	whilst	using	
2. Wanted	to	become	pregnant	
3. Husband/partner	disapproved	
4. Wanted	more	effective	
method	
5. Side	effects/health	concerns	
6. Lack	of	access/too	far	
7. Costs	too	much	
8. Inconvenient	to	use	
F.	Up	to	god/fatalistic	
A.	Difficult	to	get	
pregnant/menopausal	
D.	Marital	dissolution/separation	
X.	Other	(specify)	
	
Column	3	codes:	
0. MSIC	CCA	
1. MSIC	CTK	
2. MSIC	CBB	
3. MSIC	CSR	
4. Local	market	
5. Local	
pharmacy	
6. Friend	
7. Other	NGO	
8. Prefer	not	to	
say	
9. Other	
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Appendix	4:	Statistical	analysis	plan	for	trial	
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Appendix	5:	Evidence	of	permission	to	include	published	work	
Cochrane	review	(Chapter	2)	
	
	
	
Intervention	development	(Chapter	3)	
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Trial	protocol	(Chapter	4)	
	
	
Trial	results	(Chapter	5)	
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Appendix	6:	Counselling	guide	
	
A.	Introduction	
‘This	is	a	phone	call	from	Marie	Stopes	counsellor.	Please	can	you	tell	me	your	name	and	age?’	
‘Is	this	a	convenient	time	for	you	to	talk?’	If	NO,	arrange	another	time	to	call	client	
	
B.	Seek	information	from	client	
‘The	purpose	of	the	phone	call	is	for	me	to	provide	support	regarding	contraception.	
To	start	with	I	would	like	to	ask	you	some	questions.’	
‘What	was	the	reason	that	you	pressed	‘1’	OR	‘What	was	the	reason	that	you	didn’t	respond	to	the	
voice	message?’	
	
C.	Provide	counselling	advice	 	
‘Are	you	currently	using	a	method	of	contraception?’	
Coil	(1)	 	 ‘It	is	good	that	you	are	using	such	an	effective	and	safe	method	of	contraception	
to	avoid	becoming	pregnant	at	this	time’	
‘Do	you	have	any	questions	about	the	method	you	are	using	/	any	side-effects?’	
• Provide	appropriate	advice	on	side-effects	[see	additional	
information	in	the	Counsellor	Standard	Operating	Procedure	
handbook]	
• If	using	injection,	offer	injection	reminder	
Implant	(2)	 	
Injection	(3)	 	
	
Pill	(4)	 	 ‘Do	you	use	the	pill	every	day	/	are	you	comfortable/fine	with	the	pill	/	any	side-
effects?’	
• Provide	appropriate	advice	on	side-effects	
• Remind	client	pill	only	effective	if	taken	every	day	at	same	time	
• Offer	pill	reminder	
‘Would	you	like	some	information	about	other	effective	long-acting	contraception	
methods?’	(SEE	BELOW)	
	
Condom	(5)	 	 ‘Condom	is	good	for	STI/HIV	prevention’	‘Does	your	partner	use	condoms	every	
time	you	have	intercourse?’	
• Remind	client	condom	only	effective	if	used	correctly	every	time	
‘Would	you	like	some	information	about	other	effective	long-acting	contraception	
methods?’	(SEE	BELOW)	
	
Calendar	(6)	
Withdrawal	(7)	
	 ‘This	is	not	an	effective	method	to	prevent	pregnancy.	You	are	at	risk	of	becoming	
pregnant	again’	
‘Would	you	like	some	information	about	other	effective	long-acting	contraception	
methods?’	(SEE	BELOW)	
	
	
Permanent	(8)	 	 Ask	client	if	they	still	require	voice	messages	
Other	(9)	 	 Please	state:	
No	method	(10)	 	 ‘Is	there	any	reason	why	you	are	not	using	a	method?’	
• Give	same	advice	as	for	calendar/withdrawal		
	
Reason	for	non	use	 Counselling	and	advice	
Want	to	become	pregnant	(1)	 Advice	avoid	pregnancy	for	6	months	
Abstain	(2)	 Ask	reason.	‘When	do	you	think	you	will	need	contraception	
again?’	
Husband/partner	disapprove	(3)	 Ask	reason	e.g.	Uncomfortable	with	coil	/	afraid	of	infertility	
‘Would	you	like	me	to	discuss	with	your	husband?’	
Cost	(4)	 Explain	cost	of	injection	/	IUD	cheap	(especially	compared	to	
abortion)	also	cheap	per	year	
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Distance	(5)	 Long-acting	methods:	one	visit	protects	for	many	years	
Local	provider	e.g.	injection	from	health	centre/private	clinic	
Side	effects/health	concerns	(6)	 Depend	on	method	
Reassure,	refer	to	clinic	or	suggest	other	long-acting	methods	
Lack	of	knowledge	(7)	 Give	information	on	methods	
Other	(8)	 Please	state:	
	
Information	about	long-acting	methods	
“Here	are	some	advantages	of	the	long-acting	methods	(such	as	coil,	implant,	injection,	permanent):		
• They	are	the	most	effective	methods	to	prevent	unplanned	pregnancy	
• Safer	for	your	health	&	cheaper	for	you	rather	than	have	repeat	abortion	
• They	do	not	effect	your	future	fertility’	
• You	don’t	have	to	remember	to	take	it	every	day”	
	
Method	 Advantages	 Availability	
Coil	 Protects	for	10	years,	no	hormone,	normal	
period	
MSI	clinic	>	MSI	
partner	clinic	
Implant	 Protects	3-5	years,	good	for	ladies	any	age	
Injection	 Protects	for	3	months,	one	hormone,	
secret	
MSI	clinic,	HC	
Permanent	
(vasectomy/sterilisation)	
Free,	never	need	contraception,	good	if	
completed	family	
Some	MSI	clinics*	
	
D.	Outcome	of	phone	call	 	
‘So	what	do	you	plan	to	do	for	contraception?’	
Client	will	same	continue	method	(1)	 	 	 	
Client	will	start	new	method(2)	 	 	 	
Client	will	change	method	(3)	 	 Name	of	new	method:	
Client	will	stop	using	current	method	(4)	 	 	 	
Client	plans	to	continue	not	using	a	method	(5)	 	 	 	
	
‘I	would	like	to	confirm	what	I	have	arranged	for	you’	
Pill	or	injection	reminder	(1)	 	 Date:	 	
Refer	to	clinic	for	check	up	(2)	 	 Clinic:																									
Appointment	made	at	clinic	(3)	 	 Clinic:																				Date:	
Additional	follow	up	phone	call(4)	 	 Date:	
Cancel	future	voice	messages/opt	out	(5)	 	 	 	
	 	 	 	
Advice	given	to	someone	other	than	client	 	 Who?:	 	
	
‘You	will	receive	another	voice	message	in	two	weeks	time	and	you	can	press	‘1’	to	request	a	call	from	a	
counsellor	or	‘2’	if	you	are	fine.	If	you	need	to	speak	to	a	counsellor	before	then	you	can	call	the	MOTIF	
service’	
	
	
	
